[[AdvancedFormat]]
[[Block:Block 19]]

    [[Question:Text]]
    [[ID:q4248]]
    <blockquote>
        <p class="text-snippet" data-id="4248">rs2488457, known in the literature as c.-1123C>G, represents a variant in the upstream promoter region of the PTPN22 gene on chromosome 1. In at least some studies and in some populations, the minor allele is linked to slightly increased risk for autoimmune diseases such as Crohn's disease, type-1 diabetes, multiple sclerosis, rheumatoid arthritis, lupus, and celiac disease. No independent role of the -1123 G>C and+2740 A>G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations. Further evidence of a primary, causal association of the PTPN22 620W variant with type 1 diabetes. PTPN22: its role in SLE and autoimmunity. On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population. Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. rs2476601 T allele (R620W) defines high-risk PTPN22 type I diabetes-associated haplotypes with preliminary evidence for an additional protective haplotype. Overview of the Rapid Response data. Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families. The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1. A PTPN22 promoter polymorphism -1123G>C is associated with RA pathogenesis in Chinese. No association of PTPN22 polymorphisms with susceptibility to ocular Behcet's disease in two Chinese Han populations.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1683]]
    <blockquote>
        <p class="text-snippet" data-id="1683">rs1801028 is a SNP in the dopamine D2 receptor DRD2 gene. A meta-analysis comprising 27 samples and over 3,707 schizophrenia patients concluded that Cys/Ser heterozygotes, i.e. rs1801028(C;G) genotypes, were at elevated risk for schizophrenia when compared to either homozygote genotype (rs1801028(C;C) or rs1801028(G;G)). The odds ratio was 1.4 (p<0.005). An earlier meta-analysis comprising over 9,000 schizophrenia patients concluded pretty much the same thing: the Cys311 (rs1801028(G)) allele frequency led to an odds ratio of 1.43 (CI: 1.16-1.78, p<0.001) for this risk allele. A study of ~120 Chinese patients with schizophrenia concluded that Cys/Ser heterozygotes may not respond to risperidone treatment as well as Ser/Ser homozygotes.A paper has been published describing mistakes made in assigning allele status for this SNP:  (free full text) Misassigned alleles can annihilate efforts to control quality in otherwise well-designed genetic association analyses. To date, the issue remains underreported, as is exemplified by studies of a diallelic DRD2 missense variant in schizophrenia. For this variant, allele frequency data have been either misassigned, or incorrectly cited on four consecutive occasions. Contrary to conjecture, low heterozygosity has not guarded against the error with regard to rs1801028, a SNP that features a canonical base pair transversion, G:C.In the case of rs1801028, rs1801028(C) is the more common allele, encoding the amino acid Serine at position 311, whereas rs1801028(G) encodes Cysteine.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q9]]
    <blockquote>
        <p class="text-snippet" data-id="9">rs2230806, also known as Arg219Lys or R219K, is a SNP in the ABCA1 ATP-binding cassette, sub-family A (ABC1), member 1 gene. The rs2230806(G) allele encodes the arginine (R), and the (A) allele encodes the lysine (K).A meta-analysis published in 2011 comprising 22 studies with 6597 cases and 15,369 controls studied the association between the rs2230806 and risk for coronary artery disease. Overall, rs2230806(A) significantly associated with a higher HDL-C level in Asians and does lower the risk (odds ratio 0.76, CI: 0.68-0.85, p=3.78e-07) of coronary artery disease in Asians and Caucasians. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. ABCA1 polymorphisms and Alzheimer's disease. Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms. The effect of ABCA1 gene polymorphisms on ischaemic stroke risk and relationship with lipid profile. Modifier effects between regulatory and protein-coding variation. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. A survey of ABCA1 sequence variation confirms association with dementia. Association of selected ABC gene family single nucleotide polymorphisms with postprandial lipoproteins: results from the population-based Hortega study. ABCA1 gene variants regulate postprandial lipid metabolism in healthy men. Increase in HDL-C concentration by a dietary portfolio with soy protein and soluble fiber is associated with the presence of the ABCA1R230C variant in hyperlipidemic Mexican subjects.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3640]]
    <blockquote>
        <p class="text-snippet" data-id="3640">rs4778241 is part of a haplotype spanning 166kB on chromosome 15, defined by 13 SNPs listed below, found in 97% of all Caucasians with blue eyes. In this haplotype, variations in rs1129038 and rs12913832 are relatively common in Caucasians though rare among other ethnic groups.The "h-1" haplotype found in homozygous state in 97% of individuals with blue eye color is composed as follows :rs4778241(C)<br>rs1129038(A)<br>rs12593929(A)<br>rs12913832(G)  (this appears to be the causative SNP)<br>rs7183877(C)<br>rs3935591(G)<br>rs7170852(A) (this snp seems flipped, or odd)<br>rs2238289(T)<br>rs3940272(C)<br>rs8028689(T)<br>rs2240203(A)<br>rs11631797(G)<br>rs916977(G)<br> A three-single-nucleotide polymorphism haplotype in intron 1 of OCA2 explains most human eye-color variation. Three genome-wide association studies and a linkage analysis identify HERC2 as a human iris color gene. A single SNP in an evolutionary conserved region within intron 86 of the HERC2 gene determines human blue-brown eye color. A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population. Genotyping of five single nucleotide polymorphisms in the OCA2 and HERC2 genes associated with blue-brown eye color in the Japanese population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2653]]
    <blockquote>
        <p class="text-snippet" data-id="2653">rs3813929, also known as -759C/T, is a SNP in the 5-hydroxytryptamine (serotonin) receptor 2C HTR2C gene.A study of 107 patients with schizophrenia being treated with olanzapine reported a protective effect against weight-gain from the (T) allele of this SNP; zero patients (of 28) with a rs3813929(T) allele had a body mass index increase of >=10% (p=0.002), whereas (C;C) homozygotes did. This effect may also involve nearby SNP rs518147. T allele showed borderline significant association with higher BMI and incidence of lifetime depression | major depressive disorder among 4978 persons from the European Prospective Investigation into Cancer (EPIC)-Norfolk study, however, only the association with BMI remained borderline significant within the full EPIC-Norfolk cohort (20,981 persons) The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study. Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia. Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Focus on HTR2C: A possible suggestion for genetic studies of complex disorders. HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study. Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project. Association of polymorphisms of the serotonergic system with smoking initiation in Caucasians. Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction. Functional consequences of two HTR2C polymorphisms associated with antipsychotic-induced weight gain.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2476]]
    <blockquote>
        <p class="text-snippet" data-id="2476">rs2653349, also known as G1246A, is a SNP in the HCRTR2 hypocretin-orexin gene. It has been linked primarily to cluster headaches. The more common allele (G) has been linked to increased risk; alternatively, this could be seen as implying that the less common (A) allele reduces cluster headache risk.In the (first) study, 100+ Italian patients were analyzed to reveal that rs2653349(G;G) genotypes were at 5x increased risk for the disorder, compared with (A;G) and (A;A) genotypes. A study of 200+ German patients indicated that (G;G) homozygotes were at 2x increased risk (CI: 1.32-2.92, p = 0.0007) for cluster headaches.A meta-analysis of 3 pooled studies concluded that the rs2653349(G;G) genotype showed a higher disease risk compared to the remaining genotypes (odds ratio 1.69, CI:1.11-2.58).Not all studies have found this association; a study of Northern Europeans did not find an association.Also, a study has been performed to find out if treatment success for cluster headaches is correlated with rs2653349 genotype. Among 184 Caucasian patients, while the rs2653349(G) allele was significantly associated with cluster headaches, treatment outcomes with triptans, oxygen, verapamil and corticosteroids were not.Independently, a study has been performed to see if rs2653349 might be associated with migraine; in this study at least, the answer was no. The LUCA study, the largest performed meta-analysis couldn't find evidence for an association between rs2653349 and cluster headaches.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4886]]
    <blockquote>
        <p class="text-snippet" data-id="4886">Several tightly linked SNPs in the STAT4 gene have been linked to risk for risk haplotype for systemic lupus erythematosus (SLE). The strongest association is found for either of two perfectly linked SNP alleles, rs10181656(G) and rs7582694(C), both yielding an odds ratio of 1.71 in this study of ~700 Swedish SLE patients.The risk for SLE was also calculated to increase as a function of the total number of risk alleles for this SNP plus 2 others in the IRF5 gene, rs10488631 and a CGGGG indel, rs77571059. Compared to individuals with 0 or 1 risk alleles, the risk for SLE increased 1.82-fold for each additional risk allele from this group. The odds ratio for SLE is 2.08 (CI: 1.53-2.83) for carriers of 2 risk alleles, and goes up to 13.0 (CI: 3.78-44.3) for carriers of 5 or 6 risk alleles (compared to those with 0 or 1). Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren's syndrome. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Variation in STAT4 is associated with systemic lupus erythematosus in a Finnish family cohort. Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn's disease and early disease onset. Association of genetic variations in the STAT4 and IRF7/KIAA1542 regions with systemic lupus erythematosus in a Northern Han Chinese population. A single-nucleotide polymorphism of the STAT4 gene is associated with systemic lupus erythematosus (SLE) in female Chinese population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q395]]
    <blockquote>
        <p class="text-snippet" data-id="395">Conflicting reports of possible small increase in Alzheimer's risk. Currently dubious at best.rs2373115 is one of several SNPs in the GAB2 gene indicating an increased risk (OR 4.1) of late-onset Alzheimer's disease, but apparently only in individuals also carrying ApoE4 alleles, i.e. rs429358(C) alleles  rs2373115 marker does not modify the risk of Alzheimer's disease in Spanish APOE e4 carriers.rs2373115(G) is the risk allele. (p = 9 x 10(-11)) was associated with an odds ratio of 4.06 (confidence interval 2.81-14.69)However, a separate study of 1,749 Alzheimer patients concluded that this GAB2 SNP is "at best a minor genetic determinant" since the authors of this study observed only a slight tendency for an increase of the (G;G) genotype (odds ratio of 1.3 vs (G;T) and (T;T), CI:1.0-1.6, p=0.09) and for an increase in the G allele frequency (odds ratio 1.3, CI:1.0-1.6, p=0.05) in ApoE4-carriers.   A new (Dec 2008) meta-analysis concludes that, yes, indeed, rs2373115 is associated with increased risk for Alzheimer's disease among ApoE4 carriers, with an odds ratio of 1.58 (CI: 1.17 - 2.14, p = 3 x 10e-3), but only among carriers. This meta-analysis pooled published studies with a new study of 443 AD cases. A study of 579 Italian Alzheimer's patients saw this association, but only in ApoE4 non-carriers, suggesting it might be an independent risk factor for the disease.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3241]]
    <blockquote>
        <p class="text-snippet" data-id="3241">SNP rs3025058 was first described in 1995 as a variant upstream of, and influencing the regulation of, the MMP3 gene. Most commonly, the version of this SNP with a run of 5 A's is called the 5A allele, and an allele with 6 A's is called 6A. Thus, the homozygous genotypes are either 5A/5A or 6A/6A, and the heterozygote genotype is published as 5A/6A. Incidentally, the MMP3 gene is also called stromelysin-1, and although there is a SNP in dbSNP in the orientation that shows the polynucleotide run as A's (rs35068180) the entry that has population frequency data is the one discussed here, rs3025058, which is from the other strand and thus shows the string as T's.There have been numerous studies in the last 10+ years linking either the 5A or 6A allele to risk for myocardial infarction or coronary artery disease. A relatively recent meta-analysis combining seven previously published studies concluded that the 5A allele is indeed a plaque-disrupting risk factor (odds ratio 1.26, CI: 1.1 - 1.4, p<0.001), while the 6A allele is associated with greater progression of coronary atherosclerosis and the 6A/6A genotype is associated with a worse progression of coronary artery disease after angioplasty. However, all these studies show a lot of heterogeneity, and gender, age, and ethnicity are all likely to alter the influence of these alleles.  rs1799864(G), rs3025058(A) and rs662 were associated with increased risk, and rs1800775(A) with reduced risk of recurrent venous thromboembolism no influence on varicose veins</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q505]]
    <blockquote>
        <p class="text-snippet" data-id="505">rs28940279, also known as c.854A>C, E285A or p.Glu285Ala, is a SNP in the ASPA gene.rs28940279 is one of several known causal SNPs of Canavan disease. Canavan disease is a degenerative disease of the nervous system. It is a childhood onset disease which begins in early infancy. It is characterized by disordered muscular behavior (e.g., hypotonia, hyperextension) and neurological symptoms, such as blindness, developmental and cognitive delays. The neurological findings appear to be due to demyelination and leukodystrophy. Histology indicates the presence of spongy degeneration; cytology confirms astrocytic swelling of normal neurons and abnormality of astrocyte mitochondria.  Ultimately, sufferers become extremely ill and die on average at 18 months of age.rs28940279 is a SNP in the aspartoacylase ASPA gene.   The A-C transversion results in a substitution of alanine, a hydrophobic small-chain amino acid, for a glutamate (which is both large and charged). This substitution, E285A, is at a residue predicted to be part of the catalytic domain of aspartocyclase. This missense mutation is predicted to have drastic effects on the catalytic domain because of the vast difference between the amino acids.In particular, this substitution is common in Ashkenazi Jews, with carrier frequency approximately 1 in 60 individuals.  This suggests that some degree of founder effect is responsible for its prevalence within the Ashkenazi Jewish population. In particular, one study suspects that the mutation originated in the Vilna area, in Poland or Lithuania depending on the political timeperiod of origin.  This suggests that it is a newer variant than others found in the more broad European population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4927]]
    <blockquote>
        <p class="text-snippet" data-id="4927">suggested the contribution of rs237025 to type-1 diabetes, however in  this failed to replicate.This SNP is also known as Met55Val, M55V, or A163G.This was the first SNP in SNPedia. The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population. SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes. Association study of NFKB1 and SUMO4 polymorphisms in Chinese patients with psoriasis vulgaris. Constructing gene association networks for rheumatoid arthritis using the backward genotype-trait association (BGTA) algorithm. Evaluating gene x gene and gene x smoking interaction in rheumatoid arthritis using candidate genes in GAW15. Case-control association analysis of rheumatoid arthritis with candidate genes using related cases. Analyses of single marker and pairwise effects of candidate loci for rheumatoid arthritis using logistic regression and random forests. Classification of rheumatoid arthritis status with candidate gene and genome-wide single-nucleotide polymorphisms using random forests. Evaluation of a SNP map of 6q24-27 confirms diabetic nephropathy loci and identifies novel associations in type 2 diabetes patients with nephropathy from an African-American population. Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population. Overview of the Rapid Response data. The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1066]]
    <blockquote>
        <p class="text-snippet" data-id="1066">rs1061170 is a SNP in the complement factor H CFH gene; it is also known as Tyr402His or p.Y402H. The rs1061170(T) allele encodes the more common Tyr (Y), while the generally rarer rs1061170(C) encodes the His (H).This SNP has been associated primarily with age related macular degeneration, and to a lesser extent, with longevity.This  research paper shows that CFH Y402H is the relevant mutation. A haplotype of rs1061170 rs3753394 rs800292 rs1329428 (TGTC) was found to confer a significantly increased likelihood of exudative AMD. rs1061170 (aka Y402H 1277 T>C) was not associated with exudative AMD.CFH variations appear to contribute to ARMD in Caucasians, but not in Japanese CFH variant rs1061170 Y402H is strongly associated with both dry and wet AMD rs1061170(C) alleles are significantly associated with increased susceptibility to early AMD in Taiwan Chinese populations.Some SNPs in other genes (like C7 and MBL2) may protect individuals with one or two of the rs1061170(C) risk alleles.  An analysis of the joint effects of rs1061170, rs11200638 and rs10490924 on AMDIn a 4 year study of longevity of 491 nonagenarians in the Finnish Vitality 90+ study, risk factor-adjusted mortality was significantly higher among the rs1061170(C) carriers compared to non-carriers (odds ratio 1.78, CI 1.19-2.67, p = 0.005), and the survival curves of these carriers and non-carriers deviated significantly (p = 0.016). In other words, in this study, rs1061170(T;T) individuals generally lived longer than (C) allele carriers. age related macular degeneration</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1606]]
    <blockquote>
        <p class="text-snippet" data-id="1606">rs70991108 is a polymorphism consisting of a 19-bp deletion in the first intron of the dihydrofolate reductase DHFR gene. The wild-type (non-deletion) allele is a bit more common than the deletion allele in most populations. Several studies have linked this SNP to alterations in folic acid (and folate) metabolism. A study of 1,215 subjects  from the Framingham Offspring Study concluded that rs70991108 influences the prevalence of circulating folic acid levels. Specifically, folic acid intake over 500ug/d led to high circulating (unmetabolized) folic acid levels in subjects homozygous for the deletion genotype. When folic acid intake was under 250ug/d, the deletion/deletion homozygotes had lower RBC folate (732.2 nmol/L) compared with the non-deletion genotype (844.4 nmol/L). A 2-year follow-up study of 122 newly diagnosed patients with acute lymphoblastic leukemia (ALL) found that carriers of a rs70991108 deletion allele were at increased risk for hepatic toxicity from methotrexate treatment. Hepatic toxicity was increased ~2x and ~4.6x for heterozygous and homozygous rs70991108 deletion genotypes, respectively (p=0.05). If a carrier of a rs70991108 deletion allele was also a carrier of a rs1801133(T) allele, the risk for hepatic toxicity was even higher (odds ratio 6.8, p=0.018).Studies have also looked for connections between this SNP and the risk of having a baby born with spina bifida, but the results are inconsistent between studies:  PMID 14735580, PMID 15755837: suggested the del/del genotype increased risk for spina bifida and pre-term delivery  : suggested that the del/del genotype actually reduced risk for spina bifida  : found no connection whatsoever between the del/del genotype and spina bifida risk</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q869]]
    <blockquote>
        <p class="text-snippet" data-id="869">Association between rs2799573 and psychiatric disorders was shown in a 2013 study by the Cross-Disorder Group of the Psychiatric Genomics Consortium . In this study, genome-wide SNP data consisting of 1,250,922 autosomal SNPs were analyzed to identify genetic variants associated with autism spectrum disorder, ADHD, bipolar disorder, major depressive disorder, and schizophrenia. 33,332 cases and 27,888 controls included both unrelated and family-based samples (trios). A multinomial logistic regression procedure was used to identify the best-fitting model of relations between genotype and phenotype. This SNP, on chromosome 10 in an intron of CACNB2, was one of four genome-wide significant signals associated with the five psychiatric disorders (p = 4.29 x 10-8). The risk allele T exhibited allele frequency of 0.715 in controls. CACNB2 encodes a voltage-gated calcium-channel subunit that interacts with other calcium-channel subunits to facilitate their function and increase peak calcium current. Although CACNB2 had not been previously identified as a risk gene for schizophrenia and bipolar disorder, its interactor CACNA1C, was known to be a susceptibility gene for bipolar disorder , schizophrenia, and major depressive disorder . Effects of CACNA1C variants on emotion processing circuitry, attention, and memory were demonstrated in fMRI studies . Consistent with this, one of the four significant signals from the 2013 study lies within an intron of CACNA1C. Other peaks identified in this study were rs2535629 and rs11191454.In addition, a variant within CACNB2 52 kb away from rs2799573 was one of the most significant signals in an independent GWAS of bipolar disorder in Han Chinese. All samples analyzed in the Cross-Disorder Group of the Psychiatric Genomics Consortium study were of European ancestry.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1027]]
    <blockquote>
        <p class="text-snippet" data-id="1027">rs10757274 is a SNP located in chromosomal region 9p21; to date (2009), it is the strongest genetic predictor of early myocardial infarction (heart attack) discovered so far. SNPs in this region are also associated with increased risk of stroke, abdominal aortic aneurysm (AAA), and intracranial aneurysm.Based on a large (20,000+) study primarily of Caucasian females, it appears that on its own, this single SNP does not improve on the discrimination or classification of predicted heart disease risk achieved by traditional risk factors, high-sensitivity C-reactive protein, and a family history of premature myocardial infarction. rs10757274 and rs2383206 can double the risk of heart disease. About one in every four Caucasians are thought to carry the gene variants. rs10757278 in the same region has been linked to diabetes  / blog post  about investigating rs10757274 and rs2383206/ part 2 in the series mentions rs10811661/ part 3 in the series mentions rs1333040, rs2383207 and rs10116277 rs10811661 This SNP was also associated with increased risk for coronary artery disease in a Korean population. Also found to be significant in a study of 416 Italian myocardial infarction patients. A study of 7,893 participants in the Rotterdam Study did '''not''' find any association between rs10757274 and either coronary heart disease or myocardial infarction. rs10757274, rs2383206, rs1333049 haplotype associated with early-onset CHD (p=7.9 x 10(-7)) A study of 492 sudden and/or arrhythmic deaths and 1460 matched controls concluded that each rs10757274(G) allele conferred an odds ratio of about 1.3 for sudden cardiac death (p=0.003-0.001).  Note: odds ratios cited for genotypes are from</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2841]]
    <blockquote>
        <p class="text-snippet" data-id="2841">rs1127354 (Pro32Thr/P32T, 94C>A) is a SNP within the ITPA (Inosine triphosphate pyrophosphatase) gene. (note: rs1127354 supersedes rs41320251) abolishes ITPA activity in homozygous individuals and reduces the activity to 25% in heterozygous subjects, mercaptopurine metabolism (sig. higher methyl mercaptopurine nucleotides levels + higher probability of severe febrile neutropenia in A carriers treated with mercaptopurine) Mutations in the gene encoding the Wnt-signaling component R-spondin 4 (RSPO4) cause autosomal recessive anonychia. Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine. Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate. Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction. ITPA gene variant protects against anemia induced by pegylated interferon-alpha and ribavirin therapy for Japanese patients with chronic hepatitis C. Common genetic polymorphism of ITPA gene affects ribavirin-induced anemia and effect of peg-interferon plus ribavirin therapy. Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C. Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes. Efficacy of splenectomy in preventing anemia in patients with recurrent hepatitis C following liver transplantation is not dependent on inosine triphosphate pyrophosphatase genotype. Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment. Association of ITPA gene polymorphisms and the risk of ribavirin-induced anemia in HIV/hepatitis C virus (HCV)-coinfected patients receiving HCV combination therapy. Comparison of three different methods for the evaluation of IL28 and ITPA polymorphisms in patients infected with HCV.Hepatitis C Treatment Side Effects</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5416]]
    <blockquote>
        <p class="text-snippet" data-id="5416">In a Swiss cohort: "Carriers of KIBRA rs17070145 T allele had 24% better free recall performance 5 min after word presentation (P = 0.000004) and 19% better free recall performance 24 hours after word presentation (P = 0.0008) than did noncarriers."In a US cohort: "T allele carriers had significantly better memory scores than non-carriers in the Buschke's Selective Reminding Test (SRT). Performance on another episodic memory task, the Rey Auditory Verbal Learning Test (AVLT), was also significantly different between allele groups."In another Swiss cohort, with a visual episodic memory task: "T allele carriers also performed significantly better than did noncarriers in this population.""Functional magnetic resonance imaging detected KIBRA allele-dependent differences in hippocampal activations during memory retrieval." Replication in a healthy elderly cohort. Age-dependent association of KIBRA genetic variation and Alzheimer's disease risk. Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study. KIBRA genetic polymorphism influences episodic memory in later life, but does not increase the risk of mild cognitive impairment. Failure to replicate effect of Kibra on human memory in two large cohorts of European origin. Evidence for an association between KIBRA and late-onset Alzheimer's disease. Association of KIBRA and memory. Caspase-1 genetic variation is not associated with Alzheimer's disease risk. KIBRA: A New Gateway to Learning and Memory? Impact of common KIBRA allele on human cognitive functions. The role of memory-related gene polymorphisms, KIBRA and CLSTN2, on replicate memory assessment in the elderly.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2922]]
    <blockquote>
        <p class="text-snippet" data-id="2922">rs9536314, also known as c.1062T>G, p.Phe352Val and F352V, represents a variant in the KL (Klotho) gene on chromosome 13. Together with rs9527025 (C370S), which it co-segregates with, a haplotype ("KL-VS") has been described that is reported to increase klotho secretion and may alter its functions; the alternative haplotype is named KL-FC (due to the F from F352V and C from C370S). The klotho protein is a hormone found primarily in the kidney and choroid plexus of the brain. At the genetic level, the Klotho gene is reported to affect longevity in mice  and perhaps humans , and KL-VS heterozygosity (but not homozygosity) has been associated with greater brain cortical volume . At the protein level, older adults with higher plasma klotho concentrations tend to show lower less decline with age on standardized cognitive tests , adults with higher stress tend to have lower plasma klotho levels , and transgenic mice bred to have excess human amyloid precursor protein (to simulate Alzheimer's disease) score better on some tests when their klotho levels are increased .Most of the studies cited above for studies of klotho in humans should be considered preliminary for at least two reasons: they are not based on large sample sizes, and, they haven't been replicated by independent investigators. In addition, there is a report showing no difference in the klotho plasma levels between FC/FC and FC/VS individuals , as well as a report showing KL-VS heterozygotes had poorer cognitive function than noncarriers , in contrast to the studies cited above. Variation in longevity gene KLOTHO is associated with greater cortical volumes</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2548]]
    <blockquote>
        <p class="text-snippet" data-id="2548">In at least UK populations, and perhaps others, SNP rs2187668 is a tag SNP for the HLA-DRB1 0301 allele.The HLA-DRB1 0301 allele is the allele presenting the highest risk for developing lupus, and it appears to act in a dominant manner (i.e. inheriting 2 copies is no worse than inheriting 1 copy). In dbSNP orientation, the risk allele is rs2187668(A), with an odds ratio of 2.3x (CI: 1.7 - 3.2, permuted p < 0.0001). From individuals with the most common rs2187668(G;G) genotype, risk is reduced for celiac disease, with an odds ratio of 0.30x according to a study of ~800 patients.rs2187668(A) also tags the tightly linked DQB1 0201 allele, which in turn is linked to DQA1 0501; together, these are known as the DQ2.5 haplotype. This is the most common haplotype associated with celiac disease in Europeans. A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Newly identified genetic risk variants for celiac disease related to the immune response. Genome-wide association analysis by lasso penalized logistic regression. No association of multiple type 2 diabetes loci with type 1 diabetes. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. Association of variants in HLA-DQA1-DQB1, PTPN22, INS, and CTLA4 with GAD autoantibodies and insulin secretion in nondiabetic adults of the Botnia Prospective Study.Kidney Disease</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q40]]
    <blockquote>
        <p class="text-snippet" data-id="40">rs4148739 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review , ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not.rs4148739 is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.When treated for depression with citalopram, paroxetine, amitriptyline, or venlafaxine (substrates of the protein encoded by ABCB1), a highly statistically significant association between the overall genetic variability of these SNPs and the remission was reported by Uhr et al in a study of ~400 German inpatients. However, this result has to be treated with caution. A well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis  failed to replicate several Uhr et al. results for other ABCB1 SNPs.The 9 SNPs in the linkage block identified are :  rs2235067  rs4148740  rs2032583  rs4148739  rs11983225  rs2235040  rs12720067  rs7787082  rs10248420</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1228]]
    <blockquote>
        <p class="text-snippet" data-id="1228">risk of the development of substance dependence significantly increased with the number of "G" alleles at rs6454674 and SNP8 (rs806368);T/T genotypes had significant interaction effects (p = .0003 for comorbid drug dependence (DD) and alcohol dependence (AD), .0002 for DD, and .007 for AD). SNP3 and SNP8 together exerted stronger genetic effects on SD (substance dependence) than either did individually. The peak delta values among all the markers were seen for SNP3 and SNP8 (rs806368) rs806368(C) together with rs1049353(A) or rs1049353(G) make up a haplotype associated with PTSD, with the C-A haplotype somewhat associated (p=0.04) with higher risk of PTSD and the C-G haplotype associated (p=0.01) with a lower risk of PTSD. Alcoholic patients with TGT haplotype (corresponding to rs6454674-rs1049353-rs806368 polymorphisms in this order) were less prone to have AD (p = 0.017).TGC haplotype were more likely to develop AD.Impulsivity was significantly associated with the 6-repeat allele of the triplet repeat polymorphism (AATn/A6; p < .0001), as well as four SNPs in or near the CNR1 receptor gene: rs1535255 (p = .001), rs2023239 (p = .004), rs1049353 (p < .001) and rs806368 (p < .0006). These studies provide data to suggest that the CNR1 receptor gene may be significantly associated with impulsivity in SWC Indians. the associations were female specific. Haplotype 1-1-2 of markers rs2023239-rs12720071-rs806368(C) was associated with nicotine dependence and FTND score in the 2 samples (P < .001 and P = .009, respectively).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2524]]
    <blockquote>
        <p class="text-snippet" data-id="2524">rs13266634, also known as c.973C>T or p.Trp325Arg, is a SNP in the zinc transporter protein member 8 SLC30A8 gene that has primarily been associated with type-2 diabetes in several studies. This SNP is also known as the Arg325Trp or R325W variant; the (C) allele encodes the arginine (R), and the (T) allele encodes the tryptophan (W). significantly associated p = 0.0073; in 1,630 Japanese subjects with type-2 diabetes and in 1,064 controlsThe major alleles of the SLC30A8 SNP rs13266634 and the HHEX SNP rs7923837 associate with reduced insulin secretion, but not with insulin resistance.  46% of European non-diabetic offspring of type-2 diabetes patients are rs13266634(C;C) homozygotes; they are diabetes-prone and characterised by a 19% decrease in first-phase insulin release following an intravenous glucose load.  Note: this SNP, rs13266634, is not represented on the Affymetrix 5.0 chip. Since it is also in an area of high recombination, it also lacks a proxy on the Affy chip and thus could not have been detected in the large genome-wide type-2 diabetes study performed by the Wellcome Trust Consortium.  1,638 type-2 diabetes patients and 1,858 controls rs13266634 in SLC30A8 (OR 1.20, 95% CI: 1.09-1.33, p = 3.9 x 10(-4)).  rs13266634(C) allele is associated with younger age of onset of type-1 diabetes This SNP was confirmed to be associated with type-2 diabetes in a study of 500+ Japanese patients plus pooled meta-analysis with 6 previous association studies (also of Japanese)./ spitotoon associated with blood sugar levels (glycated hemoglobin levels) rs13266634(C)</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2480]]
    <blockquote>
        <p class="text-snippet" data-id="2480">rs12913832 is a SNP near the OCA2 gene that may be functionally linked to blue or brown eye color, due to a lowering of promoter activity of the OCA2 gene. Blue eye color is associated with the rs12913832(G;G) genotype.PMID 18172690, PMID 18252222For green versus blue eye color  rs12913832 in OCA2/HERC2 has a score of 51.5 and an estimated allelic OR of 8.43 . The SNP rs1667394 in this same region has an estimated OR of  (4.85&#8211;10.06). rs12913832 is also part of a haplotype spanning 166kB on chromosome 15, defined by 13 SNPs listed below, that is found in 97% of all Caucasians with blue eyes. In this haplotype, variations in rs1129038 and rs12913832 are relatively common in Caucasians though rare among other racial groups. rs12913832-T (brown eye) homozygotes compared to rs12913832-C (blue eye). correlations with skin, eye, and hair color variation.The "h-1" haplotype found in homozygous state in 97% of individuals with blue eye color is composed as follows :rs4778241(C)<br>rs1129038(A)<br>rs12593929(A)<br>rs12913832(G)<br>rs7183877(C)<br>rs3935591(G)<br>rs7170852(A)<br>rs2238289(T)<br>rs3940272(C)<br>rs8028689(T)<br>rs2240203(A)<br>rs11631797(G)<br>rs916977(G)<br> blog coverage A genome-wide association scan in admixed Latin Americans identifies loci influencing facial and scalp hair features</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2009]]
    <blockquote>
        <p class="text-snippet" data-id="2009">rs601338 is found on chromosome 19 in the alpha(1,2)-fucosyltransferase FUT2 gene. The wild-type rs601338(G) encodes the "secretor" (Se) allele, while rs601338(A) encodes the "non-secretor" (se) allele.A study of 115 Swedish adults concluded that rs601338(A;A) homozygotes have genetic immunity to infection by the Norwalk norovirus, a major (and contagious) cause of acute gastroenteritis worldwide among adults.   This illness is also known as "cruise ship gastroenteritis."Being a non-secretor may have other consequences, such as greater susceptibility to infection by influenza viruses and by some types of bacteria. 23andMe discusses these / topics.In some non-Caucasian populations, a different SNP is responsible for non-secretor phenotypes. For example, although the Se allele is absent in Japanese, 15% are non-secretors based on being homozygous for the non-secretor "sej" allele of SNP rs1047781. It also appears to affect the composition of the microbiome , with secretors apparently having higher levels of Bifidobacteria.  Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. Common variants of FUT2 are associated with plasma vitamin B12 levels. Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity. Development of a fingerprinting panel using medically relevant polymorphisms. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Common genetic variation and the control of HIV-1 in humans. Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project. FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection.Norovirus Resistance</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2445]]
    <blockquote>
        <p class="text-snippet" data-id="2445">rs7080536, also known as c.1601G>A, p.Gly534Glu and G534E, is a variant in the HABP2 gene on chromosome 10. Originally noticed in a group of individuals from Marburg, Germany, the rs7080536(A) allele and corresponding variant protein is also known as the Marburg I (MI) variant. The HBAP2 gene may also be referred to as FSAP (Factor VII Activating Protein or Protease) in some texts.The rs7080536(A) allele is associated as a risk factor for several conditions, including:  Carotid stenosis    A study of 800+ individuals found odds ratio of 6.6 CI:1.6 - 27.7.  Clinical stroke   A study of 8,000 individuals concluded that the Marburg I polymorphism was associated with an increased risk of clinical stroke (HR 1.60, CI: 1.13-2.28) and all-cause mortality (HR 1.33, CI: 1.04-1.71).  Venous Thromboembolism (VTE)   In a relatively small study (300 patients, 200 controls), the Marburg I variant was seen as an independent risk factor for VTE (OR 3.5, CI: 1.2-10.0) and  also idiopathic VTE (OR 6.2, CI: 2.0-18.9).   A larger study of ~900 patients determined that the Marburg I variant was associated with the development of deep venous thrombosis (OR 1.65, CI:1.16-2.34) and recurrent thromboembolic events (OR 2.13, CI; 1.35-3.36) OR (95% CI).   Familial Nonmedullary Thyroid cancer   Carriers of a Marburg I variant have about a 2x higher risk for thyroid cancer based on a study of 400+ patients. Functional studies indicated that the HABP2 protein may normally have a tumor-suppressive effect, but the G534E variant results in a loss of that function.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q41]]
    <blockquote>
        <p class="text-snippet" data-id="41">is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review , ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not. rs4148740 is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.When treated for depression with citalopram, paroxetine, amitriptyline, or venlafaxine (substrates of the protein encoded by ABCB1), a highly statistically significant association between the overall genetic variability of these SNPs and the remission was reported by Uhr et al in a study of ~400 German inpatients. However, the result for rs4148740 has to be treated with caution. A well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis  failed to replicate several Uhr et al. results for other ABCB1 SNPs in this block.The 9 SNPs in the linkage block identified are :  rs2235067  rs4148740  rs2032583  rs4148739  rs11983225  rs2235040  rs12720067  rs7787082  rs10248420</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q825]]
    <blockquote>
        <p class="text-snippet" data-id="825">This SNP, located in an intron of the BTBD9 gene, has a variant that is seen somewhat more frequently in individuals with restless legs syndrome. The risk allele is rs3923809(A); carriers of two such alleles, i.e. those with rs3923809(A;A) genotypes, are estimated to be 1.9 fold more likely to have restless legs syndrome than rs3923809(G;G) individuals. The authors of this study suggest that perhaps half of the cases of restless legs syndrome may involve the rs3923809 risk genotypes. Consistent with this finding, another report about rs3923809 links the (G) minor allele to a lower frequency of restless legs syndrome with an overall odds ratio of 0.57 (CI: 0.48-0.68). Note that 70-80% of all individuals in European populations carry one or two copies of the (A) major allele, yet restless legs syndrome is thought to affect less than 10% of all adults. Therefore, although an individual may be at higher risk based on their genotype, the genotype by itself certainly isn't able to predictably cause restless legs syndrome.The association between rs3923809 and RLS has been replicated in three European populations, and shows the most consistent effect across populations of several SNPs studied.The results of a 2013 study of Korean patients suggest that the role of BTBD9 in the pathogenesis of restless legs syndrome is more universal across populations than previously reported and more efforts should be focused on the role of epistasis in the genetic architecture of restless legs syndrome. A significant association was found for rs3923809 and rs9296249 in BTBD9.   Association of restless legs syndrome variants in Korean patients with restless legs syndrome.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q42]]
    <blockquote>
        <p class="text-snippet" data-id="42">rs7787082 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review , ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not.  rs7787082 is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.When treated for depression with citalopram, paroxetine, amitriptyline, or venlafaxine (substrates of the protein encoded by ABCB1), a highly statistically significant association between the overall genetic variability of these SNPs and the remission was reported by Uhr et al in a study of ~400 German inpatients. However, the result for rs7787082 has to be treated with caution. A well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis  failed to replicate several Uhr et al. results for other ABCB1 SNPs in this block.The 9 SNPs in the linkage block identified are :  rs2235067  rs4148740  rs2032583  rs4148739  rs11983225  rs2235040  rs12720067  rs7787082  rs10248420</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1567]]
    <blockquote>
        <p class="text-snippet" data-id="1567">rs1611115 (C-1021T) is a SNP near the dopamine beta-hydroxylase (DBH) gene.per OMIM, the T allele is associated with lower DBH expression in plasma (16 of TT genotype had DBH activity of 4.1, 46 of CT genotype had DBH activity of 25.2, and 112 of CC genotype had DBH activity of 48.1 nmol/min/ml)Association tests related to affective disorders such as ADHD were performed using four independent samples, healthy volunteers (N = 387), patients with affective disorders (N = 182), adult attention deficit hyperactivity disorder (ADHD) patients (N = 407), and patients with personality disorders (N = 637). Personality disorder patients carrying the DBH TT genotype exhibited higher neuroticism and novelty seeking scores as compared to individuals with the (C;C) or (C;T) genotype. Analyses on the level of the neuroticism and novelty seeking subscales revealed that the DBH (T;T) genotype was primarily associated with personality features related to impulsiveness and aggressive hostility. Also adult ADHD patients carrying the homozygous (T;T) genotypes displayed by significantly increased neuroticism scores; when both personality disorder and adult ADHD patient were analyzed together, (T;T) carriers also displayed by significantly lower conscientiousness levels. This study concludes that rs1611115(T;T) homozygotes appear to be at increased risk for personality traits related to impulsiveness, aggression, and adult ADHD. Dopamine-beta-hydroxylase in postural tachycardia syndrome. T allele associated with lower plasma DBH levels, and accounts for up to 52% of variation in plasma DBH, but not linked to increased susceptibility to postural tachycardia syndrome (POTS).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q849]]
    <blockquote>
        <p class="text-snippet" data-id="849">This SNP, along with SNPs rs660895 and rs3817964, is a tag SNP for the HLA-DRB1 0401 allele.The HLA-DRB1 0401 allele has been associated with higher risk for rheumatoid arthritis, and in particular, rheumatoid vasculitis. The association is seen particularly for individuals carrying two copies of, i.e. homozygous for, the allele. The reported odds ratio for rs6910071(G;G) homozygotes is 6.2 (CI: 1.01 - 37.9).The risk for rheumatoid arthritis may be higher for individuals carrying one copy (one "dose") of the HLA-DRB1 0401 allele, if they also carry a different HLA-DRB1 risk allele. In particular,  0401/ 0404 individuals are reported to have an odds ratio for rheumatoid vasculitis of 4.1 (CI: 1.1 - 16.2), and  0401/ 0101 individuals have an odds ratio of 4.0 (CI: 1.4 - 11.6).  rs6910071 was found to be associated with rheumatoid arthritis based on a study by the eMERGE network in which electronic medical records were searched to find clinical associations associated with selected SNPs. A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. A principal-components-based clustering method to identify multiple variants associated with rheumatoid arthritis and arthritis-related autoantibodies. Elastic-net regularization approaches for genome-wide association studies of rheumatoid arthritis. Genome-wide analysis of haplotype interaction for the data from the North American Rheumatoid Arthritis Consortium. A genome-wide association scan for rheumatoid arthritis data by Hotelling's T2 tests. A two-stage search strategy for detecting multiple loci associated with rheumatoid arthritis. Assessment of gene-covariate interactions by incorporating covariates into association mapping. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1987]]
    <blockquote>
        <p class="text-snippet" data-id="1987">rs1421085 is a SNP located in the first intron of the FTO (fat mass and obesity associated) gene on chromosome 16. This SNP showed the most association with obesity in the original work by Dina et al .  The rs1421085 T-to- C single-nucleotide alteration underlies the association between FTO and obesity by disrupting ARID5B-mediated repression of IRX3 and IRX5. This disruption leads to a developmental shift from browning to whitening programs and loss of mitochondrial thermogenesisWithin the FTO gene, many SNPs appear to be co-inherited. The SNP showing the strongest association with body weight (i.e. body mass index, BMI) is not rs1421085, although this SNP is one of co-inherited SNPs in the FTO gene region. For more information, refer to the FTO gene or the most studied of FTO SNPs, rs9930506. However, in one study of 583 extremely obese women with several FTO SNPs, the strongest association was indeed with rs1421085 (p=3.04x10<sup>-10</sup>, OR = 1.75, CI: 1.47-2.08).  Note: The three FTO SNPs, rs1421085, rs17817449, and rs9939609, are in strong linkage disequilibrium (pairwise r<sup>2</sup>>0.97), and there are two primary haplotypes, C-G-A (42.0 %) and T-T-T (55.5 %).  This SNP is also associated with adult obesity in Mexicans. rs17782313(C) more snacking, however rs1421085(C) did not influence eating behavior rs1421085(C) and rs17817449(G) significantly associated with increased BMI. Our results suggest that FTO may be one of the worldwide obesity-risk genes. Genetic associations with traits in 23andMe customers. 23andMe White Paper.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q31]]
    <blockquote>
        <p class="text-snippet" data-id="31">rs12720067 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review , ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not. rs12720067 is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.When treated for depression with citalopram, paroxetine, amitriptyline, or venlafaxine (substrates of the protein encoded by ABCB1), a highly statistically significant association between the overall genetic variability of these SNPs and the remission was reported by Uhr et al in a study of ~400 German inpatients. However, the result for rs12720067 has to be treated with caution. A large (900 subjects) well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis  failed to replicate several Uhr et al. results for other ABCB1 SNPs in this block.The 9 SNPs in the linkage block identified are :  rs2235067  rs4148740  rs2032583  rs4148739  rs11983225  rs2235040  rs12720067  rs7787082  rs10248420</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2732]]
    <blockquote>
        <p class="text-snippet" data-id="2732">rs1143634, also known as +3954, is a SNP in the IL-1 beta IL1B gene.A study of 556 adults in the Western Australian coronary heart disease (CHD) population concluded that rs1143634(T;T) homozygotes had larger waist circumference, by 1.8cm on average, compared to major allele (C;C) homozygotes. This association was even more pronounced in patients with higher levels of obesity or inflammatory markers.rs1143634 increases susceptibility to Alopecia Areata 2.67 times for heterozygotes (CT) and 1.13 times for homozygotes (TT) rs1143634 increases susceptibility to Alzheimer's disease 2.33 times for homozygotes (TT) rs1143634 increases susceptibility to Cervical lesions, low-grade squamous intraepithelial lesions 4.29 times for heterozygotes (CT) and 3.57 times for homozygotes (TT) rs1143634 increases susceptibility to Duodenal ulcer 1.14 times for carriers of the T allele rs1143634 increases susceptibility to Inflammatory bowel disease 7.32 times for carriers of the T allele rs1143634 increases susceptibility to Joint destruction in Rheumatoid Arthritis 1.70 times for carriers of the T allele rs1143634 increases susceptibility to Myasthenia gravis 1.29 times for heterozygotes (CT) and 4.63 times for homozygotes (TT) rs1143634 increases susceptibility to Nephropathy in Type I Diabetes 2.03 times for heterozygotes (CT) and 5.01 times for homozygotes (TT) rs1143634 increases susceptibility to Peptic ulcer disease 1.06 times for carriers of the T allele rs1143634 increases susceptibility to Periodontitis 2.85 times for heterozygotes (CT) and 4.89 times for homozygotes (TT) rs1143634 increases susceptibility to Periodontitis 3.33 times for carriers of the T allele rs1143634 increases susceptibility to Survival in pancreatic cancer for carriers of the T allele rs1143634 increases susceptibility to Ulcerative colitis 1.89 times for heterozygotes (CT) and 1.59 times for homozygotes (TT)</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1227]]
    <blockquote>
        <p class="text-snippet" data-id="1227">risk of the development of substance dependence significantly increased with the number of "G" alleles at rs6454674 and SNP8;T/T genotypes had significant interaction effects (p = .0003 for comorbid DD and AD, .0002 for DD, and .007 for AD). SNP3 and SNP8 together exerted stronger genetic effects on SD than either did individually. The peak delta values among all the markers were seen for SNP3 and SNP8 (rs806368)rs806377(C) together with rs6454674(G) make up a haplotype associated (p=0.008) with higher risk of ADHD. In addition, the haplotype was more associated (p=0.03) with ADHD in males than in females with the risk haplotype.  Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. No association of CNR1 gene variations with susceptibility to schizophrenia. Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations. Cannabinoid receptor 1 gene association with nicotine dependence. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Candidate genes for cannabis use disorders: findings, challenges and directions. The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults. The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects. Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women? Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women. Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2764]]
    <blockquote>
        <p class="text-snippet" data-id="2764">rs2104286 has also been reported in a large study to be associated with type-1 diabetes.The risk allele (oriented to the dbSNP entry) is (A); the odds ratio associated with heterozygotes is 1.30 (CI 1.02-1.65), and for homozygotes, 1.57 (CI 1.25-1.99). The same (A) allele of rs2104286, which is located in the first intron of the IL2RA gene, was calculated to confer a slight increase (19%) in the risk of developing multiple sclerosis. PMID tbd;  NEJM 357, 29 July 2007, DA Hafler et al.Note that the (A) allele is the most common at this position in all known populations. blog post giving perspective on the significance of this SNP with respect to multiple sclerosis news announcement rs2104286 was significantly associated with UK cases of juvenile idiopathic arthritis (JIA)(allelic odds ratio = 0.76, CI: 0.66-0.88, trend p=0.0002), and the association was strongest in a cohort of patients with oligoarthritis, the most common subtype of JIA. This SNP was most strongly associated with female patients and those positive for antinuclear antibodies. Genotype data for SNP rs2104286 for controls was combined with the data for that SNP obtained from a genome-wide association study (WTCCC GWA), giving a total control sample size of 6787. This association with rs2104286 was replicated in a second study cohort of JIA cases from the USA (odds ratio 0.84, CI: 0.65-1.0, trend p=0.05). Meta-analysis of the two cohorts yielded highly significant evidence for association (odds ratio 0.76, CI: 0.62-0.88, p-value 4.9 x 10<sup>-6</sup>). plos rs12722489 and rs2104286 influence multiple sclerosis and type-1 diabetes</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4700]]
    <blockquote>
        <p class="text-snippet" data-id="4700">rs27072, a SNP in the dopamine transporter SLC6A3 gene, has been associated with more severe symptoms upon alcohol withdrawal, such as seizures, in a study of 250 Caucasian alcohol-dependent patients. Two haplotypes appear to be tagged by this SNP and a neighbor, rs27048.  The rs27072 polymorphism has been shown to be significantly associated with ADHD in clinical samples of Canadian children aged 6 to 16 Feng et al., 2005 and  the significant association was also reported by Ouellet-Morin et al. in a Canadian twin study, 2008 (Am. J. of Medical Genetics Part B, 147B:1442-1449 (2008). The interaction between the dopamine transporter gene and age at onset in relation to tobacco and alcohol use among 19-year-olds.Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese.Dopamine Transporter Gene Variant Affecting Expression in Human Brain is Associated with Bipolar Disorder.Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD).Association of the dopamine transporter gene and ADHD symptoms in a Canadian population-based sample of same-age twins.Candidate gene studies of ADHD: a meta-analytic review. Association between polymorphism of the dopamine transporter gene and early smoking onset: an interaction risk on nicotine dependence. Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers. Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene. Haplotypes of dopamine and serotonin transporter genes are associated with antisocial personality disorder in alcoholics. Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia. The role of dopamine transporter (SLC6A3) and dopamine D2 receptor/ankyrin repeat and kinase domain containing 1 (DRD2/ANKK1) gene polymorphisms in personality traits.Alcohol Dependence</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2231]]
    <blockquote>
        <p class="text-snippet" data-id="2231">see rs2282679, a near-perfect proxy for rs4588rs4588(C), the more common allele in most populations, encodes a threonine (Thr) at position 436 in the vitamin D binding protein (VDBP); in older literature, this is numbered as position 420.rs4588(A), the rarer allele, encodes a lysine (Lys) at this position.see discussion at the GC gene for how rs4588 and rs7041 together define three forms of the VDB protein Gene-environment interaction effects on the development of immune responses in the 1st year of life. The genetics of chronic obstructive pulmonary disease. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach. Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health Study. A candidate gene association study of 77 polymorphisms in migraine. An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: The Women's Genome Health Study. Associations between common variants in GC and DHCR7/NADSYN1 and vitamin D concentration in Chinese Hans. Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5192]]
    <blockquote>
        <p class="text-snippet" data-id="5192">rs13225917 represents a relatively rare SNP tested by the 23andMe v3 chip. Due to its rarity, its effects have not and likely won't be determined through GWAS surveys. In HapMap populations, it's most common among Mexicans and Japanese occurring on the dominant European haplotype, and no homozygous A-allele carriers exist in HapMap, OpenSNP or 1000 Genomes, though this might be due to the overall rarity of the rs13225917(A) allele. The mutation causes an aspartate (D) to asparagine (N) change at position 310 (D310N, p.Asp310Asn) in the Tetratricopeptide repeat protein 26 (TTC26), which might (or might not) result in a damaging missense variant. The protein is IFT complex B protein, also known as DYF13 in nematodes, and it has a proposed function-dependent name of IFT56.TTC26 is thought to play a critical role in ciliogenesis and normal cilia (cellular "hairs") function, as determined by protein similarity, and it is highly conserved between ciliated species studied. In studies on Zebrafish, disabling the gene prevented normal development of photoreceptor sensory and other cilia. The protein is necessary for assembly of full length cilia, although the effect (if any) of rs13225917 on its functioning has not been determined. One publication  speculates that this protein may play a role in Inherited Retinal Degeneration and so screening for TTC26 mutations in human ciliopathy|ciliopathies could be warranted, but to date there is no evidence supporting rs13225917 as a mutation of any consequence. TTC26/DYF13 is an intraflagellar transport protein required for transport of motility-related proteins into flagella. Knockdown of ttc26 disrupts ciliogenesis of the photoreceptor cells and the pronephros in zebrafish. The tetratricopeptide repeat: a structural motif mediating protein-protein interactions.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q228]]
    <blockquote>
        <p class="text-snippet" data-id="228">rs5051 is a SNP in the promoter of the angiotensin AGT gene, and presumably due to it's tight linkage with rs699, the rs5051(T) allele - as oriented to the dbSNP entry, not as published - has been associated with increased risk for hypertension and complications thereof. rs5051(T) is associated with higher plasma angiotensinogen levels, and therefore the increased risk of essential hypertension. The frequency of the rs5051(T) allele is also generally higher in African populations compared to Caucasian populations, correlating to the higher incidence of hypertension in African population.rs5051 is also known as "A-6G"; the "A" allele when referred to using this nomenclature is rs5051(T), and the "G" allele is rs5051(C). For more details, see rs699.rs5051(T;T) homozygotes have been reported to be at increased risk for Crohn's disease, as based on one cohort of ~350 Australian patients. The odds ratio was 2.38 (CI: 1.32-4.32, p=0.007). The authors suggest that association of an AGT SNP with Crohn's disease supports a potential role for angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of Crohn's disease. A population association study of angiotensinogen polymorphisms and haplotypes with left ventricular phenotypes. Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis. An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3. Disease-associated mutations that alter the RNA structural ensemble. Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q218]]
    <blockquote>
        <p class="text-snippet" data-id="218">Several susceptibilities have been linked to rs1042714, a SNP in the ADRB2 gene that is also known as the Q27E SNP. The rs1042714(C) allele encodes the glutamine (Gln; "Q"), and the rs1042714(G) allele encodes the glutamic acid (Glu; "E").A study of 304 patients found that the Glu27 allele led to increased risk for idiopathic venous thromboembolism; the reported odds ratio was 1.40 (CI: 1.09-1.79, p=0.006) for carriers of at least one risk allele.A study of 334 families with at least one child with autism found that increased risk associated with the rs1042714(G;G) homozygous genotype; the odds ratio reported was between 1.33-1.60 (CI: 1.07-2.58). The risk was approximately doubled among mothers who had clinical markers for pregnancy related stress. In a study of 342 patients with type-2 diabetes, the rs1042714(G;G) genotype was associated with reduced risk compared to carriers of a rs1042714(C) allele, with an odds ratio of 0.56 (CI: 0.36-0.91).A study of 294 Italian ischemic stroke patients found increased risk associated with the rs1042714(G;G) genotype, with an odds ratio of 1.68 (CI: 1.17-2.41, p=0.005).A large study of almost 8,000 patients found no consistent evidence for association with obesity, type-2 diabetes or hypertension, however, there was some association between the rs1042714(G) allele and systolic blood pressure.Among 215 adults treated with topical beta-blockers to reduce intraocular pressure (IOP), rs1042714(C;C) genotypes were significantly more likely to experience a (desirable) IOP decrease of 20% or more (odds ratio 2.00, CI: 1.00-4.02).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q30]]
    <blockquote>
        <p class="text-snippet" data-id="30">rs11983225 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review , ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not. rs11983225 is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.When treated for depression with citalopram, paroxetine, amitriptyline, or venlafaxine (substrates of the protein encoded by ABCB1), a highly statistically significant association between the overall genetic variability of these SNPs and the remission was reported by Uhr et al in a study of ~400 German inpatients. However, the result for rs11983225 has to be treated with caution. A well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis  failed to replicate several Uhr et al. results for other ABCB1 SNPs in this block.The 9 SNPs in the linkage block identified are :  rs2235067  rs4148740  rs2032583  rs4148739  rs11983225  rs2235040  rs12720067  rs7787082  rs10248420 Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q27]]
    <blockquote>
        <p class="text-snippet" data-id="27">rs10248420 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review , ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not. rs10248420 is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.When treated for depression with citalopram, paroxetine, amitriptyline, or venlafaxine (substrates of the protein encoded by ABCB1), a highly statistically significant association between the overall genetic variability of these SNPs and remission was reported by Uhr et al in a study of ~400 German inpatients.. However, this result has to be treated with caution. A well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis  failed to replicate several Uhr et al. results for other ABCB1 SNPs.The 9 SNPs in the linkage block identified are :  rs2235067  rs4148740  rs2032583  rs4148739  rs11983225  rs2235040  rs12720067  rs7787082  rs10248420 rs10248420 and rs2032583 associated with colonic disease Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5056]]
    <blockquote>
        <p class="text-snippet" data-id="5056">rs2230926, also known as c.380T>G, p.Phe127Cys and F127C, is a SNP in the TNFAIP3 gene on chromosome 6. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3) gene encodes the A20 protein, a key molecule in numerous immunologic and other processes due to it's role in controlling  NF-B activation.Meta-analysis found 1.4x risk of rheumatoid arthritis for rs2230926(G;G) An association was found between Systemic lupus erythematosus (SLE) and rs2230926.Three independent SNPs in the TNFAIP3 region (rs13192841, rs2230926 and rs6922466) are associated with systemic lupus erythematosus (SLE) among individuals of European ancestry.In Sjgren's syndrome patients, the rs2230926(G) allele more than doubles the risk of primary Sjogren's Syndrome-associated Non-Hodgkin Lymphoma, according to a study which replicated the initial report in both UK and French patient cohorts of ~500 patients. The meta-analysis of the UK and French cohorts confirmed the initial finding, with odds ratios of 2.48 (CI: 1.87 - 3.28, p=0.0037) and 2.60, (CI: 1.91 - 3.53, p=0.0031), respectively. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Complex genetic association of 6q23 with autoimmune rheumatic conditions. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases. TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis. Associations between TNFAIP3 gene polymorphisms and rheumatoid arthritis: a meta-analysis.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5147]]
    <blockquote>
        <p class="text-snippet" data-id="5147">rs10818488, a SNP located in between the C5 and TRAF1 genes, was identified as the SNP from this region showing maximal association with rheumatoid arthritis in a study of ~2000 Dutch, Swedish, and American patients. This study also reported that this SNP was significantly (p = 0.008) associated with increased disease progression as determined by radiographic damage over time in rheumatoid arthritis patients. The risk allele for rs10818488 is the minor allele, (A). If (and as) reported from just the Dutch RA patients, the odds ratio associated with rs10818488(A;G) heterozygotes is 1.38 (CI 1.04-1.83, p = 0.027) and with rs10818488(A;A) homozygotes 2.06 (95% CI 1.42-2.98, p = 1.29E-3). Combining data from all 2,000 patients, the odds ratio associated with rs10818488(A) is 1.26 (CI 1.15-1.37, pcombined = 1.40E-8) with a  population attributable fraction (or risk) of 6.1% (CI 4.0-8.5).A study of RA patients from Crete also found that the rs10818488(A) allele represented increased risk for rheumatoid arthritis.A further study of 1,356 western Europeans confirmed the association between the rs10818488(A) allele and rheumatoid arthritis, finding that individuals with this allele have a 1.2x increased risk for the disease (CI: 1.04-1.5). The rs10818488(A) allele was associated with the susceptibility to rheumatoid factor-negative polyarthritis with an 11% increase in allele frequency (OR 1.54, CI: 1.09 to 2.18, p = 0.012) in a study of 338 Caucasian patients with juvenile idiopathic arthritis.Note that rs10818488 is reported to be in complete (100%) linkage disequilibrium with rs2416808, in other words, the genotype of one perfectly predicts the other.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q37]]
    <blockquote>
        <p class="text-snippet" data-id="37">rs2235067 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review , ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not.rs2235067 is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.When treated for depression with citalopram, paroxetine, amitriptyline, or venlafaxine (substrates of the protein encoded by ABCB1), a highly statistically significant association between the overall genetic variability of these SNPs and the remission was reported by Uhr et al in a study of ~400 German inpatients. However, the result for rs2235067  has to be treated with caution. A well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis  failed to replicate several Uhr et al. results for other ABCB1 SNPs in this block.The 9 SNPs in the linkage block identified are :  rs2235067  rs4148740  rs2032583  rs4148739  rs11983225  rs2235040  rs12720067  rs7787082  rs10248420 ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4967]]
    <blockquote>
        <p class="text-snippet" data-id="4967">rs1801198, also known as c.776G>C, p.Arg259Pro and R259P, is a common variant in the TCN2 gene on chromosome 22. Note that in older (pre-2003) literature this variant was known as c.775G>C.A relatively small study published in 2016 of ~170 adults over 60 years of age concluded that rs1801198(G;G) individuals have significantly (~3x) higher risk  of peripheral neuropathy, even with a normal vitamin B-12 status, and especially if their folate intake is >800 micrograms/day (i.e. 2 times the Recommended Dietary Allowance, with a reported OR of 6.9, CI:1.31- 36.36). In other words, excess folate (including folic acid) is more likely to lead to a burning, tingling or numbness in the hands and feets of older adults who happen to be rs1801198(G;G) genotypes. There was no difference in neuropathy risk between genotypes when folate intake was less than 800 micrograms per day; overall, the odds of neuropathy were 3-fold higher for GG genotypes than for CC genotypes (OR 3.33, CI: 1.15-9.64). Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environmental influence on the worldwide prevalence of a 776C->G variant in the transcobalamin gene (TCN2). Folate and one-carbon metabolism gene polymorphisms and their associations with oral facial clefts. Folate-related gene polymorphisms as risk factors for cleft lip and cleft palate. Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer. Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects. Polymorphic variants of genes involved in homocysteine metabolism in celiac disease. Folate and choline metabolism gene variants in relation to ovarian cancer risk in the Polish population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3218]]
    <blockquote>
        <p class="text-snippet" data-id="3218">rs1051792, also known as MICA-129, Val129Met and V129M, is a G>A transition at residue 129 of the MHC class I polypeptide-related sequence A MICA gene.It has been found in the same training cohort as above that the A allele in the patient and the donor (p=0.066 and 0.013) is associated with a reduced overall survival and an increased risk of relapse (p=0.007 and p=0.003). According to these results, the presence of the G allele in the patient associated with the incidence of cGvHD (p=0.002) and patients homozygous to the A allele had an increased risk of relapse (p=0.02). In contrast to HLA-E molecules, which are ligands for inhibitory NK receptors, MICA is ligand for activating NKG2D receptors. Patient who are homozygous for a valine at residue 129 of MICA are at higher risk of chronic GvHD after HLA-matched sibling HCT in comparison to patient who have a methionine at this position. This risk was independent of acute GvHD, suggesting that the residue 129 play a role in alloimmune responses and thus maybe protective against GvHD, (Boukouaci W, et al. 2009). MICA mismatching between patient and donor has a great influence on the clinical outcome because of the fact that MICA is polymorphic with over 84 recognized unique alleles (). According to two studies done to evaluate the role of mismatching MICA genes and risk of acute GvHD, it was shown that MICA mismatching was associated with an increased risk of grades II-IV acute GvHD but not grades III-IV acute GvHD in both HLA matched and mismatched transplant, and that was correlated notably with the GvHD of the GI tract (P=0.05). (Parmar S, et al. 2009), (Anderson E, et al.  2009).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q908]]
    <blockquote>
        <p class="text-snippet" data-id="908">The rs3087243 SNP is also known in the literature as the CT60 G>A or the +6230G>A polymorphism, and it is located in the CTLA4 gene. In Asian (Japanese) populations, the presence of an rs3087243(G) allele represents a 1.3 fold increased risk of autoimmune thyroid disease, and for those with autoimmune thyroid disease, a 1.5 fold increased risk of type-1 diabetes. However, in individuals without autoimmune thyroid disease, no association was seen between this SNP and type-1 diabetes. The authors speculate that earlier studies may have reported associations between this SNP and type-1 diabetes that were actually primarily based on the association with autoimmune thyroid disease.This same SNP, rs3087243, has also been implicated as a (minor) risk factor for developing rheumatoid arthritis (RA). A study of 2,000+ European RA patients led to a calculated odds ratio of 1.13 (CI: 1.03 - 1.24) for the rs3087243(G) risk allele. In a study of 395 Spanish patients with lupus, rs3087243(G) allele carriers were calculated to have an odds ratio of 1.71 (CI: 1.18-2.49, p=0.003, p(corr) = 0.006).In a different study involving recipients of liver transplants, although also with Spanish patients, the rs3087243(G) allele was significantly associated with acute rejection (odds ratio 1.49, p(corr)=0.038). Patients who lacked this allele had the lowest risk of acute rejection development. Allograft survival data did not show statistical differences between genotypes.  rs2292399 and rs2903692 both significantly associated with type 1 diabetes odds ratio 1.37 and 1.28. A joint analysis revealed that rs3087243, rs2292399, and rs2903692, but not INS rs689, were significant risk factors for the cooccurrence of AITD</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1440]]
    <blockquote>
        <p class="text-snippet" data-id="1440">This is a CYP2C8 SNP. The CYP2C8 3 allele is mapped to both rs10509681 and rs11572080). In a 2009 article titled "Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?" It is claimed that individuals carrying minor alleles of this SNP (usually heterozygotes, since minor homozygotes are rare) may show increased risk of developing acute gastrointestinal bleeding during the use of NSAIDs that are CYP2C8 or CYP2C9 substrates, such as aceclofenac, celecoxib, diclofenac, ibuprofen, indomethazine, lornoxicam, meloxicam, naproxen, piroxicam, tenoxicam and valdecoxib. In a 2008 article (reviewed in ) titled "Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding," the study discovered that carriers of CYP2C8 3 (a minor allele of both rs10509681 and rs11572080) had a GI bleeding event risk OR=1.81 (95% CI=0.953.46; P=0.071) and risk increased if carriers drank more than 20g alcohol/day to an OR=1.99 (95% CI=1.063.74; P=0.034). As CYP2C8 3 and CYP2C9 2 rs1799853 variant alleles are in linkage disequilibrium, patients are likely to carry the risk allele to both 8 3 and 9 2, and when they do, The OR (95% CI) for carriers of such a genotype is increased to 1.94 (1.133.33), P=0.017.   A 2013 NIH review titled "PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8" reiterated that "some data suggest that the combined presence of minor risk alleles CYP2C8 3 (rs10509681 and rs11572080) and CYP2C9 2 rs1799853 is a determinant of NSAID-induced gastrointestinal bleeding." They cited .</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1161]]
    <blockquote>
        <p class="text-snippet" data-id="1161">identifies a region associated with nicotine dependence in this particular study (1,050 dependents, 879 non-dependent controls, all of European descent), noted as distinct from the loci which rs16969968 defines Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Variants in nicotinic receptors and risk for nicotine dependence. Systematic biological prioritization after a genome-wide association study: an application to nicotine dependence. Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with 'pleasurable buzz' during early experimentation with smoking. Nicotinic receptor gene variants influence susceptibility to heavy smoking. A testable prognostic model of nicotine dependence. Genome-wide and candidate gene association study of cigarette smoking behaviors. Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Associations of variants in CHRNA5/A3/B4 gene cluster with smoking behaviors in a Korean population. Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance. Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers. Single nucleotide polymorphisms in CHRNA5 rs16969968, CHRNA3 rs578776, and LOC123688 rs8034191 are associated with heaviness of smoking in women in Northeastern Ontario, Canada. Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC. Analysis of detailed phenotype profiles reveals CHRNA5-CHRNA3-CHRNB4 gene cluster association with several nicotine dependence traits.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3951]]
    <blockquote>
        <p class="text-snippet" data-id="3951">"We studied a population-based sample of Caribbean-origin Hispanics (n = 920, aged 45-74 y) living in the Boston area. Obesity measures (waist and hip circumference, BMI) did not differ between GG subjects and carriers of the A allele (GA and AA). In multivariate linear regression models, we found a significant interaction between complex carbohydrate intake as a continuous variable and PLIN 11482 G > A genotype for waist circumference (P = 0.002). By dichotomizing complex carbohydrate intake, we found significantly different effects across PLIN 11482G > A genotypes. When complex carbohydrate intake was <144 g/d, waist circumference was larger in PLIN 11482G > A carriers (P = 0.024). Conversely, when complex carbohydrate intake was >/=144 g/d, waist and hip circumferences were less in PLIN 11482G > A carriers (P < 0.05). These interactions were not found for simple sugars or total carbohydrates. In subjects with higher complex carbohydrate intake, the minor allele was protective against obesity, whereas in subjects with lower carbohydrate intake, the minor allele was associated with increased obesity."  Study of the impact of perilipin polymorphisms in a French population. Common variations in perilipin gene, central obesity, and risk of type 2 diabetes in US women. Effects of perilipin (PLIN) gene variation on metabolic syndrome risk and weight loss in obese children and adolescents. PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Relationship between perilipin gene polymorphisms and body weight and body composition during weight loss and weight maintenance. Perilipin polymorphism interacts with saturated fat and carbohydrates to modulate insulin resistance. Preliminary findings on the role of PLIN1 polymorphisms on body composition and energy metabolism response to energy restriction in obese women.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1973]]
    <blockquote>
        <p class="text-snippet" data-id="1973">A study of 5 genes in 3,741 Japanese men, some of whom lived significantly longer than average (centarians), concluded that the FOXO3 gene (also known as FOXO3A) harbors several SNPs linked to longevity, including this SNP, rs2802292, as well as rs2764264 and rs13217795.   The odds ratio for rs2802292(G;G) vs (T;T) carriers was 2.75 (p = 0.00009; adjusted p = 0.00135). It is not known yet if this correlation is specific to Japanese males.This is discussed extensively at  geneticfuture as a longevity snp. (T) shorter lifespan (G) longer lifespanQuoted from the geneticfuture article:"No-one should consider this association to be definitive until it's been replicated in independent cohorts.Secondly, the effects of this variant are likely to differ between groups. According to the HapMap database the frequency of the "die early" (T) version of the variant varies substantially between populations: it's around 76% in Japanese, slightly more common (81%) in Chinese, less common (58%) in Europeans, and quite rare (17%) in West Africans. Given that the Japanese have the highest life expectancy of any of these populations, this is a counter-intuitive result, which reinforces the fact that there are many genes and other factors influencing variation in longevity."/ 23andMe blog longevity rs2802288(A) increased the odds of living to 100 by 1.5x. rs2802288 is located very close to rs2802292 which was previously reported to have a similar effect.A study of males from the Southern Italian Centenarian Study also replicated the association between rs2802288, a proxy of rs2802292, and longevity, with an odds ratio of 1.51 (CI: 1.15-1.98,  p = 0.003).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3029]]
    <blockquote>
        <p class="text-snippet" data-id="3029">This SNP, located in an intron of the LOXL1 gene, was initially reported to be associated with exfoliation glaucoma. However, it was shown in the same study to no longer be significant once two other SNPs, which cause actual changes in the LOXL1 protein, were identified. More specifically, the risk allele rs2165241(T) was found to be associated with glaucoma only because it effectively predicted (with 90% probability) the actual high-risk haplotype consisting of rs1048661(G) and rs3825942(C), as oriented with respect to their entries in dbSNP. However, a meta-analysis published in 2010 concluded that it's likely that SNPs rs1048661 and rs2165241 are not directly implicated in the pathogenesis of glaucoma; only the nearby rs3825942 seemed to be the disease-associated SNP.  rs2165241 was significantly associated with XFG and XFS (p=4.13x10e-9 for an additive model, heterozygote odds ratio = 4.42 (CI: 2.3-8.5), homozygote odds ratio = 34.19 (CI: 4.48-261), with the rs2165241 (T) allele being the risk allele, found in 83.1% of cases versus 52.4% in controls, based on a study of 62 Caucasian patients. Significant association was also found for rs3825942 (p=1.89x10e-6). rs1048661 (G), rs3825942 (G), and rs2165241 (T) are highly associated with XFS and XFG in American and European populations. The GGT haplotype constitutes a major risk haplotype for exfoliation. Confirmed as risk for pseudoexfoliation (PEX) and pseudoexfoliation glaucoma (PEXG) in populations of German and Italian descent.rs2165241 increases susceptibility to Exfoliation glaucoma 3.62 times for carriers of the T allele rs2165241 increases susceptibility to Glaucoma 1.96 times for carriers of the T allele rs2165241 increases susceptibility to Primary open-angle glaucoma 1.04 times for carriers of the T allele</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3153]]
    <blockquote>
        <p class="text-snippet" data-id="3153">rs2229616, a variant in the MC4R gene known as V103I, has been associated with appetite regulation, body mass index (and thus obesity), and other features of metabolic syndrome.The most common allele is rs2229616(G); the rarer (A) allele encodes the 103I (isoleucine), and this (A) allele has been associated in a study of 8,000+ Caucasians with a significantly decreased waist circumference (-1.46 cm, p = 0.020), decreased glycosylated hemoglobin (HbA1c) (-0.09%, p = 0.040), and increased HDL-cholesterol (HDL-C) (+1.76 mg/dl, P = 0.056), but no change in blood pressure. The odds of having three or more components of the metabolic syndrome were substantially reduced among carriers of an rs2229616(A) allele (odds ratio = 0.46, p = 0.003). Basically, rs2229616(A) carriers are on average slightly leaner than rs2229616(G;G) homozygotes.  Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Medical sequencing at the extremes of human body mass. Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Val103Ile polymorphism of the melanocortin-4 receptor gene (MC4R) in cancer cachexia. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). From monogenic to polygenic obesity: recent advances. Melanocortin-4 receptor polymorphisms in Turkish pediatric obese patients. Polymorphisms of INSIG2, MC4R, and LEP are associated with obesity- and metabolic-related traits in schizophrenic patients. Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3025]]
    <blockquote>
        <p class="text-snippet" data-id="3025">Two SNPs from chromosome 4q25, rs2200733 and rs10033464, were found to be associated with atrial fibrillation in a study of both European and Asian populations. The odds ratio associated with one or more copies of either risk allele was ~1.4x. The results derived from a study of 78 Italians with atrial fibrillation (AF) and atrial flutter (AFL) agree with previously reported findings from the Icelandic study (), which also found that the rs2200733(T) was associated with AF/AFL disease. In 1,661 Icelandic ischemic stroke samples and two large European replication sets combined, rs2200733 was associated with cardioembolic stroke (CES) (odds ratio 1.54, p = 8.05 x 10e-9). rs2200733 even showed association to ischemic stroke that was not classified as cardioembolic stroke. rs2200733 and rs10033464 are strongly associated with AF in four cohorts of European descent.  A study of 1,166 Caucasian patients following coronary artery bypass grafting concluded that rs2200733(T) carriers had increased long-term mortality (hazard ratio 1.57, CI: 1.10 - 2.24) and higher risk for postoperative atrial fibrillation (odds ratio 1.41, CI: 1.04 - 1.91). rs2200733 was found to be associated with atrial fibrillation based on a study by the eMERGE network in which electronic medical records were searched to find clinical associations associated with selected SNPs. genesherpa does a blog post about this snp rs2200733(T;T) individuals have a mean PR interval (a risk factor for atrial fibrillation) of 189.5 &#177; 35.8 ms in comparison to mean PR intervals of 172.0 &#177; 29.0 and 171.0 &#177; 27.1 ms for (C;T) and (C;C) genotypes, respectively (p = 0.013 and p = 0.0056), according to this study.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4944]]
    <blockquote>
        <p class="text-snippet" data-id="4944">rs713598 is one of three SNPs that form the main haplotypes behind the ability to perceive as bitter the taste of the compound phenylthiocarbamide (PTC) and similar molecules in foods (like cabbage and raw broccoli) or drinks (like coffee and dark beers).Due to it's minus orientation and nearly 50/50 split of allele frequency it is easily confused. In the orientation shown in dbSNP and used in SNPedia rs713598(G) is the "non-tasting" allele rs713598(C) is the "tasting" alleleIn the GRCh37 orientation currently (2017) reported by 23andMe rs713598(C) is the "non-tasting" allele rs713598(G) is the "tasting" alleleTasting is dominant, so heterozygotes are able to taste bitterness.If you are a "taster", you're also likely to carry at least one rs10246939(C) and one rs1726866(C) allele since, along with rs713598(G), these three SNPs form the most common tasting haplotype. If you lack these alleles, you're quite likely (~80%) to be a non-taster of bitterness, meaning that foods that may taste bitter to others taste far less bitter to you.  TAS2R38 (phenylthiocarbamide) haplotypes, coronary heart disease traits, and eating behavior in the British Women's Heart and Health Study. Prevalence of common disease-associated variants in Asian Indians. A combinatorial approach to detecting gene-gene and gene-environment interactions in family studies. Bitter taste receptors influence glucose homeostasis. A non-synonymous variant in ADH1B is strongly associated with prenatal alcohol use in a European sample of pregnant women. Sex differences in the effects of inherited bitter thiourea sensitivity on body weight in 4-6-year-old children. Implication of the G145C polymorphism (rs713598) of the TAS2r38 gene on food consumption by Brazilian older women.Bitter Taste Perception</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3033]]
    <blockquote>
        <p class="text-snippet" data-id="3033">rs3798220, also known as I4399M or Ile4399Met, is a SNP in the apolipoprotein(A) LPA gene that has been reported to be associated with elevated plasma lipoprotein(a) Lp(a) and increased cardiovascular risk, and in particular, coronary artery disease.In one study, 25,131 initially healthy Caucasian participants in the Women's Health Study were followed for ~10 years. rs3798220(C) allele carriers (3.7%) in the placebo (i.e. not receiving aspirin) group had a 2x higher risk of major cardiovascular events than non-carriers (age-adjusted hazard ratio (HR) of 2.21, CI: 1.39-3.52). Among rs3798220(C) carriers, the risk was reduced more than twofold by aspirin: for aspirin compared with placebo the age-adjusted HR was 0.44 (CI: 0.20-0.94). The risk was not significantly reduced among non-carriers (age-adjusted HR=0.91, CI: 0.77-1.08). This interaction between carrier status and aspirin allocation was significant (P=0.048). In summary, rs3798220(C) carriers had higher plasma lipoprotein(a) and had double the risk of cardiovascular events, but also benefited more from taking aspirin. In another study, compared with noncarriers, carriers of the 4399M risk allele (2.7% of controls) had an adjusted odds ratio for severe CAD of 3.14 (CI: 1.51 to 6.56), and had 5-fold higher median plasma lipoprotein(a) levels (P=0.003), leading to the conclusion that the LPA I4399M SNP is associated with severe CAD and plasma lipoprotein(a) levels. celera says rs3798220 is an independent predictor of risk for  Coronary Heart Disease in men and women event reduction from low dose aspirin therapy in womenCarriers of the rs3798220(C) have higher levels of plasma Lp(a).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1832]]
    <blockquote>
        <p class="text-snippet" data-id="1832">rs1799963 is a SNP far more commonly known as the G20210A mutation of the prothrombin F2 gene. 23andMe's i3002432 is another name for rs1799963.Due to the interactions of the corresponding protein with the Factor V protein, SNPs in these two coagulation-related genes are often studied together. In particular, rs1799963 is often studied together with rs6025.In a 2013 meta-analysis of 31 databases, the analysis of i3002432 / rs1799963 (PT20210A or prothrombin or Factor 2) was based on 9,134 cases and 17,606 controls. The AG variant average risk for Venous Thromboembolism was 2.8, and risk was higher for younger subjects ((< 45 years old, OR: 3.19;  45 years old, OR: 2.57) and for women taking oral contraceptives (women not using OCs, OR: 2.73; women using OCs, OR: 5.58). Further analysis by outcome revealed that more the risk for Cerebral venous sinus thrombosis was highest at 4.4 (based on 303 cases and 2,723 controls), whereas for Venous thromboembolism OR was 3.0, and for Venous thrombosis (w/o pulmonary embolism) OR 2.6. The AA variant risk was 6.74, but the odds ratio for homozygotes was based on only 28 subjects among cases and 4 controls. A larger risk was seen in rs6025 Factor V Leiden SNP variants. For a more complete discussion, see rs6025., In addition to the literature associating the G20210A variant with thromboembolism in general, several studies have found that this variant significantly (2 - 20 fold) increases the risk for ischemic stroke (aka cerebral ischemia) in individuals with patent foramen ovale (PFO), or hole in the heart. It is estimated that PFO is present in ~25% of the (normal/healthy) population. JAMA discusses the value of testing this snp for venous thromboembolism</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1833]]
    <blockquote>
        <p class="text-snippet" data-id="1833">This polymorphism is also known as Factor V HR2, H1299R, His1299Arg (due to the resulting change from Histidine to Arginine in the protein) and A4070G (due to the allele being G instead of A).Research shows that is related to the more commonly known "Factor V Leiden" mutation rs6025 ."Factor V Leiden is present in 5% to 7% of the general population and 20% to 40% of individuals with venous thrombosis. The factor V R2 polymorphism is associated with decreased levels of factor V and it significantly increases risk of venous thrombosis in individuals who are heterozygous for the factor V Leiden mutation. Coexistence of the R2 polymorphism rs1800595 with factor V Leiden rs6025 increases the risk for venous thrombosis approximately to a 16-fold increased risk. The average age of the first thrombotic event is six years younger in individuals who are heterozygous for both factor V Leiden and the R2 polymorphism than in those with factor V Leiden alone. The R2 polymorphism is common in the general population, with one copy (heterozygous) in 10% of individuals. Among patients with venous thrombosis, approximately 12% are heterozygous for the R2 polymorphism."   labcorp"Factor V HR2 Allele, DNA Mutation Analysis is useful in patients who are carriers of Factor V Mutation (Leiden). Coinheritance of Factor V Mutation (Leiden) is associated with a 3-4-fold increased risk of venous thrombosis compared to inheritance of Factor V Mutation (Leiden) alone."   homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (Factor V Leiden) and His1299Arg substitutions in Factor V."   of the HR2 Haplotype in the Factor V Gene Confers an Increased Risk of Venous Thromboembolism to Carriers of Factor V R506Q (Factor V Leiden)."   1: R2 Haplotype SNPs.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4674]]
    <blockquote>
        <p class="text-snippet" data-id="4674">This snp influences skin pigmentation. The allele p.L374F indicates light-skinned european ancestry  c.1122C>G, p.Phe374Leu (NCBI dbSNP rs16891982) in SLC45A2 was associated with protection from malignant melanoma (OR, 0.41; 95% CI, 0.24-0.70; P=0.008 after adjustment for multiple testing)An association study conducted on a population of European origin concluded that the rare (in Europeans, at least) allele L374, i.e. rs16891982(C) in dbSNP orientation, significantly increases the possibility of having black hair color, with an odds ratio of around 7. This population-based case-control study investigated a number of pigmentation-related SNPs and their correlation with cutaneous malignant melanoma (CMM) in an Australian population. rs16891982 (variant F374L) was found to be associated with odds ratios of 3.44, 2.86, 1.68, and 1.68 for all study subjects (1,738 CMM cases and 4,517 controls), subjects with northern European ancestry (1,438 cases and 3,098 controls), northern European subjects adjusted for hair, eye, and skin colour, and northern European subjects adjusted for the MC1R genotype, respectively (p<0.001 for all). A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. Genome-wide association study of tanning phenotype in a population of European ancestry. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Haplotypes in SLC24A5 Gene as Ancestry Informative Markers in Different Populations. Ancestry analysis in the 11-M Madrid bomb attack investigation. Genetic determinants of hair and eye colours in the Scottish and Danish populations. Digital quantification of human eye color highlights genetic association of three new loci. Spectrum of candidate gene mutations associated with Indian familial oculocutaneous and ocular albinism. Genetic analysis of the SNPforID 34-plex ancestry informative SNP panel in Tunisian and Libyan populations.Squamous Cell Carcinoma</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1724]]
    <blockquote>
        <p class="text-snippet" data-id="1724">rs5370, also known as Lys198Asn or K198N, is a SNP in the endothelin-1 EDN1 gene on chromosome 6. The generally more common rs5370(G) allele encodes the Lys (K), and the rarer rs5370(T) allele encodes the Asn (N). Among the French-Canadian founder population of the Saguenay Lac St-Jean region of Quebec, rs5370(T) was associated with lower HDL cholesterol values in women (p = 1.3 x 10e-5), but not in men. In a study of 1,000+ Western Australians, no association was seen between HDL levels and rs5370. A study of ~400 rheumatoid arthritis patients found a 3x increase in the adjusted odds of being hypertensive for rs5370(T;T) homozygotes compared to (G;G) homozygotes (odds ratio 2.89, CI: 1.02 - 8.19, p=0.011). After adjustment for multiple potential confounders, haplotype analysis revealed an additive effect of the rs1800541-rs5370  T-T haplotype on hypertension (OR = 2.96, CI: 1.28 - 6.86; p = .011), systolic blood pressure (SBP) (beta = 6.75 +/- 2.57 mm Hg; p = .009), and pulse pressure (PP) (beta = 4.37 +/- 2.12 mm Hg; p = .040) rs2368564  and rs5370 reduced risk of edema (P=0.003 and P=0.028, respectively). rs1801253 with increased susceptibility to edema (P=0.034) rs5370(T;T) genotypes were the factor most significantly associated with reduced risk of diabetic retinopathy (odds ratio = 0.19, CI: 0.07-0.53; p=0.002) and with later onset of type-2 diabetes ((T;T): 59 years; (G;G) and (G;T): 53 years; p=0.02), in a Chinese population of diabetics.High Blood Pressure (Hypertension)</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5128]]
    <blockquote>
        <p class="text-snippet" data-id="5128">rs4570625, also known as G-703T, is a SNP in the tryptophan hydroxylase 2 TPH2 gene. This SNP has been linked to several psychiatric and/or behavioural phenomena, including:   rs4570625 and rs4565946 linked to the pathogenesis of early-onset obsessive compulsive disorder  rs4570625 and rs11178997 in TPH2's regulatory region display preferential transmission   rs4570625(G;G) homozygosity was a significant predictor of clinical placebo response, being associated with greater improvement in anxiety symptoms./ g2b2mh is rs4570625(G;G) is a significant predictor of clinical placebo response? maybe  not panic disorder with a possible gender-dependent effect Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Association between a polymorphism in the promoter region of the TPH2 gene and the personality trait of harm avoidance. Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation. Case-control and family-based association studies of candidate genes in autistic disorder and its endophenotypes: TPH2 and GLO1. Characterization of a functional promoter polymorphism of the human tryptophan hydroxylase 2 gene in serotonergic raphe neurons. Genetic variation of serotonin function and cognitive control. Tryptophan hydroxylase 2 gene and alcohol use among college students. Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response. TPH2 gene variants and anxiety during alcohol detoxification outcome. Epistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 variations does not impact alcohol dependence disorder features. Alternative splicing and extensive RNA editing of human TPH2 transcripts. Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in Chinese Han population. Pharmacogenetics of antidepressant response. Serotonin and early cognitive development: variation in the tryptophan hydroxylase 2 gene is associated with visual attention in 7-month-old infants. Emotion appraisal and the tryptophan hydroxylase 2 (TPH2) gene. Common variants in the TPH2 promoter confer susceptibility to paranoid schizophrenia.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4229]]
    <blockquote>
        <p class="text-snippet" data-id="4229">rs689466 is a SNP in the COX-2 gene, also known as the prostaglandin-endoperoxide synthase 2 PTGS2 gene.A Scottish and Danish case-control study including 732 Crohn's disease (CD) cases, 973 ulcerative colitis (UC) cases, and 1157 healthy controls found that the rs689466(G) allele was associated with higher risk for ulcerative colitis and inflammatory bowel disease, especially among those who never smoked. The reported odds ratios were 1.25 and 1.47, rspectively. This allele was also associated with younger age at diagnosis and with extensive ulcerative colitis. Cyclooxygenase-2 polymorphisms in Parkinson's disease. Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance. Association of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid calcium in the Diabetes Heart Study. Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk. Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression. Cyclooxygenase-2 polymorphisms and susceptibility to esophageal cancer: a meta-analysis. Interaction of cyclooxygenase-2 promoter polymorphisms with Helicobacter pylori infection and risk of gastric cancer. Variation in human genetic polymorphisms, their association with Helicobacter pylori acquisition and gastric cancer in a multi-ethnic country. Functional genetic variations of cyclooxygenase-2 and susceptibility to acute myeloid leukemia in a Chinese population. Population-specific genetic associations with oesophageal squamous cell carcinoma in South Africa. Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q36]]
    <blockquote>
        <p class="text-snippet" data-id="36">rs2235040 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review , ten studies reported that ABCB1 SNPs have clinical effect in depression and eight - that they do not.A study of ~400 of German psychiatric inpatients with depression conducted in 2007 by Uhr et al.  found that rs2235040(A) carriers treated with ABCB1 substrates were more likely to remit. However, this result failed to reproduce in a large (900 outpatient subjects) and better designed double-blind study of a well-researched ABCB1 substrate citalopram in depression (STAR-D study). According to a recent meta analysis , no significant association of antidepressant treatment outcome with this SNP. There was a significant association with treatment outcome in the inpatients subsample but data regarding rs2235040 and treatment outcome among inpatients entirely stemmed from the study by Uhr et al.The 9 SNPs in the linkage block identified are :  rs2235067  rs4148740  rs2032583  rs4148739  rs11983225  rs2235040  rs12720067  rs7787082  rs10248420In contrast,  reported on two SNPs from the block, rs2032583 and rs2235040, that these SNPs are in a weak disequilibrium (not always inherited together) in their 81% white population. Other results from  are unreliable because the authors used an antidepressant sertraline, which is, likely, not an ABCB1 substrate , as an example of an ABCB1 substrate and treated most of the patients in the study with sertraline.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5344]]
    <blockquote>
        <p class="text-snippet" data-id="5344">rs8050894, is located on chromosome 16 in the gene VKORC1.  VKORC1 is the primary target of the drug warfarin (Coumadin), a commonly used oral anticoagulant.  rs8050894 is one of several polymorphisms found in VKORC1 that is associated with specific warfarin doses ().  Other polymorphisms in VKORC1 (rs7196161, rs9923231, rs9934438, rs2359612) are equally predictive of warfarin dose requirement in both European and Asian-descent individuals.Other polymorphisms found in the gene cytochrome P450 2C9 (CYP2C9) influence the metabolism of warfarin and have a smaller effect on warfarin dose.  These polymorphisms are rs1799853 (CYP2C9 2) and rs1057910 (CYP2C9 3). In several hundred Europeans, no association was found between rs8050894 and risk for ischemic stroke. Genetic-based dosing in orthopedic patients beginning warfarin therapy. Evaluation of genetic factors for warfarin dose prediction. Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations. Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans. Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement. Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction. Warfarin pharmacogenetics. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans. Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy. Estimation of the warfarin dose with clinical and pharmacogenetic data. Warfarin sensitivity genotyping: a review of the literature and summary of patient experience. The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1908]]
    <blockquote>
        <p class="text-snippet" data-id="1908">Based on a study of ~2500 female patients of European ancestry with sporadic postmenopausal breast cancer, this SNP in the FGFR2 showed the greatest risk. The risk allele is rs1219648(G), with a pooled odds ratio of 1.64 (CI:1.42-1.90) for rs1219648(G;G) homozygotes, and an odds ratio of 1.20 (CI: 1.07-1.42) for rs1219648(A;G) heterozygotes, compared with rs1219648(A;A) homozygotes.rs1219648 represents the SNP in the FGFR2 gene with the strongest association with breast cancer. However, nearby SNPs are almost as predictive. In particular, the following SNP alleles all have linkage values of 0.96 or greater with the rs1219648(G) allele in European populations: rs2981579(A) rs2420946(T) rs11200014(A) An experimental rationale is presented indicating that this SNP is part of a haplotype that increases risk for ER+ breast cancer by increasing FGFR2 transcription.  rs1219648 is not associated with endometriosis risk. rs1219648 may account for a substantial fraction of breast cancer in Arab (12%), Ashkenazi (15%), and Sephardi Jewish (22%) populations.  Based on a study of 1,049 Chinese breast cancer patients, carriers of risk alleles at three SNPs (rs2981582, rs1219648 and rs2420946) were at 1.36x increased risk for breast cancer (CI: 1.13-1.62, p = 0.001). A study of 1,173 Caucasian ovarian cancer patients did not find strong support for an association with rs1219648. A study of 1,225 Caucasian breast cancer patients found a significant association between rs1219648 but only in women with estrogen receptor positive (ER+), progesterone receptor positive (PR+) and HER2/Neu negative (HER2-) tumors. An interaction was also observed between combined hormone replacement therapy use and rs1219648 genotypes on breast cancer risk in Caucasian women (p = 0.010).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2750]]
    <blockquote>
        <p class="text-snippet" data-id="2750">A relatively rare allele at SNP rs11209026, in the IL23R gene, appears to provide a fairly strong protective effect against the development of Crohn's disease in both Jewish and non-Jewish populations. Note that in this study the (A;A) and (A;G) genotypes were combined for statistical reasons (there were too few (A;A) individuals to study by themselves), so the risk is shown as equal for both. associated With Inflammatory Bowel Diseases but Not With Celiac Diseasers11209026 had a protective effect for IBD in the case-control analysis (odds ratio OR 0.19, 95% confidence interval CI 0.10-0.37, P= 6.6E-09). Both CD (OR 0.14, CI 0.06-0.37, P= 3.9E-07) and UC (OR 0.33, CI 0.15-0.73, P= 1.4E-03) were associated with IL23R. rs2241880 was associated with CD susceptibility (OR 1.36, CI 1.12-1.66, P= 0.0017). The population-attributable risk of carrying allele G is 0.24 and is 0.19 for homozygosity for allele G in CD.With reference to ankylosing spondylitis, the rs11209026(A) allele also has a protective effect. The odds ratio for carriers is 0.63 (p=2.8x10e-5) based on a large study of over 1,000 Caucasian patients.PMID 17952073, PMID 18037607This SNP is also part of a haplotype with rs7530511 associated with psoriasis.. And in  rs11209026 was also confirmed to be associated with psoriasis. significant associations with rs1004819, rs7517847, and rs11209026. Having any CARD15 variant was associated with a significant risk for CD (P < 0.0001).  Replicated reduced risk for Crohn's disease and ulcerative colitis with rs11209026(A) allele in a study of Italian patients.A genome-wide association study using DNA samples from 1,052 individuals with ulcerative colitis and preexisting data from 2,571 controls, all of European ancestry, concluded that this SNP and several others were associated with altered risk for the disease.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q918]]
    <blockquote>
        <p class="text-snippet" data-id="918">rs1129844, also known as c.208G>A, p.Ala23Thr and A23T, is a SNP in the CCL11 gene on chromosome 17. The CCL11 gene encodes eotaxin-1, a chemokine protein who's serum and cerebrospinal fluid levels increase with age and may correlate with decreased neurogenesis. This SNP has made the news based on a (single) study reporting that carriers of an rs1129844(A) allele might have delayed onset of Alzheimer's disease compared to individuals lacking an (A) allele. An analysis of 72 whole genome scans of selected Colombian PSEN1 E280A carriers, i.e. rs63750231(A;C) genotypes, all of whom have '''early-onset''' Alzheimer's, found that a protective haplotype delayed Alzheimer disease onset by up to 10 years. The only coding SNP in this protective haplotype associated with delayed AD onset was rs1129844. A follow-on study in 152 Alzheimer patients in a UCSF cohort (average onset age 63 years, which is considered late-onset and is the more common type of Alzheimer's) did not find a statistically significant protective effect for the rs1129844(A) allele, but did observe a "trend" towards protection in the data. The (A) allele has a frequency of about 16% in most populations ( ExAC), although the study suggests that 1 in 4 individuals may carry this allele. A news brief about this is  here.An analysis of 117 whole genome scans of Colombian E280A PS1 carriers found that a protective haplotype delayed Alzheimer disease onset by 10 years. These E280A carriers are certain to develop dementia. The only SNP within a coding region of a gene in this protective haplotype associated with delayed AD onset was rs1129844, The protective haplotype occurred in 1 in 4 carriers; the A allele also occurs with a frequency of approximately 25%. A follow-on study confirmed the protection of rs1129844 in 152 AD patients.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4000]]
    <blockquote>
        <p class="text-snippet" data-id="4000">rs705381, also known as -161C/T and -162A/G, is a SNP in the upstream promoter region of the PON1 gene.  (The assumption of equivalence between these names is based on the results of searching for rs705381 in the  Variant Name Mapper.) In a study of 101 mostly Caucasian patients prescribed the atypical antipsychotic risperidone, carriers of a rs705381(C) allele were less likely to gain significant weight compared to rs705381(T;T) carriers, as assessed by physiogenomic analysis of corresponding weight profiles. Two other SNPs, rs8179183 and rs6837793, were also significantly associated with weight profiles in these patients. In a study of 461 participants in the HERITAGE cohort (172 African-American, 289 Caucasian), the combination of rs705381 with "PON-126" (RS ID unknown) were found to significantly contribute to trait-anxiety scores.  The authors also cite another paper, , which found that this SNP accounts for 2.4% of the variation in PON1 expression.  Which allele correlates  with increased trait-anxiety scores and/or reduced PON1 expression is unclear.HapMap frequencies for this SNP seem dubious.  They list rs705381(T;T) as being at or near 100% for the population groups reported by SNPedia.  However, the raw data at HapMap for this SNP are largely no-call (e.g. CEU: NN=87, TT=82, CT=3).  The other diversity studies listed at  dbSNP show C as the more common allele (e.g. AFD_AFR_PANEL: CC=47.8%, CT=39.1%, TT=13.0%).  Anecdotal data submitted by participants at 23andme also show C as being more common (CC=4, CT=1, TT=2).  The diversity data have therefore been removed until these discrepancies can be resolved. A common haplotype within the PON1 promoter region is associated with sporadic ALS. A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3411]]
    <blockquote>
        <p class="text-snippet" data-id="3411">rs11570112, also known as c.2992C>T, p.Gln998Ter and Q998X, represents a rare mutation in the MYBPC3 gene on chromosome 11. For multiple reasons discussed below, interpretation of the impact of this SNP is highly problematic.In addition to the reporting discrepancies between two different DTC labs (AncestryDNA and 23andMe) discussed below, the ClinVar record is decidedly mixed about whether this is, or is not, a pathogenic mutation for hypertrophic cardiomyopathy. After initially being classified of uncertain significance in 2011 by LabCorp, it was classified as benign in 2013 by both an NIH lab and by GeneDx, but in 2014, GeneDx re-classified it as pathogenic. Furthermore, in a dissertation published in July 2015 for a Masters in Genetic Counseling , rs11570112 was discussed in depth as a variant with conflicting interpretation between ClinVar and labs in the SHaRe academic consortium specializing in cardiomyopathy diagnosis /, citing one group as saying it was benign and the other of uncertain significance.AncestryDNA seems to report the common genotype for this SNP on OpenSNP as C,C on the plus strand, which shows up as G,G on the minus strand in Promethease.  23andme seems to report the common genotype for this SNP as GG on the plus strand, which shows up as C,C on the minus strand on Promethease.  This is an ambiguous flip (C/G).  Th first 10 or so C,C checked on OpenSNP were all AncestyDNA reports, and given the extremely low frequency of the pathogenic allele, this is most likely an ambiguous flip problem.  AncestryDNA users with a homozygous "pathogenic" GG reported by Promethease seem more likely to be wild type.  Additionally, both C,C and G,G are far more common on OpenSNP than C,G, which deviates from Hardy-Weinberg.  Additionally, newer 23andme (v4) microarrays do not seem to report any data for this SNP at all.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3471]]
    <blockquote>
        <p class="text-snippet" data-id="3471">Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. Analysis of variants in DNA damage signalling genes in bladder cancer. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway. Association and interactions between DNA repair gene polymorphisms and adult glioma. Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. Association between the NBS1 E185Q polymorphism and cancer risk: a meta-analysis. Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer. Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer. The NBS1 genetic polymorphisms and the risk of the systemic lupus erythematosus in Taiwanese patients. Unique DNA repair gene variations and potential associations with the primary antibody deficiency syndromes IgAD and CVID. Functional polymorphisms in the NBS1 gene and acute lymphoblastic leukemia susceptibility in a Chinese population. DNA Repair System and Prostate Cancer Progression: The Role of NBS1 Polymorphism (rs1805794). Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5025]]
    <blockquote>
        <p class="text-snippet" data-id="5025">This SNP affects the risk of developing tuberculosis.  AA genotype was found to be more significantly associated with tuberculosis. Allele frequencies for guanine (G) and A were found to be 0.95 and 0.05 in the control group and 0.86 and 0.14 in the TB patient group, respectively. The risk of developing tuberculosis was increased 6.04- and 1.60-fold for carriers of the AA and GA genotypes, respectively.The variant of rs5743708 known as Arg753Gln or R753Q appears to protect against Lyme disease.  Linked to preterm birth rs4696480 (T-16934A and Arg753Gln) and rs5743708) (Thr399Ile) earlier birth for infants carrying (-16934TA/AA and 753ArgGln/GlnGln) Genetic polymorphisms and susceptibility to lung disease. Lemierre's syndrome and genetic polymorphisms: a case report. Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Genetic variation and haplotype structures of innate immunity genes in eastern India. Toll-like receptor 2 variants are associated with acute reactive arthritis. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis. Role of polymorphic variants as genetic modulators of infection in neonatal sepsis. Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk. Inflammatory mediators gene polymorphisms in preeclampsia. Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C. Further evidence for the relevance of TLR2 gene variants in spontaneous bacterial peritonitis.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4882]]
    <blockquote>
        <p class="text-snippet" data-id="4882">Several tightly linked SNPs in the STAT4 gene have been linked to risk for risk haplotype for systemic lupus erythematosus (SLE). The strongest association is found for either of two perfectly linked SNP alleles, rs10181656(G) and rs7582694(C), both yielding an odds ratio of 1.71 in this study of ~700 Swedish SLE patients.The risk for SLE was also calculated to increase as a function of the total number of risk alleles for this SNP plus 2 others in the IRF5 gene. Compared to individuals with 0 or 1 risk alleles, the risk for SLE increased 1.82-fold for each additional risk allele from this group. The odds ratio for SLE is 2.08 (CI: 1.53-2.83) for carriers of 2 risk alleles, and goes up to 13.0 (CI: 3.78-44.3) for carriers of 5 or 6 risk alleles (compared to those with 0 or 1). Association of STAT4 with rheumatoid arthritis in the Korean population. Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. STAT4 polymorphism is associated with early-onset type 1 diabetes, but not with late-onset type 1 diabetes. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis. Variation in STAT4 is associated with systemic lupus erythematosus in a Finnish family cohort. Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment. Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn's disease and early disease onset. Genetic risk factors in lupus nephritis and IgA nephropathy--no support of an overlap. Abnormal Genetic and Epigenetic Changes in Signal Transducer and Activator of Transcription 4 in the Pathogenesis of Inflammatory Bowel Diseases.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1691]]
    <blockquote>
        <p class="text-snippet" data-id="1691">rs6280, also known as '''Ser9Gly''', is a SNP in the dopamine receptor D3 DRD3 gene. The rs6280(C) allele encodes a glycine, and the (T) allele encodes a serine (in dbSNP orientation).In a study of 88 patients being treated for schizophrenia with olanzapine, those who were rs6280(C;C) homozygotes had greater positive symptom remission (endpoint rating of minimal or none on all PANSS clinical response positive items, 39.1%), as compared with (C;T) or (T;T) genotypes (13.8%; p = 0.033). Ser9Gly has been implicated in executive function in some studies, but the results are conflicting.  Gly/Gly carriers showed significantly (p = 0.002) poorer performance than Ser/Ser carriers on executive functioning tasks in a somewhat small Caucasian sample (84 patients with first-episode psychosis and 85 controls).  Gly/Ser heterozygotes had 23% more preservative errors on the WCST compared to Ser/Ser homozygotes in a small (216) healthy Han Chinese sample (p = 0.009). Differences between homozygotes were not statistically significant.  No association between WCST scores and Ser9Gly was found in 138 schizophrenic patients. Associated in a family association study and pooled sample of 2,037 with nicotine dependence in Americans of European descent. Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive-compulsive personality disorder in patients with major depression. DRD3 polymorphism for an individual with Gly/Gly (C;C) genotype is 2.4 (P = 0.017) times more likely to be diagnosed with OCPD. Male gender was also found to be a significant predictor of OCPD diagnosis (OR = 2.82, P = 0.001). DRD3 may contribute to the development of OCPD. This association was tested using two independent groups of individuals with a history of depression, from a clinical sample (n = 149) and a family study (n = 213).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2095]]
    <blockquote>
        <p class="text-snippet" data-id="2095">rs1050829 is a SNP within the G6PD gene and is located the X chromosome. G6PD codes for the enzyme glucose-6-phosphate dehydrogenase, which helps protect the cell from oxidative damage.  Depending on genotype, an individual may possess one of two primary versions of the G6PD gene; type A and type B. Type A is predominantly found in people who have African ancestry.  Mutations of G6PD can cause varying degrees of G6PD deficiency, which is a disease affecting red blood cells.  For example, an A to G substitution mutation at the rs1050829 locus (also known as A376G) is associated with reduced production of G6PD enzyme. Other mutations causing G6PD deficiency include; rs1050828. The G6PD deficient genotype A- (~8-20% reduction of G6PD) is typically defined by the possession of both the rs1050829 G allele and the rs1050828 A allele. G6PD deficiency frequency is highest in malarial regions where G6PD deficient individuals are typically less affected by malarial infection ().The minor allele of this SNP should be reclassified as benign according to  Study of malaria in Gambian children uses the rs1050829 allele to help detect G6PD deficient individuals.  A total of 72 SNPs were genotyped in two populations in eastern Sudan (Hausa and Massalit), as well as, a cohort of malaria hospital patients and a control sample set (n=449).  The study found that in comparison to controls (n=69), Massalit individuals (n=60) who possess the rs105829 G allele were less susceptible to malarial infection (p=0.02). In a G6PD deficient Jordanian clinical population, the A376G allele was found to be at a frequency of 21% in males (n=47) and 9% in females (n=16).  Whereas the G6PD deficient G202A/A376G genotype was found to be 19%.  Examines the frequency of G6PD deficiency genotypes in African malarial drug clinical trail patients from five different populations (Burkina Faso, Ghana, Kenya, Nigeria, Tanzania, and Mali).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1868]]
    <blockquote>
        <p class="text-snippet" data-id="1868">This page represents an arbitrary SNP. The main text body of a SNP page summarizes the associations between SNP variants and a range of human traits (body height, disease risk, response to drugs, even behavior). The science that supports these associations (peer-reviewed publications with citations) is indicated by links to / PubMed abstracts in the form of <nowiki></nowiki> or PMID 12345678 style citations.Technically, there was once a valid rs1234, but it has long since been merged into a different identifier, due to the natural changes of that system. For this reason, on SNPedia, we will use this SNP to explain how to use many key SNPedia features.To the upper right you will see a box with these fields: is a snp . This tells you that you are looking at a page about a snp. You may sometimes see the words gene or genotype. is mentioned by . This will show you what other pages on SNPedia are related to this snp. dbSNP  rs1234 . This will take you to the the graphs of population diversity on its / ncbi dbsnp page. hapmap rs1234. overlay snpedia on the  hapmap genome ensembl rs1234 . Takes you to the snp report at  ensembl google . Automatic google search 23andMe . Links to the 23andMe.com web site where registered users can find their own genotypes for this SNP. 23andMe all. Links to the 23andMe.com web site where registered users can find discussions about this SNP.The colored box indicates the frequency of each genotype in 4 HapMap populations. CEU is European so the box indicates that 10% of Europeans are (A;A) colored brown, 60% are (A;C) colored green, and 30% are (C;C) colored blue. The Chinese (CHB) and Japanese (JPT) are mainly (C;C).  Click on the question mark for help (population diversity)|more information.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2351]]
    <blockquote>
        <p class="text-snippet" data-id="2351">rs37973 is a SNP in the promoter region of the glucocorticoid induced transcript 1 GLCCI1 gene on chromosome 7. In asthmatics corticosteroid treatment increases GLCCI1 protein in lung white blood cells. This increase is suggested to be followed by the inflammatory cells apoptosis and resolution of the inflammation.  The amount of GLCCI1 protein induced by glucocorticoids was significantly lower in the bronchial epithelial cells of rs37973(G;G) patients as compared to wild type homozygotes possibly resulting in inferior response..Based on 4 populations totaling 900+ asthma patients, the rs37973(G) allele was associated (p = 0.0007, pooled data) with less improvement of lung function in response to inhaled glucocorticoids such as budesonide. The mean (&#177;SE) increase in forced expiratory volume in 1 second (FEV1) in treated rs37973(G;G) patients was about one third of that seen in rs37973(A;A) patients (3.2&#177;1.6% vs. 9.4&#177;1.1%). Based on dividing the response into highest vs lowest quartiles of response, the allelic odds ratio of falling into the lowest responding quartile based on an additive genetic model was calculated to be 1.52 (CI: 1.13 - 2.03). Genotype accounted for about 7% of overall inhaled glucocorticoid response variability.This result failed to replicate in an analysis of corticosteroid clinical trials in a population of 1,900 non-Hispanic white patients with asthma. rs37973 did not influence change from baseline in forced expiratory volume. There was only a non-significant trend toward less response in rs37973(G;G) patients.In a study of 400 Japanese patients with bronchial asthma receiving inhaled corticosteroids, the pulmonary function was not significantly different in rs37973(G;G) compared with rs37973(A;A) genotypes. However, rs37973(G;G) was associated with about 3-fold increased odds of requiring further treatment in addition to inhaled corticosteroids, principally, tiotropium and anti-IgE (omalizumab)..</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4575]]
    <blockquote>
        <p class="text-snippet" data-id="4575">rs6259, also known as Asp327Asn, is a SNP in the sex hormone-binding globulin SHBG gene. The rs6259(G) allele encodes the Asp, while the rs6259(A) allele encodes the Asn.rs6259 was associated with decreased risk of endometrial cancer,  particularly among postmenopausal women (odds ratio 0.79, CI: 0.62-1.00), in a case-control study of 1,199 endometrial cancer patients and 1,212 controls. There was an inverse association of soy intake and tea consumption being more evident for those with the rs6259(G;G) genotype, particularly premenopausal women (P(interaction) = 0.06 and 0.02, respectively, for soy isoflavones and tea intake). In other words, premenopausal rs6259(G;G) women have reduced risk for endometrial cancer when they intake more soy and consume more tea.  Human variant sex hormone-binding globulin (SHBG) with an additional carbohydrate chain has a reduced clearance rate in rabbit   Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer. Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect. Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer. Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women. Asp327Asn polymorphism of sex hormone-binding globulin gene is associated with systemic lupus erythematosus incidence. Serotonin-1A receptor gene polymorphism and the ability of antipsychotic drugs to improve attention in schizophrenia. Usefulness of Mendelian randomization in observational epidemiology. Coffee and caffeine consumption in relation to sex hormone-binding globulin and risk of type 2 diabetes in postmenopausal women. Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome. Quantitative trait analysis suggests polymorphisms of estrogen-related genes regulate human sperm concentrations and motility.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3544]]
    <blockquote>
        <p class="text-snippet" data-id="3544">rs10494366, a SNP in the NOS1AP gene encoding the nitric oxide synthase I adaptor protein, accounts for some of the variation seen in abnormal heart rhythms, in particular, the QT interval. Based on studies totaling ~4,000 individuals of Caucasian ancestry, homozygotes for one allele have shorter QT intervals, while homozygotes for the other allele have a longer QT interval. A follow-up study determined that one rs10494366(G) allele was associated with a 3.8-ms (CI: 3.0 - 4.6ms, p=7.8x10(-20)) increase in QT interval duration, and two (G) alleles had twice that increase. No increase in risk for sudden death due to a cardiac problem was associated with this SNP, though.  rs10494366 minor homozygotes had a 9.3 msec longer QT interval compared to major homozygotes (p=5.7x10(-5)); rs10918594 minor homozygotes had a 12.5 msec longer QT interval compared to major homozygotes (p=1.5x10(-6)). Restricting analyses to the diabetic EAs strengthened the effect despite the reduction in sample size (11.3 msec difference, p=5.1x10(-5); 13.9 msec difference, p=1.6x10(-6), respectively).  Patients with rs10494366(G;T) or (G;G) genotypes have an increased mortality risk (hazard ratio 2.8) compared to (T;T) genotypes upon treatment with sulfonylurea antidiabetic drugs. Glibenclamide is less effective in reducing glucose levels and mortality rates were higher compared with glibenclamide users with the (T;T) genotype. However, in tolbutamide and glimepiride users, the (G;T) and (G;G) genotypes were associated with a reduced mortality rate. rs10494366, rs4657139 and rs16847548 were significantly associated with adjusted QT interval in whites. relative hazard of SCD associated with each C allele at rs16847548 was 1.31. rs12567209 was also independently associated with SCD in whites (relative hazard 0.57, 95% confidence interval 0.39 to 0.83, P=0.003). No significant associations observed in blacks.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q581]]
    <blockquote>
        <p class="text-snippet" data-id="581">rs1799807, also known as D70G, is a SNP in the BCHE gene.  This SNP affects the structure, activity, and substrate specificity of the BuChE (butyrylcholinesterase) enzyme. Cholinesterases and cholinesterase inhibitors, p. 48 The variant form, rs1799807(G), replaces aspartate with glycine at the secondary substrate/inhibitor binding site.  This single base substitution yields the "atypical" version of BChE.  This version has a lower affinity for many substrates, including many Cholinesterase Inhibitors (CIs).  A different cholinesterase (acetylcholinesterase, AChE) is an important component of neurotransmission by acetylcholine (ACh), terminating the action of ACh after it has been released during neurotransmission. BChE is found widely in the plasma and normally binds to CIs, protecting AChE from being inhibited by CIs and so maintaining normal neurotransmission by acetylcholine.Practical consequences of altered substrate affinity from this SNP include:  Succinylcholine, commonly used as an anesthetic, depends on BChE hydrolysis for recovery.  rs1799807(G;G) homozygotes experience a much delayed return to spontaneous breathing following its use.    "Atypical" BChE has a low affinity for CI alkaloids naturally occuring in certain plants, particularly those in the nightshade family (potato, tomato, peppers, eggplant, etc.).  rs1799807(G) carriers may be more prone to physiological consequences of AChE inhibition from eating these foods.  Many pesticides are CIs, including organophosphates and carbamates.  rs1799807(G) carriers may have atypical reactions to pesticide residues on foods and in the environment.  Many nerve agents, such as Sarin and VX gas, as well agents used to protect soldiers against them, such as pyridostigmine, are CIs.  rs1799807(G) carriers may be more susceptible to exposure to these agents.  "Atypical" BuChE, rs1799807(G), has 30% lower enzymatic activity than the wild-type enzyme.  Homoygous carriers of this polymorphism, rs1799807(G;G), display extreme anxiety after exposure to CIs.    Pseudocholinesterase Deficiency</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2759]]
    <blockquote>
        <p class="text-snippet" data-id="2759">the association may be specific to Crohn's disease, as opposed to all types of IBD. significant associations with rs1004819, rs7517847, and rs11209026. Having any CARD15 variant was associated with a significant risk for Crohn's disease (P < 0.0001). rs7517847 (P=4.9x10(-9), OR 0.65, 0.56-0.75), is statistically independent of rs11209026.  Replicated reduced risk for Crohn's disease with the rs7517847(G) allele in a study of Italian patients, but not ulcerative colitis. Each incidence of the G allele was associated with a decrease in Crohn's Disease in New Zealand populations studied. Investigation of the IL23R gene in a Spanish rheumatoid arthritis cohort. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. Association analysis of IL-12B and IL-23R polymorphisms in myocardial infarction. Fine mapping versus replication in whole-genome association studies. CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population. IL23R: a susceptibility locus for celiac disease and multiple sclerosis? IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. No association between interleukin 23 receptor gene polymorphisms and systemic lupus erythematosus. Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjogren syndrome in Hungarian population samples. Interleukin-23 receptor gene variants in Hungarian systemic lupus erythematosus patients. Polymorphisms of IL23R and Vogt-Koyanagi-Harada syndrome in a Chinese Han population. Association of the interleukin-23 receptor gene variant rs11209026 with Crohn's disease in German children. Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn's disease and early disease onset. An investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3048]]
    <blockquote>
        <p class="text-snippet" data-id="3048">rs3736228 is a SNP in the LRP5 gene that is also known as Ala1330Val or A1330V; the more common (C) allele encodes the Ala (alanine), while the rarer (T) allele encodes the Val (valine), which is the risk allele.rs3736228(T) is associated with vertebral fractures and reduced bone mineral density (BMD), with an overall odds ratio for fractures of 1.06 per allele (CI: 1.01-1.12; 7802 fractures among 31,199 individuals studied). More specifically, the rs3736228(T) allele was associated with reduced lumbar spine BMD (p = 2.6 x 10<sup>-9</sup>), and femoral neck BMD (p = 5.0 x 10<sup>-6</sup>).Note that rs4988321, another LRP5 SNP (also known as Val667Met), was independently associated with BMD in this same study. news rs3736228 was associated with a 30% increase in the risk of both osteoporosis and osteoporotic fractures. Both increases were significant, at P=0.002 and P=0.008, respectively.  rs3736228 associated with decreased bone mineral density (p=6.3x10(-12) for lumbar spine and p=1.9x10(-4) for femoral neck) and an increased risk of both osteoporotic fractures (odds ratio OR 1.3, 95% CI 1.09-1.52, p=0.002) and osteoporosis (OR 1.3, 1.08-1.63, p=0.008). rs4355801 associated with decreased bone mineral density (p=7.6x10(-10) for lumbar spine and p=3.3x10(-8) for femoral neck) and increased risk of osteoporosis (OR 1.2, 95% CI 1.01-1.42, p=0.038). The presence of both risk alleles increased the risk of osteoporotic fractures (OR 1.3, 1.08-1.63, p=0.006) and this effect was independent of bone mineral density.A later study (2009) also found an association between rs3736228 and hip BMD; subjects with rs3736228(T;T) genotypes had 8.4% higher total-hip BMD compared to other genotypes (p = 0.009) at baseline in a study of 249 osteoporotic Caucasian men.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4492]]
    <blockquote>
        <p class="text-snippet" data-id="4492">rs1799889 is an insertion/deletion polymorphism in the promoter region of the SERPINE1 gene, which is also known as plasminogen activator inhibitor type 1 (or PAI1 or PAI-1). There are several entries in dbSNP covering this same position; the one here in SNPedia is the one with population frequency. The most common allele has a run of 5 G's in the area around this SNP, and in the literature the allele is commonly called the 5G allele. A deletion of one nucleotide leads to the "4G" allele, i.e. rs1799889(-).The 4G allele has been reported to increase risk for atherosclerosis and coronary artery disease ; on the other hand, the 5G allele may increase the risk of abdominal aortic aneurysm (AAA). In combination with the A2 allele of the ITGB3 gene, rs5918, the increased risk of myocardial infarction in a Finnish study population was 4 fold higher (odds ratio = 4.5, p=0.001), particularly in males (odds ratio = 6.4, p=0.0005) .  Plasminogen activator inhibitor-1 gene: selection of tagging single nucleotide polymorphisms and association with coronary heart disease. 4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. No association between the promoter polymorphisms of PAI-1 gene and sporadic Alzheimer's disease in Chinese Han population. Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome. Polymorphic variation of genes in the fibrinolytic system and the risk of ovarian cancer. Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. Clotting factor gene polymorphisms and colorectal cancer risk. Promoter polymorphisms of SERPINE1 are associated with the antidepressant response to depression in Alzheimer's disease.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q33]]
    <blockquote>
        <p class="text-snippet" data-id="33">rs2032583 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. Clinical studies on antidepressant drug dosage, plasma medication levels and treatment outcome suggest monotonic associations for tricyclic antidepressant drugs  and threshold models or higher order relationships for selective serotonin reuptake inhibitors  and newer antidepressant drugs ,. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is to be confirmed. A study of ~400 of German psychiatric inpatients with depression conducted in 2007 by Uhr et al  found that rs2032583(C) carriers treated with ABCB1 substrates had better chances on remission. However,could not be reproduced in a large (~900) -trial with outpatient with major depression treated with the ABCB1 substrate citalopram (STAR-D study, level 1). According to a recent meta analysis , the significant association of antidepressant treatment outcome among all studies with this SNP becomes insignificant after Bonferroni correction for multiple comparisons. However, the association remained significant after Bonferroni-correction in a subgroup-analysis of all inpatients.rs2032583 is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The 9 SNPs in the linkage block identified are :  rs2235067  rs4148740  rs2032583  rs4148739  rs11983225  rs2235040  rs12720067  rs7787082  rs10248420In contrast,  reported on two SNPs from the block, rs2032583 and rs2235040, that these SNPs are close to HardyWeinberg equilibrium (not inherited together) in their 81% white population. Other results from  are unreliable because they picked an antidepressant sertraline, which is, likely, not an ABCB1 substrate , as an example of an ABCB1 substrate and treated a majority of patients in the study with it.  rs10248420 and rs2032583 associated with colonic disease</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3052]]
    <blockquote>
        <p class="text-snippet" data-id="3052">rs4988321 is a SNP in the LRP5 gene that is also known as Val667Met or V667M; the more common (G) allele encodes the Val (valine), while the rarer (A) allele encodes the Met (methionine), which is the risk allele.rs4988321(A) is associated with vertebral fractures and reduced bone mineral density (BMD), with an overall odds ratio for vertebral fractures of 1.26 per allele (CI: 1.08-1.47; 2001 fractures among 20,488 individuals studied). More specifically, the rs4988321(A) allele was associated with reduced lumbar spine BMD density (p = 3.3 x 10<sup>-8</sup>), and femoral neck BMD (p = 3.8 x 10<sup>-5</sup>).Note that rs3736228, another LRP5 SNP (also known as Ala1330Val), was independently associated with BMD in this same study. No association was found between rs4988321 and either hip or spine BMD in a study of 249 Caucasian osteoporotic or osteopenic men. triallelic and on a chip Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men. Genome-wide association with bone mass and geometry in the Framingham Heart Study. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with peak bone mass in non-sedentary men: results from the Odense androgen study. Association between LRP5 polymorphism and bone mineral density: a Bayesian meta-analysis. Replication study of candidate genes/loci associated with osteoporosis based on genome-wide screening. The conjugation of benzoic acid in the African bat, Epomops franqueti. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders. LRP5 coding polymorphisms influence the variation of peak bone mass in a normal population of French-Canadian women.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1158]]
    <blockquote>
        <p class="text-snippet" data-id="1158">rs1051730, also known as D398N, is a SNP in the nicotinic acetylcholine receptor alpha 3 subunit CHRNA3 gene.In two recent (2008) studies, together comprising over 6,000 lung cancer patients of European ancestry, the rs1051730(T) allele was very significantly associated with increased risk. Having one copy (i.e. being a rs1051730(C;T) genotype) increased risk for lung cancer about 1.3x, and having two copies (rs1051730(T;T) individuals) represented 1.8x increased risk. Up to 14% of lung cancer incidence may be attributable to this allele.PMID 18385738, PMID 18385676An independent study published at the same time concluded that (T) allele carriers for SNP rs1051730 are not at higher risk of becoming smokers compared to (C) carriers. However, if they do smoke, (T) carriers are quite likely to smoke more cigarettes than (C) carriers, and as an apparent consequence, they are at higher risk for lung cancer as reported in this and other studies. This study therefore links rs1051730 directly to nicotine dependence, and indirectly to lung cancer. According to DeCODE, the CC genotype at rs1051730 is associated with 0.88x risk of peripheral arterial disease (PAD). Note: publications tend to refer to the risk allele as "A", however, the orientation reported for rs1051730 in dbSNP is for the opposite strand, so in keeping with reporting all SNPs in the orientation published in dbSNP, SNPedia refers to this same risk allele as the (T) allele. / 23andMe blog (T;T) once more smoke per day. rs1051730 influences how much alcohol it takes to have you feel a buzz. More professorially: rs1051730 influences the level of response to alcohol intake, as measured by body sway after having a 10am "3 drink challenge". rs1051730(T;T) individuals respond slower to alcohol, which generally is considered to actually increase their long-term risk of alcohol abuse./ 23andMe blog (T;T) makes it harder to quit smokingPeripheral Artery Disease</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5027]]
    <blockquote>
        <p class="text-snippet" data-id="5027">rs3775291 is a SNP in the TLR3 gene associated with an amino acid change in the corresponding protein. In the orientation as shown in dbSNP, the more common rs3775291(G) allele encodes a leucine while the rarer rs3775291(A) allele encodes a phenylalanine.rs3775291 has been associated with one form of age related macular degeneration (ARMD), specifically, the form known as "dry" ARMD, also known as geographic atrophy. A study of 3 case-control groups of Americans of European descent, comprising about 900 ARMD patients in total, indicated that having one rs3775291(A) allele reduces the odds of having dry ARMD about 30%, and being a rs3775291(A;A) homozygote cuts your odds by more than half. Specifically, the odds ratio of having dry ARMD with one minor allele is 0.712 (CI: 0.50-1.0), and for two minor alleles, 0.437 ( CI: 0.227-0.839). This was highly significant for the pooled populations (p = 1.24x10e&#226;&#8364;&#8220;7) and also in each population independently(p = 0.002-0.005).Results of three independent samples did not confirm previously reported association of rs3775291 with AMD, individually or combined. Gene-environment interaction effects on the development of immune responses in the 1st year of life. Toll-like receptor polymorphisms and age-related macular degeneration. Vaccine immunogenetics: bedside to bench to population. Personalized vaccines: the emerging field of vaccinomics. Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis. Molecular pathology of age-related macular degeneration. Multilocus analysis of age-related macular degeneration. Toll-like receptor signaling pathway variants and prostate cancer mortality. Toll-like receptor 3 polymorphism rs3775291 is not associated with choroidal neovascularization or polypoidal choroidal vasculopathy in Chinese subjects. A functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection. Age-related macular degeneration-susceptibility single nucleotide polymorphisms in a han chinese control population. Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4552]]
    <blockquote>
        <p class="text-snippet" data-id="4552">rs3184504 is a nonsynonymous SNP in the SH2B3 gene, and it is also known as R262W.In a recent (2008) study of non-HLA SNP associations of 1600+ celiac disease patients, this SNP was considered one of the most significant. The odds ratio for the minor allele was 1.19 (CI:1.10-1.30, p=1.33x10e-7). rs653178, another SNP in strong linkage disequilibrium (r<sup>2</sup>>0.99) with rs3184504, was also associated with celiac disease. associated with type-1 diabetes/ 23andMe blog coronary artery disease and heart attackSNP Risk Version Effect  rs646776 T 1.19  rs17465637 C 1.14  rs1746048 C 1.17  rs6725887 C 1.17  rs11206510 T 1.15  rs3184504 T 1.13  rs2306374 C 1.15  rs3782886 C 1.44/ 23andMe blog blood pressure Pharmacogenetic implications for eight common blood pressure-associated single-nucleotide polymorphisms.|OA=1}} Genome-wide association study SNPs in the human genome diversity project populations: does selection affect unlinked SNPs with shared trait associations? Determinants of platelet count in humans. The carriage of the type 1 diabetes-associated R262W variant of human LNK correlates with increased proliferation of peripheral blood monocytes in diabetic patients. Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control. Genetics of coronary artery disease: focus on genome-wide association studies. Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Genetic evidence for a role of IL33 in nasal polyposis. Signals of recent positive selection in a worldwide sample of human populations. Type 1 diabetes in the BB rat: a polygenic disease. Shared and distinct genetic variants in type 1 diabetes and celiac disease. The expanding genetic overlap between multiple sclerosis and type I diabetes. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease. Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1). On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1448]]
    <blockquote>
        <p class="text-snippet" data-id="1448">SNP rs1057910(A), located in the cytochrome p450 CYP2C9 gene, most commonly encodes the amino acid isoleucine at position 359, and the resulting allele is also known as CYP2C9 1. rs1057910(C) encodes a leucine at this same position, and the resulting allele is called CYP2C9 3. This SNP is also known as Ile359Leu or A1075C.The effect of CYP2C9 variants on drug metabolism should not be predicted without also considering CYP2C9 2, defined as the common loss of function variant rs1799853(T) (NM_000771:c.430C>T, NP_000762:p.144R>C)   /. Studies of the effects of these alleles include:  rs1057910(C;C) genotypes may clear drugs like celecoxib (trade name Celebrex) twice as slowly as rs1057910(A;A) genotypes; the rs1057910(A;C) genotypes are in-between clearance rates. Lower clearance rates will lead to higher internal concentrations of the drug. It is not clear whether this could lead to increased efficacy and/or increased side effects.   rs1057910(C;C) genotypes are poor metabolizers of tolbutamide, a sulfonylurea hypoglycemic drug used in the treatment of diabetes.   rs1057910(C;C) genotypes are poor metabolizers of phenytoin, a drug used to treat epilepsy, and therefore tend to need lower doses.  Note however that the / CPIC (and  FDA) recommend testing for the HLA-B 15:02 allele, since carriers are at significantly increased risk of Stevens-Johnson syndrome (SJS/PTEN).  rs1057910(C;C) genotypes are poor metabolizers of glipizide, a second generation sulfonylurea drug structurally similar to tolbutamide and also used as an oral hypoglycemic agent.   rs1057910(C;C) genotypes are poor metabolizers of warfarin, and therefore unusually sensitive.    See also  OMIM 601130.0001Individuals carrying this SNP may show increased risk of developing acute gastrointestinal bleeding during the use of NSAIDs that are CYP2C8 or CYP2C9 substrates, such as aceclofenac, celecoxib, diclofenac, ibuprofen, indomethazine, lornoxicam, meloxicam, naproxen, piroxicam, tenoxicam and valdecoxib.12x risk of severe cutaneous adverse reactions when taking antiepileptic drug phenytoin.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1765]]
    <blockquote>
        <p class="text-snippet" data-id="1765">blog ENPP1 harbors a mutation with a derived state known to protect against obesity and type II diabetes27 that is present in 90% of non-Africans but virtually absent in Africans  K121Q (rs1044498) The Q allele of ENPP1 K121Q is associated with hyperglycemia and insulin resistance in whites. increased fasting plasma glucose (FPG), A1C, fasting insulin, and insulin resistance by homeostasis model assessment (HOMA-IR; all P = 0.01-0.006).  Association of ENPP1 gene polymorphisms with hand osteoarthritis in a Chuvasha population. Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesity. ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study. Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Gender differences in the relationship of ENPP1/PC-1 variants to obesity in a Turkish population. Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes. The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program. Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study. Association of maternally inherited GNAS alleles with African-American male birth weight. Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder. The ENPP1 K121Q polymorphism is not associated with type 2 diabetes or obesity in the Chinese Han population. Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans. Meta-analysis of association studies between five candidate genes and type 2 diabetes in Chinese Han population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5244]]
    <blockquote>
        <p class="text-snippet" data-id="5244">Although the insertion is supposed to be the minor allele, the majority of FTDNA v2 and 23andMe v2 results show II as the result, so use caution when interpreting this result.rs34815109 is one of four SNPs all describing an insertion/deletion polymorphism in the promoter region of the UGT1A1 gene. This gene encodes a protein that modifies hepatic bilirubin in order to allow it to be excreted. SNPs that reduce the activity of the UGT1A1 gene therefore tend to increase serum bilirubin levels.The rs34815109(TA) allele represents the insertion variant, which actually adds a seventh (TA) pair to what is already a string of six (TA) pairs; this reduces the activity to 30% of normal, and is thus the risk allele. The risk allele is commonly referred to as the UGT1A1 28 allele, and it is homozygous in ~10% of the US population.Risks associated with the rs34815109(TA) allele are almost always associated with the homozygous (TA;TA) genotype, with smaller (or no) effects seen for rs34815109(-;TA) heterozygous carriers. These risks include:  An increased risk for breast cancer is reported in premenopausal African-American women, based on a study of 200 women. The reported odds ratio was 1.8 (CI: 1.0-3.1, p=0.06) for carriers of one or more UGT1A1 28 alleles.  In colorectal cancer patients being treated with irinotecan, adverse side effects (neutropenia and/or severe diarrhea) are reported to be strongly associated with the number of UGT1A1 28 alleles. Patients homozygous for the  28 allele are 3.5 times more likely to develop severe neutropenia compared with individuals with the wild genotype. The FDA has approved a genetic test for UGT1A1 status to be used to determine dosage when considering irinotecan therapy  FDA press release. However, no prospective study has examined whether a reduced dose of irinotecan results in a reduced rate of adverse drug events.  Hyperbilirubinemia, a potentially toxic increase in bilirubin levels, is possible among rs34815109(TA;TA) individuals treated with the drug tranilast.The three other SNPs that describe the same polymorphism are:  rs34983651  rs35600288  rs5839491</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1839]]
    <blockquote>
        <p class="text-snippet" data-id="1839">rs6427196 is located in the F5/NME7 region on chromosome 1q24.2 at position 167747847.  This SNP is in the 3&#8217; untranslated region of F5.  F5, also known as coagulation factor V (proaccelerin, lavile factor), encodes an essential cofactor of the blood coagulation cascade and defects in this gene have been known to result in either an autosomal recessive hemorrhagic diathesis or an autosomal dominant form of thrombophilia.  Recently, this SNP has been found to be associated with venous thromboembolism (VTE).  VTE, which can manifest itself as either deep venous thromboembolism (DVT) or pulmonary embolism (PE), is a common cardiovascular condition with a high mortality rate .  Annually, ~2 million adults develop DVT and approximately 600,000 PE hospitalizations and 60,000 deaths occur .  In a study done by Tang et al., a two-stage genome-wide association study (GWAS) was conducted by first analyzing the top SNP associations for total incident VTE in CHARGE (cohorts for heart and aging research in genomic epidemiology) and then the second-stage studies were performed using data from three case-control studies: the Mayo Clinic VTE Study, the MARseille Thrombosis Association VTE Study, and a French case-control study on early-onset VT.  In the CHARGE GWAS, 1,618 VTE cases were included from 44,499 participants, all of which were of European origin.  From that, the top 1,047 SNPs identified as having the greatest association were analyzed in 3,231 VTE cases and 3,536 controls.The initial CHARGE GWAS revealed that the rs6427196 G minor allele had a risk ratio (RR) of 1.82 with a 95% confidence interval (CI) of 1.58 to 2.10.  The p-value of this association was 1.97 x 10-16.  The second-stage analysis gave a RR of 2.31 with a 95% CI of 2.04 to 2.62 and a p-value of 2.56 x 10-38.  At this point, all the studies were combined to give an overall RR and p-value which indicated rs6427196 as the highest associated SNP with VTE.  The overall RR was 2.07 (95% CI = 1.89 &#8211; 2.28) and a p-value of 4.47 x 10-51.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q34]]
    <blockquote>
        <p class="text-snippet" data-id="34">rs2235015 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein (P-glycoprotein - Pgp) that transports certain molecules across the blood-brain barrier. SNPs in ABCB1 may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. Clinical studies on antidepressant drug dosage, plasma medication levels and treatment outcome suggest monotonic associations for tricyclic antidepressant drugs  and threshold models or higher order relationships for selective serotonin reuptake inhibitors PMID 28648553 and newer antidepressant drugs ,.  However, the link between the increased brain concentrations of antidepressants and a clinically significant response is still to be confirmed. According to a recent review , ten studies reported that ABCB1 SNPs have clinical effect on depression outcome and eight - that they do not. However those 18 studies are difficult to compare because they vary within their study design concerning following factors: population (ethnicity, psychiatric condition), tested SNPs, tested antidepressants (Pgp substrates and Pgp non-substrates) and doses, inclusion of drug metabolism monitoring and statistical correction for multiple testing.A study of ~400 of German psychiatric inpatients with depression conducted in 2007 by Uhr et al  found that rs2235015(T) carriers treated with ABCB1 substrates were more likely to remit. However, this result could not be reproduced in a large (N~900) trial with outpatients with major depression treated with the ABCB1 substrate citalopram (STAR-D study, level 1). According to a recent meta analysis , no significant association of antidepressant treatment outcome with this SNP among all studies, but the association remained significant in a subgroup-analysis of all inpatients. rs2235015 is near the 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. rs2235015 has an r<sup>2</sup> value of >0.5 with this group :  rs2235067  rs4148740  rs2032583  rs4148739  rs11983225  rs2235040  rs12720067  rs7787082  rs10248420</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1354]]
    <blockquote>
        <p class="text-snippet" data-id="1354">rs10046 is a SNP potentially linked in a gender-specific manner to hypertension rs10046(C;C) associated with miscarriages (P = 0.017) Polymorphisms associated with circulating sex hormone levels in postmenopausal women. Multilocus analysis of SNP and metabolic data within a given pathway. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants. Genome-wide association with bone mass and geometry in the Framingham Heart Study. Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set. Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome. Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study. A single-nucleotide polymorphism in the aromatase gene is associated with the efficacy of the aromatase inhibitor letrozole in advanced breast carcinoma. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer. Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer. Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women. Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women. Epistasis between FSHR and CYP19A1 polymorphisms is associated with premature ovarian failure.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q249]]
    <blockquote>
        <p class="text-snippet" data-id="249">rs2494732 is a SNP in the AKT1 gene, encoding one of three serine/threonine-protein kinases regulating numerous processes such as cell survival, growth and angiogenesis. Medical conditions that may be linked to the rarer (minor) rs2494732(C) allele include drug response, schizophrenia, and drug-related psychoses, in particular, cannabis-related psychosis.  A study of 442 healthy, once-a-month cannabis users between the ages of 16-23 to see if AKT1 variants influenced acute psychosis response concluded that the number of rs2494732(C) alleles predicted (p = 0.015) acute (i.e. temporary) psychotic response to cannabis. Basically, the more copies someone had of this SNP, the more likely they were to have mind-altering symptoms while stoned. Other factors studied, including gender, ethnicity, and years of cannabis use, did not predict whether they would have these (transient) symptoms. Note that this side-effect (psychosis or paranoia) was infrequent in an absolute sense regardless of genotype. A case-control study of 489 first-episode psychosis patients concluded that while rs2494732 was not associated with an increased risk of a psychotic disorder, with lifetime cannabis use, or with frequency of use, there was a significant association between psychosis and cannabis use. rs2494732(C;C) individuals with a history of cannabis use had an increased likelihood of a psychotic disorder (odds ratio 2.18, CI: 1.1 - 4.3) when compared with users who were (T;T) carriers. The interaction between the rs2494732 genotype and frequency of use was also somewhat significant (likelihood ratio = 13.39; p = .010). Among daily users, (C;C) carriers had a 7x increase in the odds of psychosis compared with (T;T) carriers (odds ratio 7.23, CI: 1.37 - 38.12). among (likely Japanese) 120 first-episode neuroleptic-naive schizophrenics treated with risperidone genotyped for 30 variants in misc. dopamine and serotonin (receptors and otherwise) two SNPs in DRD2 (rs1799989 and rs1800497) and two SNPs in AKT1 (rs3803300 and rs2494732) were significant predictors of treatment response to risperidoneThe ancestral allele is C in the  dbSNP database.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q214]]
    <blockquote>
        <p class="text-snippet" data-id="214">This is a good proxy for alpha-2B-adrenergic receptor gene (ADRA2B) deletion polymorphism (del301303; rs4066772). The minor rs2229169 allele was in a strict linkage disequilibrium with the deletion of three amino acids in ADRA2B (Ins/Del301-303) in a mixed AfricanAmerican/white group  and in a large Chinese study .Alpha-2B adrenergic receptors contribute to norepinephrine stimulation in the brain and to peripheral vasoconstriction. The deletion polymorphism del301303 encodes a version of the receptor that, unlike normal alpha-2B receptors, fails to decrease its activity (desensitize) in response to prolonged stimulation . This may result in both negative cardiovascular consequences and positive cognitive effects.A large population cohort of Finnish middle-aged men (1606 men, mean age at the start 53 years) was followed for the average time of 18 years. Acute coronary events defined as hospitalizations for myocardial infarction or prolonged acute chest pain were more frequent in the men with del301303 polymorphism: Del/Del OR=1.57 (P=0.002), Del/Ins OR=1.25 (P=0.077), Ins/Ins OR=1. Associations with the number of sudden cardiac deaths and overall cardiac heart disease mortality were also observed, but they would not be significant after correcting for multiple comparisons. A study of Koreans compared more than 600 patients hospitalized for an ischemic stroke with control subjects. The deletion polymorphism conferred higher risk of ischemic stroke: Del/Del OR=1.78 (P=0.007), Del/Ins OR=1.25 (P=0.107), Ins/Ins OR=1. Association of the deletion genotype with small-vessel disease was the main contributor to the risk. In a study of more than 400 young Swiss adults, the carriers of del301303 polymorphism had about 20% better memory for emotional photographs, both positive and negative. This enhancement of emotional memory was selective: the level of emotions caused by the photographs, the memory for neutral photographs, working memory, and attention were not dependent on genotype. Among the Rwandan genocide refugees, the same authors found the deletion to be associated with increased re-experiencing of traumatic events but independently from PTSD, which was distributed equally among the genotypes. Homozygous rs2229169 Chinese subjects, being by extension del301303 homozygotes, also had about 20% better (shorter) reaction time in a stop-go cognitive test as compared to wild-type homozygotes.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3414]]
    <blockquote>
        <p class="text-snippet" data-id="3414">Icelanders with two copies of the rare T allele at SNP in the MYH6 gene, also known as c.2161, have an increased risk of sick sinus syndrome (SSS), also known as sinus node dysfunction. No rs# has yet been assigned to this location. SSS is a group of disorders that affect heart rhythm.MYH6 c.2161C>T was discovered in a GWAS published in March 2011 .  The discovery phase included 792 Icelandic cases with 37,592 Icelandic controls.  The SNPs with the strongest associations with SSS were rs2231801, rs28730774 and 14-22399934.  Since rs28730774 was the most significant SNP on the HumanOmni1-Quad chip (p = 1.6E-11; OR = 3.49; minor allele frequency = 0.01), it was studied further. In the second phase of the study, 7 chip-typed Icelandic cases (4 with the rs28730774 SNP) and 80 chip-typed Icelandic controls were subjected to whole genome sequencing.  In this analysis, the MYH6 c.2161C>T variant had the strongest association with SSS.  The mutation is located in exon 18 of the MYH6 gene and leads to an arginine to tryptophan amino acid alteration at amino acid 721.       In a follow-up validation study, the odds-ratio was calculated as OR = 12.95 with a p-value = 3.8E-5.  No homozygotes were identified.  Additionally, 184 Danish, 94 Dutch and 1498 US controls were compared to 135 US SSS cases, and no carriers of MYH6 c.2161C>T were found. The lifetime risk of being diagnosed with sick sinus syndrome was reported to be around 6% for non-carriers of c.2161C>T but approximately 50% for carriers of this (c.2161C>T) variant.  alpha-MyHC is also associated with a 4.16-beat per minute decrease in heart rate (p=0.0019).The minor allele (T) results in a missense mutation in the ''MYH6'' gene, encoding the alpha-myosin heavy chain (alpha-MyHC) protein.  This protein is a fast ATPase present mainly in atrial tissue.  The p.Arg721Trp variant resides in part of the converter domain of alpha-MyHC and is important for amplifying structural rearrangements of myosin during contraction.  This variant has been predicted to result in structural alterations .       As of May 2011, no frequency data are available.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4031]]
    <blockquote>
        <p class="text-snippet" data-id="4031">rs8192678 encodes a SNP also known as Gly482Ser; the (A) allele encodes the Ser. Some reports have linked this SNP to risk for hypertension and systolic blood pressure (SBP). However, a meta-analysis of 13,000+ individuals did not find any such association. However, gene-age interaction was apparent. For diastolic blood pressure (DBP), p(interaction)<0.0001; for systolic BP, p(interaction)=0.026. In younger individuals (<50yrs; n=2511) the rs8192678(A) allele was associated with higher DBP (p=4.2 x 10<sup>-12</sup>) and SBP (p=7.2 x 10<sup>-12</sup>), but no association was evident for individuals over 50yrs (n=5088). Analysis of PGC-1alpha variants Gly482Ser and Thr612Met concerning their PPARgamma2-coactivation function. PPARGC1A coding variation may initiate impaired NEFA clearance during glucose challenge. Frequencies of single nucleotide polymorphisms in genes regulating inflammatory responses in a community-based population. Medical sequencing at the extremes of human body mass. Polymorphisms of the peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy. PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study. Association study between PPARGC1A Thr394Thr/ Gly482Ser polymorphisms and type 2 diabetes. Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis. The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease. PGC-1alpha as modifier of onset age in Huntington disease. Is there an optimum endurance polygenic profile? The Role of the PGC1alpha Gly482Ser Polymorphism in Weight Gain due to Intensive Diabetes Therapy. Do PPARGC1A and PPARalpha polymorphisms influence sprint or endurance phenotypes? Is there an interaction between PPARD T294C and PPARGC1A Gly482Ser polymorphisms and human endurance performance? Localization of sequence variations in PGC-1alpha influence their modifying effect in Huntington disease. Meta-analysis of association studies between five candidate genes and type 2 diabetes in Chinese Han population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5034]]
    <blockquote>
        <p class="text-snippet" data-id="5034">rs4986790, a SNP also known as Asp299Gly (and also 896A/G) in the TLR4 gene, is often studied along with a cosegregating SNP known as Thr399Ile, rs4986791. (TLR4 encodes a receptor involved in the innate immune response.) Together, these SNPs have been reported to be associated with a wide variety of both infectious and non-infectious diseases, although there are conflicting or even contradictory results also reported in some cases. The risk allele for rs4986790 is (G).Reported associations include :  Diabetic neuropathy   These SNPs may be protective   Heart disease   Men with the risk alleles for both SNPs are at increased risk for myocardial infarction in this study of over 2000 individuals.    rs4986790(G) carriers are not at increased risk for myocardial infartions, at least in this study of ~200 individuals.    rs4986790(G) carriers are less likely to have heart attacks, in this study of ~400 individuals.    Individuals with the risk alleles for both SNPs have a lower incidence of carotid stenosis   Premature birth   Individuals with the risk alleles for both SNPs have a higher incidence for having their pregnancies associated with premature birth   Bacterial vaginosis   Pregnant rs4986790(G) carriers are at increased risk for higher pH and a 10 fold higher level of certain bacteria   Bacterial infection   Individuals with the risk alleles for both SNPs are more prone to gram-negative bacterial infections   Septic shock   Individuals with the risk alleles for both SNPs are at higher risk for septic shock   Respiratory syncytial virus infection   Individuals with the risk alleles for both SNPs are at higher risk for this type of viral infection.   Asthma   Although not seen to influence the incidence of developing asthma, rs4986790(G) carriers who had asthma are reported to be more severely affected.   Allograft rejection   Carriers of the risk alleles of either rs4986790 or rs4986791 have a lower rate of acute allograft rejection following lung transplantation.   Alzheimer's disease   A study of 626 Northern Italian Alzheimer patients (427 women and 199 men; age range: 53-98 years; mean age: 74.88 +/- 8.44) found that rs4986790 was associated with increased risk for the disease.  cirrhosis rs4986790 and rs4986791 Results of three independent samples did not confirm previously reported association of rs4986790 with AMD, individually or combined.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1058]]
    <blockquote>
        <p class="text-snippet" data-id="1058">rs708272, also known as the TaqIB polymorphism of the CETP gene, may influence the levels of the "good" cholesterols, the high density lipoprotein (HDL) cholesterols. Generally, the B2 allele is considered to lead to higher HDL levels.However, high HDL cholesterol, at least when combined with another HDL raising SNP (rs1800588), doesn't appear to actually protect individuals from coronary artery disease, at least based on one study of ~800 Caucasian male patients. A similarly confusing picture emerges from a study of two populations of 10,000+ individuals each. The distribution of the CETP genotype was observed to be different in population-based studies compared with studies in populations selected by high cardiovascular risk, and contradictory results were seen when trying to figure out if the TaqIB SNP predicted whether drugs would lower plasma lipids or cardiovascular outcome.A meta-analysis concluded that there probably was a statistically significant, but weak, association for this SNP. For each rs708272(T) allele inherited, individuals had lower mean CETP mass (-9.7%; CI: -11.7% to -7.8%), lower mean CETP activity (-8.6%; CI: -13.0% to -4.1%), higher mean high-density lipoprotein cholesterol (HDL-C) concentrations (4.5%; CI: 3.8%-5.2%), and higher mean apolipoprotein A-I concentrations (2.4%; CI, 1.6%-3.2%). The combined per-allele odds ratios (ORs) for coronary disease were 0.95 (CI: 0.92-0.99).A prospective cohort study of 18,245 initially healthy American women over a 10-year period found similar results with respect to HDL-C levels and (inversely) risk of myocardial infarction; rs708272(T) was associated with a per-allele increase in HDL-C levels of 3.1 mg/dL and a concordant 24 percent lower risk of future myocardial infarction (age-adjusted HR 0.76, CI: 0.62-0.94).rs708272 has also been associated with reduced coronary heart disease risk in those drinking alcohol. More specifically, a 2014 study by Mehlig et al., ( studying 618 patients with CHD found that the B2B2 genotype, rs708272(T;T)), had a reduced risk (odds ratio 0.21) for CHD in intermediate vs low drinkers. Review: CETP & CAD Risk</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2225]]
    <blockquote>
        <p class="text-snippet" data-id="2225">rs421016, also known as L444P or Leu444Pro, is a SNP causing an amino acid change in the GBA gene; it is among the most common mutations associated with Gaucher disease of any type.  Amino acid predictions from genome sequence may predict this as L483P or Leu483Pro; this disparity in position calling may be due to a 39 peptide signal sequence. Polyphen 2 predicts  P04062 L483P to be "possibly damaging" with a score of 0.857 (sensitivity: 0.83; specificity: 0.93). ( P04062 is the uniprot ID for GBA.)The risk allele (in current dbSNP orientation) is (G), and as the inheritance is autosomal recessive, individuals must either be compound heterozygotes (for two different GBA mutations) or rs421016(G;G) homozygotes to develop Gaucher disease. There are over 300 mutations now known to occur in the GBA gene, with many associated with increasing risk for either type I, II, or III Gaucher disease.This SNP (along with others associated with Gaucher disease) is studied extensively in Ashkenazi Jewish populations where it is found in relatively high frequency.Note: this SNP used to have a "mirror" SNP, rs35095275, representing the opposite strand yet the same exact nucleotide position; it has now been merged into this SNP.One copy of rs421016(G) has also been shown to increase the risk of Parkinson's disease ~5 fold across multiple ethnicities, and to lower a bit the age of onset of Parkinson's. In one study, the estimated age-specific risk for Parkinson's disease at 60 and 80 years of age was 4.7% and 9.1% among Gaucher disease patients, i.e. those carrying two Gaucher GBA mutations, compared with 1.5% and 7.7% among GBA mutation heterozygotes, and 0.7% and 2.1% for carriers of zero Gaucher GBA mutations, respectively. Note that these risks are pooled over multiple GBA mutations including rs421016 as well as other GBA variants. Genotype assignment in Gaucher disease by selective amplification of the active glucocerebrosidase gene. Complex alleles of the acid beta-glucosidase gene in Gaucher disease. Characterization of mutations in Gaucher patients by cDNA cloning. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4025]]
    <blockquote>
        <p class="text-snippet" data-id="4025">Variations in the peroxisome proliferator-activated receptor-gamma gene and melanoma risk. PPAR-gamma gene polymorphisms and psoriatic arthritis. The Genetics of PPARG and the Skeleton. The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma gene with serum osteoprotegerin levels in healthy Korean women. Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia. Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China. PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease. Association of FTO with obesity-related traits in the Cebu Longitudinal Health and Nutrition Survey (CLHNS) Cohort. Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. PPARG by dietary fat interaction influences bone mass in mice and humans. Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. Genetic Variability of RXRB, PPARA, and PPARG in Wegener's Granulomatosis. Association and interaction of PPAR-complex gene variants with latent traits of left ventricular diastolic function. Joint effect of peroxisome proliferator-activated receptor gamma genetic polymorphisms and estrogen-related risk factors on breast cancer risk: results from a case-control study in Taiwan. Variants of the human PPARG locus and the susceptibility to chronic periodontitis. PPARG gene promoter polymorphism is associated with non-traumatic hip fracture risk in the elderly Slovenian population: a pilot study. Application of back propagation artificial neural network on genetic variants in adiponectin ADIPOQ, peroxisome proliferator-activated receptor-gamma, and retinoid X receptor-alpha genes and type 2 diabetes risk in a Chinese Han population. Association of PPAR-gamma gene polymorphisms with obesity and obesity-associated phenotypes in north indian population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1841]]
    <blockquote>
        <p class="text-snippet" data-id="1841">rs324420, also known as c.385C>A or Pro129Thr, is a SNP in the fatty acid amide hydrolase FAAH gene, which has shown associations with some substance use disorders. rs324420(C) encodes the more common Pro, while the (A) allele encodes the Thr.Among 80 individuals with drug abuse or alcoholism and over 1,000 controls, the odds ratio for risk of problem drug or alcohol use among rs324420(A;A) individuals was 4.5 (CI: 2.2 - 8.4); the odds ratio for risk of street drug use was 2.2 (CI: 1.3&#8211;3.7); and the odds ratio for risk of combined street drug use and problem drug/alcohol use was 4.9 (CI: 2.5&#8211;9.7)When this study was pooled with the results of another study of 249 subjects with documented multiple different drug addictions compared to drug free individuals of the same ethnic backgrounds, the results were consistent and even more significant (p = 0.00003). Risk for drug dependence (and drug abuse was associated with rs324420(A;A) homozygotes. In a study of 40 daily marijuana users who abstained for 24 h and were then presented with a cue-elicited craving paradigm, followed by smoking a marijuana cigarette, rs324420(A) was significantly associated with changes in withdrawal after abstinence and with happiness after smoking marijuana, but was not associated with changes in heart rate after smoking or with changes in craving or other acute effects.This variant has also been associated with pain insensitivity. In a 2016 study, ~1000 women undergoing surgery for breast cancer were tested for cold and heat pain sensitivity; rs324420(A;A) individuals reported significantly lower cold pain sensitivity and less need for postoperative analgesia. The rs324420(A;C) genotype was also seen in a woman with unusually high pain tolerance, along with a ~8kb heterozygous microdeletion of the adjacent FAAH pseudogene.And from a different perspective, a 2016 study published in the Journal of Happiness Studies found "a strong correlation between a nation's happiness and the presence of the (rs324420) A allele in the fatty acid amide hydrolase (FAAH) gene". ( news mention; )  See also  OMIM</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2172]]
    <blockquote>
        <p class="text-snippet" data-id="2172">rs17026688 is a SNP located in an intron of the glutamate decarboxylase-like 1 GADL1 gene. It is linked to rs17026651, and both are 100% linked to a 1 base deletion known as 'GADL1 IVS8+48delG' (rs201973599).In a study of ~1,700 patients of Han Chinese descent with bipolar disorder, researchers discovered that almost all of the patients who responded well to lithium treatment had at least one IVS8+48delG GADL1 allele. Initially, the researchers were focused on two nearby SNPs, rs17026688 and rs17026651, that turned out to be proxies (due to being in high linkage disequilibrium) for the deletion variant. rs17026688(T) is the "response allele", meaning that at least in these Asian patients, bipolar patients who are carriers of at least one (T) allele are predicted to respond well to lithium treatment; rs17026688(C;C) patients are predicted to respond poorly.The odds ratios and probabilities for this study are so high that the authors are able to calculate sensitivity, specificity, and positive and negative predictive values (PPV; NPV) for the connection between this DNA variant and being a bipolar patient who will respond well (or not) to lithium treatment. In a pooled cohort of ~400 patients, roughly divided equally between those responding well to lithium or not, the odds ratios, p values, sensitivity, specificity, PPV and NPV were around 80, 1 x 10e-50, 93%, 87%, 83% and 95%, respectively. To put it another way, while overall about half of all patients had a response allele and half didn't, only 1 in 14 patients who responded well to lithium lacked a response allele, and only 1 in 8 of those who did not respond well had a response allele. The authors naturally suggest the use of these SNPs as useful biomarkers for which patients with bipolar disorder will respond well to lithium treatment, and they also intend to (1) look for additional GADL1 gene variants acting similarly, especially in non-Asian populations given the rarity of this particular deletion variant outside of Asian population, and (2) see if these variants influence lithium treatment outcomes in other affective disorders such as major depressive disorder.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5447]]
    <blockquote>
        <p class="text-snippet" data-id="5447">rs1344706 is a SNP in the ZNF804A gene, and it is probably the first SNP to have been reported as achieving genome-wide significance for psychosis. Reviews the literature, and concludes that rs1344706 is "robustly, if modestly" associated with increased risk for schizophrenia.  A genome-wide association study of schizophrenia (479 cases, 2,937 controls) followed by additional testing and a meta-analysis concluded that the strongest evidence for association was around ZNF804A (rs1344706; p = 1.61 x 10e-7) and that the finding was strengthened when the affected phenotype included bipolar disorder (p = 9.96 x 10e-9). Executive function, neural circuitry, and genetic mechanisms in schizophrenia. Apoptotic engulfment pathway and schizophrenia. Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpoint. Expanding the range of ZNF804A variants conferring risk of psychosis. Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia? ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia. The impact of a genome-wide supported psychosis variant in the ZNF804A gene on memory function in schizophrenia. ZNF804A may be associated with executive control of attention. Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population. Evidence of sex-modulated association of ZNF804A with schizophrenia. Impact on schizotypal personality trait of a genome-wide supported psychosis variant of the ZNF804A gene. ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype. Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A. The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms. Association of the ZNF804A gene polymorphism rs1344706 with white matter density changes in Chinese schizophrenia. Genome-wide supported psychosis risk variant in ZNF804A gene and impact on cortico-limbic WM integrity in schizophrenia. ZNF804a regulates expression of the schizophrenia-associated genes PRSS16, COMT, PDE4B, and DRD2. The effects of psychosis risk variants on brain connectivity: a review. Association analysis of ZNF804A (zinc finger protein 804A) rs1344706 with therapeutic response to atypical antipsychotics in first-episode Chinese patients with schizophrenia.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4729]]
    <blockquote>
        <p class="text-snippet" data-id="4729">rs4149056, also known as c.521T>C, Val174Ala or V174A, is a SNP in the SLCO1B1 gene, which encodes the 'organic anion transporting polypeptide 1B1' (OATP1B1) protein. This protein, found primarily in the liver, regulates the uptake of numerous drugs and natural compounds. The rs4149056(C) SNP defines the SLCO1B1 5 allele.The rs4149056(C) allele gives rise to an amino acid change (from valine to alanine at residue 174) which has reduced uptake/transport activity. Therefore, drugs metabolized by OATP1B1 tend to build up to higher circulating concentrations than they would otherwise..The drugs known (or in some cases, thought) to be transported less well by the variant OATP1B1 protein encoded by the rs4149056(C) allele include: Several cholesterol lowering statins, generally leading to reduced inhibitory effects on liver cholesterol synthesis and possibly worse side effects, by such drugs as:  simvastatin  pravastatin  rosuvastatin  pitavastatin fexofenadine repaglinide methotrexate the SN-38 active metabolite of irinotecan rifampicin caspofungin lopinavir rs4363657 in nearly complete linkage disequilibrium with rs4149056 SNP (r<sup>2</sup>=0.97), which has been linked to statin metabolism. rs4149056(C) odds ratio for myopathy among 20,000 individuals taking either 40 or 80mg of simvastatin daily was 4.5 (CI: 2.6-7.7) per copy of the C allele, and 16.9 (CI: 4.7-61.1) in (C;C) as compared with (T;T) homozygotes. The Gene Sherpa points out a 16x odds ratio for myopathy when taking statins and suggests fenofibrates might be a good alterative.From Coriell (re SLCO1B1 haplotypes): rs72559745 (SLCO1B1 1)AAAA rs56061388 (SLCO1B1 3)TTTT rs4149056 (SLCO1B1 5)TTTT rs55901008 (SLCO1B1 6)TTTT A study of ~500 individuals taking statins concluded that rs4149056(C), i.e. SLCO1B1 5, was associated with statin-induced side-effects, most likely somewhat correlated to the number of such alleles being carried. A study of >4000 individuals with type 2 diabetes using routine prescribing data from the Electronic Medical Record in Tayside Scotland suggests high proportion rs4149056(C) homozygotes discontinue or reduce their  doses of statins / 23andMe blog discussion of this SNP SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalinkStatin Response</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3256]]
    <blockquote>
        <p class="text-snippet" data-id="3256">rs2333227 is a SNP in the promoter region of the myeloperoxidase MPO gene; it is also known as the -463 variant. It has been implicated in Alzheimer's disease, lung cancer, gastric cancer, and lupus nephritis in SLE patients.In connection with Alzheimer's disease (AD):  A study of 127 Finnish patients concluded that the rs2333227(T) allele increased the risk of Alzheimer's disease by 3.8 fold. This was derived by noting that a man with an ApoE allele has an AD odds ratio of 3.0 if they don't also have an rs2333227(T) allele, and an odds ratio of 11.4 if they do.  A study of 148 Italian sporadic AD patients yielded an odds ratio for the rs2333227(C;C) genotype (as oriented in dbSNP orientation) of 1.78 (CI: 1.13-2.80). The presence of rs669(G;G), in addition to rs2333227(C;C), appears to  synergistically increase the risk of AD to an odds ratio of 25.5 (CI: 4.65-139.75), regardless of ApoE status.In connection with lung cancer:  A pooled analysis of data from 10 studies (3688 cases) found an odds ratio for lung cancer of 0.88 (CI: 0.80-0.97) for rs2333227(C;T) heterozygotes, and 0.71 (CI: 0.57-0.88) for (T;T) homozygotes. This protective effect applied to both men and women, and appeared to apply to "ever" smokers but not "never" smokers.In connection with lupus nephritis:  While there was no association with lupus (SLE) per se in this study of 200+ African-American patients, the risk of developing lupus nephritis among SLE patients was significantly higher among rs2333227(C;T) heterozygotes compared with (C;C) homozygotes (odds ratio 2.11, CI: 1.12-3.97), and it was even higher for (T;T) homozygotes versus (C;C) (odds ratio 3.52, CI: 1.41-8.77).In connection with gastric cancer:  rs2333227(T) carriers are at increased risk for gastric cancer, based on a study of 157 Taiwanese patients. If they are also H. pylori-infected, they have a 7.9x increased risk of gastric cancer, either intestinal or diffuse types.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5184]]
    <blockquote>
        <p class="text-snippet" data-id="5184">A meta-analysis including eight studies (totaling 6,976 cases and 7,089 controls) reports an association between rs179247 (A) with Graves disease (odds ratio 1.4, CI: 1.353-1.495, p<0.001), and the associations were the same under dominant, recessive and co-dominant models. A 2016 study titled "Dissecting the Genetic Susceptibility to Graves' Disease in a Cohort of Patients of Italian Origin"  found that Three SNPs in the 3q locus showed a nominal association with Graves' disease: rs13097181 (p=3.7103, OR: 2.0), rs7633131 (p=7.7103, OR: 1.7), and rs6792646 (p=7.8103, OR: 1.5). In addition, they found associations with the TSHR gene at rs179247 (p=3.94106), the CTLA-4 gene at rs231775 (p=1103), and the TG gene at rs2069561 (p=0.029). No risk alleles were identified; they merely aimed to prioritize genes and SNPs in relation to Graves' disease. In contrast, "Notably, there were no associations with CD40, CD25, and FOXP3." They concluded that "Our findings highlight the importance of ethnic variation in the association of different polymorphisms with GD even within the same candidate gene.". Published 2010. Both rs179247 allele A (P=1.210(-2)-6.210(-15), OR=1.38-1.45) and rs12101255 allele T (P=1.010(-4)-3.6810(-21), OR=1.47-1.87) exhibited strong association with GD in all three cohorts. . Published 2009. "28 SNPs revealed association with GD (P < 0.05), with strongest SNP associations at rs179247 (P = 8.90 x 10(-8), OR = 1.53, 95% CI = 1.32-1.78), rs3783948 (P = 6.5  10 5 , OR = 1.52, 95% CI = 1.301.78), and rs12101255 (P = 1.95 x 10(-7), OR = 1.55, 95% CI = 1.33-1.81).  They also provided "preliminary evidence that the disease-associated genotypes of rs179247 (AA) and rs12101255 (TT) show reduced mRNA expression ratios of flTSHR relative to two alternate TSHR mRNA splice variants."</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5326]]
    <blockquote>
        <p class="text-snippet" data-id="5326">Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. Polymorphisms in the vascular endothelial growth factor gene and the risk of familial endometriosis. Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Vascular endothelial growth factor gene polymorphisms may predict the risk of acute graft-versus-host disease following allogeneic transplantation: preventive effect of vascular endothelial growth factor gene on acute graft-versus-host disease. Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformation. Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis. The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. Gene polymorphism of vascular endothelial growth factor -1154 G>A is associated with hypertensive nephropathy in a Hispanic population. Genetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphisms. Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritis. Contribution of VEGF polymorphisms to variation in VEGF serum levels in a healthy population. Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma. Pooled-analysis of the associations between three polymorphisms in the VEGF gene and age-related macular degeneration. Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy. Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: differential effect of cigarette smoking. Role of Vascular Endothelial Growth Factor Polymorphisms in the Treatment Success in Patients with Wet Age-related Macular Degeneration.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2574]]
    <blockquote>
        <p class="text-snippet" data-id="2574">rs17238540, also known as SNP 29, is located in the HMG-CoA reductase HMGCR gene. The protein encoded by this gene is the target for drugs designed to inhibit its action, in order to lower cholesterol levels. SNPs in the HMGCR gene may affect how well such drugs (typically statins) work.In a study of ~1,500 patients treated with 40mg/d of pravastatin, rs17238540(G;T) heterozgyotes had a mean decrease in total cholesterol of 32.5 mg/dL (0.85 mmol/L), while the mean change for rs17238540(T;T) homozygotes was 41.8 mg/dL (1.09 mmol/L), a reduction in overall efficacy of 22.3% (absolute difference, 9.3 mg/dL, CI: 3.8-14.7 mg/dL, p<.001). The drop in total cholesterol was almost completely due to the decrease in LDL cholesterol, as there was no significant difference in the change in HDL cholesterol with pravastatin between genotypes.A separate study of 1,000 Scottish individuals taking statins found that 28% of rs17238540(T;T) individuals failed to reach target compared with 51% of the individuals carrying a (G) allele, yielding an adjusted odds ratio for failure of 2.93 (CI: 1.61-5.34) mmol/l, p=0.0005. Additionally, they found that heterozygotes had a 13% smaller reduction in total cholesterol (-32.3 vs. -37.1%, p=0.0081) and a 27% smaller reduction in triglycerides (-27.5 vs. -37.6%, p=0.0046), leading to their conclusion that rs17238540(G;T) heterozygotes may respond less well to statin therapy in terms of lowered total cholesterol and triglycerides. This SNP is in tight linkage (r<sup>2</sup>>0.90) with another, rs17244841, so practically speaking, they are equivalent to each other. Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin. Common genetic variation in six lipid-related and statin-related genes, statin use and risk of incident nonfatal myocardial infarction and stroke. The HMG-CoA reductase gene and lipid and lipoprotein levels: the multi-ethnic study of atherosclerosis. The role of HMGCR alternative splicing in statin efficacy. A single nucleotide polymorphism in the 3-hydroxy-3-methylglutaryl-coenzyme A reductase gene ( HMGCR) influences the serum triacylglycerol relationship with dietary fat and fibre in the European Prospective Investigation into Cancer and Nutrition in Norfolk (EPIC-Norfolk) study.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5035]]
    <blockquote>
        <p class="text-snippet" data-id="5035">rs4986791, a SNP also known as Thr399Ile (and also 1196C/T) in the TLR4 gene, is often studied along with a cosegregating SNP known as Asp299Gly, rs4986790. (TLR4 encodes a receptor involved in the innate immune response.) Together, these SNPs have been reported to be associated with a wide variety of both infectious and non-infectious diseases, although there are conflicting or even contradictory results also reported in some cases. The risk allele for rs4986791 is (T).Reported associations include :  Diabetic neuropathy   These SNPs may be protective   Heart disease   Men with the risk alleles for both SNPs are at increased risk for myocardial infarction in this study of over 2000 individuals.    rs4986790(G) carriers are not at increased risk for myocardial infartions, at least in this study of ~200 individuals.    rs4986790(G) carriers are less likely to have heart attacks, in this study of ~400 individuals.    Individuals with the risk alleles for both SNPs have a lower incidence of carotid stenosis   Premature birth   Individuals with the risk alleles for both SNPs are at higher risk for having their pregnancies associated with premature birth.   Bacterial vaginosis   Pregnant rs4986790(G) carriers are at increased risk for higher pH and a 10 fold higher level of certain bacteria   Bacterial infection   Individuals with the risk alleles for both SNPs are more prone to gram-negative bacterial infections   Septic shock   Individuals with the risk alleles for both SNPs are at higher risk for septic shock   Respiratory syncytial virus infection   Individuals with the risk alleles for both SNPs are at higher risk for this type of viral infection.   Asthma   Although not seen to influence the incidence of developing asthma, rs4986790(G) carriers who had asthma are reported to be more severely affected.   Allograft rejection   Carriers of the risk alleles of either rs4986790 or rs4986791 have a lower rate of acute allograft rejection following lung transplantation.   Allograft complications   A study of 300+ recipients of hematopoietic-cell transplants concluded that the adjusted hazard ratio for a recipient of developing a life-threatening invasive aspergillosis infection was 6.16x higher (CI: 1.97-19.26, p=0.002) if the donor carried these TLR4 risk alleles. This risk was statistically significant for unrelated recipients of transplants (odds ratio, 5.0, CI: 1.04-24.01, p=0.04) but did not quite meet the p=0.05 significance criteria for related recipients (odds ratio, 2.29, CI: 0.93-5.68, p=0.07).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q216]]
    <blockquote>
        <p class="text-snippet" data-id="216">Also known as Arg389, variation at this SNP, located in the ADRB1 gene, may encode either the amino acid glycine or arginine at amino acid position 389 of the corresponding protein, the beta-1 adrenergic receptor (hence why it is frequently called Arg389Gly). This protein is the target of beta blocker drugs, and so how well the drug works to help lower a patients high blood pressure depends in part on this SNP. The status of this SNP is often reported together with the status of SNP rs1801252, which encodes an amino acid variant at position 49 of the same (ADRB1) protein. The rs1801253(G) allele encodes the glycine.One of the best known studies of the effects of these 2 separate SNPs on the average efficacy of the beta blocker metoprolol in lowering blood pressure (BP) can be summarized for patients with the corresponding genotypes as follows : rs1801252(A;A) and rs1801253(C;C) carriers: 15 point drop in BP rs1801252(A;G) and rs1801253(C;C) carriers:  9 point drop in BP rs1801252(A;A) and rs1801253(C;G) carriers:  6 point drop in BP rs1801252(A;G) and rs1801253(C;G) carriers: <1 point drop in BPThis SNP may also determine whether the drug bucindolol will have any effect on a particular patient.In a separate study of 600+ women initially referred for coronary angiography and then followed for 6 years, during which time 115 experienced a heart problem, rs1801253(G;G) individuals were calculated to be at higher risk (adjusted hazard ratio 3.63, CI: 1.17&#226;&#8364;&#8220;11.28). This risk was specifically for myocardial infarction, and was only seen in women without obstructive coronary artery disease.Other press releases or articles include:  Alters response to heart failure drugs bisoprolol, metoprolol, and carvedilol   This  press release provides a helpful summary of the PMID 16844790| research paper.  Patent filings, such as USPTO application 20060177838 and others, include claims that "being homozygous in the .beta..sub.1AR gene to encode an arginine at position 389 {ie rs1801253} in the gene product provides the patient with a physiology that is amenable to treatment with bucindolol."(This is a SNP in a different gene.)Beta-Blocker Response</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2371]]
    <blockquote>
        <p class="text-snippet" data-id="2371">rs5443, a SNP in the G-protein beta3 subunit (GNB3) gene that is more commonly known as the C825T variant, has been linked to a number of metabolic conditions including obesity, coronary artery disease, insulin resistance and therefore diabetes, left ventricular hypertrophy, and hypertension. It has also been linked to how well a patient responds to Viagra (sildenafil). Several studies have been unable to replicate one or more of the associations in at least some populations between this SNP and these conditions. The more notable studies include: rs5443(T) allele carriers are 2-3 fold more likely to be obese in Caucasian, Chinese, and African American populations.  rs5443(T) carriers are clearly at higher risk for hypertension, but this review indicates that whether they are also at increased risk for stroke and left ventricular hypertrophy remains controversial.  rs5443(T;T) women gain significantly more weight during pregnancy than rs5443(C;T) or rs5443(C;C) women, and had a significantly higher pre-pregnancy body mass index.   rs5443(T;T) genotypes respond to Viagra better. 91% of them have a "positive erectile response" upon taking Viagra, whereas only around 50% of rs5443(C;T) and rs5443(C;C) individuals respond equivalently to the drug. The odds ratio for the positive response was 10.0 (CI: 1.2 - 81.1, p = 0.01).   rs5443(T;T) patients receiving clozapine over a long term for the treatment of schizophrenia gain significantly more weight (16%) compared to patients carrying at least one rs5443(C) allele in a study of Chinese patients.  rs5443(T) carriers taking triptans for the treatment of migraines or cluster headaches were ~3 fold more likely to respond positively compared with rs5443(C;C) homozygotes (OR 2.96, CI:1.34 - 6.56, p=0.0074) in a study of ~200 Caucasian patients.  rs5443(C;T) genotypes are more prevalent in gastroesophageal reflux disease (GERD) patients relative to healthy controls (odds ratio 1.43, CI: 1.04&#8211;1.98). rs5443(C;C) individuals do not lose weight under sibutramine therapy whereas (C;T) and (T;T) individuals do, based on a study of 131 obese Taiwanese patients. / 23andMe blog</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2001]]
    <blockquote>
        <p class="text-snippet" data-id="2001">This snp influences obesity however   the most strongly linked neighboring snp is rs9939609  some evidence suggests rs1421085 may be the true causative snpThis  plos genetics paper reports rs9930506 showed the strongest association with BMI (p = 8.6  10-7), hip circumference (p = 3.4   10-8) and weight (p = 9.1   10-7). homozygotes for the rare "G" allele were were 1.3 BMI units heavier than homozygotes for the common "A" allele. This SNP did not show any association with obesity, type-2 diabetes or any other related traits in a study of 3,210 Chinese subjects. Furthermore, the minor allele frequency was much lower in Chinese populations compared to populations of European descent. rs9930506 (A;A) showed decreased levels of methylated PPARGC1A in comparison with AG + GG genotypes, suggesting a potential role of promoter PPARGC1A methylation in metabolic programming. Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. Variations in the FTO gene are associated with severe obesity in the Japanese. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Common variation in the fat mass and obesity-associated (FTO) gene confers risk of obesity and modulates BMI in the Chinese population. FTO variants are associated with obesity in the Chinese and Malay populations in Singapore. Fat mass-and obesity-associated (FTO) gene variant is associated with obesity: longitudinal analyses in two cohort studies and functional test. Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Using new tools to define the genetic underpinnings of risky traits associated with coronary artery disease: the SardiNIA study. Tests for candidate-gene interaction for longitudinal quantitative traits measured in a large cohort. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. Common SNPs in FTO gene are associated with obesity related anthropometric traits in an island population from the eastern Adriatic coast of Croatia. Risk of type 2 diabetes and obesity is differentially associated with variation in FTO in whites and African-Americans in the ARIC study. FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. Influence of genomic variation in FTO at 16q12.2, MC4R at 18q22 and NRXN3 at 14q31 genes on breast cancer risk.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5318]]
    <blockquote>
        <p class="text-snippet" data-id="5318">This position is referred to as the -1154 position in many VEGF-associated publications. The normal (or wild type) form of this SNP is a (G). The (A) form reduces the activity of this gene, resulting in less VEGF protein.Individuals with one or more rs1570360(A) alleles are reported to be at about a 3 fold higher risk of developing Sudden Infant Death Syndrome . A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis. Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schonlein purpura. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Functional variation in VEGF is not associated with type 2 diabetes in a United Kingdom Caucasian population. Possible gender-dependent association of vascular endothelial growth factor (VEGF) gene and ALS. VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. VEGF C-634G polymorphism is associated with protection from isolated ventricular septal defect: case-control and TDT studies. VEGF polymorphisms are associated with severity of diabetic retinopathy. Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma. A systematic meta-analysis of genetic association studies for diabetic retinopathy. An analysis of growth, differentiation and apoptosis genes with risk of renal cancer. The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. No association of VEGF polymorphims with Alzheimer's disease. VEGFA polymorphisms and cardiovascular anomalies in 22q11 microdeletion syndrome: a case-control and family-based study. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy. Human genetics of diabetic retinopathy: current perspectives. Gene polymorphism of vascular endothelial growth factor -1154 G>A is associated with hypertensive nephropathy in a Hispanic population. Association of polymorphisms/haplotypes of the genes encoding vascular endothelial growth factor and its KDR receptor with recurrent pregnancy loss. Genetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphisms. Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients. Contribution of VEGF polymorphisms to variation in VEGF serum levels in a healthy population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4885]]
    <blockquote>
        <p class="text-snippet" data-id="4885">rs7574865, a SNP in the third intron of the STAT4 gene, has been reported in a large study of Swedes to be associated with both rheumatoid arthritis (RA) and lupus (SLE). Among other studies, it has been confirmed in a meta-analysis of 8 studies totaling 7,381 patients and over 10,000 controls from both European and Asian populations.The risk allele (oriented to the dbSNP entry) is (T); the odds ratio associated the presence of a risk allele was 1.3 for rheumatoid arthritis and 1.55 for lupus (SLE). The paper states that, "Homozygosity of the risk allele, as compared with absence of the allele, was associated with a more than doubled risk for lupus and a 60% increased risk for rheumatoid arthritis." A study of 124 Caucasian patients with primary Sj&#246;gren's syndrome, an autoimmune disease related to RA and SLE, also found the rs7574865(T) allele to be associated with higher risk for this condition (p=0.01). The GT genotype is associated with 1.42x and the TT with 2.28x odds.  associated with SLE characterized by double-stranded DNA autoantibodies (MAF = 35.1%, OR = 1.86, p<10(-19)), nephritis (MAF = 34.3%, OR = 1.80, p<10(-11)), and age at diagnosis<30 years (MAF = 33.8%, OR = 1.77, p<10(-13)) The combined ORs for RA and SLE, respectively, were 1.27 (P = 8.4 x 10(-9)) and 1.61 (P = 2.1 x 10(-11)) for allele frequency distribution; these ORs in the Japanese were quite similar to those previously observed in the Caucasian population RA risk associated with rs7574865(T) allele was also found in studies of 923 Spanish, 273 Swedish, and 876 Dutch patients. The rs7574865(T) allele is associated with increased risk for type-1 diabetes; the odds ratio is 1.94, CI: 1.29-2.91, p = 0.0012, based on a study of Greek patients.A study of RA patients from Crete also found that the rs7574865(T) allele represented increased risk for rheumatoid arthritis. A study of 2,776 Spanish subjects found that the rs7574865(T) allele was associated with rheumatoid arthritis, Crohn's disease, ulcerative colitis, and type-1 diabetes, but not with multiple sclerosis.Scleroderma</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1043]]
    <blockquote>
        <p class="text-snippet" data-id="1043">/ part 2 in the series mentions rs564398  Heterogeneity in meta-analyses of genome-wide association investigations. Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids. Association analysis of type 2 diabetes Loci in type 1 diabetes. Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Worldwide population differentiation at disease-associated SNPs. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Genetic predisposition, Western dietary pattern, and the risk of type 2 diabetes in men. Genome-based prediction of common diseases: methodological considerations for future research. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. Simultaneous genotype calling and haplotype phasing improves genotype accuracy and reduces false-positive associations for genome-wide association studies. Influence of control selection in genome-wide association studies: the example of diabetes in the Framingham Heart Study. Epistatic interactions of CDKN2B-TCF7L2 for risk of type 2 diabetes and of CDKN2B-JAZF1 for triglyceride/high-density lipoprotein ratio longitudinal change: evidence from the Framingham Heart Study. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. Association study of genetic variants in eight genes/loci with type 2 diabetes in a Han Chinese population. Genetic risk profiling for prediction of type 2 diabetes. Association between type 2 diabetes and CDKN2A/B: a meta-analysis study. Association between type 2 diabetes genetic susceptibility loci and visceral and subcutaneous fat area as determined by computed tomography.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1374]]
    <blockquote>
        <p class="text-snippet" data-id="1374">CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival. Cytochrome P450 1A1 (CYP1A1) polymorphisms and breast cancer risk in Korean women. Assessment of interactions between PAH exposure and genetic polymorphisms on PAH-DNA adducts in African American, Dominican, and Caucasian mothers and newborns. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer. Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Relationship between genetic polymorphisms of phase I and phase II metabolizing enzymes and DNA damage of workers exposed to vinyl chloride monomer. Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome. Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression. CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women. African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer. Association of nasopharyngeal carcinoma risk with cytochrome P450 CYP1A1 gene polymorphisms. Impact of CYP1A1 and COMT genotypes on breast cancer risk in Mexican women: a pilot study. Quantitative trait analysis suggests polymorphisms of estrogen-related genes regulate human sperm concentrations and motility. Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk. Analysis of 4 single-nucleotide polymorphisms in relation to cervical dysplasia and cancer development using a high-throughput ligation-detection reaction procedure. Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE study (SFCE). Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1728]]
    <blockquote>
        <p class="text-snippet" data-id="1728">rs4444903 is a SNP, also known as +61, located in the promoter region of the epidermal growth factor EGF gene that influences the amount of EGF produced. The rs4444903(G) allele appears to produce higher amounts of EGF than the (A) allele.A study of 2 Caucasian populations of patients with alcoholic cirrhosis indicates that, for these patients, the presence of the risk allele rs4444903(G) increases the chances of developing hepatocellular carcinoma (liver cancer). After adjusting for age, sex, race, etiology, and severity of cirrhosis the number of (G) copies led to an odds ratio for either (G;G) or (A;G) genotypes versus the (A;A) genotype of 3.49 (CI: 1.29-9.44, p=.01). In another study, analysis of 197 glioma patients showed that the rs4444903(G) allele conferred higher risks for gliomas (odds ratio 1.32, CI: 1.04-1.67), glioblastomas (OR, 1.47, CI: 1.02-2.10), and oligodendrogliomas (OR, 1.55, CI: 1.07-2.23). In general, the risk was about the same for a carrier or one or two (G) alleles, however, no significant association was observed with patients' overall survival.A study of 126 Indian gallbladder cancer patients concluded that the rs4444903(G;G) genotype was at increased risk, but only in females (odds ratio 3.45, CI: 1.52-7.82, p = 0.003).effects lots of no known riskpmids15373782 15729146 16214932 16214933 16214934 16214935 16217151 16217152 16217153 rs4444903, rs2298991, rs7692976 and rs4533485 significantly interacted with gender for acute respiratory distress syndrome  risk.popular in pubmed Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis. Development of a fingerprinting panel using medically relevant polymorphisms. Genetic factors associated with intestinal metaplasia in a high risk Singapore-Chinese population: a cohort study. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels and renal cell carcinoma risk in a Chinese population. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2435]]
    <blockquote>
        <p class="text-snippet" data-id="2435">This SNP, in the GSTP1 gene influences asthma risk; the (A) allele encodes the Ile, while the (G) allele encodes the Val. This SNP is also known as GSTP1Val105, or GSTP1 Ile105Val.Despite evidence of antioxidant effects of vitamin E in vitro and in animal studies, large, randomized clinical trials have not substantiated a benefit of vitamin E in reducing inflammation in humans. In healthy control subjects, the effect of &#945;-tocopherol supplementation on the production of inflammatory cytokines appears to be dependent on an individual's genotype. These genotype-specific differences may help explain some of the discordant results in studies that used vitamin E. Persons having the alleles AA or AG had an increase in interleukin-6 (IL-6) upon supplementing alpha-tocopherol (the most common form of Vitamin E in a North American diet) while those with GG saw a decrease. This  research paper shows that 13- to 21-year-olds exposed to tobacco smoke at home, with this mutation had more severe asthma than those without the mutation. rs1695 is also mentioned in this  bbc articleSeveral papers published findings associating GSTP1 Ile105Val genotypes with bronchial, childhood, or atopic asthma. Note that some studies, however, have not observed any association between this SNP and asthma in certain populations , or even more paradoxically, have observed that rs1695(G;G) homozygotes appear to be somewhat protected (OR 0.29) from developing asthma compared to individuals with rs1695(A;G) or (A;A) genotypes. A cohort of 1,610 children in the US were studied to determine that the risk for new-onset asthma was highest in rs1695(A;A) homozygotes who participated in 3 or more sports in high-ozone communities. These children were at 6x higher risk (CI: 2.2-7.4). A study of 3,000 Chinese women with breast cancer concluded that rs1695(G;G) genotype was significantly associated with greater breast cancer risk, particularly in premenopausal women (odds ratio 1.69, CI: 1.17-2.43). The odds increased further if such women reported eating little cruciferous vegetables (then the odds ratio was 2.08, CI: 1.20-3.59).A relatively small study of 58 patients with different types of cancer receiving docetaxel concluded that rs1695(A;A) homozygotes (i.e. Ile105/Ile105 homozygotes) had a higher risk of developing docetaxel-induced peripheral neuropathy (DIPN), particularly grade 2 or higher. The odds ratio reported was 6.1 (CI: 1.17-31.9, p=0.03).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1472]]
    <blockquote>
        <p class="text-snippet" data-id="1472">Also known as c.100C>T (p.Pro34Ser or P34S), the wild type (normal) allele at this SNP is (C). The (T) variant indicates the presence of a non-wild type CYP2D6 variant, but it appears in many different variants so it can not be used to determine the presence of any particular variant. The most common variants it appears in are CYP2D6 10 and CYP2D6 4, but these are not the only ones. While this is the defining mutation for CYP2D6 10, it is not possible by itself for this mutation to determine a particular variant. In addition, the CYP2D6 4 variant includes this mutation, but the defining mutation 1846G>A SNP is not available in the common direct to consumer testing services.While it is not possible for this mutation to identify one particular variant, all the variants in which it appears have reduced or no CYP2D6 activity.If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine  is observed. Other drugs metabolized by CYP2D6 include dextromorphan, sparteine, nortriptyline, atomoxetine , and codeine.Nakamura et al  suggest that thermal instabilities and reduced intrinsic clearance by the protein encoded by the rs1065852(T) allele are the main reasons Asians show lower metabolic activities than Caucasians for drugs metabolized mainly by CYP2D6, since this (T) allele occurs in higher frequency in Asians.A study of several hundred Chinese breast cancer patients treated with either tamoxifen or toremifene reported that for the 50 women who were CYP2D6 10 homozygotes (i.e. rs1065852(T;T)), the group treated with toremifene had a significantly higher 5-year disease-free survival (DFS) rate than the group treated with tamoxifen (90.9% vs. 67.9%, p = 0.031). For the remaining rs1065852 (C;C) and (C;T) patients, there was no significant difference between the 5-year DFS rates of those treated with one drug versus the other.It is also suggested that poor metabolizers of debrisoquine will be poor metabolizers of metoprolol, diltiazem (brand name cardizem), and propafenone.  Genotyping panel for assessing response to cancer chemotherapy. Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms. Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1353]]
    <blockquote>
        <p class="text-snippet" data-id="1353">rs743572, known best as the CYP17 -34 T/C or T>C variant, is a variant in the 5' upstream region of the CYP17A1 gene. CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study. Genetic variation in CYP17 and endometrial cancer risk. Variants in hormone biosynthesis genes and risk of endometrial cancer. Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women. Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women. Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome. African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer. Solitary and multiple uterine leiomyomas among Caucasian women: two different disorders? Common Variation in the CYP17A1 and IFIT1 Genes on Chromosome 10 Does Not Contribute to the Risk of Endometriosis. The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers. CYP17 gene polymorphisms and prostate cancer risk: A meta-analysis based on 38 independent studies. Association of single nucleotide polymorphism in CYP17 and ERalpha genes with endometriosis risk in southern Chinese women. CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4313]]
    <blockquote>
        <p class="text-snippet" data-id="4313">rs2506030 is a Single Nucleotide Polymorphism in gene RET. Its ancestral/non-risk allele is A and derived allele G. RET (ret proto-oncogene) is a cadherin family member and encodes a receptor tyrosine kinases. Functionally, it is involved in neural crest development. Its located on the plus strand at 10q11.2 of the human genome spanning over 50K bp. There are 21 exons in the gene and 2 isoforms. Other than Hirschsprung disease, mutations in this gene is also associated with Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma.Hirschsprung disease (HSCR) or congenital aganglionosis is a developmental defect characterized by the absence of neuronal ganglia in the myenteric and submucosal plexuses. Patients can be classified into 3 sub categories based on the length of the colon: short segment, long segment, or total colonic aganglionosis (TCA). The incidence is roughly 15/100,000 in population of European descent and twice as high for Asians. HSCR is a non-Mendelian disease. Mutations in a few genes have been identified to be associated with HSCR: RET, GDNF, NRTN, SOX10, EDNRB, EDN3, ECE1, ZEB2, PHOX2B, KIAA1279, TCF4, and L1CAM.rs2506030 was first identified by Charkravartis group in a family-based GWAS study published in 2015. A total of 220 European American trios with short-segment HSCR were recruited and their DNA genotyped using Affymetrix platform, resulting in 500,000 SNPs. Association was tested using case pseudo-control and rs2506030 is statistically significantly different in the two groups (p value 2.78 10^-15). Furthermore, the statistical significance was confirmed in a replication study of 429 more HSCR trios of all segment lengths (p value 2.02 10^-4, combined p value 4.44 10-15, odds ratio = 2.0). Note that rs2506030 is independent of another common RET SNP rs2435357, which is common in HSCR patients based on previous studies. They hypothesize that rs2506030 affects a RET enhancer. Another study by the same group further studied rs2506030 in HSCR patients. This study includes a population case control comparison as well as family based association testing. Comparing the allele frequencies in cases and controls, there was a significant difference between allele frequencies in rs2506030  (p value 4.7 10^-10). Similarly, there is significant statistical evidence (p value = 5.3 10^9) of higher frequency of risk allele homozygotes in cases. OR was estimated to be 1.8. In addition, TDT was performed in 254 trios and 72 duos and the risk allele is over transmitted to probands (p = 9.5 10^-6).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2824]]
    <blockquote>
        <p class="text-snippet" data-id="2824">rs2004640, a SNP in the IRF5 gene in chromosomal region 7q32.1, is one of several SNPs associated with systemic lupus erythematosus (SLE). This association has been observed in multiple populations (Caucasian, Asian, and African-Americans).The association was first noted in two relatively large studies of Caucasian patients.PMID 15657875, PMID 16642019In ~600 Korean SLE patients, the odds ratio for the rs2004640(T) risk allele was 1.44 (CI: 1.34-1.55, overall p=1.85x10e-23). The rs2004640-T/rs2280714-T haplotype involved in both the alternative splice donor site and the elevated expression of the IRF5 protein also had a highly significant association with SLE (pooled p=2.11x 10e-16). Reconfirmed for African-Americans Reconfirmed in ~370 female Caucasian patients Reconfirmed in ~380 UK SLE families Pooled data from two populations (Japanese and Korean) were combined to determine that the rs2004640(T) allele frequency was significantly increased in SLE patients (p = 8.3 x 10<sup>-5</sup>). A variant located 64 bp upstream of the first untranslated exon (exon 1A), consisting of a 5 bp insertion/deletion CGGGG (rs77571059), may be the causative SNP in this region that is most responsible for increasing SLE risk. In a Korean population, rs2004640 was associated with both the anti-CCP Ab-positive (odds ratio 1.47, CI: 1.15-1.88, pcorr = 0.01) and SE-positive group (odds ratio 1.54, CI: 1.14-2.09, pcorr = 0.03) forms of rheumatoid arthritis.  Combined analysis pooling 3 independent cohorts yielded an association with an odds ratio of 1.21, CI: 1.07-1.38, pooled p = 0.0031 in a dominant model. rs2004640(T;T) is associated with susceptibility to systemic sclerosis in a study of ~800 French Caucasian patients, with an odds ratio of 1.58 (CI: 1.18 - 2.11, p trend 0.002). A meta-analysis comprising 5 case-control studies, totaling 6,582 rheumatoid arthritis cases and 5,375 controls, concluded that several IRF5 gene SNPs were indeed (still) significantly associated with the disease. The rs2004640(G) allele was associated with a slight protective effect (odds ratio 0.9, CI: 0.85-0.96, p = 0.002). Of 3 IRF5 SNPs studied, the rs2280714(A) SNP (and not this one) had the strongest association (odds ratio 1.42, CI: 1.15-1.75) in Japanese SLE patients. Association with multiple sclerosis (along with several other SNPs) was observed after combining data from Swedish and Spanish case/control studies and a Finnish trio study.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3475]]
    <blockquote>
        <p class="text-snippet" data-id="3475">rs1064395 is a single nucleotide variant (SNV) found in the neurocan gene (NCAN) that has been implicated as a predictor of both bipolar disorder (BD) and schizophrenia. BD is characterized by a fluctuation between manic episodes and severe depression.  Schizophrenia is characterized by hallucinations, both visual and auditory, paranoia, disorganized thinking and lack of normal social skills.  NCAN is a chondroitin sulfate proteoglycan that is involved in cell adhesion and migration.  It contains 14 exons and spans 41 kb of the genome at the location 19p12. OMIM It has also been found that, in mice, this gene is expressed in a localized way in the cortical and hippocampal regions of the brain which are responsible for cognition and regulation of emotions. In 2011, a study by Cichon et al identified rs1064395 in a genome-wide association study (GWAS) for Bipolar Disorder (BD).  This study was done by analyzing around 500,000 autosomal SNPs and 12,000 X-chromosomal SNPS in 682 patients with BD and 1300 controls. The patients studied were from Europe, the USA, and Australia.  The study then went forward to test the top 48 hits from their initial GWAS with an independent cohort of 1729 cases and 2313 controls, which narrowed down their significant hits to a list of eight.  These eight were then used in a meta analysis.  The rs1064395 was highly significant with a p-value of 3.02X10-8 and an odds ratio of 1.31, with A being the risk allele. The authors then further validated with a much larger sample size (6030 cases and 31,749 controls) and found a p-value of 2.74X10-4 and an odds ratio of 1.12 which, combined with their previous study lead to an overall p-value of 2.14X10-9 and an odds ratio of 1.17. In 2012, a study by M&#252;hleisen et al investigated this same SNP in case control studies involving schizophrenic patients. They designed a patient-control study using samples from patients with European ancestry.  The initial study included a cohort of 5061 patients and 9655 controls.  The risk A-allele was found more frequently in schizophrenic patients then in controls with a p-value of 2.28X10 -8 and an odds ratio of 1.11.  They followed up this initial experiment using a independent cohort from the Schizophrenia Psychiatric GWAS Consortium that included 5537 patients and 8043 controls. This follow up inquiry yielded a p-value of 0.0239 and an odds ratio of 1.07.  Thus, these authors concluded that, not only is rs1064395 predictive of BD, it is also predictive of schizophrenia.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5122]]
    <blockquote>
        <p class="text-snippet" data-id="5122">rs1386494 is a SNP in the tryptophan hydroxylase 2 (TPH2) gene on chromosome 12.  It is located about 20,000 bp from the 5' end of the gene.   This SNP has been found to be associated with various mental health disorders.  TPH1 and TPH2 are two isoforms of the rate-limiting enzyme for the biosynthesis of 5-HT (serotonin), a neurotransmitter involved in many neurological processes.  Both isoforms have been studied extensively as genetic markers of mental health.  Many association studies have linked the TPH1 gene to suicidality, alcoholism and depression.   However, the second TPH isoform was not discovered until more recently, when it was observed that TPH1 knockout mice were still able to produce normal levels of 5-HT.    It has been shown to be expressed exclusively in the brain, suggesting that it could play a major role in psychiatric disorders. The association between the SNP rs1386494 and major depression (MD) was first reported in a study of a cohort of 300 Caucasian patients with MD.  rs1386494 was found to be the most significantly associated of all 10 SNPs studied, with a p-value of 0.0012.   Another study of the association between the TPH2 gene and depression was conducted in a Finnish population of 119 patients who showed treatment risistance.  The researchers showed that A/A depression patients had significantly more severe depression, as measured by the Montgomery and sberg Depression Rating Scale (MADRS), (p < 0.001) but showed a greater decline in MADRS score as a result of electroconvulsive therapy (ECT) treatment (p = 0.03).    Several other studies have confirmed the association of this SNP and linked SNPS with major depression. Similarly, rs1386494 has been linked to suicide attempts.  In a case study of 263 individuals who committed suicide and matched control patients, SNP, haplotype and LD studies support association between the TPH2 SNP and completed suicide.   However, a study of 150 alcohol-dependent patients reported no significant association with alcohol-related suicide behavior.   Both studies were conducted in Caucasian populations.More recently, studies have linked rs1386494 with schizophrenia in Asian populations.  In a case-control study of 289 Malaysians, the G allele was found to be enriched in schizophrenic patients.  Due to the low occurrence of suicidality in the study population, the authors rule out the role of suicidal behavior in this association, supporting a more direct neurological role of this SNP.  In a study of TPH2 SNPs in panic disorder, rs1386494 was found to have a gender-specific effect, where the association was seen only the female subgroup.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1711]]
    <blockquote>
        <p class="text-snippet" data-id="1711">/ g2b2mh blog In a population of healthy individuals, those that carry common variants (such as rs760761, rs1018381, rs2619522) located in the dysbindin (DTNBP1) gene, a risk factor for schizophrenia, show minor cognitive impairments such as decreased attentional capacity, worse performance on memory tasks, and alterations in schizotypal beliefs and experiences. The association between several SNPs in the DTNBP1 gene, most especially rs760761, and schizophrenia was confirmed in a new sample of 1021 cases and 626 controls from Ireland. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. A powerful strategy to account for multiple testing in the context of haplotype analysis. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia. DTNBP1 genotype influences cognitive decline in schizophrenia. Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder. Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings. Failure to confirm allelic and haplotypic association between markers at the chromosome 6p22.3 dystrobrevin-binding protein 1 (DTNBP1) locus and schizophrenia. Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder. The dystrobrevin-binding protein 1 gene: features and networks. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Association study of candidate variants from brain-derived neurotrophic factor and dystrobrevin-binding protein 1 with neuroticism, anxiety, and depression. Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors. Association of the dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS). A genome-wide investigation of SNPs and CNVs in schizophrenia. The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation. Effect of the dysbindin gene on antimanic agents in patients with bipolar I disorder. Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2475]]
    <blockquote>
        <p class="text-snippet" data-id="2475">rs2395029 is a SNP in the major histocompatibility complex (MHC) region, and several studies have shown that the rs2395029(G) allele is 99.9% predictive of the presence of an HLA-B 5701 allele in many (but not all) Caucasian and Hispanic populations. This HLA allele, in turn, has been associated with several conditions.A study of 51 cases of flucloxacillin drug-induced liver injury (DILI), an important cause of serious liver disease, along with a replication study of another 23 cases, found that the rs2395029(G) carriers were at highly increased risk (odds ratio 80, p=8.7x10(-33)).  see also: / 23andMe blog rs2395029(G;G) increases the odds of drug-induced liver injury in response to flucloxacillin by 45x This SNP is thought to be involved in determining the HIV viral load set point during the asymptomatic period of infection. This SNP is estimated to explain 9.6% of the total variation in the viral set point.Humans show remarkable variation in vulnerability to infection by HIV-1 and especially in the clinical outcome following infection. One striking and largely unexplained difference is the level of circulating virus in the plasma during the non-symptomatic phase preceding progression to AIDS. This is known as the ''viral set point'' and can vary among individuals by as much as 4 to 5 logs. The HCP5 (HLA complex P5) gene is located 100 kb centromeric from HLAB on chromosome 6.  HCP5 is a good candidate to interact with HIV-1, possibly through an antisense mechanism. Moreover, HCP5 is predicted to encode two proteins, and the associated polymorphism results in an amino acid substitution in one of these.rs9264942 is also reported to be associated with reduced HIV viral load set point.In most European populations, the rs2395029(G) allele is in tight linkage disequilibrium (r2 = 1) with the HLA-B 5701 allele, and therefore is predictive of hypersensitivity to the drug abacavir, an antiviral used to treat HIV+ individuals. However, the linkage between rs2395029 and HLA-B 57:01 is not well studied in African and Asian populations, and in one Italian population, the linkage is questionable.. nature Abacavir hypersensitivity rs2395029 rs2395029 reported to be associated with psoriasis in a large US/UK study rs2395029 was found to be associated with psoriasis based on a study by the eMERGE network in which electronic medical records were searched to find clinical associations associated with selected SNPs. HIV-1 nonprogressors (odds ratio, 3.47)Marker HLA-B 5701 hypersensitivity to the HIV drug abacavir;  FDA warning hereHIV ProgressionAbacavir HypersensitivityFloxacillin Toxicity</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2747]]
    <blockquote>
        <p class="text-snippet" data-id="2747">SNP rs1004819, in the IL23R gene, is associated with increased risk for Crohn's disease in both Jewish and non-Jewish populations. The same risk allele is also reported to increase the risk for developing ankylosing spondylitis, based on a large study of over 1,000 Caucasian patients. The odds ratio is 1.2 (p=8.8x10e-5).PMID 17952073, PMID 18037607 significant associations with rs1004819, rs7517847, and rs11209026. Having any CARD15 variant was associated with a significant risk for CD (P < 0.0001).  Investigation of the IL23R gene in a Spanish rheumatoid arthritis cohort. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population. Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. IL23R haplotypes provide a large population attributable risk for Crohn's disease. Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients. Association of polymorphisms in the Interleukin 23 receptor gene with osteonecrosis of femoral head in Korean population. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. Genetic epistasis of IL23/IL17 pathway genes in Crohn's disease. No association between interleukin 23 receptor gene polymorphisms and systemic lupus erythematosus. Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjogren syndrome in Hungarian population samples. Interleukin-23 receptor gene variants in Hungarian systemic lupus erythematosus patients. Genome-wide association studies--a summary for the clinical gastroenterologist. Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis. Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients. The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease. Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn's disease and early disease onset. Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. An investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2549]]
    <blockquote>
        <p class="text-snippet" data-id="2549">In this 2007 article, titled "Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls," rs9272346 has been reported to be associated with type-1 diabetes. The risk allele (oriented to the dbSNP entry) is (A); the odds ratio associated with heterozygotes is 5.49 (CI 4.83-6.24), and for homozygotes (AA), the risk is 18.52 (CI 12.69-27.03). The P value is extremely significant at 5.47  10-134, considering the threshold for genome-wide significance. NOTE: In previous edits of this page, it has been noted that "the (A) allele of rs9272346 is common in various human populations, and one could consider the (G) allele as protective." However, the authors of  seem to disagree. (Of course, other significant genetic and/or environmental factors could be protecting the multitude of individuals with AG). In several other lines of their table, the allele identified as the risk allele is _not_ the minor allele. The authors are aware of the conventions for ODs for risk vs. protection, stating that risk allele ODs will be normally 1-2 and protective ODS are between 0.5-1 (Supplement 1, page 3). In light of this, if they wished to signify the G allele was protective, they would have given a protective allele odds-ratio in the range 0.5-1 to AG. Of course, any OD as large as 5.49 (for AG), much less 18.25 (for AA) is quite a significant risk factor compared to all other ODs on its table. Yet it cannot be a typographical error, since the rs9272346 OD of 5.49 and P values were replicated in their Supplement 1 page 43.  Their significant P values were confirmed to some degree in a 2015 study listed on this page. In this 2015 article titled "Association of 32 type 1 diabetes risk loci in Pakistani patients," among 191 Pakistani cases and controls, the P value for rs9272346 was (p = 2.83E  09). However, no risk allele or odds ratio was mentioned. They cited the 2007 study on this page. They noted that "it has been difficult to determine individual effects of HLA genes 17."  Risk alleles for multiple sclerosis identified by a genomewide study. Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment. Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations. A study of CNVs as trait-associated polymorphisms and as expression quantitative trait loci.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q952]]
    <blockquote>
        <p class="text-snippet" data-id="952">rs4810485 is a SNP associated with rheumatoid arthritis (RA), a chronic autoimmune disease characterized by joint inflammation. At this locus, the minor allele, T, protects against RA. The SNP is located on chromosome 20q13 in the second intron of the CD40 gene, which encodes a receptor that is expressed on the surface of multiple immune cells. CD40 binds the ligand CD154 which is expressed by activated T cells, and this interaction plays a critical role in T cell helper activity in the immune system. rs4810495 is closely linked with another SNP, rs1883832, that appears to lesson translation of the CD40 gene, affecting this critical signaling pathway that leads to B cell proliferation . Mouse model knockouts of CD40 have been shown to alleviate arthritis . The association between rs4810485 and RA was first identified through a genome-wide association study (GWAS) meta-analysis and two subsequent replication studies in patients with European ancestry . This study looked at the major allele G versus the minor allele T in a meta-analysis of previous GWAS followed by two replication studies. In the GWAS meta-analysis, which had 3,393 cases and 12,460 controls, they found rs4810485 to be associated with RA with a p-value of 2.4x10-7 and an odds ratio of 0.83. Two replication studies looking at 31 loci in combined 3,929 cases and 5,807 controls found the position to be associated with the disease with a p-value of 0.0032 and an odds ratio of 0.91. Jointly, the meta-analysis and replication studies showed an association with a p-value of 8.2x10-9 surpassing a conservative level of significance for joint analysis and an odds ratio of 0.87, suggesting that the minor allele T gives a modest protective effect against RA.The association with RA was confirmed in a targeted validation study in the United Kingdom with 3,962 cases and 3,531 control patients . This study found rs4810485 to be associated with RA with a p-value of 2x10-4 and an odds ratio of 0.86. Since this was a targeted study looking at 4 specific loci, the p-value is significant. Again, the odds ratio suggests a modest protective affect for the minor allele T.An additional study looked at this SNP and its association with RA in individuals of Korean ancestry . This study found no association between rs4810485 and RA in patients with Korean ancestry. The targeted validation study looked at 5 SNPs associated with RA in Europeans in 1,113 Korean cases and 988 controls, and found a p-value of 0.39 and an odds ratio of 1.06, suggesting no association between the SNP and RA in Koreans. This case highlights the importance of accounting for ancestry when testing genome-wide associations.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4983]]
    <blockquote>
        <p class="text-snippet" data-id="4983">Survey of allelic expression using EST mining. A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis. potential markers of iron deficiency anaemia risk: two in the transferrin gene TF (rs3811647, rs1799852) and two in the HFE gene (C282Y, H63D), explain 35% of the genetic variation or heritability of serum transferrin in menstruating women. The minor allele of rs3811647 was associated with higher serum transferrin levels and lower transferrin saturation, while the minor alleles of rs1799852 and the C282Y and H63D mutations of HFE were associated with lower serum transferrin levels. serum transferrin: Two SNPs on TF gene, rs1799852 (MAF 0.09), and rs2280673 (MAF 0.34), which were independently influencing variation in serum transferrin (nominal p = 4.7 &#215; 10&#8722;6 and 2.3 &#215; 10&#8722;4, respectively).  rs1799852 and rs2280673 were also associated with serum ferritin (p = 0.04 and 0.003) but not with serum iron or transferrin saturation.  These findings are potentially important for our understanding of iron metabolism and of regulation of hepatic protein secretion, and also strongly support the hypothesis that the genetic architecture of some endophenotypes may be simpler than that of disease. potential markers of iron deficiency anaemia risk: two in the transferrin gene TF (rs3811647, rs1799852) and two in the HFE gene (C282Y, H63D), explain 35% of the genetic variation or heritability of serum transferrin in menstruating women. The minor allele of rs3811647 was associated with higher serum transferrin levels and lower transferrin saturation, while the minor alleles of rs1799852 and the C282Y and H63D mutations of HFE were associated with lower serum transferrin levels. serum transferrin: Two SNPs on TF gene, rs1799852 (MAF 0.09), and rs2280673 (MAF 0.34), which were independently influencing variation in serum transferrin (nominal p = 4.7 &#215; 10&#8722;6 and 2.3 &#215; 10&#8722;4, respectively).  rs1799852 and rs2280673 were also associated with serum ferritin (p = 0.04 and 0.003) but not with serum iron or transferrin saturation.  These findings are potentially important for our understanding of iron metabolism and of regulation of hepatic protein secretion, and also strongly support the hypothesis that the genetic architecture of some endophenotypes may be simpler than that of disease.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3362]]
    <blockquote>
        <p class="text-snippet" data-id="3362">rs1801394, also known as A66G or Ile22Met, is a SNP in the methionine synthase reductase MTRR gene. This gene encodes one of the two enzymes involved in the production of methionine (the other is MTR). The protein encoded by an rs1801394 allele has a lower affinity for MTR () and is inconsistently associated with homocysteine level, although it is a risk factor for neural tube defects () and Down syndrome () in conditions of higher homocysteine.Based on a study of British patients with primary brain tumors, (1,005 glioma cases and 631 meningioma cases), rs1801394(G;G) individuals were at higher risk for meningioma (odds ratio 1.41, CI: 1.02-1.94). In general, genotypes associated with increased 5,10-methylenetetrahydrofolate levels are associated with elevated risk for these types of brain cancer. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. Dietary vitamin B6 intake and the risk of colorectal cancer. Folate and one-carbon metabolism gene polymorphisms and their associations with oral facial clefts. BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. No association of single nucleotide polymorphisms in one-carbon metabolism genes with prostate cancer risk. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. One-carbon metabolism and breast cancer: an epidemiological perspective. Lack of association between genetic polymorphisms in enzymes associated with folate metabolism and unexplained reduced sperm counts. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk. Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer. Folate and choline metabolism gene variants and development of uterine cervical carcinoma. Polymorphic variants of genes involved in homocysteine metabolism in celiac disease. Folate and choline metabolism gene variants in relation to ovarian cancer risk in the Polish population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q152]]
    <blockquote>
        <p class="text-snippet" data-id="152">This SNP, in the ACTN3 gene, encodes a premature stop codon in a muscle protein called alpha-actinin-3. The polymorphism alters position 577 of the alpha-actinin-3 protein. In publications the (C;C) genotype is often called RR, whereas the (T;T) genotype is often called XX. According to  (T;T) is under-represented in elite strength athletes, consistent with previous reports indicating that alpha-actinin-3 deficiency appears to impair muscle performance. However in 2016   failed to replicate casting some doubt. The most common nucleotide at this position, (C), encodes an arginine (amino acid code R), the alternative T allele encodes a stop codon (X). Hence, the SNP is referred to as R577X, with homozygotes being either RR or XX and heterozygotes being RX. XX individuals completely lack the expression of alpha-actinin-3.One of the earliest report studying a relatively small number of Australian elite (i.e. ~Olympic) athletes found that, at least in females, the R allele (ie rs1815739(C)) is associated with sprinters, while the X allele (rs1815739(T)) is associated with endurance athletes. No female or Olympic-level sprinters were XX homozygotes (rs1815739(T;T)). The association tended the same way but was statistically weaker in males. . There have been several subsequent studies, but few with large sample sizes and thus few with much statistical power. An example of a typical study: no increase in endurance ability was associated with the X allele in elite male cyclists. An extensive / blog post from one of the original authors of this research.One paper has found that the X allele profile of centenarians resembles that of world-class elite endurance athletes. This is one of the SNPs reported by NutraHacker SNPs|NutraHacker. Distribution and effects of nonsense polymorphisms in human genes. Is there an optimum endurance polygenic profile? ACTN3 R577X polymorphism and Israeli top-level athletes. Is the interaction between HIF1A P582S and ACTN3 R577X determinant for power/sprint performance? ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players. Web-based, participant-driven studies yield novel genetic associations for common traits. ACTN3 R577X and other polymorphisms are not associated with elite endurance athlete status in the Genathlete study. Association between the ACTN3 R577X polymorphism and female endurance athletes in China. Are 'endurance' alleles 'survival' alleles? Insights from the ACTN3 R577X polymorphism. ACTN3 genotype, athletic status, and life course physical capability: meta-analysis of the published literature and findings from nine studies. ACTN3 R577X polymorphism and performance phenotypes in young Chinese male soldiers.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q453]]
    <blockquote>
        <p class="text-snippet" data-id="453">Rs10766071 is a SNP in aryl hydrocarbon receptor nuclear translocator-like (ARNTL). Rs10766071 has been associated with shorter sleep duration as measured by polysomnography&#8212; a method for recording the activity of the brain, eyes, muscles, and heart while the subject sleeps. The A allele (major allele) is associated with higher sleep duration and the G allele (minor allele) is associated with shorter sleep duration (n=414). However, only one individual with the GG genotype was in the study. G is the ancestral allele and is also the minor variant (frequency = .0851) (dbSNP).ARNTL encodes a basic helix-loop-helix (bHLH) PAS domain transcription factor (PMID:11163178).Studies have shown that ARNTL is an important component of the transcriptional-translational feedback loop (TTFL) which regulates circadian rhythms. Homozygous ARNTL null mutant mice loose circadian rhythmicity, as measured by activity patterns, when transferred to constant darkness, demonstrating that ARNTL plays a key role in maintaining circadian rhythmicity (PMID:11163178). Rs1076671 was one of 13 significant SNPs (after Bonferroni correction) discovered by Kripke et al. (PMID:25660813) to be associated with sleep variables. Their study consisted of a cohort of patients of likely European ancestry who were recruited from a &#8220;busy academic sleep practice.&#8221; Patients consisted mostly of individuals who had been given a tentative diagnosis of sleep apnea, and had been sent for a polysomnography to confirm. All patients were 21 years or older.The authors of the paper collected DNA samples from the patients and then performed custom Illumina golden gate assay for 768 single nucleotide polymorphisms. This subset of SNPs was chosen because they were relevant to circadian rhythm regulation. Patients were surveyed about their sleep schedule and habits and polysomnographs were recorded of each patient. Thirty-eight phenotypic measures were analyzed. The authors performed linear or logistic regression analyses and then performed a Bonferroni correction for the total number of SNPs tested. The p-value for this association was 5.3x10-5 prior to Bonferroni correction. Importantly, this SNP is not genome-wide significant.  References: Database of Single Nucleotide Polymorphisms (dbSNP). Bethesda (MD): National Center for Biotechnology Information, National Library of Medicine. dbSNP accession: rs10766071 (dbSNP Build ID: 120/142). Available from:  PMID: 25660813: Kripke, Daniel F., et al. "Genetic variants associated with sleep disorders." Sleep Medicine (2014).PMID:11163178: Bunger, Maureen K., et al. "Mop3 is an essential component of the master circadian pacemaker in mammals." Cell 103.7 (2000): 1009-1017.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5427]]
    <blockquote>
        <p class="text-snippet" data-id="5427">rs25489, a SNP also known as Arg280His located in the DNA-repair gene XRCC1, is associated with an increased risk for breast cancer based on a study of 1,100 Cypriot women. The odds ratio for the rs25489(A;A) homozygote is 4.68, CI: 1.01-21.7, p=0.03.rs25489(A;G) prostate cancer patients being treated by radiation therapy are more likely (67% compared to 24%, p=0.048) to develop erectile dysfunction after irradiation than (G;G) patients, based on a study of 135 patients. A meta-analysis concludes that this SNP is not associated with risk of gastric cancer. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. Multiplex pyrosequencing of two polymorphisms in DNA repair gene XRCC1. DNA repair gene XRCC1 polymorphisms and bladder cancer risk. Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Genotyping panel for assessing response to cancer chemotherapy. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma. Gene-environment interactions between DNA repair polymorphisms and exposure to the carcinogen vinyl chloride. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study. Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. Polymorphisms in base excision DNA repair genes and association with melanoma risk in a pilot study on Central-South Italian population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5099]]
    <blockquote>
        <p class="text-snippet" data-id="5099">rs3729547, is a SNP that was recently shown to be mildly associated with dilated cardiomyopathy (DCM)  in the Han Chinese population and hypertrophic cardiomyopathy in the Indian population.  . This SNP is located within  the coding sequence of the TNNT2 gene, which encodes a component of the troponin complex critical for proper sarcomeric contractility in cardiomyocytes, the cell type driving contraction in the heart. A number of earlier studies have shown that mutations in TNNT2 can lead to dilated cardiomyopathy.    characterized by a thinning of the ventricular wall, or conversely, hypertrophic cardiomyopathy (HCM), characterized by a thickening of the ventricular wall. Both conditions lead to an overall weakening of the heart muscle and can lead to heart failure or sudden cardiac death.  The molecular mechanisms whereby mutations in the same gene (TNNT2) can lead to two diseases (DCM and HCM) with such contrasting phenotypes are still not well-understood. In a study by Li et al, rs3729547 (C to T) and another tagging SNP also in TNNT2, rs3729843 (G to A),  were shown to be associated with DCM in a cohort of Han Chinese individuals (X2= 6.63, P = 0.036; X2 = 9.787, P = 0.008, respectively) The risk allele for rs3729547 is T and the risk allele for rs3729843 is A. rs3729547 is a synonymous (isoleucine) variant whereas rs3729843 is a noncoding SNP. In this study, the authors investigated the association between 10 tagging SNPs (these two included) and DCM using matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry (MALDI-TOF-MS). However, the patients from this study were all members of the Han Chinese population, and therefore, these SNPs must be studied in the context of another ethnic group to validate strong associations between these SNPs and DCM. Additionally, this study was limited by its sample size, as only 97 DCM patients and 189 healthy unrelated controls partook in this study. In a second study published by Rani et al, the TNNT2 gene was sequenced in 162 patients with hypertrophic cardiomyopathy (HCM) and in 179 healthy controls. HCM phenotype ranged from moderate to severe, but a limited number of corrective operations were performed in these HCM patients. In contrast to the Li et al paper, this study was conducted exclusively in patients from India. Fifteen associated variants were uncovered, including rs3729547 (C to T) and rs3729843 (G to A), which were found to be in high linkage disequilibrium in the HCM patients. They also identified a 5bp deletion polymorphism in this Indian population that was previously shown to be associated with HCM patients of French, Spanish, and Japanese origin.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4745]]
    <blockquote>
        <p class="text-snippet" data-id="4745">rs736893 is related to sickle cell anemia, a genetic disease in which red blood cells form an abnormal crescent shape as opposed to the normal disc shape /. In the United States, it's estimated that sickle cell anemia affects 70,000&#8211;100,000 people, mainly African Americans. A New England Journal of Medicine study conducted in the US reported an average life expectancy of 42 in males and 48 in females . The landmark 1949 Science paper titled " Sickle Cell Anemia, a Molecular Disease by Pauling established the molecular basis for this sickle cell anemia and introduced notions that will become central to molecular medicine.  Sickle cell leg ulcers are common complications of sickle cell anemia . As of 2010, despite the fact that this complication has been recognized since the early times of sickle cell disease, there has been little improvement in the efficacy of its management and clinical outcome over the past 100 years . In a  study, investigators found significant associations between rs736839 (18q21.1) and sickle cell leg ulcers. Using the Benjamini and Hochberg algorithm to control FDR, this SNP was the only one found with FDR under 10%. In this study, the odds ratio for rs736893 was 1.95, with 95% confidence interval of (1.35&#8211;2.82). Homozygous C is associated with elevated levels of risk for sickle cell leg ulcers. In contrast, having at least one of T is considered less risky. This case-control study involved 387 cases and 920 controls. The genotype associations were adjusted for sex and age because men and older individuals are more likely to be afflicted .Although not in a gene, rs736839 is adjacent to SMAD7, which is part of the Transforming Growth Factor&#8211;b/Bone Morphogenetic Protein (TGF-beta/BMP) pathway. In a separate case-control SNP association study, IGF1R and genes in the TGF-beta / BMP pathway has been linked to sickle cell anemia .The Transforming growth factor beta (TGF-beta) signaling pathway is involved in many cellular processes in both the adult organism and the developing embryo including cell growth, cell differentiation, apoptosis, cellular homeostasis and other cellular functions. In spite of the wide range of cellular processes that the TGF-beta signaling pathway regulates, the process is relatively simple. TGF-beta superfamily ligands bind to a type II receptor, which recruits and phosphorylates a type I receptor. The type I receptor then phosphorylates receptor-regulated SMADs (R-SMADs) which can now bind the coSMAD SMAD4. R-SMAD/coSMAD complexes accumulate in the nucleus where they act as transcription factors and participate in the regulation of target gene expression.  Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1611]]
    <blockquote>
        <p class="text-snippet" data-id="1611">(Published 2008) Researchers noted that reduced fT3/fT4 ratios may be significant, since various bodily tissues and organs differ in their level of dependence on fT3 and fT4. They analyzed 18 SNPs of DIO1, DIO2, and DIO3 and measured thyroid hormone levels in 552 people on L-T4 hormone replacement therapy, and three healthy control groups not on L-T4 therapy (totalling 2513 people). Analysis was adjusted for age and sex.   Among patients, the _minor_ allele of rs11206244 was associated with reduced fT3:fT4 ratio from 0.193 in Common homozygous to 0.175 in Minor homozygous (-0.18) p for trend = 0.004).   Among patients, the _major_ allele of rs2235544 was associated with reduced fT3:fT4 ratio (from 0.196 in Minor homozygous to 0.177 in Common homozygous (-.019), p for trend = 0.01).   The two SNPs rs2235544 and rs11206244, were in linkage disequilibrium (LD)  (r2 = 0.41), and rs2235544 was driving the association.   Polymorphisms of rs2235544 in both cases and controls achieved genome-wide significance for effect on fT3/fT4 ratio(p=3.6x10-13) in the general population, each minor allele increasing the ratio by 0.2SD.  Polymorphism did not affect TSH levels.   None of the SNPs in the other deiodinase genes DIO2 DIO3 influenced T3, T4 or TSH serum levels.   Reverse T3 (rT3) levels were not studied.  Regardless of the polymorphism of rs2235544, the fT3:fT4 ratio and fT3 levels were consistently and significantly lower in hypothyroid patients on L-T4 therapy than in healthy controls, and patients' mean TSH was also lower than in controls.  A 2014 study "Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer" confirmed an earlier study's finding of LD (linkage disequilibrium) between rs11206244 T and rs2235544 A in DIO1.  A 2013 study "A Meta-Analysis of Thyroid-Related Traits Reveals Novel Loci and Gender-Specific Differences in the Regulation of Thyroid Function" explained that "even mild alterations in thyroid function are associated with weight changes, atrial fibrillation, osteoporosis, and psychiatric disorders." (Abstract). The study focused on genome-wide association data in 26,420 euthyroid (healthy, not hypothyroid or hyperthyroid) individuals phenotyped for serum TSH and 17,520 for FT4 levels. The meta-analysis highlighted a list of 26 SNPs from a wide variety of genes.   For DIO1 rs2235544 A/C, the A allele (51% frequency) was associated with an increase in FT4 levels, with a slightly larger effect on males than females. . This 2008 review discussed findings from previous research. The C allele of rs2235544 was associated with increased D1 function and increased FT3/T4 ratio.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2847]]
    <blockquote>
        <p class="text-snippet" data-id="2847">rs11208534 is a polymorphism within intron 3 of the Janus-activated kinase (JAK1) gene on human chromosome 1.  This SNP is reported by dbSNP as having A (ancestral) and G alleles, with a minor allele frequency of 19.2% (dbSNP). JAK1 is a membrane-associated protein-tyrosine kinase involved in the interferon-alpha/beta and &#8211;gamma pathways, which are important for immune responses to pathogens. Activation of JAK-family proteins occurs after binding of interferons to cell-surface receptors, and results in tyrosine phosphorylation of members of the STAT (signal transducer and activator of transcription) protein family, inducing the expression of many other genes involved in diverse biological processes including various antiviral responses .This SNP has been associated with increased risk of developing severe symptoms upon infection with dengue virus. Symptoms of dengue infection vary widely in severity, and are classified by the WHO (listed in order of increasing severity) as undifferentiated fever, dengue fever (DF), dengue hemorrhagic fever (DHF) and severe hypovolemic shock, or dengue shock syndrome (DSS). DF commonly includes high fever, general flu-like symptoms, and sometimes severe bleeding. DHF is characterized by high fever, major hemorrhaging, circulatory failure, and extremely low blood platelet counts and if untreated can progress to DSS ( correlation was found between rs11208534 and the development of symptoms consistent with DHF in a 2010 study in Brazil of individuals seropositive for dengue virus . The top hit out of 728 SNPs in 56 genes predicted to be involved in a cellular response to viral infection was rs11208534, for which the authors report T (major) and C (minor) alleles of rs11208534, not A and G as on dbSNP. Cases (n = 50) were recruited from patients with DHF-like symptoms by active hospital surveillance in the city of Salvador, Brazil. Controls (n = 236) who had experienced symptoms of DF, but not DHF, were recruited from families living within 1 kilometer of index cases, and were matched in age categories under and over 15 years. The association between rs11208534 and DHF (P-value 2.9x10-4; OR 5.2 (95% CI 2.1-12.7) just failed to reach the Bonferroni-corrected significance threshold of 2.6x10-4 by itself, but when combined with two other highly linked SNPs in the JAK1 gene region, rs310196 and rs2780831 (D&#8217; 0.856 and 1.0 to rs11208534 respectively), the association reached significance with a P-value of 2.1x10-4. This study provides evidence that polymorphisms in the JAK1 gene, including this one, may provide differential susceptibility to dengue virus infection, and likely other viruses as well. Dengue hemorrhagic fever is associated with polymorphisms in JAK1  Mechanisms of type-I- and type-II-interferon-mediated signalling</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1388]]
    <blockquote>
        <p class="text-snippet" data-id="1388">rs762551, also known as -164A>C or -163C>A, is a SNP encoding the CYP1A2 1F allele of the CYP1A2 gene. CYP1A2 is an enzyme responsible for the metabolism of caffeine and some drugs.The baseline activity of the enzyme is similar in CYP1A2 1F allele carriers and non-carriers. However, rs762551(A) codes for the "high inducibility" form of the enzyme, characterized by higher enzyme activity in the presence of an inducer such as smoking or heavy coffee consumption . In non-smokers, there was no significant difference in CYP1A2 activity between the genotypes. In smokers, however, the A/A homozygotes had 1.6x higher CYP1A2 activity than A/C and C/C genotypes . Similarly, among non-smokers, only in heavy coffee consumers (more than 3 cups daily) the A/A homozygotes had about 1.4x higher CYP1A2 activity. There was no differences in CYP1A2 activity by genotype in non-heavy coffee consumers. A study of healthy premenopausal non-hormone using women concluded that drinkers of 3 or more cups of coffee per day tended to have lower breast volume (smaller breasts), but only if they had at least one rs762551(C) allele (p(interaction)=0.02), which was said to be consistent with reports that coffee protects only C-allele carriers against breast cancer.Another study by this same group looked at coffee consumption as related to breast cancer. Among 458 such patients (age 25-99 years), rs762551(A;A) women (about 1/2 of the total study) who drank 2 or more cups of coffee per day tended to have a later age at diagnosis compared with low coffee consumption (59.8 versus 52.6 years, p = 0.0004). These patients were also more likely to have ER- tumors than patients with low consumption (14.7% versus 0%, p = 0.018). Coffee consumption had no associations in carriers of a rs762551(C) allele.An independent study of 411 BRCA1 mutation carriers (170 cases and 241 controls) looked at the association between breast cancer, coffee consumption before age 35, and CYP1A2 genotype. While CYP1A2 genotype did not affect breast cancer risk, women with at least one rs762551(C) allele who consumed coffee had a 64% reduction in breast cancer risk, compared with women who never consumed coffee (odds ratio 0.36, CI: 0.18-0.73). No such protective effect was seen in rs762551(A;A) women.A study of 2,000 Costa Ricans who survived a first heart attack observed a general trend between coffee consumption and increased risk among carriers of rs762551(C) alleles, i.e. more coffee led to increased nonfatal heart attack risk. No association was seen for rs762551(A;A) individuals.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q337]]
    <blockquote>
        <p class="text-snippet" data-id="337">This position is odd. Under the older reference genome build36, it was on the plus strand; in build37 it is on the minus strand. This makes it very prone to some ambiguous flip confusion in the literature, plus, 23andMe users have self-reported the flipped form. IN addition, instead of the usual SNP listed as having 2 alleles, all 4 alleles are reported in dbSNP, even if this is probably due to the strand changes. dbSNP currently says the normal allele is C, and T is the rare geno which causes a premature stop, early in the gene. We at SNPedia suspect that the A & G alleles are not common enough to have ever been genuinely reported, but for de-novo mutations each allele would be non-synonymous and result in a different amino acid. , a SNP located in the AMPD1 gene and also known as 'C34T', has at times been called the "most prevalent genetic disease mutation", at least in Caucasians.  Perhaps up to 10% of Caucasians and African-American carry one C34T allele (i.e. carry one rs17602729(A) allele) - and actually, most of them are unaware of any medically related issues since they don't typically have any particular symptoms that would warrant a trip to the doctor.So what's the issue? The AMPD1 gene encodes the enzyme adenosine monophosphate deaminase, which is one of the key enzymes used to process the energy source ATP. The C34T variation causes a premature stop in the protein, leading to a nonfunctional AMPD1 enzyme. Some individuals - but by no means all or even a majority apparently - who are AMPD1 deficient get muscle cramps and pains when they exert themselves. The most common genotype bringing this about is rs17602729(A;A), i.e. the individuals who carry two copies of the C34T allele and therefore have no functioning AMPD1 allele. It is not known why only some of C34T homozygotes experience muscle myalgia.Heterozygotes, i.e. rs17602729(A;G) individuals, do not seem to suffer any exercise or fitness related deficit. In fact, one of the best elite Caucasian distance runners is known to be a C34T heterozygote. In fact, heterozygotes for rs17602729 may even have advantages over those lacking a C34T allele. The most striking study reported that C34T heterozygotes are 8.6 fold (CI: 3.05 - 23.87) more likely to survive for more than 5 years without needing a heart transplant after a congestive heart failure related hospitalization than the wild-type homozygotes (i.e. rs17602729(G;G) homozygotes).  Similarly, C34T heterozygotes with coronary artery disease seem to fare better than wild-type homozygotes. This is one of the SNPs reported by NutraHacker SNPs|NutraHacker.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2722]]
    <blockquote>
        <p class="text-snippet" data-id="2722">rs187238, also known as -137 G/C, is a SNP in the interleukin 18 IL18 gene.Based on studying autopsies of 700 men in the Helsinki Sudden Death Study, there was a significant interaction between IL-18 genotype and hypertension impacting on the risk of sudden cardiac death (SCD) due to coronary heart disease (CHD). Among rs187238(G;G) homozygotes, hypertension was a major risk factor for SCD due to CHD (adjusted odds ratio 3.75, CI:1.78-7.91, p < 0.001) and hypertension also associated with larger coronary atherosclerotic plaque areas (p = 0.002) and the occurrence of complicated plaques (adjusted OR 8.38, CI: 2.39-29.33, p < 0.001). Among rs187238(C) allele carriers, hypertension was not a significant risk factor for CHD-related SCD or CAD and did not associate with the development of coronary atherosclerotic plaques.  Interleukin-18-promoter polymorphisms are not relevant in rheumatoid arthritis. Association study of functional genetic variants of innate immunity related genes in celiac disease. Analysis of polymorphisms of the interleukin-18 gene in type 1 diabetes and Hardy-Weinberg equilibrium testing. Interleukin 18 and human immunodeficiency virus type I infection in adolescents and adults. Cytokine gene polymorphisms and atopic disease in two European cohorts. (ECRHS-Basel and SAPALDIA). NeuroD1 gene and interleukin-18 gene polymorphisms in type 1 diabetes in Dalmatian population of Southern Croatia. Frequencies of single nucleotide polymorphisms in genes regulating inflammatory responses in a community-based population. Interleukin-18 promoter polymorphism associates with the occurrence of sudden cardiac death among Caucasian males: the Helsinki Sudden Death Study. Interleukin-18 gene polymorphisms and haplotypes in patients with oral lichen planus: a study in an ethnic Chinese cohort. Polymorphism of interleukin-18 promoter influences the onset of kidney graft function after transplantation. Interleukin (IL)-18 polymorphism 133C/G is associated with severe respiratory syncytial virus infection. Promoter polymorphism of interleukin-18 in angiographically proven coronary artery disease. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Novel polymorphism of interleukin-18 associated with greater inflammation after cardiac surgery. Interleukin-18 gene (IL18) promoter polymorphisms in patients with rheumatoid arthritis. Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients. Haplotype analysis of the interleukin-18 gene in Czech patients with allergic disorders. Evaluation of 6 candidate genes on chromosome 11q23 for coeliac disease susceptibility: a case control study. Inflammatory mediators gene polymorphisms in preeclampsia. Analysis of interleukin-18 promoter polymorphisms and changes in interleukin-18 serum levels underscores the involvement of interleukin-18 in recurrent spontaneous miscarriage. Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality. Association of polymorphisms in interleukin-18 and interleukin-28B with Hepatitis B recurrence after liver transplantation in Chinese Han population. Interleukin-18 promoter polymorphisms and risk of idiopathic recurrent pregnancy loss in a Tunisian population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4956]]
    <blockquote>
        <p class="text-snippet" data-id="4956">rs12255372, also known as IVS4G>T and c.483+9017G>T, is a well-studied SNP in the TCF7L2 gene on chromosome 10. In some studies, it has been linked to slight increases in risk for type-2 diabetes, breast cancer and aggressive prostate cancer.'''  Type-2 Diabetes Risk Overview:''' numerous papers report an increase in risk, on the order of 1.5 - 2x for the risk genotypes compared to the non-risk genotype. Key papers include:   reports the association of rs12255372 and rs7903146 with Type-2 diabetes in a Finnish sample.  rs12255372 Common variants (rs12255372 and rs7903146) in TCF7L2 seem to be associated with an increased risk of diabetes among persons with impaired glucose tolerance   Considered for type-2 diabetes with rs7903146 rs12255372 rs10885406.    Associated in a study of ~1000 Hispanic-Americans with reduced insulin secretion as measured by acute insulin response and adjusted for the degree of insulin sensitivity (p = 0.036).   This SNP was confirmed to be associated with type-2 diabetes in a study of 500+ Japanese patients plus pooled meta-analysis with 6 previous association studies (also of Japanese).  A HuGE review and meta-analysis including over 35,000 type-2 diabetes cases and 39,000 controls concluded that the Bayesian odds ratio for rs12255372(T;T) homozygotes and (G;T) heterozygotes versus (G;G) homozygotes was 1.885 (95% credible interval (CrI): 1.698 - 2.088) and 1.360 (95% CrI: 1.291 - 1.433), respectively. Along with 3 other TCF7L2 SNPs, a multiplicative genetic model was indicated.'''  Breast Cancer Risk Overview:''' some papers report a small increase in risk, around 1.1 to 1.2x for the risk genotypes compared to the non-risk genotype, and other papers report no increased risk. Key papers include:   is the paper which links it to Breast cancer. It suggests the T allele as increasing risk.   Meta-analysis totaling 4800 breast cancer cases finds a small risk increase (1.07 to 1.17x, depending on genetic model) for T allele   Mayo Clinic study of 800 patients found no association between rs12255372 and risk for breast cancer or ovarian cancer   A study of 7,700 Hispanic patients did find increased risk for the rs12255372 T allele, however, it was of borderline statistical significance'''  Prostate Cancer Risk Overview:'''    In a study of 1,457 prostate cancer cases and 1,351 controls, while there was no association with overall risk, males who were rs12255372(T;T) homozygotes and who had prostate cancer were at elevated relative risk of more aggressive prostate cancer, as defined by high Gleason score (OR = 1.7, CI: 1.0-2.8) or regional/distant stage (OR = 1.7, CI: 1.1-2.6) disease.Many other papers mention rs12255372, including:</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2392]]
    <blockquote>
        <p class="text-snippet" data-id="2392">. Published 2013. this article discussed the SNP risk for osteoarthritis in a selenium-deficient region, following up on the 2010 study also cited here. "Kashin-Beck disease (KBD) is a kind of degenerative osteoarthropathy." It found that "Haplotypes TCC, TTC and TTT of rs1050450, rs1800668 and rs3811699 in GPX1 showed a significant association with KBD and controls with P value of 0.0421, 5.0E-4 and 0.0066, respectively."  (Abstract). Published 2010, this article discussed the SNP risk for osteoarthritis in a selenium-deficient region. "Kashin-Beck disease (KBD) is a disabling osteoarthropathy involving growth cartilage endemic to selenium (Se)-deficient regions in China." "Four polymorphisms including GPX1 (rs1050450), TrxR2 (rs5748469), SEPP1 (rs7579) and DIO2 (rs225014) were analyzed for 161 KBD patients and 312 controls." However, Only GPX1 (rs1050450) polymorphisms that were heterozygote proline/leucine or homozygote leucene/leucene conferred a risk compared with the other variant: "odds ratio=1.781; 95% confidence interval: 1.127-2.814." "No association was observed between the other three single nucleotide polymorphisms (SNPs) and KBD risk.". Published 2009. GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer. Gene x Gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study. Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography. Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years. A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk. Oxidative response gene polymorphisms and risk of adult brain tumors. The Mn-superoxide dismutase single nucleotide polymorphism rs4880 and the glutathione peroxidase 1 single nucleotide polymorphism rs1050450 are associated with aging and longevity in the oldest old. Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects. Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast. Gene polymorphisms against DNA damage induced by hydrogen peroxide in leukocytes of healthy humans through comet assay: a quasi-experimental study. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Genetic polymorphisms in antioxidative enzymes are associated to forced expiratory volume in 1 s (FEV1) in smokers independently of asthma. GPx-1 polymorphism (rs1050450) contributes to tumor susceptibility: evidence from meta-analysis. Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: relationship to markers of oxidative stress in men from Auckland, New Zealand. Antioxidant enzyme polymorphisms and neuropsychological outcomes in medulloblastoma survivors: a report from the Childhood Cancer Survivor Study.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1484]]
    <blockquote>
        <p class="text-snippet" data-id="1484">Also known as c.506-1G>A or 1846G>A, the normal (or wild type) form of this SNP is a (G) as defined on the reverse/minus strand. The (A) form disrupts proper mRNA formation, resulting in a nonfunctional CYP2D6 protein. The associated allele is also known as CYP2D6 4. The CYP2D6 4 allele is the most common nonfunctioning variant of CYP2D6.If two copies of this (or similar) changes are inherited, poor metabolism ('PM') of debrisoquine  is observed. Many other drugs are typically first metabolized by CYP2D6 including dextromorphan, sparteine, metoprolol, nortriptyline and many other antidepressants and codeine. Of course, sometimes the active form of a drug is the one post-CYP2D6 metabolism; an example of this is tamoxifen, where the active form (endoxifen) is formed primarily via CYP2D6 metabolism; less functioning CYP2D6 can mean less benefit from taking the drug.The CYP2D6 4 allele (i.e. rs3892097(A)) has been postulated by researchers over the years to have many potential consequences, both positive and negative.On the positive side: this allele may reduce the risk of certain cancers, such as bladder and lung , and it may correlate with somwhat less severe neurodegeneration in Alzheimer's .On the other hand, at least two studies PMID 14991823, PMID 15174030 have concluded that the risk of developing Parkinson's disease upon exposure to pesticides is increased from 3 to 8 fold among carriers of CYP2D6 4 alleles. The risk to CYP2D6 4 carriers appears proportional to the degree of pesticide exposure, with no additional risk of developing Parkinson's seen for CYP2D6 4 carriers with no pesticide exposure, and the highest increased risk of developing Parkinson's seen for CYP2D6 4 carriers with frequent exposure to pesticides.Patients prescribed tricyclic antidepressants (TCA) who are homozygous for the CYP2D6 4 allele metabolize these drugs more slowly, which puts them at higher risk for adverse side effects. A study of ~1100 Dutch patients reports: (1) 6 fold more side effects upon switching antidepressants for CYP2D6 4 homozygotes, but not for heterozygotes, and (2) that the effective and maintenance doses of antidepressants for CYP2D6 4 homozygotes are lower than for patients with one or more higher metabolizing CYP2D6 alleles. rs3892097(A;A) patients taking a beta blocker drug such as metoprolol are at ~4x increased risk for bradycardia, based on a study of 1,533 patients in the Rotterdam Study. These CYP2D6  4/ 4 homozygotes have the 'poor metabolizer' (PM) phenotypes, and had adjusted heart rates that were 8.5 beats/min lower compared with  1/ 1 extensive metabolizers (EMs) (p < 0.001), leading to an increased risk of bradycardia in PMs (odds ratio of 3.86, CI: 1.68-8.86,  p = 0.0014).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3833]]
    <blockquote>
        <p class="text-snippet" data-id="3833">Minor allele (T) of this SNP uniquely identifies what is known as the PROGINS allele in the progresterone receptor gene PGR.Two SNP's tagging a partial haplotype of the PGR gene were associated with an increased risk of ovarian cancer among homozygous carriers as compared with noncarriers: rs1042838 (PROGINS allele; odds ratio OR = 3.23, 95% confidence interval CI = 1.19 to 8.75, P = .022) and rs608995 (minor allele; OR = 3.10, 95% CI = 1.63 to 5.89, P<.001). The study suggest the effect is likely entirely due to rs608995, whose minor allele was almost always seen with PROGINS allele. For rs1042838, the risk allele in orientation to the corresponding dbSNP entry is (T). Subsequent studies have not replicated this high odds ratio, nor the apparent recessive model in this study. The small number of homozygous carriers in the study probably explains this outlier. A 2010 study  of 2888 cases and 4483 controls could not reproduce the association of this SNP with ovarian cancer, even adjusting for ethnicity and BMI. The study concludes their sample size had >90% power to detect OR 1.3 for this SNP, so if an effect exists it must be quite small. A pooled analysis of 4788 ovarian cancer cases and 7614 controls in 2008 suggested that PROGINS risk is limited to invasive endometrioid subtype , to that effect a 2010 study found association with endometrial cancer  with same risk haplotypes as the earlier haplotype study on ovarian cancer. A 2014 metastudy  however did find association between PROGINS and ovarian cancer, but statistically significant only for Caucasians, those having never used oral contraceptives, and serous (endometrial) cancers, while another meta-study  looking at endometrial cancer specifically found association (OR 1.52-2.72, p = 0.0008-0.03) among European women in particular.This SNP has also been reported to be associated with migraine-associated vertigo (p&#8201;=&#8201;0.0007). SNPs in genes involved in female hormonal pathways have been a subject of particular interest in the study of migraines because females appear to be more prone to migraines than males. Previous studies had suggested that the minor allele of this SNP might also influence breast cancer. However, a 2009 European study of 30,000 breast cancer cases, compared to 30,000 controls, found no association, or as they put it, "persuasive evidence against an overall association between invasive breast cancer risk and (this SNP)". Association of the progesterone receptor gene polymorphism (PROGINS) with endometriosis: a meta-analysis. Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies. Association of progesterone receptor with migraine-associated vertigo Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3010]]
    <blockquote>
        <p class="text-snippet" data-id="3010">rs1800588, also known as the -514C/T polymorphism of the LIPC gene, may influence the levels of the "good" cholestorols, the high density lipoprotein (HDL) cholesterols. Generally, the (T) allele (as published) is considered to lead to higher HDL levels.However, high HDL cholesterol, at least when combined with another HDL raising SNP (rs708272), doesn't appear to actually protect individuals from coronary artery disease, at least based on one study of ~800 Caucasian male patients.  Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adults. A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study. Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: the Atherosclerosis Risk in Communities (ARIC) Study. New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background. Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. LIPC variants in the promoter and intron 1 modify HDL-C levels in a sex-specific fashion. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study. Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach. Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Development of a fingerprinting panel using medically relevant polymorphisms. Common lipid-altering gene variants are associated with therapeutic intervention thresholds of lipid levels in older people. beta-Carotene conversion products and their effects on adipose tissue. Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population. Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Molecular interactions between HNF4a, FOXA2 and GABP identified at regulatory DNA elements through ChIP-sequencing. Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease. Using a latent growth curve model for an integrative assessment of the effects of genetic and environmental factors on multiple phenotypes. Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project. Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3159]]
    <blockquote>
        <p class="text-snippet" data-id="3159">Also known as "C/T(-13910)" or just 13910T, and located in the MCM6 gene but with influence on the lactase LCT gene, rs4988235 is one of two SNPs that is associated with the primary haplotype associated with hypolactasia, more commonly known as lactose intolerance in European populations. , In these populations, the rs4988235(T) allele is both the more common allele and the one associated with lactase persistence; individuals who are rs4988235(C;C) are likely to be lactose intolerant.Note that while lactose intolerance is usually reported only for rs4988235(C;C) homozygotes, at least one publication finds that lactase enzyme activity actually forms a continuum across the three rs4988235 genotypes, being lowest in C/C homozygotes, intermediate in T/C heterozygotes, and highest in T/T homozygotes. It is therefore likely the heterozygotes may also experience symptoms of lactose intolerance at times (depending on age and amount of lactose).In populations of sub-Saharan Africans, though, the rs4988235(T) allele is so rare that it's unlikely to be predictive of lactase persistence, and other SNPs are predictive instead. PMID 15106124, PMID 17159977  See also  OMIM 601806.0001 Measuring European population stratification with microarray genotype data. Adult-type hypolactasia is not a predisposing factor for the early functional and structural changes of atherosclerosis: the Cardiovascular Risk in Young Finns Study. Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. Heterogeneity in gene loci associated with type 2 diabetes on human chromosome 20q13.1. Genetic testing for adult-type hypolactasia in Italian families. Lactase persistence-related genetic variant: population substructure and health outcomes. Gender differences in genetic risk profiles for cardiovascular disease. Genetic lactase non-persistence, consumption of milk products and intakes of milk nutrients in Finns from childhood to young adulthood. Geographical structure and differential natural selection among North European populations. Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting. A non-synonymous variant in ADH1B is strongly associated with prenatal alcohol use in a European sample of pregnant women. Polymorphism in the oxytocin promoter region in patients with lactase non-persistence is not related to symptoms. European lactase persistence genotype shows evidence of association with increase in body mass index. Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Haplotype allelic classes for detecting ongoing positive selection. Usefulness of Mendelian randomization in observational epidemiology. Adult-type hypolactasia and lactose malabsorption in Poland. Association of the LCT-13910C>T polymorphism with obesity and its modulation by dairy products in a Mediterranean population. Lactase persistence genotypes and malaria susceptibility in Fulani of Mali. The lactase persistence -13910C>T polymorphism shows indication of association with abdominal obesity among Portuguese children.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q199]]
    <blockquote>
        <p class="text-snippet" data-id="199">rs2241766, also known as c.45T>G, represents a synonymous variant in the ADIPOQ gene on chromosome 3. Some studies report that the less common rs1501299(G) allele, is associated with decreased cancer risk compared with the more common (T) allele.A study of 733 breast cancer cases for 10 SNPs concluded that the rs2241766(G;T) genotype, in combination with certain genotypes at rs1501299, was at reduced risk (odds ratio 0.61, CI: 0.46-0.80). After categorizing individuals by adiponectin signaling status, this study found that compared with low signalers (the most frequent), intermediate signalers had a 0.64x decrease in breast cancer risk (CI: 0.490.83), and high signalers had a 0.15x lower breast cancer risk (CI: 0.021.28, p(trend) = 0.001).Adiponectin signaling status was assigned as follows (as oriented in dbSNP):rs1501299(C,C) + rs2241766(T,T) = low signaler<br>rs1501299(A,C) + rs2241766(T,T) = low signaler<br>rs1501299(C,C) + rs2241766(G,T) = low signaler<br>rs1501299(A,A) + rs2241766(T,T) = intermediate signaler<br>rs1501299(A,C) + rs2241766(G,T) = intermediate signaler<br>rs1501299(C,C) + rs2241766(G,G) = intermediate signaler<br>rs1501299(A,C) + rs2241766(G,G) = high signaler<br>rs1501299(A,A) + rs2241766(G,G) = high signaler<br>rs1501299(A,A) + rs2241766(G,T) = high signaler<br>Based on these criteria, adiponectin signaling status is now determined by genosets Gs325 and Gs326 for Promethease users.Note that  adiponectin, a hormone produced by adipose tissue (body fat), is involved in lipid metabolism.In other words, you are a low adiponectin signaler, and thus have basically average breast cancer risk, if you have one of these combinations of alleles: rs1501299  CC and also rs2241766 either GT or TT rs1501299  AC and also rs2241766 TTYou are an intermediate adiponectin signaler (Gs325), and thus possibly at 0.64x reduced risk of breast cancer compared to low signallers, if you have one of these combinations of alleles:  rs1501299 CC and also rs2241766 GG  rs1501299 AC and also rs2241766 GT  rs1501299 AA and also rs2241766 TTYou are a high adiponectin signaler (Gs326), and thus have the lowest (perhaps 0.15x) risk if you have one of these combinations of alleles:  rs1501299 AC and also rs2241766 GG  rs1501299 AA and also rs2241766 either GG or GT</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1609]]
    <blockquote>
        <p class="text-snippet" data-id="1609">(Published 2008) Researchers noted that reduced fT3/fT4 ratios may be significant, since various bodily tissues and organs differ in their level of dependence on fT3 and fT4. They analyzed 18 SNPs of DIO1, DIO2, and DIO3 and measured thyroid hormone levels in 552 people on L-T4 hormone replacement therapy, and three healthy control groups not on L-T4 therapy (totalling 2513 people). Analysis was adjusted for age and sex.   Among patients, the _minor_ allele of rs11206244 was associated with reduced fT3:fT4 ratio from 0.193 in Common homozygous to 0.175 in Minor homozygous (-0.18) p for trend = 0.004).   Among patients, the _major_ allele of rs2235544 was associated with reduced fT3:fT4 ratio (from 0.196 in Minor homozygous to 0.177 in Common homozygous (-.019), p for trend = 0.01).   The two SNPs rs2235544 and rs11206244, were in linkage disequilibrium (LD)  (r2 = 0.41), and rs2235544 was driving the association.   Polymorphisms of rs2235544 in both cases and controls achieved genome-wide significance for effect on fT3/fT4 ratio(p=3.6x10-13) in the general population, each minor allele increasing the ratio by 0.2SD.  Polymorphism did not affect TSH levels.   None of the SNPs in the other deiodinase genes DIO2 DIO3 influenced T3, T4 or TSH serum levels.   Reverse T3 (rT3) levels were not studied.  Regardless of the polymorphism of rs2235544, the fT3:fT4 ratio and fT3 levels were consistently and significantly lower in hypothyroid patients on L-T4 therapy than in healthy controls, and patients' mean TSH was also lower than in controls.  A 2012 study "The Relationship of Deiodinase 1 Genotype and Thyroid Function to Lifetime History of Major Depression in Three Independent Populations," researchers "confirmed prior findings that two variants in deiodinase 1 (DIO1), including a variant in the 3 UTR of DIO1 (rs11206244), were associated with altered free thyroxine (FT4) levels in both White and African American subjects. We also found that rs11206244 genotype was associated with lifetime MD (Major Depression) in White female subjects, in particular those from high-risk cohorts. However, we found no association of current FT4 levels with lifetime MD in either ethnic group. We conclude that genetic variation influencing thyroid function is a risk factor for MD." (Abstract) This 2008 review discussed findings from previous research, such as: Carriers of the T allele of (rs11206244) exhibited higher rT3/T4 and lower T3/rT3 ratios in serum, suggesting a negative effect of this variant on D1 expression and/or activity.  In contrast, the G allele of (rs12095080) correlated with lower rT3/T4 and higher T3/rT3 ratios, suggesting increased D1 expression and/or activity of this variant.  the C allele of rs2235544 was associated with increased D1 function and increased FT3/T4 ratio.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5395]]
    <blockquote>
        <p class="text-snippet" data-id="5395">Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program. Association analysis of type 2 diabetes Loci in type 1 diabetes. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Clinical review: the genetics of type 2 diabetes: a realistic appraisal in 2008. Common type 2 diabetes risk gene variants associate with gestational diabetes. Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study. Meta-analysis in genome-wide association studies. Genetic predisposition, Western dietary pattern, and the risk of type 2 diabetes in men. Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: a study of 16,003 Swedish adults. A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion. Genome-based prediction of common diseases: methodological considerations for future research. No association of multiple type 2 diabetes loci with type 1 diabetes. Genetic architecture of type 2 diabetes: recent progress and clinical implications. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Is the thrifty genotype hypothesis supported by evidence based on confirmed type 2 diabetes- and obesity-susceptibility variants? Underlying genetic models of inheritance in established type 2 diabetes associations. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. Influence of control selection in genome-wide association studies: the example of diabetes in the Framingham Heart Study. The effect of multiple genetic variants in predicting the risk of type 2 diabetes. Prioritizing genes for follow-up from genome wide association studies using information on gene expression in tissues relevant for type 2 diabetes mellitus. A genomics study of type 2 diabetes mellitus in U.S. Air Force personnel. Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in type 2 diabetes in a Chinese population. Obesity and diabetes genes are associated with being born small for gestational age: results from the Auckland Birthweight Collaborative study. Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective study. Genetic risk profiling for prediction of type 2 diabetes. Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q213]]
    <blockquote>
        <p class="text-snippet" data-id="213">rs553668 represents a polymorphism in the ADRA2A gene on chromosome 10. Although it has been studied for quite a while, as all the citations below show, there are very few if any statistically robust conclusions about it, and almost none of the studies reported below have been independently replicated. In "Association of the ADRA2A polymorphisms with the risk of type 2 diabetes: a meta-analysis." a meta-analysis of publications prior to September 2012 showed no overall association between rs553668 and T2D risk, but did find an association with very high (poor) P-value for Europeans under recessive gene model (GT=AA, OR=1.36, p=0.02, 95% CI: 1.05, 1.76).In "Genetic association of adrenergic receptor alpha 2A with obesity and type 2 diabetes." rs553668 was found to correlate with obesity in Swedish population, but not significantly for BMI-corrected T2D risk. ADRA2A is involved in sympathetic nervous system's inhibition of insulin secretion and lipolysis, so direct effect on T2D is usually sought, but the Swedish study suggest it could work through body mass. It also mentions that rs553668 has additionally been reported to be associated with risk of obesity in Caucasians and African Americans , hypertension in African Americans , and with platelet aggregation . "Exercise-induced muscle vasodilatation and genetic polymorphisms of alpha-adrenergic receptors, endothelial nitric oxide synthase and bradykinin receptor B2 in individuals without overt heart disease" provides some evidence of a link to vascular function in exercise.  "ADRA2A is a cystic fibrosis modifier gene" concludes that rs553668 is modifier of Cystic Fibrosis severity. Genetic polymorphism of the alpha 2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans. A polymorphism in the alpha2a-adrenoceptor gene and endurance athlete status. Clinical and pharmacological significance of alpha2-adrenoceptor polymorphisms in cardiovascular diseases. Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Qu&#233;bec Family Study. Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels. A preliminary candidate genotype-intermediate phenotype study of satiation and gastric motor function in obesity. ADRA2A polymorphisms and ADHD in adults: possible mediating effect of personality. Genetic variations in the alpha(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine. Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies. The rs553668 polymorphism of the ADRA2A gene predicts the worsening of fasting glucose values in a cohort of subjects without diabetes. A population-based study. Association of the ADRA2A polymorphisms with the risk of type 2 diabetes: a meta-analysis. Genetic association of adrenergic receptor alpha 2A with obesity and type 2 diabetes.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q403]]
    <blockquote>
        <p class="text-snippet" data-id="403">Apolipoprotein E ApoE status is technically defined by two different SNPs, rs429358 and rs7412.  This SNP, rs4420638, is situated about 14kb away in the adjacent ApoC1 gene and is co-inherited with ApoE and thus associated with late-onset Alzheimer's disease.rs4420638 (the proxy SNP) is not independent of rs429358. These two SNPs are correlated with each other and it's believed that most of the association with AD at rs4420638 is due to its proximity to rs429358. That said, rs4420638 is not a perfect proxy for rs429358 either -- rs4420638 correlates better for certain genotypes and for certain ethnicities. For example, if you have the genotype at rs4420638 that is more correlated with the e4 allele of APOE, you still only have a 50% chance of actually having the e4 allele. And rs4420638 is not very predictive for any genotype in African populations. The (G;G) form of this SNP indicates increased risk of Alzheimer's disease, however the probability and amount of increased risk is subject to some disagreement. The initial report concerning this SNP indicated a high likelihood that rs4420638(G;G) homozygotes were predictably ApoE4/ApoE4 homozygotes and thus at significantly (15 fold or higher) risk for Alzheimer's. However, one testing service has estimated pers. communication that 25% to 50% of people with the (G;G) are  not  actually ApoE4 homozygotes, and are more likely to be at ~2-3x increased risk based on being ApoE3/ApoE4 heterozygotes. If you were tested on deCODEme or 23andMe v3 platform, ignore this proxy and just check your status at rs429358 and rs7412. 23andme added rs429358 for people who tested on the v3 platform on 04/14/2011, so you should re-download your data if you haven't.This  AlzForum.org article suggests that ApoE4/ApoE4 homozygotes have a ~15-fold increased risk for developing the disease compared to ApoE3/ApoE3 carriers, whereas rs4420638(A;G) individuals have a ~3-fold increased risk.ApoE4 status is notable as being the variation that several well known scientists, including Nobel Prize winner User:Watson|James Watson, request not to learn when having their own genomes analyzed.Meta-analyses have also supported the association between the ApoE4 allele and somewhat increased risk for heart disease, with an odds ratio of 1.42 (CI: 1.26 - 1.61)./ 23andMe blog each rs4420638(G) lowered CRP by 21.8% also associated with higher total cholesterol, LDL choelsterol and triglycerides, and lower HDL cholesterolNote: the :Category:On_chip_Affy500k|Affymetrix 500K chip is said to poorly tag (ie assay) this particular SNP. According to / a 23andMe discussion This is one of the SNPs which were re-analyzed April 2009. Customers with older data may wish to redownload. SNPs effected rs4420638, rs34276300, rs3091244, rs34601266, rs2033003, rs7900194, rs9332239, rs28371685, rs1229984, and rs28399504.G allele is associated with 6.61mg/dl increase in LDL cholesterol (bad cholesterol).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5055]]
    <blockquote>
        <p class="text-snippet" data-id="5055">rs361525 is also known as the TNF-238 SNP, and occasionally the rs361525(A) allele is referred to as 238.2 (with the more common (G) allele being 238.1). This SNP in the tumor necrosis factor-alpha gene has been linked to a wide variety of conditions:  Breast cancer   A large study of over 5,000 Caucasian women found that rs361525(A) allele carriers were at somewhat elevated risk for breast cancer compared to the (G;G) genotype, with an odds ratio per allele of 1.18, CI: 1.04-1.35, p(trend)= 0.008.   However, a 2009 European study of 30,000 breast cancer cases, compared to 30,000 controls, found no association, or as they put it, "persuasive evidence against an overall association between invasive breast cancer risk and (this SNP)".   Graft versus host disease (GVHD)   A study of ~100 allogeneic haematopoietic stem cell transplant recipients in Brazil concludes that graft versus host disease (GVHD) is about twice as frequent if either the donor or the recipient is a carrier of the rs361525(A) allele.   Otitis or ear infections   Children who are rs361525(G;G) homozygotes may be more prone to ear infections; adjusted odds ratio 2.29, p=0.03).   Nasal polyps   The rs361525(A;A) genotype was associated with increased risk for nasal polyps in a study of 82 Turkish patients.   Psoriasis   A study of 160 Polish psoriasis patients indicated that the frequency of the rs361525(A) allele was significantly increased (16.8% vs. 3.1%, p=0.000017, odds ratio 8.79, CI: 2.606-29.678), and furthermore, the onset age was lower in rs361525(A) carriers.   Diabetes and verbal memory   rs361525(A) carriers showed a slower decline of verbal memory over a period of 48 weeks in a study of elderly patients with type-2 diabetes.   Sudden infant death syndrome (SIDS)   rs361525(G;G) babies may be at higher risk for sudden infant death syndrome (SIDS) based on a relatively small number (148) of Norwegian infants studied.   Exfoliation glaucoma   A study of 204 patients with exfoliation glaucoma (XFG) concluded that rs361525 is unlikely to be a major risk factor for XFG in Caucasians.   Lymphoma  A US study  of 1,172 lymphoma patients and 982 controls looked at 57 SNPs in 36 immune function genes. Five SNPs in two cytokine genes, tumor necrosis factor-alpha and lymphotoxin-alpha, were associated with a 1.31x increase in non-Hodgkin lymphoma (OR, 1.31; 95% CI, 1.06-1.63; P = 0.01) and with a 1.64x increase in the subtype known as diffuse large B cell lymphoma (OR, 1.64; 95% CI, 1.23-2.19; P = 0.0007). The other four SNPS are listed below. The cytokine genes affect inflammatory and innate immune responses.   rs1800629   rs1799724   rs909253   rs2239704</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2655]]
    <blockquote>
        <p class="text-snippet" data-id="2655">rs6318 (Cys23Ser / C23S or 68G>C / G68C) is a SNP within the serotonin 2C receptor HTR2C gene located on the X chromosome. Since it is located on the X chromosome, males will be hemizygous and either (C;-) or (G;-), whereas females will either homozygous (C;C) or (G;G) or heterozygous (C;G). In most of the studies cited below, heterozyous (C;G) females were roughly statistically equivalent to females carrying the common non-risk (G;G) genotype.One relatively large (4,000 men and 2,000 women) study published in late 2013 of Caucasian catheterization patients has studied the association between rs6318 genotype and risk of having an "end" cardiac event, defined as either death or a heart attack, in the years following entry into the study (i.e. presumably following their catheterization). Patients were followed for up to 11 years, with a median follow-up time of 5.3 years. Different rs6318 genotypes had statistically significant differences in their odds of having end cardiac events as follows: 29% of (G;-) men; 35% of (C;-) men; ~26% of (G;G) or (C;G) women; and 36% of (C;C) women. This works out to hazard ratios from the fully adjusted model for male rs6318(C;-) compared to the more common (G;-) males of 1.23 (CI: 1.02-1.36, p=0.02), and 1.62 (CI:1.07-2.47, p=0.02) for female (C;C) genotypes compared to the more common (G;G) females. The authors postulate that rs6318 is associated with higher stress-related cortisol levels, and suggest (without any evidence so far) that rs6318(C;C) women and (C;-) men may benefit from either behavioural therapy or the use of a serotonin receptor antagonist such as agomelatine.  'significant excess of Ser allele carriers in patients compared to normal controls' (in 513 patients with recurrent MDD, 649 patients with bipolar affective disorder, and 901 normal controls) Further evidence supporting the association between 5HTR2C gene and bipolar disorder== antipsychotics == in a small sample of 45 autistic patients taking risperidone for up to one year, assoc. w/ prolactin elevation and BMI / waist circumference with risperidone usage rs6313(T) (102T) allele of HTR2A, the rs5443(T) (825T) allele of GNB3, the Rs6318(G) (23Cys) allele of HTR2C, and the rs1801253(C;C) (64Arg/Arg) genotype of ADRB3, were significantly associated with olanzapine-induced weight gain among 164 schizophrenic (per DSM-IV-TR) psychiatric inpatients no association with anti-psychotic induced weight gain noted in 104 Caucasian psychiatric inpatients</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4740]]
    <blockquote>
        <p class="text-snippet" data-id="4740">'''rs12913975''' is an A/G single nucleotide polymorphism (SNP) of the SMAD6 gene that has been associated with the prognosis of non-small cell lung cancer (NSCLC) patients. The most common nucleotide or 'major allele' of this SNP is G, which is also the dominant allele. The minor allele is A, which according to data from the 1000 Genomes project occurs in the sampled population at a frequency of 15.8% (observed 345 times in 2183 people). HapMap data (July 2005) from 1208 individuals from 13 populations included population specific genotype frequencies for this SNP  dbSNP.A 2011 study published by Li ''et al.'' examined 33 SNPs in 13 TGF-beta pathway genes to estimate the effect of genotype on brain metastasis in 116 NSCLC patients. The authors found that NSCLC patients with the G/G genotype of the rs12913975 SNP had a significantly increased risk of brain metastasis compared to patients with the A/G genotype over the two years following initial time of lung cancer diagnosis (hazard risk: 2.540, 95% confidence interval: 1.204-5.359, p = 0.014). Hazard ratios and confidence intervals were estimated using cox proportional hazards model for the multivariate survival analyses adjusted for sex, age, clinical stage, tumor histology, Karnofsky performance status, and smoking status. A two-tailed t- test was used to determine significance of associations. This finding may allow clinicians to use the rs12913975 SNP as a measure of an NSCLC patients&#8217; risk of developing brain metastasis. It is not known whether this SNP plays a functional role in the potential of NSCLC tumors to metastasize to the brain. However, the SNP is located in the SMAD6 gene, an inhibitor of TGF-beta signaling that is a pathway affected in different cancers, so this may in fact be a functional variant  PMID: 23284751.In 2011 Lin ''et al.'' determined the effect of genotype on survival in 598 advanced-stage NSCLC patients across 227 SNPs in 23 TGF-beta pathway-related genes to estimate. The authors identified the rs12913975 SNP as a genetic variant significantly associated with the overall survival of NSCLC patients (hazard risk: 1.29, 95% confidence interval: 1.05-1.59, p = 0.01). Furthermore, they found that the G/G allele of this SNP had a significant positive effect on the survival of NSCLC patients using chemoradiation (hazard risk: 0.61, 95% confidence interval: 0.42-0.90, p = 0.01), but that this trend was not significant when patients used only chemotherapy (hazard risk: 0.76, 95% confidence interval: 0.56-1.02, p = 0.29). Hazard ratios and confidence intervals were estimated using cox proportional hazards model for the multivariate survival analyses adjusted for age, sex, ethnicity, smoking status, clinical stager, pretreatment PS, and therapy modality. A two-tailed chi-squared or Fisher&#8217;s exact test was used to determine significance of associations.  PMID: 21515830</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1551]]
    <blockquote>
        <p class="text-snippet" data-id="1551">rs776746, also known as 6986A>G, is a SNP encoding the (nonfunctional) CYP3A5 3 allele of the CYP3A5 gene.CYP3A5 3 has been studied especially in connection with the metabolism of tacrolimus, an immunosuppressive drug used in organ transplantation. The optimal therapeutic dose is in a relatively narrow window, so blood concentration monitoring is recommended. CYP3A5 3 carriers tend to build up higher levels of tacrolimus than CYP3A5 1 carriers, unless their tacrolimus intake is reduced.Carrying two non-expressing CYP3A5 3 alleles (in other words, the rs776746(G;G) genotype) is very common among Caucasians (over 85% of all), and is still relatively common (perhaps about half of all people) in many other populations other than those that are of African descent. Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. Prevalence of common disease-associated variants in Asian Indians. Genotyping panel for assessing response to cancer chemotherapy. Joint effects of inflammation and androgen metabolism on prostate cancer severity. The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis. Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans. Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa. The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia. No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II. Explaining variability in ciclosporin exposure in adult kidney transplant recipients. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients. The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes. Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity. Dosing equation for tacrolimus using genetic variants and clinical factors. Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation. Identification of Factors Affecting Tacrolimus Level and 5-Year Clinical Outcome in Kidney Transplant Patients.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q919]]
    <blockquote>
        <p class="text-snippet" data-id="919">rs1024611, also known as the -2578A>G SNP due to its position in the promoter of the monocyte chemoattractant protein-1 MCP-1 CCL2 gene, influences the production of its corresponding protein, a chemokine involved in inflammatory responses.In a study focusing on 679 apparently healthy siblings of people with premature heart disease, investigators found that carriers of an rs1024611(C) allele - oriented as in dbSNP, not as published - independently predicted the risk of exercise induced ischemia in general. The odds ratio was reported to be 1.86 (CI: 1.14-3.04, p=0.014), regardless of race, age, sex and other factors. However, it is not clear if this risk carries over to individuals who lack siblings with heart disease.discussed in the / 23andMe blog as being relevant to HIV  rs1024611 is not associated with systemic sclerosis in a multicenter study of 345 European patientstuberculosis Association study of functional genetic variants of innate immunity related genes in celiac disease. Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation. Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus. Polymorphisms within inflammatory genes and colorectal cancer. Association of the -2510A/G chemokine (C-C motif) ligand 2 polymorphism with knee osteoarthritis in a Korean population. The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility. Genome-wide association with select biomarker traits in the Framingham Heart Study. A genome-wide association study identifies protein quantitative trait loci (pQTLs). Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa. Analysis of inflammation- and atherosclerosis-related gene polymorphisms in branch retinal vein occlusion. Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians. Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis. Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals. Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects. The -A2518G polymorphism of monocyte chemoattractant protein-1 is associated with Crohn's disease. Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis. CCL2 and CCR2 polymorphisms are associated with markers of exercise-induced skeletal muscle damage. Combined effect of inflammatory gene polymorphisms and the risk of ischemic stroke in a prospective cohort of subjects with type 2 diabetes: a Go-DARTS study. CCL3 genotype and current depression increase risk of HIV-associated dementia. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. Monocyte chemoattractant protein-1 in schizophrenia: -2518A/G genetic variant and protein levels in Armenian population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2593]]
    <blockquote>
        <p class="text-snippet" data-id="2593">rs138213197, also known as c.251G>A, p.Gly84Glu and G84E, is a SNP in the homeobox transcription factor HOXB13 gene located in a cluster of HOX genes on ch 17q21&#8211;22. This gene is a member of the abdominal B subfamily, which have posterior domains of expression, including in the vertebrate urogenital system. HOXB13 maintains a relatively high level of expression in the adult prostate. G84E consists of the non-conservative replacement of a glutamic acid for a glycine at this position in the HOXB13 protein.In early 2012, findings were published based on exome sequencing of 200 genes spanning the ch17q21-22 region of primarily Caucasian prostate cancer patients (and matched controls). Deemed a "rare but recurring mutation", rs138213197(T) was discovered and then validated in a larger case-case study. Overall, rs138213197(T) was reported to lead to a 20-fold higher risk for prostate cancer, based on having been observed in 72 of ~5,000 patients but in only 1 person out of 1400 controls (so overall odds ratio 20.1, CI: 3.5 - 803.3, p=8.5&#215;10&#8722;7).Subsequent studies convincingly replicate this result:    Confirmed with odds ratio of 7.1 (CI: 4.62&#8211;10.78, p = 10e-19) based on 10,000 patients of various ethnicities (and ~60,000 controls).    Confirmed with odds ratio of 3.4 (CI: 2.2&#8211;5.4, p = 10e-6 or less) based on 5,000 Swedish patients. For this population, male G84E carriers have an estimated 33% cumulative risk to age 80 yr of prostate cancer, compared to 12% (CI: 11&#8211;13) among noncarriers.     Confirmed with odds ratio of 5.8 (CI: 1.3 - 26.5, p = .01) based on 1,800 Canadian patients.    Confirmed with odds ratio of 3.3 (CI: 1.21 &#8211; 8.96) in 1,300 Caucasian men.    Confirmed with odds ratio of 7.9 (CI: 1.8 - 34.5, p = .0062) based on 928 Caucasian patients.    G84E not present in 671 Chinese patients or 1,536 controls, but a novel HOXB13 SNP, G135E found by sequencing in 3 of the cases (and no controls).Is rs138213197 also associated with breast cancer risk? Maybe, maybe not - it's too early to tell:    This study of 4,000+ Canadian and Polish patients indicates not; frequency of allele was 0.16%.    Of 877 patients, 6 women with BRCA1/2 wild-type, familial breast cancer (none Ashkenazi) Jewish ancestry had the variant, hence an odds ratio 5.7 (CI: 1-40, p=0.02).Additional studies examining the origin of the G84E variant have determined that the haplotype background it is seen within is observed most frequently in Nordic countries, most strikingly within the Finnish population, suggesting that rs138213197 is a founder mutation that arose around the year 1800 in Northern Europe.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4715]]
    <blockquote>
        <p class="text-snippet" data-id="4715">According to David Hinds of 23andMe on community forums, "nearly everyone (99.97%) is getting called as CC, and there is no clear heterozygote cluster" ... "the genotype calls for rs25531 on our platform are not meaningful." Looking at OpenSNP frequency data, this seems to be universal for direct to consumer genotyping services at this stage.The minor allele (G) of rs25531 is almost always in phase with the long (L) allele of the 5-HTTLPR, which is the most commonly studied variation in this region. The (L) long allele may be associated with lower levels of serotonin.The article and video from "The Atlantic" suggests that children with the short allele (A), may need and benefit greatly from more maternal support  contrast to earlier reports linking rs25531, a SNP in the serotonin transporter SLC6A4 gene, to obsessive compulsive disorder (OCD), a March 2007 publication finds no significant association studying "the largest sample size of OCD patients (N=347) and controls (N=749) ever investigated". A separate study of 75 patients suffering mood disorders after traumatic brain injury (TBI) concluded that there was no evidence of association between rs25531 and depression post-TBI.A small study (62 patients and 62 matched controls) investigated this SNP in relation to blushing. (Blushing is considered to be one of the prime pathophysiological markers of social anxiety disorder.) The less active 5-HTTLPR genotypes were nominally significantly associated with increased blushing propensity in patients with social anxiety disorder, and association remained significant even when statistically controlled for he influence of depression.A study of 94 depressed patients who attempted suicide compared to 94 without psychiatric disorders found no evidence of an association with rs25531.A study of 97 "normal" individuals concluded that rs25531(G;G) individuals selectively process positive affective material alongside selective avoidance of negative affective material, in a manner absent among individuals carrying a rs25531(A) allele. To put it another way, if this conclusion drawn from a very small sample of people can be replicated, rs25531(G;G) individuals may have a tendency to be optimists and to be more resilient to stress.A study published in 2011 of 2,500+ individuals followed from 1995 - 2008 as part of the US National Longitudinal Study of Adolescent Health found that twice as many respondents with two 5-HTTLPR long variants said they were very satisfied with life compared with carriers of two short versions. Conversely, 26% of those carrying two short alleles said they were dissatisfied with life, compared with 20% of people carrying two long variants. This  blog post investigates the statistics.A study of 135 patients with major depressive disorder (mean age 31.1+/-11.6 years, 68% females) treated with escitalopram 10-20 mg/day for 12 weeks concluded that patients carrying the rs25531(A) allele may be at increased risk for side effects (e.g. headaches), but they say no associations with efficacy. Protocol for genotyping rs25531</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q195]]
    <blockquote>
        <p class="text-snippet" data-id="195">rs1501299, also known as c.276G>T, represents an intronic variant in the ADIPOQ gene on chromosome 3. It is perhaps the most studied of the common ADIPOQ gene variants; most studies report that the less common rs1501299(A) allele, as oriented in dbSNP, is associated with decreased cancer risk compared with the more common (C) allele.A study of 733 breast cancer cases for 10 SNPs concluded that the rs1501299(C;C) genotype (in dbSNP orientation) was at increased risk (odds ratio 1.80, CI: 1.14 - 2.85). After categorizing individuals by adiponectin signaling status, this study found that compared with low signalers (the most frequent), intermediate signalers had a 0.64x decrease in breast cancer risk (CI: 0.490.83), and high signalers had a 0.15x lower breast cancer risk (CI: 0.021.28, p(trend) = 0.001).Adiponectin signaling status was assigned as follows (as oriented in dbSNP):rs1501299(C,C) + rs2241766(T,T) = low signaler<br>rs1501299(A,C) + rs2241766(T,T) = low signaler<br>rs1501299(C,C) + rs2241766(G,T) = low signaler<br>rs1501299(A,A) + rs2241766(T,T) = intermediate signaler<br>rs1501299(A,C) + rs2241766(G,T) = intermediate signaler<br>rs1501299(C,C) + rs2241766(G,G) = intermediate signaler<br>rs1501299(A,C) + rs2241766(G,G) = high signaler<br>rs1501299(A,A) + rs2241766(G,G) = high signaler<br>rs1501299(A,A) + rs2241766(G,T) = high signaler<br>Based on these criteria, adiponectin signaling status is now determined by genosets Gs325 and Gs326 for Promethease users.Note that  adiponectin, a hormone produced by adipose tissue (body fat), is involved in lipid metabolism as well as glucose regulation.In other words, you are a low adiponectin signaler, and thus have basically average breast cancer risk, if you have one of these combinations of alleles: rs1501299  CC and also rs2241766 either GT or TT rs1501299  AC and also rs2241766 TTYou are an intermediate adiponectin signaler (Gs325), and thus possibly at 0.64x reduced risk of breast cancer compared to low signallers, if you have one of these combinations of alleles:  rs1501299 CC and also rs2241766 GG  rs1501299 AC and also rs2241766 GT  rs1501299 AA and also rs2241766 TTYou are a high adiponectin signaler (Gs326), and thus have the lowest (perhaps 0.15x) risk if you have one of these combinations of alleles:  rs1501299 AC and also rs2241766 GG  rs1501299 AA and also rs2241766 either GG or GTThis is one of the SNPs reported by NutraHacker SNPs|NutraHacker.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2910]]
    <blockquote>
        <p class="text-snippet" data-id="2910">rs20455, often called Arg719 or 719Arg, is a reasonably well studied SNP in the KIF6 gene. The risk allele (encoding the arginine at position 719) is rs20455(C).An extensive 2010 meta-analysis, including over 17,000 patients, suggests this variant does not significantly influence coronary artery disease risk.This SNP is one of the 5 used by Celera's genetic risk score (GRS) for coronary heart disease (CHD).  rs20455, in the KIF6 gene rs3900940, in the MYH15 gene rs7439293, in the PALLD gene rs2298566, in the SNX19 gene rs1010, in the VAMP8 geneFor each of the five variants, the GRS was increased by 1 if the subject was homozygous for the risk variant, unchanged if heterozygous, and decreased by 1 if the individual did not carry the variant. Therefore, individuals carrying all 10 possible risk variants (two copies of each of the five SNPs) were assigned a GRS of 5 and those carrying no risk variants a GRS of -5. A high GRS was defined as 3 or higher. Approximately 4% of the white cohort in ARIC was classified as high risk, and the hazard ratio for CHD after adjustment for traditional risk factors was a significant 1.57 (CI: 1.21-2.04; p<0.001). The results did not reproduce for African American participants. Carriers of the 719Arg allele of KIF6 have 34% higher risk of myocardial infarction and 24% higher risk of coronary heart disease compared with noncarriers among 25,283 women. Carriers of 719Arg receive significantly greater benefit from intensive statin therapy than do noncarriers. The benefit from intensive (compared with moderate) statin therapy was significantly greater in the 59% of the 1,778 patients who were carriers (hazard ratio 0.59, CI: 0.45 -0.77) than in those who were noncarriers (HR 0.94, CI: 0.70-1.27; p=0.018 for interaction between 719Arg carrier status and treatment). The absolute risk reduction was 10.0% in carriers versus 0.8% in noncarriers. Untreated carriers of the rs20455 risk allele had odds ratios for MI or stroke of 1.50 and 1.55 (CI: 1.05-2.15 or 1.14-2.09) in two large clinical trials. Among treated carriers, the absolute risk reduction by pravastatin therapy was 4.9% and 5.5% (CI: 1.81-7.9% or 3.5-7.5%). Therefore, in both trials carriers of a rs20455(C) SNP had an increased risk of coronary events, and statin treatment (in this case, pravastatin) reduced that risk more for such carriers than for noncarriers. Elderly carriers of a rs20455(C) (719Arg) allele with prior vascular disease received significant benefit from pravastatin; however, no benefit was observed in noncarriers with prior disease or in those without prior disease (carriers or noncarriers). Across all ethnic groups studied, pravastatin therapy significantly and substantially reduced both fatal coronary events and nonfatal myocardial infarctions only for carriers of the 719Arg allele (and not for noncarriers).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2792]]
    <blockquote>
        <p class="text-snippet" data-id="2792">rs2228145, also known as p.Asp358Ala, represents a variant in the the interleukin 6 receptor (IL6R) gene, located on chromosome 1.Patients with amyotrophic lateral sclerosis (ALS) who carry rs2228145(C) alleles appear likely to have more severe disease symptoms and faster progression than ALS patients who are rs2228145(A;A), according to a 2019 study. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects. Interleukin-6 receptor gene variations, plasma interleukin-6 levels, and type 2 diabetes in U.S. Women. Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women. Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma. Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants. Interleukin-6 receptor gene, plasma C-reactive protein, and diabetes risk in women. Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma. Inflammation and stress-related candidate genes, plasma interleukin-6 levels, and longevity in older adults. The IL6-174G/C polymorphism is associated with celiac disease susceptibility in girls. Cytokine SNPs: Comparison of allele frequencies by race and implications for future studies. Genetic ancestry modifies pharmacogenetic gene-gene interaction for asthma. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor). A gain of function polymorphism in the interleukin 6 receptor influences RA susceptibility. Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis. Association between Interleukin 31 Receptor A Gene Polymorphism and Schizophrenia in Korean Population. Novel loci, including those related to Crohn disease, psoriasis, and inflammation, identified in a genome-wide association study of fibrinogen in 17 686 women: the Women's Genome Health Study. Novel loci, including those related to Crohn disease, psoriasis, and inflammation, identified in a genome-wide association study of fibrinogen in 17 686 women: the Women's Genome Health Study. The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations. Interleukin-6 receptor gene polymorphism modulates interleukin-6 levels and the metabolic syndrome: GBCS-CVD. Interleukin-6 receptor gene polymorphisms were associated with sporadic Alzheimer's disease in Chinese Han. Influence of IL6R rs8192284 polymorphism status in disease activity in rheumatoid arthritis. Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2269]]
    <blockquote>
        <p class="text-snippet" data-id="2269">rs1799884, known also as the -30 SNP of the GCK gene, has been associated with type-2 diabetes.This SNP is one of 4 relatively common SNPs reported to represent risk for type-2 diabetes in the DESIR prospective study of 3,877 Caucasian participants. Under a recessive model, the odds ratio for rs1799884(A;A) homozygotes is 2.70 (CI: 1.51-4.83, p=0.0008); under an additive model, the odds ratio is 1.34 (CI: 1.07-1.69, p=0.01). For the 4 SNPs, each risk allele increased type-2 diabetes risk by 1.34x (p=2x10e-6), with an odds ratio of 2.48 (CI: 1.59-3.86) for carriers of 4 or more compared to those with one or none (risk alleles). A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses. Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24,053 individuals. Common variants in maturity-onset diabetes of the young genes and future risk of type 2 diabetes. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). The association of common genetic variants in the APOA5, LPL and GCK genes with longitudinal changes in metabolic and cardiovascular traits. Variants in MTNR1B influence fasting glucose levels. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents. Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study. Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae. Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study. Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk. Additive effects of genetic variation in GCK and G6PC2 on insulin secretion and fasting glucose. Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. The glucokinase gene promoter polymorphism -30G>A (rs1799884) is associated with fasting glucose in healthy pregnant women but not with gestational diabetes. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects. Association of rs780094 in GCKR with metabolic traits and incident diabetes and cardiovascular disease: the ARIC Study. Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion. Fasting hyperglycaemia and polymorphism in glucokinase promoter (rs1799884).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1211]]
    <blockquote>
        <p class="text-snippet" data-id="1211">rs1801260, a SNP in the CLOCK gene known as 3111 T/C, has been reported to influence sleep and activity patterns in patients affected by bipolar depression. From this article's abstract:"Compared to T/T homozygotes, carriers of the C allele had a similar degree of severity of depression, but showed higher activity levels in the evening, a delayed sleep onset (mean 79 min later), and a reduced amount of sleep during the night (mean 75 min less)." Allele frequencies of T3111C SNP of hClock were significantly different between schizophrenics and controls (chi(2) = 19.738, P < 0.05). Schizophrenics had a significantly higher frequency of the C allele compared with controls (OR = 2.613, 95% CI = 1.693-4.034).  (Han Chinese population.) There was a strong, significant association (P < 0.001) between both self-rating and interview-based adult ADHD assessments and the rs1801260 polymorphism with at least one T-mutation being the risk allele. rs1801260 variations associated with weight loss while on Mediterranean diet.  Carriers of the G allele displayed greater difficulty in losing weight than non-carriers.  CLOCK 3111 T/C SNP was associated with activity levels in the second part of the day, neuropsychological performance and BOLD fMRI correlates (interaction of genotype and moral valence of the stimuli).  Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Genetic differences in human circadian clock genes among worldwide populations. Genome-wide association scan for five major dimensions of personality. Circadian polymorphisms associated with affective disorders. CLOCK is suggested to associate with comorbid alcohol use and depressive disorders. ARNTL (BMAL1) and NPAS2 gene variants contribute to fertility and seasonality. Genotyping sleep disorders patients. Association between CLOCK 3111T/C and preferred circadian phase in Korean patients with bipolar disorder. SIRT1 and CLOCK 3111T>C combined genotype is associated with evening preference and weight loss resistance in a behavioral therapy treatment for obesity."Circadian locomotor output cycles kaput (CLOCK) molecule plays major roles in circadian rhythmicity and regulates daily physiological processes including digestive activity. Therefore, we hypothesized that the CLOCK 3111T/C single nucleotide polymorphism (SNP) might have adverse effects on the regulation of gastric motility.""The clock molecule plays major roles in circadian rhythmicity and regulating lipid and glucose metabolism in peripheral organs. Disruption of the circadian rhythm can lead to cardiometabolic disorders.""Here, we find that cholecystokinin (Cck) is a direct transcriptional target of CLOCK and levels of Cck are reduced in the ventral tegmental area (VTA) of Clock&#916;19 mice. Selective knockdown of Cck expression via RNA interference in the VTA of wild-type mice produces a manic-like phenotype"" C genetic variants in CLOCK 3111 T/C are more obese and lose less weight ina dietary and behavioral treatment for obesity than TT carriers and they are also moreevening-type subjects "Attention-Deficit Hyperactivity Disorder</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1068]]
    <blockquote>
        <p class="text-snippet" data-id="1068">rs11200638, a SNP in the HTRA1 promoter, is associated with a 10 fold increased risk of wet age related macular degeneration in Japanese  and Caucasian  populations. Further confirmed PMID 18207215, PMID 18206206. The genotype at highest risk is (A;A).Note, most studies have shown that that this SNP is highly predictive (i.e. is in near perfect (D'>0.98) linkage disequilibrium) with rs10490924, thus the status of one very closely predicts the status of the other.  However, one Caucasian AMD study reported the linkage disequilibrium measure for these two SNPs on 10q26, (i.e., rs10490924, which is upstream of HTRA1 in LOC387715/ARMS2, and rs11200638) as D'=0.8, and all four possible haplotypes of the two SNPs were detected in the samples.  Further, this same study reported that these two SNPs appear to contribute equally to the risk of AMD (both GA and CNV) and show no evidence of interaction with CFH .A 2011 meta-analysis concluded that rs11200638(A;G) and (A;A) carriers had 2.243 and 8.669 times the risk of developing AMD, respectively, when compared with those who carry the (G;G) genotype. rs10490924 and rs11200638 defined 2 significant haplotypes associated with increased risk of neovascular AMD. show that rs11200638 has no significant impact on HTRA1 promoter activity in three different cell lines, and HTRA1 mRNA expression exhibits no significant change between control and AMD retinas A study of 95 Taiwanese Chinese confirms rs11200638(A) allele risk for both wet and dry forms of AMD, with heterozygote odds ratio of 1.97 CI:0.81-4.81, homozygote OR = 8.59 CI: 3.28-22.49, p=6.7x10<sup>-3</sup> for an additive allele-dosage model. A study of Chinese AMD patients reports a 7.6x increased risk for rs11200638(A), and finds that smoking almost doubles the risk, to 15.7x increased risk. Carriers of both rs11200638 and rs800292 risk alleles pushes the odds ratio up to 23x. Overall, an "extremely high" population attributable risk (PAR) of 78% reported for these SNPs. An analysis of the joint effects of rs1061170, rs11200638 and rs10490924 on AMD  rs11200638 1.7x10-14 (-625G>A)is the most significant associated SNP with a high OR of 7.6 (95%CI: 3.94-14.51)  rs2672598 3.0x10-10 (-487T>C) rs1049331 3.7x10-12 (102C>T, Ala34Ala) rs2293870 3.7x10-12 (108G>T, Gly36Gly)  haplotype ACCTT, significantly predisposes to AMD (p= 6.68x10-14) smoking and rs800292 (184G>A, Val62Ile) of CFH. The combined OR for disease of smoking and rs11200638 (HTRA1) caused a 15.7 fold increased risk  The combined OR for rs800292 and rs11200638 showed a 23.3 fold increased risk An extremely high population attributable risk (PAR) of 78% was also found. A meta-analysis of 14 case-control studies published prior to Sept. 2008 concluded that rs11200638 probably increases the risk of wet AMD in all populations.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4994]]
    <blockquote>
        <p class="text-snippet" data-id="4994">A 2015 research study titled "Correlation between thyroglobulin gene polymorphisms and autoimmune thyroid disease" focused on the Han Chinese population. A total of 270 patients with AITD and 135 healthy controls were enrolled. They found "The Tg SNP frequency distribution was significantly different between Han populations of the Northern regions of Henan province and the Xi'an regions of Shaanxi province" (Abstract).  Separate ODs were found for the following TG gene SNPs:   E10SNP24 T/G rs180223 = TT 1.35, TG 11.50, GG 0.14, (TG OD was 95%CI = 4.89-27.06, p=<0.01)  E10SNP158 T/C rs2069550 = TT 1.07, TC 0.96, CC 1.03  E12SNP A/G rs853326 = AA 0.51, AG 0.23, GG 4.22 (GG OD was 95%CI = 2.65-6.73, p=<0.01)  E33SNP C/T rs2076740 = CC 1.11, CT 0.93, TT 0.98. More significant combined ODs were received when these SNPs were were combined:  GTAC = 0.22 Hypothyroidism (HY), 0.22 Graves(GD), 0.24 Hashimoto's (HT)   GCGC = 0.57 HT  GTGC = 3.57 GD, 3.50 HT  TTGC = 4.00 HY  TCGC = 5.23 HY, 3.00 GD, 4.45 HT This 2003 article titled "Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease" performed case control association studies for 14 TG SNPs in 285 Caucasian AITD patients and 150 Caucasian controls. They found that within the TG gene, "exon 10-12 SNP cluster and an exon 33 SNP were significantly associated with AITD."  Four polymorphisms, considered separately, had ODs over 1.3, but p values were not strong, between 0.003 and 0.12. (Supplementary tables 10,11,12) However, they discovered more significant ODs and p values when combining one or more exon 10-12 SNP alleles with the CC homozygous exon 33 polymorphism:     with or without E10SNP24 T/G = rs180223 = T allele,    with or without E10SNP158 T/C = rs2069550 = T allele,    with or without E12SNP A/G = rs853326 = A allele,     always with E33SNP = rs2076740 = CC polymorphism ODs for risk of AITD, GD and HT were given with the above risk alleles in combination (Table 2):   T,T,A,CC = 2.49 (p=0.0004);   T,--,--,CC = 2.42 (p=0.0005);   --,T,--,CC = 2.52 (p=0.0003);   --,--,A,CC = 2.43 (p=0.0004) The ODs for risk of HT and GD were similar, all above 2.38 with p values equally or more significant. (Tables 3,4) Adding significance for the exon 33 SNP in particular, they discovered "an interaction between HLA-DR3 and the exon 33 SNP, giving an odds ratio of 6.1 for Graves' disease." However, one must keep in mind the small sample size of this study. In addition, this study focused on a Caucasian sample, while some other studies have focused on Chinese samples.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2274]]
    <blockquote>
        <p class="text-snippet" data-id="2274">This SNP is associated with osteoarthritis (OA). It is located in the ''five prime untranslated region'' (| '''5&#8242;UTR''') of the gene encoding ''growth differentiation factor 5'' (| '''GDF5'''), a chondrogenic protein active from the embryonic stage onwards. GDF5 is also known as ''cartilage-derived morphogenetic protein 1'' or ''BMP14''. The '''risk allele T''' (+ 104T/C;rs143383) causes reduction of the GDF5 promoter sequence activity. Reduction of GDF5 in human cartilage of patients with OA by up to 27% has been observed . This effect is '''influenced by a second SNP ( rs143384 , C/T )''' in the same area. The C alleles of both SNPs form CpG dinucleotides. Demethylation of both SNP's increases GDF5 expression.  Thus the authors conclude that epigenetic manipulation offers options in developing therapies for OA. rs143383 showed significant association with hip osteoarthritis in two independent Japanese populations. It also showed association with knee osteoarthritis in Japanese and Chinese populations. is  not  a risk factor for osteoarthritis in Greek CaucasiansA subsequent study showed that the same risk allele, rs143383(T), was (somewhat) associated with osteoarthritis in European populations. The odds ratio was 1.10 for the allele, 1.28 for carrier status (p=0.03, p=0.004, respectively). The (T) allele appears to make less GDF5 protein, which eventually renders an individual somewhat more susceptible to osteoarthritis.A meta-analysis combining data from 11,000+ individuals as well as both European and Asian populations found strong evidence (p < 0.0004) confirming increased risk for osteoarthritis from the rs143383(T) allele. The best model is a dominant one, and the odds ratio reported is 1.21 in general and 1.48 for the dominant model.Another meta-analysis of 14 studies concluded that rs143383 did indeed show significant association with osteoarthritis, at least for knee osteoarthritis, and probably for hand and hip (but to a lesser degree). The effect size wasn't large, though (odds ratio 1.15, CI: 1.09-1.22, p = 9.4 x 10e-7).A haplotype of rs143383 and rs6060369 can be defined, which also links osteoarthritis to height since rs6060369 was linked to height in a study ultimately involving over 28,000 individuals.The  Medpage article on this finding notes that rs143383 was previously shown to be associated with increased risk for osteoarthritis and in this recent study  it was significantly associated with shorter height in the initial scans, at p=2.70x10e-5.Note that the authors of  refer to rs143383 in the opposite orientation compared to it's entry in dbSNP.  A study of 338 Han Chinese children affected by congenital dysplasia of the hip revealed that rs143383(T) alleles conferred a 1.4x increased risk for the disorder, particularly in females (odds ratio 1.43, CI: 1.11 - 1.85, p = 0.0078). A study of 6,365 elderly Caucasian men and women observed significant association between rs143383 and osteoarthritis, height, bone size and fracture risk in women.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1613]]
    <blockquote>
        <p class="text-snippet" data-id="1613">. Published 2009. This study analyzed polymorphisms of SNPs rs12885300 (called "(ORFa)-Gly3Asp") and rs225014 (called "Thr92Ala") in relation to DIO2 gene activity in BPAD (Bipolar disorder) patients in China. Findings in abstract: "Both SNPs were significantly higher in the BPAD patients, with odds ratios of 1.489 ... and 1.616 ... respectively. Individuals with two copies of the variant 3Gly or 92Ala were at greater risk of BPAD.... Haplotypes ORFa-3Asp-92Ala and ORFa-3Gly-92Ala indicated higher susceptibility for BPAD with odds ratios of 3.759 (95% CI=2.013-7.020) and 1.292 (95% CI=1.017-1.642), respectively, while ORFa-3Asp-92Thr probably played a protective role with an odds ratio of 0.395 (95% CI=0.284-0.549)." (Abstract). A 2008 article titled "Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis" explained that "Confirmation and replication by association in the additional osteoarthritis studies indicated a common DIO2 haplotype, exclusively containing the minor allele of rs225014 and common allele of rs12885300, with a combined recessive odds ratio of 1.79, 95% confidence interval (CI) 1.37-2.34 with P = 2.02 x 10(-5) in female cases with advanced/symptomatic hip osteoarthritis." (Abstract). This 2011 study examined various shapes of hip joints in relation to osteoarthritis (OA) risk alleles. They "observed a significant interaction between carrier status of DIO2 rs12885300 and hip OA characteristics for mode 1 (shown in Figure 1) (P = 0.005). ... This specific aspect of hip shape correlates with OA characteristics only in carriers of the susceptibility allele." (Abstract) The -258A/G (SNP rs12885300) polymorphism of the human type 2 deiodinase gene is associated with a shift in the pattern of secretion of thyroid hormones following a TRH-induced acute rise in TSH.. After thyroidectomy, high doses of L-T4 are used to suppress TSH. Since no T3 is being produced by the thyroid, the body depends on D1 and D2 enzymes to convert T4 into the active T3. This study collected 1905 serum samples from 151 patients over 8.8 to 11.5 years and analyzed four SNPs: DIO1-rs11206244 (D1-C785T) DIO1-rs12095080 (D1-A1814G)  DIO2-rs225014 (D2-Thr92Ala) DIO2-rs12885300 (D2-ORFa-Gly3Asp). Their data "suggest that the negative feedback of FT(4) on TSH is weaker in patients homozygous for the D2-rs12885300 T allele than in wild-type and heterozygous subjects." These patients "have an altered set point of the hypothalamus-pituitary-thyroid axis." However, they noted that their data depended on TSH and T4 levels alone, since T3 and rT3 were measured at only one time point during the study. A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. (Published 2008). Attempted to study rs12885300 but this SNP failed quality control due to duplicate errors and deviation from Hardy-Weinberg equilibrium. The study found significant effects with variants of another DIO1 SNP, rs2235544.See further discussion of this DIO2 gene's other SNP : rs225014</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2731]]
    <blockquote>
        <p class="text-snippet" data-id="2731">associated with ankylosing spondylitis risk of Helicobacter pylori infection. Children carrying IL1A-889T had a lower risk of H. pylori positivity, compared to those carrying -889C, with each T allele associated with 43% risk reduction (OR = 0.57, 95% CI = 0.33-0.99, p-trend = .05)upregulation of pro-inflammatory cytokines may protect against persistent H. pylori colonization. Association study of functional genetic variants of innate immunity related genes in celiac disease. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Association of common polymorphisms in inflammatory genes with risk of developing cancers of the upper aerodigestive tract. Potential influence of IL1B haplotype and IL1A-IL1B-IL1RN extended haplotype on hand osteoarthritis risk. Genetic polymorphisms and the risk of infection following esophagectomy. positive association with TNF-alpha gene -308 genotype. A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. Optimization of candidate-gene SNP-genotyping by flexible oligonucleotide microarrays; analyzing variations in immune regulator genes of hay-fever samples. A genome-wide association study identifies protein quantitative trait loci (pQTLs). A broad analysis of IL1 polymorphism and rheumatoid arthritis. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. Concurrent genotyping of Helicobacter pylori virulence genes and human cytokine SNP sites using whole genome amplified DNA derived from minute amounts of gastric biopsy specimen DNA. Tagging SNP association study of the IL-1beta gene (IL1B) and childhood-onset mood disorders. Association of -31T>C and -511 C>T polymorphisms in the interleukin 1 beta (IL1B) promoter in Korean keratoconus patients. Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cytokine SNPs: Comparison of allele frequencies by race and implications for future studies. A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support. The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer. Three polymorphisms in interleukin-1beta gene and risk for breast cancer: a meta-analysis. Role of polymorphic variants as genetic modulators of infection in neonatal sepsis. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine. Pharmacogenetics of antidepressant response. Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: a systematic review. Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. Interaction between functional polymorphic variants in cytokine genes, established risk factors and susceptibility to basal cell carcinoma of skin.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3339]]
    <blockquote>
        <p class="text-snippet" data-id="3339">rs2236225, also known as c.1958G>A, G1958A, p.Arg653Gln and R653Q, is a SNP in the MTHFD1 gene on chromosome 14, involved in folate metabolism.The Arg653Gln mutation was studied and found not to affect the enzyme activity when present, but did seem to decrease the half-life and stability.  A study in Quebec showed an association in children with mutations in MTHFD1 having increased risk for heart defects, possibly in a folate status dependent manner (IE more so if their mother was not getting enough folate during pregnancy). A 2014 meta-analysis of nine studies totaling 4,302 cases of children born with neural tube defects concluded that Caucasian mothers carrying rs2236225(C;T) or rs2236225(T;T) alleles were at increased risk, of about 1.5 - 1.7x, of having affected children compared to mothers with no (T) alleles. However, they cautioned that their results should be "viewed with caution" given the statistical uncertainties inherent in these studies.   rs1076991 C > T exerts a significant effect on promoter activity in vitro and along with rs2236225 G > A influences embryonic development. Genetic impairments in folate enzymes increase dependence on dietary choline for phosphatidylcholine production at the expense of betaine synthesis. Common genetic polymorphisms affect the human requirement for the nutrient choline. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Gene response elements, genetic polymorphisms and epigenetics influence the human dietary requirement for choline. Lymphocyte gene expression in subjects fed a low-choline diet differs between those who develop organ dysfunction and those who do not. Folate and one-carbon metabolism gene polymorphisms and their associations with oral facial clefts. Association of polymorphisms in one-carbon metabolizing genes and lung cancer risk: a case-control study in Chinese population. Folate-related gene polymorphisms as risk factors for cleft lip and cleft palate. Genetic polymorphisms in methyl-group metabolism and epigenetics: lessons from humans and mouse models. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. No association of single nucleotide polymorphisms in one-carbon metabolism genes with prostate cancer risk. Lack of association of polymorphisms in homocysteine metabolism genes with pseudoexfoliation syndrome and glaucoma. Genetic variants in phosphatidylethanolamine N-methyltransferase and methylenetetrahydrofolate dehydrogenase influence biomarkers of choline metabolism when folate intake is restricted. Epigenetic mechanisms for nutrition determinants of later health outcomes. Development of a fingerprinting panel using medically relevant polymorphisms. 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Genetics of human neural tube defects. Application of sex-specific single-nucleotide polymorphism filters in genome-wide association data. Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project. Maternal polymorphisms in folic acid metabolic genes are associated with nonsyndromic cleft lip and/or palate in the Brazilian population. Folate and choline metabolism gene variants and development of uterine cervical carcinoma. Polymorphic variants of genes involved in homocysteine metabolism in celiac disease. Folate and choline metabolism gene variants in relation to ovarian cancer risk in the Polish population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4001]]
    <blockquote>
        <p class="text-snippet" data-id="4001">The snp is suspected of being somewhat confused as an ambiguous flip, because the ReferenceAllele of T has a HapMap freq of 15% in CEU. Also notable is that dbSNP shows RefSNP Alleles:A/C/G/T, and other bits that don't quite fit. While the text below is still of use, it is likely that some of the conclusions are reversed.rs854560, also known as L55M, is a SNP in the PON1 gene.  It codes for amino acid 55 (or 54, depending on the numbering) of the paraoxonase (PON) protein.  Variants of this SNP affect levels of PON protein and mRNA and are correlated with Heart disease, aspects of Diabetes including diabetic retinopathy, and trait-anxiety scores.  The apparently more favorable form, rs854560(T), encodes a methionine and lead to elevated levels of paraoxonase, which is generally a good thing. The variant, rs854560(A), encodes an leucine, leading to less paraoxonase activity.   '''Note:''' These alleles are typically reported in the context of the mRNA sense orientation, where the (A) encodes the methionine, and the (T) encodes the leucine. rs854560 as published in dbSNP is from the opposite strand and thus the allele designation is reversed compared to the literature. Frequency of rs854560(A) allele, and of rs854560(A,A) genotype, appears to increase incidence of diabetic retinopathy. rs854560(A;A) genotype predicts higher insulin resistance, bodyweight, triglyceride levels, and blood pressure, and therefore cardiovascular risk. rs854560(A) associated with increased common carotid artery intima-media thickness compared to rs854560(T) (p value for trend 0.03), suggesting that variation in the PON1 gene contributes to early atherosclerosis in children with familial hypercholesterolemia. 274 ovarian epithelial carcinoma cases and 452 controls. rs854560 odds ratio 0.53 (CI: 0.35-0.79; p for allele-dose effect = 0.01) for women carrying the rs854560(T) allele compared with women with the (A;A) genotype rs854560(A;A) homozygotes experienced a significant increase, while rs854560(T) carriers experienced a non-significant decrease in HDL-Lp-PLA(2) activity (p = 0.030 between groups), upon fluvastatin treatment for 6 months; this may have implications for the treatment of hypercholesterolemia. In a study of 461 participants in the HERITAGE cohort (172 African-American, 289 Caucasian), the combination of rs854560 (L55M or PON55) with rs662 (Q192R or PON192) were found to significantly contribute to trait-anxiety scores.  The authors also cite another paper, , which found that the atypical version of this SNP reduces PON protein and mRNA levels.  Which genotypes correlate with increased trait-anxiety scores and/or reduced PON levels is unclear.  This paper states that the typical "L" version is TTG, and the "M" substitution is ATG.  This may help clear up the ambiguous flip if neighboring base pair information were available from the other sources as well. No association between rs854560 and amyotrophic lateral sclerosis was seen in this large meta-analysis.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2094]]
    <blockquote>
        <p class="text-snippet" data-id="2094">rs1050828, also known as c.292G>A, p.Val98Met and V98M as well as the G6PD A- mutation, is a SNP residing in the G6PD gene and is located the X chromosome. G6PD codes for the enzyme glucose-6-phosphate dehydrogenase, which helps protect the cell from oxidative damage. Depending on genotype, an individual may possess one or two primary versions of the G6PD gene; type A and type B. Type A is predominantly found in people who have African ancestry. Mutations of G6PD can cause varying degrees of G6PD deficiency, which is a disease affecting red blood cells. For example, an G to A substitution mutation at the rs1050828 (also referred to as G202A) is associated with a reduction of G6PD.  The G6PD deficient genotype A- (~8-20% reduction of G6PD) is typically defined by the possession of the rs1050828 A allele (rs1050828(A;A)).  In addition, individuals who are type A- almost always possess the rs1050829 G allele. G6PD deficiency frequency is highest in malarial regions where G6PD deficient individuals are typically less affected by malarial infection ().  Also, the literature suggests that there is association between the rs1050828 locus and various red blood cell traits in African Americans.A 2019 publication reports that this variant also has the effect of lowering HbA1c values by ~0.88%-units in hemizygous men and 0.34%-units in heterozygous women. The authors suggest that when using Hb1Ac values to diagnose type-2 diabetes, those units should be added to the measured Hb1Ac level, and a diagnosis should then be made if the sum is >6.5% (the standard diagnostic threshold).   A total of 72 SNPs were genotyped in two populations in eastern Sudan (Hausa and Massalit), as well as, a cohort of malaria hospital patients and a control sample set (n=449).  The study found that in comparison to controls (n=69), Massalit individuals (n=60) who possess the rs105828 A allele were less susceptible to malarial infection (P=0.04). Study surveyed 49,094 SNPs (covering ~2,100 candidate genes)in Caucasian (n=23,439) and African American (n=7,112) individuals from five different population cohorts.  Genome wide association results include that rs1050828 A allele found in African American individuals is strongly associated with certain erythrocyte phenotypes including; lower red blood cell, hemoglobin and hematocrit counts (all p values <2.0 x 10 <sup>-13</sup>). In order to identify SNPs associated with different red blood cell phenotypic traits a genome-wide association study was conducted on African Americans (n=16,500). The SNP rs1050828 was found to be associated with hemoglobin (Hgb), hematocrit (Hct), mean corpuscular volume (MCV), and RBC count. A cohort of African American medical patients (n=1904) was analyzed in a genome-wide association study where loci were correlated with certain red blood cell traits.  The rs1050828 locus is associated with RBC count (P=4x10<sup>-13</sup>), mean corpuscular volume (P=1x10<sup>-14</sup>), and mean corpuscular hemoglobin (P=9x10<sup>-9</sup>).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2823]]
    <blockquote>
        <p class="text-snippet" data-id="2823">Systemic Lupus Erythematosus rs10488631 rs2004640 rs10954213 and rs729302  Japanese 277 SLE patients and 201 controls. Carriers of the rs2004640T slightly increased among SLE patients (58.8%) as compared with controls (50.2%). When data from our Japanese population were combined with previously published data from a Korean population, the T allele frequency was found to be significantly increased in SLE patients (P = 8.3 x 10(-5)). While no association was observed for the rs10954213 . significant associations with 3 intron 1 SNPs (-4001, rs6953165, and rs41298401) were found. The allele frequency of rs41298401G was significantly decreased in SLE patients (13.0% versus 18.7% in controls; P = 0.017), and the allele frequency of rs6953165G, which was in absolute linkage disequilibrium with -4001A, was increased in SLE patients (8.8% versus 5.2% in controls; P = 0.034). The Caucasian risk haplotype was not present; instead, a protective haplotype carrying rs2004640G, rs41298401G, the deletion in exon 6, and rs10954213A was identified. SNP rs10954213 A variant located 64 bp upstream of the first untranslated exon (exon 1A), consisting of a 5 bp insertion/deletion CGGGG, may be the causative SNP in this region that is most responsible for increasing SLE risk, the rs# for the CGGGG insertion/deletion is rs77571059. Of 3 IRF5 SNPs studied, the rs2280714(A) SNP - and not this one - had the strongest association (odds ratio 1.42, CI: 1.15-1.75) in Japanese SLE patients. Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Association of an IRF5 gene functional polymorphism with Sjogren's syndrome. IFN-regulatory factor 5 gene variants interact with the class I MHC locus in the Swedish psoriasis population. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus. Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Relationship between polymorphism sites of IRF5, TLR-9 and SLE patients in Shandong Han population. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity. Genetic risk factors in lupus nephritis and IgA nephropathy--no support of an overlap. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Interferon alpha in systemic lupus erythematosus. A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythematosus.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q862]]
    <blockquote>
        <p class="text-snippet" data-id="862">'''rs2281845''' is a SNP located on chromosome 1q32.1, about 250 bp upstream of the first exon of the CACNA1S (voltage-dependent calcium channel, L type)gene. The linkage disequilibrium block containing rs2281845 extends 22 kb downstream and includes the TMEM9 gene (transmembrane protein 9). This SNP has been clinically  associated with tooth development. The minor allele (T) has specifically been associated with reduced mature dentition between the ages of 6 and 14 in women. In a 2011 report, a genome-wide quantitative trait association study conducted with 521,741 SNPs over 5,097 women from the Danish National Birth Cohort (DNBC) found a significant (p-value=1.31E-10) association between the rs2281845 T allele and a reduction in permanent teeth erupted (-0.105) between ages 6 and 14. To confirm this finding, an additional 3,696 individuals were also tested for this association. These subjects were drawn from three additional Danish cohorts, as well as one from the United States. The association was replicated in each of the Danish cohorts (p-values=5.43E-05, 1.09E-04, and 0.012, respectively), but the group from the United States exhibited a weak association (p-value=0.242) in the opposite direction (+0.065 teeth). This contradictory finding was attributed to small sample size and deficiencies in phenotype reporting. The original GWAS and replication datasets, when combined for a total of 8,793 subjects, showed a statistically significant (p-value=8.03E-17) negative association with number of permanent teeth (-0.103). Within the same study, three additional SNPs were identified in the initial DNBC cohort GWAS as having a significant association with number of permanent teeth between ages 6 and 14. These SNPs &#8211; rs12424086, rs4491709, rs7924176 &#8211; were each validated to statistical significance with a replication set (p-values=2.30E-12, 2.16E-14, and 5.64E-19, respectively). No loci aside from those containing these four SNPs exhibited a p-value of less than 5.0E-6. Each of these SNPs that were identified in the context of dental development may be confounded by associations with generalized maturation programs. The authors note that while the phenotype of mature teeth was measured here, the SNPs could in fact correlate better with measures of puberty such as &#8220;skeletal maturation, Tanner score and growth spurt,&#8221; with number of mature teeth simply as a manifestation of these other phenotypes. Mechanistically, rs2281845&#8217;s effect on tooth development may be linked to expression of TMEM9. In a study linking SNPs to gene expression in monocytes, several variants in linkage disequilibrium with rs2281845 were found to be significantly associated with TMEM9 expression. The SNP with highest linkage to rs2281845, rs6667912 (r2=0.42) showed a significant association (p-value=6x10E-29). Little is known regarding the function of TMEM9. It is a well-conserved, 26kDa transmembrane protein with expression throughout a wide variety of human tissues and cells. An &#8216;&#8216;in vitro&#8217;&#8217; study showed localization to the ER, late endosomes, and lysosomes along with  LAMP1 coexpression, but its function within the cell is not yet well-characterized.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1076]]
    <blockquote>
        <p class="text-snippet" data-id="1076">rs800292 is a SNP in the complement factor H CFH gene; it has been linked to blindness in age related macular degeneration. This SNP is also known as 184G>A, I62V, or Val62Ile.A haplotype of rs1061170 rs3753394 rs800292 rs1329428 (TGTC) was found to confer a significantly increased likelihood of exudative AMD CFH variations appear to contribute to ARMD in Caucasians, but not in Japanese  A study of Chinese AMD patients reports that carriers of both rs11200638 and rs800292 risk alleles pushes the odds ratio for AMD up to 23x. Overall, an "extremely high" population attributable risk (PAR) of 78% reported for these SNPs. rs800292 was associated with polypoidal choroidal vasculopathy (PCV) in a study of 130 Japanese patients.age related macular degeneration  Susceptibility genes for age-related maculopathy on chromosome 10q26. Determination of complement factor H functional polymorphisms (V62I, Y402H, and E936D) using sequence-specific primer PCR and restriction fragment length polymorphisms. Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes. Genetic variants of complement factor H gene are not associated with premature coronary heart disease: a family-based study in the Irish population. Coding and noncoding variants in the CFH gene and cigarette smoking influence the risk of age-related macular degeneration in a Japanese population. Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. Multiple gene polymorphisms in the complement factor h gene are associated with exudative age-related macular degeneration in chinese. Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy. The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration. Genetic contributions to the development of retinopathy of prematurity. Molecular pathology of age-related macular degeneration. Multilocus analysis of age-related macular degeneration. CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Compound heterozygosity of two novel truncation mutations in RP1 causing autosomal recessive retinitis pigmentosa. A particle swarm based hybrid system for imbalanced medical data sampling. Complement component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort. SERPING1 polymorphisms in polypoidal choroidal vasculopathy. Incorporating prior knowledge to facilitate discoveries in a genome-wide association study on age-related macular degeneration. Monozygotic twins with polypoidal choroidal vasuculopathy. Role of complement factor H I62V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy. Age-related macular degeneration-susceptibility single nucleotide polymorphisms in a han chinese control population. Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy. Complement polymorphisms: geographical distribution and relevance to disease. Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Association of genetic polymorphisms and age-related macular degeneration in chinese population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1370]]
    <blockquote>
        <p class="text-snippet" data-id="1370">Also known as Ile462Val A4889G CYP1A1 2C Genome amplification of single sperm using multiple displacement amplification. Decision forest analysis of 61 single nucleotide polymorphisms in a case-control study of esophageal cancer; a novel method. Multilocus analysis of SNP and metabolic data within a given pathway. CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race. Cytochrome P450 1A1 (CYP1A1) polymorphisms and breast cancer risk in Korean women. Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years. Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer. Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. Genetic variation in candidate osteoporosis genes, bone mineral density, and fracture risk: the study of osteoporotic fractures. Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect. Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk. Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Relationship between genetic polymorphisms of phase I and phase II metabolizing enzymes and DNA damage of workers exposed to vinyl chloride monomer. Clique-finding for heterogeneity and multidimensionality in biomarker epidemiology research: the CHAMBER algorithm. Gene by smoking interaction in hypertension: identification of a major quantitative trait locus on chromosome 15q for systolic blood pressure in Mexican-Americans. Genetic polymorphisms in glutathione S-transferases and cytochrome P450s, tobacco smoking, and risk of non-Hodgkin lymphoma. Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression. CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women. Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma. Association of nasopharyngeal carcinoma risk with cytochrome P450 CYP1A1 gene polymorphisms. Impact of CYP1A1 and COMT genotypes on breast cancer risk in Mexican women: a pilot study. Smoking, the xenobiotic pathway, and clubfoot. Quantitative trait analysis suggests polymorphisms of estrogen-related genes regulate human sperm concentrations and motility. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Pharmacogenetic assessment of clinical outcome in patients with metastatic breast cancer treated with docetaxel plus capecitabine. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3030]]
    <blockquote>
        <p class="text-snippet" data-id="3030">rs3825942, also known as G153D, a SNP causing an amino acid change in the lysyl oxidase 1 LOXL1 gene, has been linked to exfoliation glaucoma (also known as exfoliation syndrome). This form of glaucoma causes up to 10% of the cases of blindness in many countries, including the US.  From the abstract of this study: "Approximately 25% of the general population is homozygous for the highest risk haplotype C;C here combined with other risk SNPs and their risk of suffering XFG (exfoliation glaucoma) is over 100 times that of those only carrying low-risk haplotypes."The risk allele for this SNP is rs3825942(C), as oriented with respect to the dbSNP entry, and it confers a estimated relative risk (by itself) of 27 compared to the (T) allele. The odds ratio is 20.10 (CI 10.80-37.41). Note that the (C) allele is actually quite common in most European populations.A meta-analysis including 24 articles across 5 ethnicities (Caucasian, African, Japanese, Indian, and Chinese) concluded that rs3825942 is the common disease-associated SNP in all populations, whereas rs1048661 and rs2165241 were inconsistent. The odds ratio is approximately 10 for rs3825942(C;C), while the heterozygote rs3825942(C;T) was not statistically significant. rs3825942 was not associated with primary open angle glaucoma (POAG).With so many people at high risk, shouldn't the number of cases be much higher? Not necessarily, since glaucoma risk only becomes high in ageing|older individuals. To put it another way: plenty of folks don't live long enough to find out if they would have gotten glaucoma. The estimate for glaucoma incidence worldwide is 10-20% only for individuals over 60 years of age; in Iceland, where glaucoma incidence is high, 40% of individuals 80 or older show signs of exfoliation ''syndrome'', which has been seen to convert to exfolation ''glaucoma'' at a rate of 60% - over a 15 year period. PMID 12928689, PMID 10463402, PMID 17224761discussed in this / blog post rs1048661 (G), rs3825942 (C), and rs2165241 (T) are highly associated with XFS and XFG in American and European populations. The GGT haplotype constitutes a major risk haplotype for exfoliation. Confirmed as risk for pseudoexfoliation (PEX) and pseudoexfoliation glaucoma (PEXG) in populations of German and Italian descent. Although not conducted with a large number of patients, in a study of black South Africans the rs3825942(T) allele was the risk allele, in contrast to other populations.{PMID Auto|PMID=22065931|Title=Decreased total antioxidants status in the plasma of patients with pseudoexfoliation glaucoma.}}<!-- see the talk pageAn anonymous user points out at the risk allele is the reference. This is a 'error' in clinvar, but I believe it is the reason this one is flagged as |CLNSIG=255Ideally this would be fixed upstream, and a change here might eventually be overwritten by a bot (hence the need for this comment). I could also introduce a new flag which explicitly flags the bad geno, and while defaulting to the current behavior.--></p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2672]]
    <blockquote>
        <p class="text-snippet" data-id="2672">This SNP is unclear. According to GWAS one study says risk allele is A, another study says risk allele is C.Ambiguous flip ? Abstractassociated with type-1 diabetes, organ-specific autoimmune diseases, including Graves' disease. (odds ratio 1.47 (CI: 1.23&#226;&#8364;&#8220;1.76, p = 1.9 x 10<sup>&#226;&#8364;&#8220;5</sup>)This polymorphism may also contribute to several other autoimmune disorders. A study of 261 Chinese patients with Graves' disease failed to find any association with rs1990760. A study of 591 French Caucasian multiple sclerosis trio families found no association between rs1990760 or rs2068330 and the disease, which did not confirm one previously reported study. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. The interferon induced with helicase domain 1 A946T polymorphism is not associated with rheumatoid arthritis. Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. Assembly of inflammation-related genes for pathway-focused genetic analysis. The association between the IFIH1 locus and type 1 diabetes. IFIH1-GCA-KCNH7 locus: influence on multiple sclerosis risk. Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1). A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. The expanding genetic overlap between multiple sclerosis and type I diabetes. Shared and distinct genetic variants in type 1 diabetes and celiac disease. Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes. IFIH1 gene polymorphisms in type 1 diabetes: genetic association analysis and genotype-phenotype correlation in the Belgian population. A generalized family-based association test for dichotomous traits. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Overview of the Rapid Response data. The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome. The rs1990760 polymorphism within the IFIH1 locus is not associated with Graves' disease, Hashimoto's thyroiditis and Addison's disease. Replication of recently identified associated single-nucleotide polymorphisms from six autoimmune diseases in Genetic Analysis Workshop 16 rheumatoid arthritis data. Study of transcriptional effects in Cis at the IFIH1 locus. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-alpha and serologic autoimmunity in lupus patients. IFIH1 gene polymorphisms in type 1 diabetes: genetic association analysis and genotype-phenotype correlation in Chinese Han population. Genetic variants in IFIH1 play opposite roles in the pathogenesis of psoriasis and chronic periodontitis.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3250]]
    <blockquote>
        <p class="text-snippet" data-id="3250">rs17576, also known as Gln279Arg or Q279R, is a SNP in exon 6 of the matrix metalloproteinase-9 MMP9 gene. The rs17576(G) allele encodes the Arg (R).In a study of 385 male veterans with greater than 20 pack-years of cigarette smoking, rs17576(G) allele carriers were at higher risk for chronic obstructive pulmonary disease (COPD). The rs17576(G;G) homozygous genotype was at 3-fold increased risk for COPD.A study of 744 Chinese patients with lung cancer found that the rs17576(G;G) genotype was associated with higher risk of lung cancer with metastasis (adjusted OR, 1.79, CI: 1.03-3.08) compared to the (A;A) genotype.rs17576 is also one of two SNPs in the MMP9 gene associated with increased risk for myocardial infarction, but not coronary artery disease. The relatively weak odds ratios for carriers of one rs17576(A) allele was 1.15 (p=0.26), and for (A;A) homozygotes, 1.09 (p=0.33). However, this study of 5,000+ Caucasian patients with heart disease also indicated that a composite genotype (i.e. unphased haplotype) of the two MMP9 SNPs (rs3918242 and rs17576, respectively) yielded a significant odds ratio of 1.25 (CI: 1.07 - 1.48, p=0.007) for the (C;T)/(A;G) combination compared to (C;C)/(G;G) combination genotypes. (IVS10-8C  T; rs9406328) and (Q279R; rs17576) showed significant association with lumbar-disc herniation (odds ratio 3.03, 95% confidence interval 1.58-5.77) Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's disease. The association of single nucleotide polymorphisms in the MMP-9 genes with susceptibility to acute primary angle closure glaucoma in Taiwanese patients. Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma. Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. Matrix metalloproteinase-3 genotypes influence recovery from hepatitis B virus infection. Association of a nonsynonymous single-nucleotide polymorphism of matrix metalloproteinase 9 with giant cell arteritis. Lack of association between the rs2664538 polymorphism in the MMP-9 gene and primary angle closure glaucoma in Singaporean subjects. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. The association of membrane frizzled-related protein (MFRP) gene with acute angle-closure glaucoma--a pilot study. Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk. Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians. Investigation of the association between CALCRL polymorphisms and primary angle closure glaucoma. Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population. MMP-9 gene variants increase the risk for non-atopic asthma in children. Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis. Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph. Complex genetic mechanisms in glaucoma: an overview. Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5111]]
    <blockquote>
        <p class="text-snippet" data-id="5111">This SNP, a variant in the TP53 gene, is 1 of 25 SNPs reported to represent independently minor, but cumulatively significant, increased risk for breast cancer. For details of all 25 SNPs in this group, along with the two methods used to calculate overall risk estimates for breast cancer, refer to the SNPedia breast cancer entry.For this particular SNP, as oriented in dbSNP and to the gene, the less common G allele encodes an arginine at position 72 of the protein (where there's normally a proline), and the SNP is commonly called the Arg72 variant, although P72R and Arg72Pro are also common in the literature. Minor allele homozygotes, i.e. rs1042522(C;C) genotypes, live on average 3 years longer than major allele (G;G) homozygotes, based on a study of 9,200+ Danish individuals. The increased longevity is speculated to be related to the increased apoptosis seen for this gain of function SNP, presumably due to "increased robustness" during the period of treatment after the diagnosis of life-threatening diseases such as cancer of certain types.A study of 148 individuals with advanced nonsmall cell lung cancer (NSCLC) concluded rs1042522(G;G) genotypes were more likely to be resistant to first-line chemotherapy, especially the irinotecan plus cisplatin regimen, than those with (C;G) or (C;C) genotypes (60% vs 27%, p = .014). In multivariate analysis, the (G;G) genotype was strongly predictive for shorter progression-free survival (PFS) (hazard ratio HR = 1.952, p = .01).A study of 57 patients with advanced gastric cancer treated with paclitaxel and cisplatin combination chemotherapy found that rs1042522(G;G) and rs1042522(C;G) genotypes were significantly correlated with a lower response rate (and worse progression) to the combination chemotherapy when compared to rs1042522(C;C) homozygotes (35.7 vs. 66.7%, p-value 0.019).rs1042522 is not associated with SLE in a study of Caucasians, African-Americans, and Asian children and adults.Implicated in type-2 diabetes based on a study of 1,161 Finnish patients.  rs2279744, rs1042522, rs17878362 and rs1625895 associated with high grade endometrial cancer/ 23andMe blog African Americans with rs1042522(G;G) in the p53 gene were 2.15 times more likely to die of colorectal cancer than those with one or no copies of a G at this SNP.  In Caucasians there was no association between survival and rs1042522./ 23andMe blog rs1042522(C) might have had an easier time conceiving in colder temperatures The P72 allele was found to be significantly enriched over the R72 allele among in vitro fertilization (IVF) patients. The P72 allele serves as a risk factor for implantation failure. LIF levels are significantly lower in cells with the P72 allele than in cells with the R72 allele, which may contribute to the decreased implantation and fertility associated with the P72 allele. Patients with variant TP53 genotypes either for the Arg72Pro or the PIN3 polymorphism were at increased risk of telangiectasia, a late skin side effect of radiotherapy following breast-conserving surgery. Odds ratios were 1.66 for 72Pro carriers and 1.95 for PIN3 A2 allele carriers. Carrying both variant alleles led to a doubling of risk.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1989]]
    <blockquote>
        <p class="text-snippet" data-id="1989">Within the FTO gene, many SNPs appear to be co-inherited. The SNP showing the strongest association with body weight (i.e. body mass index, BMI) is not rs17817449, although this SNP is one of co-inherited SNPs in the FTO gene region. For more information, refer to the FTO gene or the most studied of FTO SNPs, rs9930506.  A study of 900+ Quebec individuals reported that rs17817449 was associated with BMI (p=0.0014), weight (p=0.0059) and waist circumference (p=0.0021) under an additive model, and in addition, influenced fasting insulin (p=0.011) and HOMA-IR (p=0.038).  Note: The three FTO SNPs, rs1421085, rs17817449, and rs9939609, are in strong linkage disequilibrium (pairwise r<sup>2</sup>>0.97), and there are two primary haplotypes, C-G-A (42.0 %) and T-T-T (55.5 %). This SNP is also associated with adult obesity in Mexicans. rs1421085(C) and rs17817449(G) significantly associated with increased BMI. Our results suggest that FTO may be one of the worldwide obesity-risk genes. FTO polymorphisms in oceanic populations. FTO gene SNPs associated with extreme obesity in cases, controls and extremely discordant sister pairs. Regulation of Fto/Ftm gene expression in mice and humans. Common variation in the fat mass and obesity-associated (FTO) gene confers risk of obesity and modulates BMI in the Chinese population. FTO variants are associated with obesity in the Chinese and Malay populations in Singapore. Fat mass-and obesity-associated (FTO) gene variant is associated with obesity: longitudinal analyses in two cohort studies and functional test. The FTO gene and obesity in a large Eastern European population sample: the HAPIEE study. FTO gene variation and measures of body mass in an African population. Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3. A FTO variant and risk of acute coronary syndrome. The genetics of obesity: FTO leads the way. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Common SNPs in FTO gene are associated with obesity related anthropometric traits in an island population from the eastern Adriatic coast of Croatia. Risk of type 2 diabetes and obesity is differentially associated with variation in FTO in whites and African-Americans in the ARIC study. Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic Insulin Resistance Atherosclerosis Study cohort. FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans. Rs9939609 variant of the fat mass and obesity-associated gene and trunk obesity in adolescents. The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population. Association of FTO rs17817449 SNP with obesity and associated physiological parameters in a north Indian population. Lack of an association between three tagging SNPs within the FTO gene and smoking behavior. Variants of the FTO gene in obese children and their impact on body composition and metabolism before and after lifestyle intervention. Appetite regulation genes are associated with body mass index in black South African adolescents: a genetic association study.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4963]]
    <blockquote>
        <p class="text-snippet" data-id="4963">This SNP in TCF7L2 influences the risk of Type-2 diabetes (T2D). This SNP is also known as IVS3C>T. rs7903146(C;T) rs7903146(T;T) strongly predicted future type-2 diabetes. Considered in context with rs7903146 rs12255372 rs10885406. Note: this is one of two SNPs within the TCF7L2 gene that have been reported to be associated with type-2 diabetes, the other being rs4506565. They have approximately equal power to estimate risk for type-2 diabetes, and the results from one correlate 92% of the time with the other.  Full text of the paper is available from from Plos Medicine. Or from NCBI as .  TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. reconfirmed in a diverse population Associated in a study of ~1000 Hispanic-Americans with reduced insulin secretion as measured by acute insulin response and adjusted for the degree of insulin sensitivity (p = 0.032). the CT/TT genotypes strongly predicted future type-2 diabetes. The risk T allele was associated with impaired insulin secretion, incretin effects, and enhanced rate of hepatic glucose production. TCF7L2 expression in human islets was increased 5-fold in T2D, particularly in carriers of the TT genotype.This SNP is one of 4 relatively common SNPs reported to represent risk for type-2 diabetes in the DESIR prospective study of 3,877 Caucasian participants. Under an additive model, the odds ratio for the (T) risk allele is 1.45 (CI: 1.2-1.77, p=0.0002). For the 4 SNPs, each risk allele increased type-2 diabetes risk by 1.34x (p=2x10e-6), with an odds ratio of 2.48 (CI: 1.59-3.86) for carriers of 4 or more compared to those with one or none (risk alleles).Contrary to what's been seen in most populations studied so far, the association between rs7903146 and type-2 diabetes apparently does not hold in Arab populations, based on a case-control study of 522 Saudi patients and 346 controls.A HuGE review and meta-analysis including over 35,000 type-2 diabetes cases and 39,000 controls concluded that the Bayesian odds ratio for rs7903146(T;T) homozygotes and (C;T) heterozygotes versus (C;C) homozygotes was 1.968 (95% credible interval (CrI): 1.790 - 2.157) and 1.406 (95% CrI: 1.341 - 1.476), respectively, and the population attributable risk (PAR) for the (C;T)/(T;T) genotypes of this variant is 16.9% overall. Along with 3 other TCF7L2 SNPs, a multiplicative genetic model was indicated.A study of over 13,000 individuals initially free of cancer and followed over 10+ years found that the rs7903146(T) allele was associated with increased risk of colorectal cancer, with an adjusted odds ratio of  1.25 (CI:0.85-1.83) and 2.15 (CI:1.27-3.64) for the (C;T) and (T;T) genotypes, respectively.Does the association with type 2 diabetes hold for youth as well as for ageing|adults?  Among African American youth, each copy of a rs7903146(T) allele was associated with a 1.97-fold (CI:1.37 - 2.82) increased odds for type 2 diabetes (p?<?0.0001), yet no significant association was detected in non-Hispanic white youth (adjusted odds ratio 1.14; CI: 0.73 - 1.79).</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3205]]
    <blockquote>
        <p class="text-snippet" data-id="3205">Rs2237717 (major: C, minor: T) is located in intron 11 within the MET proto-oncogene. The MET gene is primarily known to be involved in tumor metastasis . However, MET has also been shown to have roles in general neurodevelopment  and in the development of autism .  Rs2237717 has been linked to schizophrenia, ability to recognize facial emotion, and chronic rhinosinusitis. ==Association with schizophrenia and cognitive ability== Given that schizophrenic patients have a lower incidence of cancer despite more exposure to risk factors and relatives without schizophrenia appear to also have a protective effect on cancer incidence, it has been hypothesized that alterations in cancer genes (like MET, containing rs2237717) may be involved in the pathogenesis of schizophrenia . ===Schizophrenia===In a study by Burdick et al  which investigated the relation between SNPs in MET gene and schizophrenia, it was found that rs2237717 resided in an enriched haplotype of one of the four haplotype blocks. The &#8216;Block 3&#8217; haplotype was the most commonly underrepresented in the schizophrenia case group (p = 2.5e-4, OR = 0.40, 95% CI = 0.24&#8212;0.65). Rs2237717 was one of three SNPs in the haplotype block to survive correction with permutation (p = 0.002), with 37.9% of the cases and 49.6% of the controls showing the ancestral allele (C). The ancestral allele is thus considered a protective allele against schizophrenia. This test was replicated by the authors using a dominant model and the results remained significant (p = 0.001). These results represent the first report of an association between MET and schizophrenia and the second of an association of MET with susceptibility to neuropsychiatric illness (autism, . ===General cognitive ability===They also reported that the MET haplotype which was inversely correlated with schizophrenia (&#8216;Block 3&#8217; containing rs2237717) had a significant impact on neurocognition. Carriers of the major allele at rs2237717 in the comparison group performed significantly better than non-carriers on a test of general cognitive ability.==Association with facial emotional perception==Another study by Lin et al  showed the rs2237717 SNP is associated with facial emotional perception.  The CT and CC genotypes enhanced facial emotional perception as compared to those with the TT genotype (ANOVA p = 0.016 and GLM p = 0.018, controlled for age, gender, and education). There was also an interaction of rs2237717 with rs1130233 in the AKT gene in the same signaling pathway, in which the rs2237717 C carrier/ rs1130233 G carrier group showed better facial emotional perception than those with the TT/AA genotype (ANOVA p = 0.035 and GLM p = 0.015), controlled for neurocognitive functions. According to the authors, this is the first study to suggest that genetic factors can affect performance of facial emotion perception.==Association with chronic rhinosinusitis==The MET gene has been implicated in nasal polyp development , and Castano et al  showed that the minor allele at rs2237717 is associated with chronic rhinosinusitis in patients with nasal polyps (genotypic P nominal = 0.09, empirical P = 0.04, OR = 1.4, CI = 1.0-1.9). This suggests that polymorphisms in the MET gene, including rs2237717, may play a role in the susceptibility to develop CRS. Study findings apply to patients with nasal polyps and severe CRS unresponsive to surgery.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2840]]
    <blockquote>
        <p class="text-snippet" data-id="2840">The SNP is located in an intron of ''ITIH3'', a domain of a protease inhibitor. rs2535629 was recently shown to be significantly associated with multiple mental disorders: autism-spectrum disorders, attention deficit hyperactivity disorder, bipolar disorder, depression, and schizophrenia, where A is the risk allele.  However, the causative gene has not yet been determined since the SNP is in linkage disequilibrium with more than 30 genes in the surrounding 1Mb region.===Symptom-based diagnosis===Mental disorders are currently classified based on symptoms and the course of the disease, as specified by the Diagnostic and Statistical Manual of Mental Disorders (DSM). However, presentation of diseases as classified by DSM is highly heterogeneous. As genomic data is becoming more abundant, the possibility of diagnosis based on the underlying molecular cause is being discussed.===Familial mental disorders===It has long been known that relatives of mental health patients have a higher chance of having a psychiatric illness, but not necessarily the same illness as the patient.     This has led to the idea that common genetic factors underlie multiple psychiatric disorders. A GWAS carried out by Smoller ''et al'' identified three SNPs predictive of autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia &#8211; rs2535629, rs11191454, and rs2799573 &#8211; and one predictive of bipolar disorder and schizophrenia only &#8211; rs1024582. ===Implicating study===The study analyzed 33332 cases and 27888 controls, where patients were of European descent and met criteria from DSM-III revised or DSM-IV.  1,250,922 autosomal SNPs were examined.The study divided patients and controls into five groups:  Autism-spectrum disorders (4788 trio cases (two parents and an affected offspring who inherited the allele in question), 4788 trio pseudocontrols (two parents and an offspring who did not inherit the allele in question), 161 cases and 526 controls);  Attention deficit-hyperactivity disorder (1947 trio cases, 1947 trio pseudocontrols, 840 cases, 688 controls);  Bipolar disorder (6990 cases, 4820 controls);  Major depressive disorder (9227 cases, 7383 controls);  Schizophrenia (9379 cases, 7736 controls)rs2535629 has been shown to be predictive of the five disorders above with a combined odds ratio 1.10, p-value 2.54 10<sup>-12</sup>. For a complex disorder like any of the five illnesses above, odds ratio of 1.10 suggests an important genetic locus, while the p-value above indicates strong confidence in the result.===Corroborating Studies=======Bipolar Disorder====A study by the Scott ''et al'' identified rs1042779 as a predictor of bipolar disorder.  rs1042779 is 12kb away from rs2535629, but within the rs2535629 1Mb haplotype. The odds ratio of rs1042779 was 1.19, with p-value 1.8 10<sup>-7</sup>. The study included 3944 patients with bipolar disorder I and II diagnosed based on DSM-III or DSM-IV and 14507 controls. All subjects were of European ancestry.====Major Depressive and Bipolar Disorder====Another study identified rs2251219, a SNP 248kb away from rs2535629, but within the 1Mb haplotype, as significantly associated with bipolar disorder and combined major depressive disorder.  The SNP was found to have an odds ratio of 0.87 with p-value 3.63 10<sup>-8</sup>. The study analyzed individuals of European origin, of whom 8765 cases of bipolar disorder and major depressive disorder as defined by DSM-IV and 9122 controls.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3998]]
    <blockquote>
        <p class="text-snippet" data-id="3998">rs662, also known as Q192R, is a SNP in the PON1 gene.  It codes for amino acid 192 of the paraoxonase (PON) protein.  Variants of this SNP affect PON catalytic efficiency and are correlated with Heart disease and trait-anxiety scores.  The normal form, rs662(A), encodes a glutamine (Q), while the variant, rs662(G), encodes an arginine (R). The general hypothesis is that the glutamine-containing PON1 protein has higher enzymatic activity, leading to lower risk for heart disease.. However, there are publications that clearly report the opposite.Studies finding greater heart disease risk associated with the Q192 (glutamine) form include:  : 2009 study involving 10 year follow up study of 800 patients reporting a hazard ratio of 1.71 (CI:1.0 - 2.8, p=0.03) per Q allele  : 2009 study of ~1400 patients undergoing coronary angiography at the Cleveland Clinic concludes that QQ192 patients have the lowest PON1 activity and have both an increased risk of all-cause mortality (HR 2.05; CI: 1.32-3.18) and of major adverse cardiac events (HR 1.48, CI: 1.09-2.03, p = .01). See also this  Table  : 2011 study of with coronary artery disease patients receiving a stent and taking clopidogrel concluded that QQ192 homozygous individuals had the highest risk for stent thrombosis (OR 3.6; p = 0.0003) and that their PON1 plasma activity, active metabolite plasma concentration and platelet inhibition were all lower compared to RR homozygotes.Studies finding greater heart disease risk associated with the R192 (arginine) form include:  : 2010 meta-analysis of 22 eligible studies (totaling 7384 cases/11,074 controls) yields a summary odds ratio for ischemic stroke of 1.10 per G allele (CI: 1.04-1.17)  : 2013 report on ~200 Saudis concludes that the RR genotype was associated with CAD risk (OR 2.2, CI: 1.4-7.4, p < 0.01)  : Perhaps the most striking finding with such an association was reported in Japanese patients with non-insulin dependent diabetes mellitus (NIDDM). NIDDM patients with either one or two rs662(G) alleles had a 9 fold higher risk of coronary heart disease compared with rs662(A;A) NIDDM patients. 274 ovarian epithelial carcinoma cases and 452 controls. rs662 odds ratio 0.65 (CI: 0.44-0.95; p for allele-dose effect = 0.03) for ovarian cancer for women carrying the rs662(A) allele compared with women with the (G;G) genotype rs1799864(G), rs3025058(A) and rs662(G) were associated with increased risk, and rs1800775(A) with reduced risk of recurrent venous thromboembolism In a study of 461 participants in the HERITAGE cohort (172 African-American, 289 Caucasian), the combination of rs662 with rs854560 was found to significantly contribute to trait-anxiety scores.  The high trait-anxiety group included "significantly more subjects homozygous to the Alzheimer's disease- predictive PON192 variant."  The authors also cite another paper, , which found that this SNP affects PON's catalytic efficiency.  From the context, it appears that it is the "R" variant, or rs662(G), which corresponds to the higher trait-anxiety scores and reduced catalytic efficiency, though this is less explicitly stated than one might hope. No association between rs662 and amyotrophic lateral sclerosis was seen in this large meta-analysis.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q29]]
    <blockquote>
        <p class="text-snippet" data-id="29">rs1128503 is a SNP in the transporter P-glycoprotein (P-gp) 170, encoded by the ABCB1 (also known as MDR1) gene. Methadone is a substrate of this protein, so variants may affect the efficacy and optimal dosage of this drug as used for treating opiate dependence.A study of 98 methadone-maintaining patients concluded that the higher (>150 mg/day) and lower (< or =150 mg/day) methadone dose groups differed significantly in their rs1128503 status (experiment-wise p = 0.0325). Furthermore, individuals with the 3-locus genotype pattern (T;T)-(T;T)-(T;T) for SNPs rs1045642, rs2032582 and rs1128503, respectively, had an approximately 5-fold chance of requiring the 'higher' methadone dose, while individuals heterozygous for these three SNPs have an approximately 3-fold chance of stabilizing at the 'lower' methadone dose (point-wise p-value = 0.026). Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene. ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder. Multiplexed genotyping of ABC transporter polymorphisms with the Bioplex suspension array. Genotyping panel for assessing response to cancer chemotherapy. Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Bidirectional translational research: Progress in understanding addictive diseases. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population. Opiate and cocaine addiction: from bench to clinic and back to the bench. Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response. No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin. Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II. Explaining variability in ciclosporin exposure in adult kidney transplant recipients. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer. Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients. Pharmacogenetics of antidepressant response. Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome. Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy. Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation. ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians. Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population. PharmGKB summary: phenytoin pathway.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5157]]
    <blockquote>
        <p class="text-snippet" data-id="5157">rs75932628(T), a SNP in the TREM2 gene on chromosome 6 resulting in an R47H substitution, was found to confer a significantly higher risk of late-onset Alzheimer's disease based on two articles published together in 2013 in the New Engl. J. of Med.In one study, the odds ratio for rs75932628(T) was 2.9 (CI: 2.09 to 4.09, P=3.42&#215;10&#8722;10). The mutation had a frequency of 0.46% in controls 85 years of age or older. The authors also observed the association in additional sample sets (odds ratio, 2.90; 95% CI, 2.16 to 3.91; P=2.1&#215;10&#8722;12 in combined discovery and replication samples), and found that carriers of rs75932628-T between the ages of 80 and 100 years without Alzheimer's disease had poorer cognitive function than noncarriers (P=0.003).In the other study, analysis of the rs75932628(T) in a series that included 1887 patients with Alzheimer's disease showed a strong, highly significant association (odds ratio, 5.05, CI: 2.77 to 9.16; P=9.0&#215;10&#8722;9). Four other TREM2 gene variants (D87N, T66M, Y38C, and Q33X) were also associated with higher risk for a frontotemporal dementia&#8211;like syndrome when homozygous.Notably, a 2018 study has raised the possibility that in TREM2 R47H mutation carriers, an APOE4 allele may be required for Alzheimer's to develop.Other studies confirming (or in some cases, refuting) an association between R47H and Alzheimer's include: Data shows that rs75932628 is highly significantly associated with the risk of AD across 24,086 AD cases and 148,993 controls of European descent (OR 2.71, p = 4.67  10e-25). Based on a study of ~1,000 Alzheimer patients, the R47H mutation does appear to be a risk factor for AD (OR = 2.19, CI:1.04-4.51, p = .03). Individuals with p.R47H associated AD (n = 12) had significantly earlier symptom onset than individuals with no TREM2 variants (n = 551) (55.2 years vs. 61.7 years (p = .02). Based on a Caucasian population comprising ~1,600 late-onset Alzheimer cases, carriers of the R47H variant are at increased risk (OR 7.40, p = 3.66e-06). A study of 474 AD patients from the northwest region of the UK showed a significant association of the R47H mutation with AD (OR 11.08, CI: 2.55-48.09, and Yates' corrected p value = 0.000146). Meta-analysis of 2 family-based and 5 case-control cohorts yielded an overall summary estimate (using case-control data only) for an odds ratio of 1.67 (CI: 0.95-2.92) for the association between the TREM2 R47H and increased AD risk; so while this study replicates the association, it finds a weaker effect than have other studies. A study of ~3,000 AD patients from Spain did see the R47H association with AD (OR 4.12, CI: 1.21-14.00, p = 0.014). A meta-analysis comprising 32,598 subjects from 4 previous studies demonstrated the large effect of the p.R47H variant in AD risk (OR 4.11, CI: 2.99-5.68, p = 5.2710e-18). No association was seen between R47H and AD in a study of ~2,000 Japanese patients with late-onset AD.Additional studies include:</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4811]]
    <blockquote>
        <p class="text-snippet" data-id="4811">The rs4880(T) allele, part of the codon for amino acid valine at codon 16 of the antioxidant protein from the mitochrondrial superoxide dismutase 2 SOD2 gene, is the most common in most populations studied. The rs4880(C) allele gives rise to an alanine at this position is it also known as Val16Ala manganese superoxide dismutase, or A16V. There appears to be some conflict in the literature over the effect of this SNP. Having a valine at codon 16 is said to reduce enzyme activity , and thus lead to increased oxidative stress, yet in at least one study of the actual enzyme levels measured in people, SOD2 activity was 33% higher in (C;T) or (T;T) individuals compared to (C;C) individuals . Regardless of how this resolves, several phenotypic associations have been reported for this SNP, including:  A 10 fold higher risk for heart disease in hereditary hemochromatosis patients with rs4880(T;T) genotypes compared to similar patients with rs4880(C;T) or rs4880(C;C) genotypes.   An increased risk of malignant pleural mesothelioma (MPM) was found in individuals with rs4880(C;C) (OR = 3.07, CI: 1.55-6.05) genotypes. Odds ratios for developing mesothelioma were even higher for patients lacking obvious exposure to asbestos fibers.   Among prostate cancer patients with a rs4880(T;T) genotype, but not the (C;C) genotype, higher iron intake level was associated with a 2.3-fold increase in risk for aggressive forms of the cancer (OR=2.3, CI: 1.0-4.9).  rs4880(C;T) prostate cancer patients being treated by radiation therapy are more likely (8% compared to 0%, p=0.02) to exhibit a significant increase in grade 2 late rectal bleeding after irradiation than (C;C) or (T;T) patients, based on a study of 135 patients. The odds for this are worse if the patient also has the rs861539(C;T) genotype (14% vs 1%, p=0.002).  A study of non-Hispanic Caucasians with various types of brain tumors concluded that there was an increased risk of acoustic neuroma (odds ratio 2.0, CI: 1.1-2.7) associated with the alanine-encoding rs4880(C) allele.  rs4880(C) carriers with breast cancer and being treated with cyclophosphamide had worse survival rates (i.e. didn't benefit as much), based on a 2009 study of 248 US and 340 Norwegian patients.    A 2010 US study of ~450 women receiving cyclophosphamide + adjuvant therapy concluded that rs4880(C) carriers suffered slightly less side effects (HR 0.5) but had slightly worse disease-free survival rates (DFS 1.6); no associations were observed among 874 women who were followed without adjuvant therapy    A 2014 Danish meta-analysis plus study of ~300 patients receiving cyclophosphamide chemotherapy found no association with rs4880(C) genotype    A 2015 study with a relatively small number (~500) of Chinese gastric cancer patients found rs4880(C) carriers who received postoperative platinum and fluorouracil based chemotherapy were somewhat worse off than non-carriers   See also  OMIM 147460.0001  Note: rs1799725 was combined into rs4880 by dbSNPThe C allele of rs4880 appears to be slightly associated with Alzheimer's disease.  rs2758346 rs4880 and rs2855116 association with Alzheimer's disease</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1888]]
    <blockquote>
        <p class="text-snippet" data-id="1888">rs1801274 is a SNP in the Fc fragment of IgG, low affinity IIa, receptor (CD32) FCGR2A gene. rs1801274(C) encodes the arginine (R) allele, with the (T) allele encoding the variant histidine (H). The (H) isoform is considered high-binding to IgG2 and IgG3, while the (R) isoform is considered low-binding. This SNP is known in the literature by many names, including A519C and H131R. What's the importance of this? FcgR isoforms expressed on immune system cells have been linked to the pathogenic consequences triggered by autoantibodies or immune complexes in autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), as well as to the efficacy of some immunotherapeutic treatments such as rituximab.Many studies have been published about this FCGR2A SNP, roughly divided by either disorder or treatment as follows:  HIV to AIDS, including susceptibility and progression   In a study of HIV-infected men, those with a FCGR2a CC genotype progressed to a CD4+ cell count of <200/mm3 at a faster rate than individuals with either of the other genotypes (relative hazard = 1.6; p = 0.0001). However, the authors noted that the progression to AIDS was less impacted by this SNP, largely because TT homozygotes had an increased risk of pneumonia as an AIDS-defining illness.   Lymphoma   A US study  of 1,172 lymphoma patients and 982 controls looked at 57 SNPs in 36 immune function genes. The AG and AA genotypes of rs1801274 were associated with higher risk of follicular and small lymphocytic lymphomas: 1.26x (95% CI, 1.01-1.56) and 1.41x (95% CI, 1.10-1.81), respectively (P(trend) = 0.006). Hemophilia A  In a case-control study of 85 individuals a more than 3-fold increased risk of inhibitor development was found compared to patients with the RR genotype  Malaria   Based on a study of more than 1,800 individuals in India, rs1801274(T;T) homozgyotes were significantly associated with protection from disease manifestation, with stronger association observed in the malaria non-endemic region.   Systemic lupus erythematosus (SLE)   A study of 90 Japanese patients with SLE concluded that individuals with rs1801274(C) alleles were at higher risk for the disease. Classifying the reports by immunotherapeutic treatment studied yields the following:  Studies involving cetuximab:   In a study of 39 patients with metastatic colorectal cancer treated with cetuximab, the rs1801274(T) (ie H) allele was associated with longer progression-free survival (PFS; p = 0.055), by perhaps 1-2 months.   Studies involving infliximab:   A study of 91 patients with rheumatoid arthritis found that at week 30 of treatment with infliximab, rs1801274(C;C) homozygotes had a better ACR20 response (RR: 60% and HH-RH: 33.3%; p= 0.035).   Studies involving rituximab:   In a study of 58 Croatian patients with diffuse large B-cell lymphoma, rs1801274 did not influence response, event-free or overall survival.   Studies involving 3F8, an anti-GD2 antibody:   In a study of 136 patients with high risk neuroblastoma treated with the anti-GD2 antibody 3F8 plus GM-CSF immunotherapy, the rs1801274(C;C)(ie R/R) genotype was correlated with progression-free survival for the entire cohort (p = .049) and for the subset of patients with no history of prior relapse (p = .023). Malaria Complications</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3026]]
    <blockquote>
        <p class="text-snippet" data-id="3026">rs1048661, also known as R141L, a SNP causing an amino acid change in the lysyl oxidase 1 LOXL1 gene, has been linked to exfoliation glaucoma. This form of glaucoma causes up to 10% of the cases of blindness in many countries, including the US. Science DOI: 10.1126/science.1146554 From the abstract of this study: "Approximately 25% of the general population is homozygous for the highest risk haplotype and their risk of suffering XFG (exfoliation glaucoma) is over 100 times that of those only carrying low-risk haplotypes."The risk allele for this SNP is rs1048661(G), and it confers a estimated relative risk (by itself) of 3.04. The odds ratio is 2.46 (CI 1.91-3.16). Note that the (G) allele is actually quite common in most European populations.However, a meta-analysis published in 2010 concluded that it's likely that SNPs rs1048661 and rs2165241 are not directly implicated in the pathogenesis of glaucoma; only the nearby rs3825942 seemed to be the disease-associated SNP.In the original publications, the haplotypes identified as being of highest risk consisted of the combination of two SNPs together, rs1048661(G) and rs3825942(C), oriented with respect to the dbSNP entry. In the two populations studied combined (from Iceland and Sweden), the (G;C) haplotype has an odds ratio of 27.05, and the (T;C) haplotype has an OR of 8.90, relative to the (G;T) haplotype. The (T;T) haplotype is presumed to be at even lower risk than the (G;T) haplotype, but due at least in part to the high frequency of the rs1048661(G) allele, no individuals in this study carried it. In the populations studied, ~25% of all individuals in the population carry two copies of the (G;C), highest risk haplotype.If the risk of carrying two such haplotypes is multiplicative (which isn't known actually), the authors estimate that individuals carrying two copies of the (G;C) high risk haplotype would have 700 times the risk of developing this type of glaucoma compared to individuals carrying two copies of the (G;T) haplotype. Overall, (G;C) individuals are at ~2.5 fold higher risk than the average person in the populations studied.With so many people at high risk, shouldn't the number of cases be much higher? Not necessarily, since glaucoma risk only becomes high in older individuals. To put it another way: plenty of folks don't live long enough to find out if they would have gotten glaucoma. The estimate for glaucoma incidence worldwide is 10-20% only for individuals over 60 years of age; in Iceland, where glaucoma incidence is high, 40% of individuals 80 or older show signs of exfoliation ''syndrome'', which has been seen to convert to exfolation ''glaucoma'' at a rate of 60% - over a 15 year period. PMID 12928689, PMID 10463402, PMID 17224761Discussed in this / blog post Confirmed as risk for pseudoexfoliation (PEX) and pseudoexfoliation glaucoma (PEXG) in populations of German and Italian descent. rs1048661 (G), rs3825942 (G), and rs2165241 (T) are highly associated with XFS and XFG in American and European populations. The GGT haplotype constitutes a major risk haplotype for exfoliation.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2004]]
    <blockquote>
        <p class="text-snippet" data-id="2004">rs9939609 is a SNP in the fat mass and obesity associated FTO gene, aka the "Fat Gene" . The original paper describing it is here .2015 research suggests rs1421085 may be the causal snp. The researchers identified 10 different FTO SNPs in the first intron of the gene that associated with both BMI and type-2 diabetes. Because they all correlated with each other, they chose to examine one of the SNPs (rs9939609) in detail.rs9939609 has also been reported in a large study to be associated with type-2 diabetes.The risk allele (oriented to the dbSNP entry) is (A); the odds ratio associated with heterozygotes is 1.34 (CI 1.17-1.52), and for homozygotes, 1.55 (CI 1.3-1.84). In a different study, this SNP was found in a linkage block in the FTO gene with rs1121980; see rs1121980 for the association of this block with early onset obesity since it showed the strongest association.The increases in body mass index associated with rs9939609(A) carriers appears to begin at a young age and are maintained throughout adulthood, according to a study of 5,600+ Utah families.This SNP did not show any association with obesity, type-2 diabetes or any other related traits in a study of 3,210 Chinese subjects. Furthermore, the minor allele frequency was much lower in Chinese populations compared to populations of European descent.  Note: The three FTO SNPs, rs1421085, rs17817449, and rs9939609, are in strong linkage disequilibrium (pairwise r<sup>2</sup>>0.97), and there are two primary haplotypes, C-G-A (42.0 %) and T-T-T (55.5 %). 1,638 type 2 diabetes patients and 1,858 controls rs9939609 in FTO (OR 1.14, 95% CI: 1.04-1.25, p = 0.006) A study of 3,000+ UK children indicated that (A;A) genotypes were less satieted (i.e. had greater appetite) than other genotypes, indicating this risk allele for obesity is likely to influence appetite. This SNP is also associated with (severe) obesity in a study of 927 Japanese patients. This SNP may contribute to variation in plasma C-reactive protein (CRP) levels independently of obesity; average CRP levels may be 12-14% higher per rs9939609(A) allele. This SNP is also associated with adult obesity in Mexicans.  A longitudinal study of Finnish children concluded that the effect of rs9939609 on BMI only becomes evident after age 7, and that the FTO gene is not directly associated with energy intake or physical activity. Independent of fatness, the A-allele of the FTO SNP appears to increase mortality of a magnitude similar to smoking, but without a particular underlying disease pattern barring an increase in the risk of diseases of the nervous system. Each copy of the risk-allele A at rs9939609 was significantly associated with 0.45 kg/m(2) increase in BMI (95% confidence interval (CI): 0.16-0.74; P = 0.004) and 0.97 cm increase in waist circumference (95% CI: 0.21-0.65; P = 0.0002). Similar results were observed for rs8050136. may confer a modest susceptibility to obesity in an ethnicity-specific manner, but may be '''unlikely to contribute to a clinically significant diabetes risk'''. A small study (less than 700 women, divided into 4+ groups) concluded that over 3 & 6 months women in a weight-loss program who were informed they carried at least one rs9939609 risk allele lost slightly more weight than non-carriers.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4226]]
    <blockquote>
        <p class="text-snippet" data-id="4226">rs5275, also known as exon1-+837T>C, is a SNP in the PTGS2 gene.A study of 635 Caucasian bladder cancer patients found a reduced risk associated with the minor (C) allele of rs5275, (odds ratio 0.68, CI: 0.54-0.87, p=0.002, remaining significant after multiple comparison adjustment). (T;T) genotype of PTGS2 8473T>C (rs5275) was significantly correlated with a better survival when compared to the combined T/C and C/C genotype (Hazard ratio HR = 0.47; P value = 0.046 and HR = 0.16; P = 0.013, respectively) in colorectal cancer Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma. Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. Cyclooxygenase-2 polymorphisms in Parkinson's disease. Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk. A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study. Association of common polymorphisms in inflammatory genes with risk of developing cancers of the upper aerodigestive tract. Lack of association of the cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphism with risk of cervical cancer in Korean population. Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies. Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance. Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis. Association of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid calcium in the Diabetes Heart Study. Common polymorphisms of cyclooxygenase-2 and prostaglandin E2 receptor and increased risk for acute coronary syndrome in coronary artery disease. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. Cyclooxygenase-2 gene polymorphisms reduce the risk of oral premalignant lesions. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk. Toll-like receptor signaling pathway variants and prostate cancer mortality. TNF superfamily gene polymorphism as prognostic factor in early breast cancer. Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets. Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma. Gallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes. Cyclooxygenase-2 polymorphisms and susceptibility to esophageal cancer: a meta-analysis. The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene. Polymorphisms in COX-2 gene influence prostate cancer susceptibility in a northern Indian cohort. Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features. A genetic variant in 3'-untranslated region of cyclooxygenases-2 gene is associated with risk of gastric cancer in a chinese population. Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2419]]
    <blockquote>
        <p class="text-snippet" data-id="2419">rs5848(T;T) found a 3.2-fold increased risk vs C-allele carriers (95% CI: 1.50-6.73, p=0.003) for ubiquitin- and TAR DNA-binding protein 43 (TDP-43)-positive frontotemporal dementia (FTLD-U also knows as FTLD-TDP43), a progressive neurodegenerative disease affecting approximately 10% of early-onset dementia patients. Detailed haplotype analysis was conducted, indicating rs5848 as most likely causal variant. FTLD-TDP43 is divided into four subtypes, some sources suggest association with type 3 only . Association between rs5848(T;T) and frontotemporal dementia is now generally assumed in literature, despite some studies failing to reproduce it.First meta-analysis of rs5848 association with Alzheimer's disease combining previous five studies for a total of 2502 Alzheimer's disease cases and 2162 controls found association in homozygous model (TT vs. CC: OR, 1.36; 95% CI, 1.11-1.66; P=0.003) as well as recessive model. This association existed also in the Caucasian-only subset of 2227 cases and 1902 controls. Although the ''p''-value is above usually applied guidelines, the researchers concluded the data indicates association exists .  According to "First symptoms--frontotemporal dementia versus Alzheimer's disease"  as well as other sources frontotemporal dementia is often misdiagnosed as Alzheimer's disease so it is possible some studies have misdiagnosed cases. FTLD is characterized by behavioral and/or language dysfunction, but usually without the amnesic syndrome involved in Alzheimer's disease at early stage.In contrast "Reduced serum progranulin level might be associated with Parkinson's disease risk"  found that only Parkinson's disease was associated with reduces progranulin levels, but found no association between progranulin levels, rs5848 or Alzheimer's disease. "Association between GRN rs5848 polymorphism and Parkinson's disease in Taiwanese population" found association between rs5848 and Parkinson's disease, but only for female Taiwanese (OR&#8202;=&#8202;1.43, 95% CI: 1.11-1.87, P&#8202;=&#8202;0.007 for single T allele among females). Most studies have found association with neurodegenerative disorders only for recessive or homozygous model, but this is one study where odds ratio follows number of alleles (OR=2.16, 95% CI: 1.24-3.78, P&#8202;=&#8202;0.006 for two alleles among females).A functional effect is suggested in many studies such as "GRN variant rs5848 reduces plasma and brain levels of granulin in Alzheimer's disease patients"  and "Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease" . In addition "rs5848 polymorphism and serum progranulin level"  showed that progranulin level is affected by number of (T) alleles equally both in 100 patients with different forms of dementia and 36 controls: TT (164 ng/mL, 95% C.I. 138-189), CT (191 ng/mL, 95% C.I. 177-206) and CC (222 ng/mL, 95% C.I. 205-238) serum progranulin with p < 0.005. Progranulin is a growth-factor involved in regulating tumorigenesis, wound repair, development, and inflammation among other things. Rs5848 is located in the 3'-untranslated region (UTR) RNA tail of GRN in a binding-site for miR-659 which inhibits GRN translation. University of California, San Francisco is currently conducting clinical trial " Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations". Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1224]]
    <blockquote>
        <p class="text-snippet" data-id="1224">In this 2013 article titled "Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses", six previous studies of rs1049353 were reviewed. They concluded that the minor A allele may provide protection against depression in response to stress.  The gene variants also affected response to antidepressant medication. One study they cited showed that in females, the A allele may confer greater antidepressant responsiveness, but another study showed that in a population of males, the result was opposite and the G allele associated with greater antidepressant responsiveness.  Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression.Based on a 2008 study of 256 Caucasian patients being treated for depression, carriers of a rs1049353(G) allele were less likely to respond favorably, particularly if they were females with comorbid anxiety. rs806368(C) together with rs1049353(A) or rs1049353(G) make up a haplotype associated with PTSD, with the C-A haplotype somewhat associated (p=0.04) with higher risk of PTSD and the C-G haplotype associated (p=0.01) with a lower risk of PTSD.  Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents. The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men. No association of CNR1 gene variations with susceptibility to schizophrenia. Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis. Association between single nucleotide polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in southwest California Indians. Cannabinoid receptor 1 gene association with nicotine dependence. Cannabinoid type-1 receptor gene polymorphisms are associated with central obesity in a Southern Brazilian population. Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Genetic variation in cannabinoid receptor 1 (CNR1) is associated with derangements in lipid homeostasis, independent of body mass index. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. CB1 expression is attenuated in Fallopian tube and decidua of women with ectopic pregnancy. Candidate genes for cannabis use disorders: findings, challenges and directions. Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects. The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects. Eating disorders: the current status of molecular genetic research. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression. CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. G1359A polymorphism of the cannabinoid receptor gene (CNR1) and insulin resistance in patients with diabetes mellitus type 2. Role of genetic variation in the cannabinoid type 1 receptor gene (CNR1) in the pathophysiology of human obesity. Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain. Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women? A common variation in the cannabinoid 1 receptor (CNR1) gene is associated with pre-eclampsia in the Central European population. Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain. Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse on Anhedonia and Depression.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4342]]
    <blockquote>
        <p class="text-snippet" data-id="4342">'''rs6010620''' is a SNP associated with atopic dermatitis (AD).  Also known as eczema, AD is one of the most common chronic inflammatory skin disorders with a prevalence estimated up to 20% in children and 3% in adults .  It is a complex and highly heterogeneous disease that likely involves various genetic factors.  The SNP rs6010620 locates on chromosome 20q13.33, at which there are eight genes &#8212; ''PRIC285'', ''STMN3'', ''RTEL1'', ''TNFRSF6B'', ''ARFRP1'', ''ZGPAT'', and ''LIME1'' &#8212;, within a single 200-kb LD block around rs6010620.  Among them, ''TNFRSF6B'' and ''ZGPAT'' might be the susceptibility candidates whose expressions correlate with the SNP as suggested by expression quantitative trait loci (eQTL) analysis .  rs6010620&#8217;s association with AD was first identified in a genome-wide association study (GWAS) published in 2011, involving 491,905 autosomal SNPs in 1,012 cases and 1,362 controls from southern China followed by two replication studies &#8212; one with an additional 3,624 cases and 12,197 controls of Chinese Han ethnicity, the other had 1,806 cases and 3,256 controls from Germany .  rs6010620 showed evidence for AD association in both the combined Chinese population (minor/risk allele G; ''P'' = 3.00 &#215; 10-8; OR = 1.17) and in the German cohort (minor allele A; risk allele G; ''P'' = 2.87 &#215; 10-5; OR = 0.80).The association was subsequently validated in a two-stage GWAS meta-analysis carried out later (''P'' = 0.002; OR = 1.09; 95% CI 1.03&#8211;1.15) .  This GWAS involved 5,606 cases and 20,565 controls from 16 population-based cohorts of European descent in the discovery meta-analysis, and the ten most strongly associated new susceptibility loci were then examined in the replication meta-analysis encompassing an additional 5,419 affected individuals and 19,833 controls from 14 studies.The group which published the first GWAS in 2011 recently validated the association as well with 4,538 cases and 13,412 controls from multiple cities in the central and northern parts of China (''P''GG = 1.83 &#215; 10-7; OR = 1.40; 95% CI 1.23&#8211;1.58) .  rs6010620&#8217;s association with subphenotypes of AD was examined in this study, and the SNP showed significant protective effect for sporadic AD (''P''genotype = 0.01; ''P''Bonferroni = 0.006; OR = 0.60; 95% CI 0.43&#8211;0.83).  Tumor necrosis factor receptor superfamily member 6B (TNFRSF6B) is an immune receptor that plays a regulatory role in suppressing cell death .  It has been shown that mRNA expression of serum TNFRSF6B in AD patients are higher than those in healthy individuals and control subjects with non-atopic inflammatory diseases .  ''ZGPAT'', on the other hand, encodes the zinc finger CCCH-type with G patch domain-containing protein (ZIP) that transcriptionally represses several singling cascades including the epidermal growth factor receptor (EGFR) pathway .  EGFR is overexpressed in skin lesions of AD patients and inhibition of its signaling induces dysregulated chemokine profiles that augment skin inflammation .  Taken together, these results indicate that ''TNFRSF6B'' and ''ZGPAT'' are indeed plausible causal genes for AD, while further fine mapping and functional studies are still needed before an unequivocal conclusion can be made on the exact susceptibility genes at 20q13.33 .----/ 23andMe blog rs6010620 G 1.28 Glioma</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1704]]
    <blockquote>
        <p class="text-snippet" data-id="1704">The SNP '''rs2076295''' on chromosome 6p24 is located within the intronic region of the DSP gene, which encodes the protein desmoplakin. Desmoplakin is a component of the desmosome, and is an adhesive intercellular molecule that tightly links adjacent cells for cell-cell adhesion. It is part of a dynamic structure that involves other proteins, such as plakoglobin and plakophilins, which tether the cytoskeleton to the cell membrane . The minor allele rs2076295(G) is reported by dbSNP to have an allele frequency (MAF) of 0.454.A recent case-control genome-wide association study (GWAS) involving 1,616 cases and 4,683 controls (and a replication study with 876 cases and 1,890 controls) was performed on non- Hispanic white individuals with fibrotic idiopathic interstitial pneumonia (IIP) ; note the correction posted online 1 Oct 2013. The most common and severe form of IIP is idiopathic pulmonary fibrosis (IFP), and all forms of IIP (including IFP) were included in this study, in which a total of 439,828 SNPs were studied. Using an additive model for the minor allele at each SNP, a total of 19 SNPs, representing 7 chromosome locations, with genome-wide significant associations (P < 5 x 10<sup>-8</sup>) were identified in the GWAS discovery process.Apart from SNPs that have been previously associated with IIP in the MUC5B, TERT, and TERC genes , many of the other genome-wide significant SNPs reported in this study were newly discovered risk loci for IIP. Among them is '''rs2076295''' (minor allele = G; P<sub>meta</sub> = 1.1 x 10<sup>-19</sup>), which is in the intronic region of the DSP gene, with an odds ratio (OR) of 1.43 for IIP (discovery GWAS). A related lung tissue gene expression study (100 IPF cases, 94 controls) showed that DSP expression was down-regulated in cases when compared to controls (P = 0.0002), and the expression level was genotype-dependent on the SNP (P = 0.002) &#8211; relative expression of DSP decreased with the number of copies of the putative risk allele, with GG alleles having the lowest level of expression, and TT the highest. This is consistent with the additive model used in the discovery GWAS.IIP represents a group of lung diseases that are often characterized by pulmonary fibrosis or progressive scarring of the alveolar interstitium, which can eventually lead to hypoxemic respiratory insufficiency and death . Some forms are known to be associated with environmental exposures (e.g. asbestos), drug toxicity, radiation exposure, or collagen vascular diseases (e.g. scleroderma). Previous studies have focused on the association between IIP and the MUC5B, TERT, and TERC genes. MUC5B encodes mucin 5B, expressed in mucus-producing cells in the distal airways of the lung. Lung tissue from individuals with IIP has higher concentrations of MUC5B than controls. TERT and TERC are involved in the maintenance of telomere lengths, and mutations in these genes are associated with shortened telomeres in the alveolar epithelia.The recently discovered association with the DSP locus suggests that changes in cell-cell adhesion may also play a role in IIP. Desmosomes (and desmoplakin) are important in maintaining the integrity of tissues that experience mechanical stress (such as the peripheral portions of the lung), and there is strong evidence that perturbation of the desmosome disrupts epithelial homeostasis . Mutations in DSP have also been associated with other diseases that involve loss of tissue integrity, such as in arrhythmogenic right ventricular dysplasia , keratodermas , and alopecia .</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4788]]
    <blockquote>
        <p class="text-snippet" data-id="4788">rs2736990 is a SNP associated with Parkinson&#8217;s disease (PD), a neurodegenerative disorder characterized by the degradation of dopamine-producing neurons in the substantia nigra.  Rs273990 is located on chromosome 4q22 in the synuclein-alpha SNCA locus. The function of SNCA is not fully understood, but it predominately found in the presynaptic terminals of neurons, and it is thought that it plays a role in maintaining adequate supplies of synaptic vesicles.  SNCA is also a major component of Lewy Bodies (LB), protein accumulations often found in neurons in patients with PD.The best evidence for the association of rs2736990 with PD was provided in a genome-wide association study (GWAS) that found an increased frequency of the minor C allele (T is the major allele) in position 90897564 among cases compared to controls.   The study first identified this SNP in a pool of 1,713 cases and 3,978 controls of European ancestry.  The researchers then successfully replicated this significant finding in a separate group of 3,361 cases and 4,573 controls, also of European ancestry.   Estimates of effect size and statistical significance from the pooled dataset (which incorporates both groups) are as follows: OR = 1.23, p = 2.24 x 10-17 .   Several other studies have also examined the relationship between rs2736990 and PD. A group of Japanese researchers conducting a GWAS on 2,011 cases and 18,381 controls of Japanese descent found a significant association of rs2736990 with PD that survived Bonferroni correction (p-value not reported) .  Another group looked at only the rs2736990 SNP in 515 cases and 450 controls of Chinese descent and found the minor C allele was significantly more frequent in patients with PD (OR=1.26, p = 0.017).  Other studies have validated the association between rs2736990 and PD in European populations:  The Harvard NeuroDiscovery Center tested rs2736990 only in 344 cases and 275 controls and found a significant association (OR = 1.40, p = 0.0032); another group combined data from previous GWAS studies with their own data to create a GWAS dataset of 1752 cases and 1745 controls that yielded a significant association (OR = 1.29, p = 6.7 x 10-8) ; finally, a GWAS conducted on 772 cases and 2024 controls of Dutch descent found a significant association between rs2736990 and PD (OR = 1.325, p = 1.63 x 10-5). It is not known with certainty how mutations in synuclein-alpha contribute to PD; however, mutations in this gene, both missense and copy number variants, have been linked to the development of PD. In addition, rs2736990 is one of several SNP&#8217;s in the SNCA locus significantly associated with PD in GWAS studies, and the significant association of this SNP with PD has been replicated and validated in several subsequent studies.  Moreover, estimates of effect size are similar across studies.  As such, the biological plausibility of this mutation appears high.  One candidate mechanism for development of PD due to SNCA hypothesizes that misfolded or excessively produced synuclein-alpha proteins accumulate in the neuron and interfere with normal function until they eventually cause death. This theory is supported by the abundance of synuclein-alpha proteins in LB&#8217;s found in dopaminergic neurons in the substantia nigra.  However, it is unclear if these LB&#8217;s are a response to injury or themselves the cause of death. Linkage disequilibrium patterns and tagSNP transferability among European populations. Genome-wide association study confirms extant PD risk loci among the Dutch. Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study. SNCA polymorphisms, smoking, and sporadic Parkinson's disease in Japanese.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4030]]
    <blockquote>
        <p class="text-snippet" data-id="4030">Rs7665116 is located in an intronic region of the peroxisome proliferator-activated receptor gamma coactivator 1A gene, which codes for the protein PGC-1&#945;. The PGC-1 &#945; protein is involved in the regulation of mitochondrial biogenesis, thermogenesis, and molecular mechanisms responsible for cellular respiration.  PGC-1 &#945; has also been implicated in the pathogenesis of Huntington&#8217;s disease, as mutant huntingtin protein in HD patients inhibits the PGC-1&#945; system. The G polymorphism of the rs7665116 SNP has been associated with a three to five year delay in the age of onset of Huntington&#8217;s disease relative to the wildtype A allele.The rs7665116 SNP is located at the 3&#8217; end of intron 2 of PPARGC1A, in a highly conserved region of the gene. Though the majority of the variance in age of onset of Huntington&#8217;s disease is explained by the length of the CAG repeat in the HTT gene, a small portion of the variance (~4.3%) in age of onset is explained by rs7665116.  The CAG repeat length is causative of Huntington&#8217;s disease, One study conducted on a cohort of 854 European individuals (401 cases and 453 controls) revealed that the G variant of the rs76651116 SNP was associated with a delay in HD onset (p=0.0389 in the additive model and p=0.0112 in the dominant model). The association was particularly strong in the Italian population of participants, which comprised 312 of the 854 individuals (p=0.0172 in the additive model and p=0.0045 in the dominant model). For the rest of the population, the association was not statistically significant. Further studies will be necessary to determine significance in non-Italian populations.  Another study was conducted on a cohort of 400 German patients to determine various genetic modifiers of Huntington&#8217;s disease in order to create a multivariable model explaining the variance in age of onset of the disease. The transcriptional factors nuclear respiratory factor 1 (NRF-1) and mitochondrial transcription factor A (TFAM) regulate the are also implicated in mitochondrial biogenesis, and SNPs in these genes, along with rs7555116,  can explain 4.8% of the additional residual variance in the age of onset of the loss of motor coordination symptom of Huntington&#8217;s disease through a gene-gene interaction model.  The exact mechanism for these interactions remains unknown, and the experiment has yet to be replicated and corrected for multiple hypothesis testing in order to more clearly explain how NRF-1, TFAM, and PGC-1 &#945; interact to affect Huntington&#8217;s age of onset.  In general, this study underscores role of impaired mitochondrial function in the pathogenesis of Huntington&#8217;s, suggesting that upstream transcriptional factors of PCG1-1 &#945; may be useful targets for treating HD. One study conducted on a cohort of 234 (155 controls and 79 cases) Huntington&#8217;s patients of Italian descent demonstrated that the age of onset increased  depending on the genotype of rs7665116. For patients with an A/A genotype, age of onset was on average 45.08 years, while A/G patients were 48.75, and G/G patients began to show symptoms at age 49.09. Statistical significance was maintained after the application of the Bonferroni correction (p<0.02 for the additive model and p<0.005 for the dominant model).   PGC-1alpha as modifier of onset age in Huntington disease. A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4319]]
    <blockquote>
        <p class="text-snippet" data-id="4319">In mice, the genetic locus best correlated to anxiety-related behaviour contains the 'regulator of G protein signaling 2' gene . In humans, SNPs in the equivalent RGS2 gene have now been studied to see if they are correlated to anxiety related disorders.In the first part of one study, 119 families including children underwent standard lab-based behavioural assessments of behavioural inhibition, defined as a heritable temperamental profile characterized by a tendency to be shy, avoident, and behaviourally restrained in situations that are novel or unfamiliar. Along with some other RGS2 SNPs, carriers of a rs4606(G) allele were 3 fold more likely to exhibit behavioural inhibition (CI: 1.31-6.84, p = 0.0026).In the second part of this study, 744 college undergraduates (228 men, 516 women) who had been genotyped completed a personality profile known as the NEO-E (introversion) association test. Consistent with the earlier results, the same RGS2 alleles associated with behavioural inhibition were significantly (p < 0.05) associated with introversion (but not neuroticism), including rs4606(G), rs6428136(G), and rs10801152(T).In the third part of this study, 55 female undergraduates were studied by fMRI (functional MRI) emotional processing tests. Carriers of SNPs rs4606(G) or rs10801152(T) showed increased insular cortex activation, a reflection of anxiety, in these tests.Based on these results, the authors predict that social anxiety disorder is the most likely anxiety disorder to be associated with SNPs in the RGS2 gene such as rs4606.   SNPs in the RGS2 gene, including rs4606, show association with childhood temperament, adult personality, and brain function. each rs4606(C) allele was associated with a 2x (p =.026) increased risk of generalized anxiety disorder. 173 patients with panic disorder (and 173 matched controls) of German descent analyzed, leading to the conclusion that rs4606(G) carriers were at ~2x increased risk for this disorder. Note that the (G) allele appears to be the minor (rarer) allele in this study.'''Note:''' given the conflicting reports over whether the (C) or (G) allele is implicated in anxiety-related disorders, Dr. Jordan Smoller was contacted to verify that the orientation was unambiguously reported in the various publications. He has confirmed that the reports truly vary in which allele is considered the risk allele; this may be an example of the "flip-flop" phenomenon .rs4606 has also been reported to be associated with the development of Parkinson's like symptoms in schizophrenia patients treated with various drugs, as follows: A replication study was performed in which extrapyramidal symptoms (EPS) were rated in 184 US patients with schizophrenia. This group (115 African Americans, 69 Caucasian) was treated for at least a month with typical antipsychotic drugs (n=45), risperidone (n=46), olanzapine (n=50) or clozapine (n=43). The minor (G) allele showed a protective effect against antipsychotic-induced parkinsonism (AIP), with an odds ratio for AIP among rs4606(G) carriers of 0.23 (CI: 0.10-0.54, p=0.001) for the overall sample./ blog discussion 121 consecutively hospitalized, psychotic patients with Diagnostic and Statistical Manual of Mental Disorder-IV schizophrenia receiving treatment with typical antipsychotic medication (n=72) or typical antipsychotic drugs and risperidone (n=49) for at least 2 weeks were studied. After correction for multiple testing the only RGS2 SNP associated with development or worsening of parkinsonian symptoms was rs4606 (p=0.002). rs4606 modifies risk of postdisaster and lifetime post-traumatic stress disorder symptoms under conditions of high stressor exposure</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q180]]
    <blockquote>
        <p class="text-snippet" data-id="180">rs13166360 at 5p15.31 is located in an exon of adenylate cyclase 2 (ADCY2) and encodes a missense mutation (valine&#8594;leucine) in a transmembrane domain of the protein. A GWAS has associated '''rs13166360''' with bipolar disorder in people of European ancestry. == '''Clinical Background''' ==Bipolar Disorder (BD) is a severe mood disorder that is characterized by recurrent episodes of depression and mania. BD has a lifetime prevalence of 1% in the general population (4% in the United States), and therefore can be classified as a common condition. To date, there does not exist any clear associations between race or socioeconomic status, and the onset of BD. Bipolar Disorders are amongst the 10 highest burden diseases, as ranked by the World Health Organization. In particular, those suffering from bipolar disorder are at a higher risk of suicide, anxiety disorders, and substance abuse . For further information about bipolar disorder, wikipedia offers a great article: .== '''SNP Data''' ==A GWAS by Muhleisen and coworkers links '''rs13166360''' to Bipolar Disorder. The authors were motivated by the success of a previous GWAS for bipolar disorder  that had not implicated the ADCY2 gene, and added additional subjects (2,266) and controls (5,028) in order to increase the power of this study. This data primarily comes from the MooDS (Systematic Investigation of the Molecular Causes of Major Mood Disorders and Schizophrenia) consortium. The new data unique to the Muhleisen et al study, which helped to find '''rs13166360''', was primarily genotyped on the Illumina Infinium assay. In all, the combined datasets analyzed ~2.3 million SNPs from 9,747 cases and 14,278 controls that are of European Ancestry, but who currently live in Europe, Australia and the USA. This represents the largest BD GWAS to date. The datasets were merged according to a standardized genomic control &#955;-factor (1.018) in order to control for p-value inflation. The meta-analysis found 56 SNPs that passed genome-wide significance at 5 distinct genetic loci. Of these 5 loci, 3 had been previously described (ANK3, ODZ4, and TRANK1), while two were completely novel (ADCY2 and the region between MIR2113 and POU3F2)'''Rs13166360''' was found as a proxy to another novel SNP (rs17836816) in the ADCY2 gene (r2=0.95), and presented genome-wide significance (p-value 1.81x10-8 with an allelic odds ratio of 1.14). Neither had previously been described in the context of Bipolar Disorder, and ADCY2 SNPs had not previously been associated with BD. '''Rs13166360''' describes a deviation from the major allele G to T (minor allele) that encodes a Valine to Leucine missense codon in ADCY2.== '''Relation to Disease''' ==There is consensus amongst the scientific and medical community that Bipolar Disorder is a multifactorial disease, with both genetic and environmental causes. ADCY2 is an integral membrane protein that, upon activation by heterotrimertic G proteins, catalyzes formation of the secondary messenger cyclic adenosine monophosphate (cAMP) that then activates protein kinase A (PKA) pathways. Many neurotransmitters function through G protein-coupled receptors, that in turn signal through these heterotrimeric G proteins. GPCRs represent a large pool of candidate genes for neuropsychiatric disorders, and accordingly, many antipsychotics target multiple receptors at once. Since ADCY2 is a signal integrator that acts downstream of many of these signaling pathways, any altercation to its function would occur downstream of multiple receptors and neurotransmitter pathways. It is not currently known if the V147L mutation is deleterious to the protein. While multiple adenylate cyclase genes exist, ADCY2 is uniquely expressed in the brain.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1428]]
    <blockquote>
        <p class="text-snippet" data-id="1428">rs4244285 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19 2 variant. This variant is the most common reason for poor metabolism of compounds like mephenytoin (an anti-convulsant), some antidepressants, the anti-platelet drug Plavix, and some drugs used for ulcer conditions of various types. The risk allele is rs4244285(A).As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (trade name Prevacid).In Caucasians, SNPs in CYP2C19 are relatively rare (in contrast to SNPs in CYP2D6), but SNPs in this gene are common in Asians. Ulcer treatment with omeprazole to reduce Helicobacter pylori has been shown to vary depending on a patient's CYP2C19 genotype, varying from 28% in patients homozygous for CYP2C19 alleles encoding fully functional proteins to 100% in patients with variations leading to poor metabolism. The fact that poor metabolizers for many cytochrome p450s achieve higher therapeutic success for some drugs is speculated to be because for some of the drug being broken down (ie metabolized) slower, the effective concentrations are both higher and longer lasting. However, other drugs clearly work less well in carriers of reduced function CYP2C19 alleles. An example of such a drug is clopidogrel, sold under the brand name Plavix. This has now (2010) been acknowledged by the FDA, who have added a boxed warning to Plavix, alerting patients and health care professionals that the drug can be less effective in people who have CYP2C19 variants and cannot convert the drug as effectively to its active form. recent (December 2008) studies reach similar (though not identical) conclusions about the consequences of CYP2C19 2 allele carriers prescribed clopidogrel to reduce their cardiovascular risk:  A study of 245 French patients under 45 years of age prescribed clopidogrel after surviving a first heart attack concluded that rs4244285(A) allele carriers were at 4x higher risk (CI: 1&#183;81&#8212;9&#183;02, p=0&#183;0006) for subsequent adverse cardiovascular events compared to noncarriers.  A study of 2,208 French patients prescribed clopidogrel, of which 225 subsequently died and 94 had a nonfatal heart attack or stroke, came to two conclusions :   Patients carrying any two CYP2C19 loss-of-function alleles ( 2,  3,  4, or  5), had about a 2x increased risk (21.5% vs. 13.3%; adjusted hazard ratio, 1.98; CI: 1.10-3.58) for adverse cardiovascular events than CYP2C19 1 homozygotes.   Among the 1,535 patients who underwent percutaneous coronary intervention (angioplasty) during hospitalization, patients with two CYP2C19 loss-of-function alleles were at even higher risk for adverse events: 3.58x (CI: 1.71-7.51) compared to CYP2C19 1 homozygotes.  A study of 1,477 subjects with acute coronary syndromes who were treated with clopidogrel as part of the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction (TRITON-TIMI) 38 study concluded that rs4244285(A) allele carriers had a 1.53x increased risk for death from cardiovascular causes, myocardial infarction, or stroke, as compared with noncarriers (12.1% vs. 8.0%; CI: 1.07-2.19, p=0.01) and were at 3x higher risk of stent thrombosis (2.6% vs. 0.8%; CI: 1.19-8.00, p=0.02).   CYP2C19 2 loss-of-function genotypes were associated with diminished platelet response to clopidogrel treatment and poorer cardiovascular outcomes in a study of 429 healthy Amish individuals treated for 7 days (in the first study) and 227 patients undergoing percutaneous coronary intervention (angioplasty) (in the second study). Clopidogrel Efficacy</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3168]]
    <blockquote>
        <p class="text-snippet" data-id="3168">Rs4245739 at 1q32 is located in the 3&#8217; untranslated region (UTR) of MDM4, positioned 32 bp downstream from the gene.  The MDM4 oncoprotein negatively regulates the tumor suppressor protein P53, effectively inhibiting apoptosis and promoting cell growth.  Amplification of MDM4 is observed in multiple tumor types, and genome-wide association studies (GWAS) have associated SNP rs4245739 with several forms of cancer.SNPs that are situated in 3&#8217;-UTRs can potentially affect translation efficiency by altering miRNA-mediated gene regulation.  The '''rs4245739''' A > C polymorphism creates a novel binding site for miR-191 , thereby inhibiting expression of the ''MDM4'' oncogene.  Consequently, the major allele A acts as the risk allele, while the minor allele C is protective.===Prostate Cancer===A GWAS by Eeles et al.  linked rs4245739 to prostate cancer, a leading cause of cancer-related death for men in the developed world &#8211; especially in Europe and the United States.  Eeles et al. used the iCOGS chip to genotype 19,662 prostate cancer cases and 19,715 controls, all of European ancestry.  The results were subsequently pooled with data from a meta-analysis of 4 previous GWAS covering 11,085 cases and 11,463 controls in populations with European ancestry.  The combined results identified 77 loci associated with prostate cancer, which together explain ~30% of the disease&#8217;s familial risk.  One of the new SNPs identified was '''rs4245739''', which presented genome-wide significance (p = 2.1e-11).  The major allele A is the risk allele, with a per-allele odds ratio of 1.10 (95% CI: 1.05 &#8211; 1.14).  '''Rs4245739''' is correlated with rs1380576 (''r''<sup>2</sup> = 0.89), which has been linked to prostate cancer aggressiveness , as well as rs7556371 (''r''<sup>2</sup> = 0.89), which was associated with prostate cancer susceptibility in a candidate gene study .===Breast Cancer===Rs4245739 has also been linked to susceptibility for breast cancer, which ranks as the fifth-most common cause of cancer death worldwide.  In another GWAS utilizing the iCOGS array, Garcia-Glosas et al.  investigated loci associated with estrogen receptor (ER)-negative tumors, which account for ~25% of all breast cancer cases.  They genotyped 6,514 ER-negative breast cancer cases and 41,455 controls of European ancestry, the results of which were combined with a meta-analysis of 3 previous GWAS totaling 4,193 ER-negative cases and 35,194 controls, also of European ancestry.  SNP '''rs4245739''' was identified as one of four loci associated with ER-negative but not ER-positive breast cancer.  Based on the pooled results, the association with ER-negative breast cancer showed genome-wide significance (p = 2.1e-12).  The A risk allele presented an odds ratio of 1.14 (95% CI: 1.10&#8211;1.18).A candidate gene study  genotyped a total of 1,100 breast cancer cases and 1,400 controls from two regions of China.  This work focused specifically on breast cancer in relation to SNP '''rs4245739''' and its potential interplay with the P53 Arg72Pro genetic variant.  When compared to CA and CC, the AA genotype was found to be associated with breast cancer (p =  4.6e-6), with an odds ratio of 0.47 (95% CI: 0.36&#8211;0.61) for the C protective allele.  For individuals with the P53 Arg/Arg genotype, the association was even stronger (p = 5.3e-12) with an odds ratio of 0.16 (95% CI: 0.08&#8211;0.27), suggesting a possible additive effect of ''MDM4'' and ''P53'' on breast cancer susceptibility.Additionally, smaller scale studies have reported association of rs4245739 with esophageal squamous cell carcinoma  and ovarian cancer severity and progression .</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4259]]
    <blockquote>
        <p class="text-snippet" data-id="4259">rs6445975 is located on chromosome 3p14.3 and corresponds to intron 4 in the PXK gene (Phox homology domain containing serine/threonine kinase) and is associated with systemic lupus erythematosus (SLE). PXK is expressed in a variety of tissues including brain, heart, skeletal muscle, and peripheral blood lymphocytes. This SNP has also been implicated as being an important modulator of cancer cell growth . For the rs6445975 SNP, the ancestral allele is a T and the disease associated risk allele is a G.rs6445975 was first found to be associated with SLE in 2008 in women of European ancestry. The study included 720 women with SLE and 2,337 controls and showed strong evidence for association (P=7.1x10&#8211;9; OR=1.25) . Additionally, a study in 2010 found that many SLE SNPs including rs6445975 showed that an increase in genetic susceptibility to SLE was associated with early disease onset. . Other studies have shown no association of rs6445975 with SLE. A study of patients mainly of Mexican ancestry included 804 patients with SLE and 667 healthy controls and found no association (Odds ratio=1.077; 95% CI=0.8&#8211;1.45; P=0.622). Another study of 910 SLE patients and 1440 healthy controls from Chinese living in Hong Kong and 278 SLE patients and 383 controls from Thailand, also found no association of rs6445975 to SLE (P=0.36, OR=1.06, 95% CI: 0.93&#8211;1.21). . A study from 2009 investigated if rs6445975 was associated with Rheumatoid Arthritis (RA) because SLE and RA share a complex etiology. They found no association of several SLE SNPs with RA, including rs6445975 (OD=1.11; 95% CI=1.0&#8211;1.2). A study of SLE in the Chinese mainland population used 288 cases and 357 controls and showed that rs6445975 is not associated with SLE (P=0.969; OR=0.99, 95% CI=0.75&#8211;1.32). . Another study examined the association of rs6445975with SLE in 527 Korean patients with SLE and 517 healthy Korean control subjects. They found no association of the rs6445975 risk allele with SLE (OR= 1.06; P=0.57). A study investigated the link between SLE and a decreased breast cancer risk in a cohort of 3,659 breast cancer cases and 4,897controls of primarily European descent. They found a slight positive association with breast cancer for the G risk allele of rs6445975 (OR=1.0911; P=0.0097) but concluded an overall weak association of breast cancer with SLE. A recent study performed a meta-analysis of 13 separate studies and identi&#64257;ed an association between SLE and the G allele of rs6445975 in the overall population (OR=1.151, 95 % CI=1.086&#8211;1.291, P=1.8E-06). There was a signi&#64257;cant association between rs6445975 and SLE in Europeans (OR=1.198, 95 % CI=1.118&#8211;1.285, P=3.4E-07), but not in Asians as expected from other studies.  Currently there is no cure for SLE, but symptoms can be managed by immunosuppressant drug treatments such as cyclophosphamide and corticosteroids. Generally, SLE is more common in women than in men and SLE is associated with disease risk alleles of SNPs in the following genes: ITGAM, KIAA1542, PXK, FCGR2A, PTPN22 and STAT4. Additionally, SNPs in the HLA-DQA1 and IRF5 genes have been shown to have a protective phenotype in women of European ancestry but not Asian ancestry. Most of the GWA studies performed for SLE that have been duplicated, found their results to be reproducible after accounting for differences in populations such as Europeans and Asians. rs6445975 particularly, has been shown to affect Europeans but not Asians or Mexicans. Some other studies such as those performed on Mexican or African American populations have yet to be repeated and so reliable data is not currently available.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2517]]
    <blockquote>
        <p class="text-snippet" data-id="2517">rs1800562 represents a SNP that accounts for ~85% of all cases of hemochromatosis, a disorder whose symptoms include cirrhosis of the liver, diabetes, hypermelanotic pigmentation of the skin, and heart failure.  OMIM indicates that liver cancer is responsible for about one-third of deaths of rs1800562(A;A) homozygotes, and since hemochromatosis is a relatively easily treated disorder if diagnosed, this is a form of preventable cancer.The rs1800562(A) allele is known as the C282Y or Cys282Tyr mutation, and it is found at a frequency of around 5-10% in many Caucasian populations, leading to an incidence of (A;A) homozygotes around 1 in 200. Early identification of rs1800562(A;A) homozygotes can prevent complications of hemochromatosis; however, the percentage of all (A;A) homozygotes who actually develop clinical signs of hemochromatosis may be relatively low, may depend on sex (see below), and appears to be influenced by other SNPs yet to all be discovered as well as (unidentified) environmental factors, possibly including the amount of iron in the diet.In rs1800562(A;A) patients who do develop hemochromatosis, a SNP has been identified which increases the risk of cardiomyopathy (a form of heart disease). rs4880(T;T) homozygotes are at ~10 fold increased risk for dilated- or non-dilated cardiopathy based on a study of 217 patients.rs235756, a SNP in the BMP2 gene, is another SNP that may influence the development of hemochromatosis in rs1800562(A;A) individuals, at least if serum transferrin levels are a good indication. Transferrin levels increased with increasing copies of the rs235756(T) allele.  So what percent of rs1800562(A;A) individuals actually develop clinical signs of hemochromatosis? At least in the UK (Caucasian) population, a 2019 survey reported that of 2890 participants homozygous for p.C282Y (0.6%, or 1 in 156), hemochromatosis was diagnosed in 21.7% of men and 9.8% of women over an average follow up (~7 years). p.C282Y homozygous men aged 40 to 70 had a higher prevalence of diagnosed hemochromatosis (OR 411.1, CI: 299-565, p<0.001), liver disease (4.30, 2.97-6.18, p<0.001), rheumatoid arthritis (2.23, 1.51-3.31, p<0.001), osteoarthritis (2.01, 1.71-2.36, p<0.001), and diabetes mellitus (1.53, 1.16-1.98, p=0.002), versus 175,000+ controls (people with no p.C282Y mutations). During the seven year follow-up, 15.7% of homozygous men developed at least one incident associated condition versus 5.0% (p<0.001) with no p.C282Y mutations; for women, it was 10.1% vs 3.4%, p<0.001).Women who are rs1800562(A) homozygotes are less affected by hemochromatosis due to elimination of excess iron during menstruation, but may become affected after menopause.Carriers of one rs1800562(A) may be affected by a mild form of hemochromatosis if also a carrier of rs1799945(G) H63D.According to  Coriell, in Caucasian populations: (A;A) - 0.4% of individuals, carrying 2 copies of the risk variant (33-57% of such males will have quite elevated iron levels; 3-16% if female) (G;A) - 12% carry 1 copy of the risk variant and 1 copy of the non-risk variant (G;G) - 87.6% carry (only) the non-risk variant Was the C282Y mutation an Irish Gaelic mutation that the Vikings helped disseminate? Conclusion: The C282Y frequency shows a west to east decline from Ireland through the north of Europe. Vikings may have been involved in the spread of C282Y, but the mutation is probably older and may have been spread in Europe by earlier seafarers.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4223]]
    <blockquote>
        <p class="text-snippet" data-id="4223">rs20417, also known as -765G>C (and -899G >C in some older publications), is a SNP in the Prostaglandin endoperoxidase synthase 2 PTGS2 gene on chromosome 1. A 2012 review of three of the most studied PTGS2 gene variants concluded the following about rs20417:  The C variant is associated with lower promoter activity compared with the G variant;  The C variant is found in a haplotype with -1195G>A (rs689466) in Pima Indians, Chinese Asians, and Australian Caucasians, and with -1290A>G (rs689465) in a Caucasian Australian population;  The epidemiological relevance of rs20417 is unclear and/or conflicting despite numerous studies (and this includes studies of myocardial infarction, diabetes, asthma, various cancers, and the use of NSAIDs to reduce coronary heart disease risk). In a group of Pima Indians, individuals with the variant PTGS2 rs20417 CC genotype had a 30% higher Type 2 diabetes prevalence compared with subjects with the GG genotype rs20417 was not found to be associated with prostate cancer in a large case-control study (n(cases)=1608, n(controls)=3058), nor in a meta-analysis of 3 other studies. Data-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes. Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma. Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approach. Cyclooxygenase-2 polymorphisms in Parkinson's disease. Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk. A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study. Association of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms and Alzheimer's disease in Chinese. Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance. Association of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid calcium in the Diabetes Heart Study. Segment-specific genetic effects on carotid intima-media thickness: the Northern Manhattan study. COX-2 promoter polymorphisms and the association with prostate cancer risk in South African men. Cyclooxygenase-2 gene polymorphisms reduce the risk of oral premalignant lesions. Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk. The influence of COX-2 single nucleotide polymorphisms on abdominal aortic aneurysm development and the associated inflammation. Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Association of -765G>C polymorphism of the COX-2 gene with recurrent embryo implantation failure in Southern Chilean women. Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma. A polymorphism in the cyclooxygenase 2 gene in type 1 diabetic patients with nephropathy. Cyclooxygenase-2 polymorphisms and susceptibility to esophageal cancer: a meta-analysis. Interaction of cyclooxygenase-2 promoter polymorphisms with Helicobacter pylori infection and risk of gastric cancer. Functional genetic variations of cyclooxygenase-2 and susceptibility to acute myeloid leukemia in a Chinese population. Polymorphisms in COX-2 gene influence prostate cancer susceptibility in a northern Indian cohort. Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features. Cyclooxygenase-2 -765G>C polymorphism is associated with C-reactive protein levels in resistant smokers but not in chronic obstructive pulmonary disease patients. Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1891]]
    <blockquote>
        <p class="text-snippet" data-id="1891">rs396991 is a SNP in the Fc fragment of IgG, low affinity IIIa, receptor (CD16a) FCGR3A gene. rs396991(T) encodes the phenylalanine (F) allele, with the (G) allele encoding the variant valine (V). The (V) isoform is considered high-binding to IgG1 and IgG3, while the (F) isoform is considered low-binding. This SNP is known in the literature by many names, including A559C, T559G, 158F/V, and 176F/V.What's the importance of this? FcgRIIIa stimulatory receptors are expressed by most cells in the immune system, including monocytes, dendritic cells, macrophages, natural killer cells, platelets and endothelial cells, as well as a subpopulation of T-cells. FcgR isoforms have been linked to the pathogenic consequences triggered by autoantibodies or immune complexes in autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), as well as to the efficacy of some immunotherapeutic treatments such as rituximab.Many studies have been published about this FCGR3A SNP, roughly divided by either disorder or treatment as follows:  HIV to AIDs, including susceptibility and progression:   In a study of 2 cohorts of men infected with HIV, the rs396991(T;T) (ie F/F) genotype was underrepresented in patients with Kaposi's sarcoma, whereas the heterozygous genotype was associated with its development. A similar association was observed between rs396991 genotypes and human herpesvirus-8 (HHV-8) seropositivity.  Crohn's disease   A study of 300+ patients with Crohn's disease determined that the rs396991(T) allele had an odds ratio of 1.58 (CI: 1.06-2.35) and the (G;T) genotype an odds ratio of 1.64 (CI: 1.08-2.5) for the disease.  Rheumatoid arthritis   Meta-analysis of 10 different studies concluded that amongst European subjects (and not Asians), the VV (rs396991(G;G)) genotype was associated with increased risk for rheumatoid arthritis, with an odds ratio of 1.374 (CI: 1.101-1.714, p = 0.005) as compared to the FF genotype.   Although rs396991 is unlikely to play a major role by itself in susceptibility to rheumatoid arthritis, the presence of the rs396991(G) high-binding allele may predispose shared epitope positive individuals to the disease.Classifying the reports by immunotherapeutic treatment studied yields the following:  Studies involving rituximab:   In a study of ~200 Korean patients, the FCGR3A valine (V) allele was significantly correlated with a higher complete response rate to rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (R-CHOP) therapy compared with the phenylalanine (F) allele (88% in V/V vs 79% in V/F vs 50% in F/F; p = .002), although it did not correlate with survival in patients with diffuse large B-cell lymphoma (DLBCL).   In a study of 58 Croatian patients with diffuse large B-cell lymphoma, rs396991 did not influence response, event-free or overall survival.   A study of 49 patients receiving rituximab for previously untreated follicular non-Hodgkin's lymphoma concluded that rs396991(G;G) patients have a 75% to 90% chance of experiencing a clinical response to rituximab monotherapy, whereas patients with at least one rs396991(T) allele have a 25% to 51% chance of responding.   Another study of 89 patients with follicular lymphoma found that rs396991 genotype was associated with the response rate and freedom from progression after treatment with rituximab.   Studies involving cetuximab:   In a study of 39 patients with metastatic colorectal cancer treated with cetuximab, the rs396991(G) (ie F) allele was associated with longer progression-free survival (PFS; p = 0.055), by perhaps 1-2 months.  Studies involving trastuzumab:   A retrospective analysis of 1,251 patients included in a phase III trial of women with ERBB2/HER2-positive breast cancer concluded that rs396991(G) carriers (i.e. FCGR3A-158 V carriers) benefit the most, as measured by disease-free survival, from trastuzumab use compared to rs396991(T:T) (i.e. FCGR3A-158 F/F) genotypes.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5319]]
    <blockquote>
        <p class="text-snippet" data-id="5319">Vascular endothelial growth factor gene polymorphisms in Behcet's disease. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis. Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schonlein purpura. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Functional variation in VEGF is not associated with type 2 diabetes in a United Kingdom Caucasian population. VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. VEGF C-634G polymorphism is associated with protection from isolated ventricular septal defect: case-control and TDT studies. Genetic markers and biomarkers for age-related macular degeneration. Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. Polymorphisms in the vascular endothelial growth factor gene and the risk of familial endometriosis. Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Molecular pathology of age-related macular degeneration. Vascular endothelial growth factor gene polymorphisms may predict the risk of acute graft-versus-host disease following allogeneic transplantation: preventive effect of vascular endothelial growth factor gene on acute graft-versus-host disease. Variation in the vascular endothelial growth factor gene, carotid intima-media thickness and the risk of acute myocardial infarction. Polymorphisms in genes involved in DNA repair, cell growth, oxidative stress and inflammatory response, and melanoma risk. Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis. A systematic meta-analysis of genetic association studies for diabetic retinopathy. An analysis of growth, differentiation and apoptosis genes with risk of renal cancer. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Association of vascular endothelial growth factor polymorphisms with asthma in Tunisian children. The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer. VEGFA polymorphisms and cardiovascular anomalies in 22q11 microdeletion syndrome: a case-control and family-based study. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy. Functional vascular endothelial growth factor gene polymorphisms and diabetes: effect on coronary collaterals in patients with significant coronary artery disease. Human genetics of diabetic retinopathy: current perspectives. Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival. Vascular endothelial growth factor gene polymorphisms and rheumatoid arthritis. Genetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphisms. Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritis. Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients. Contribution of VEGF polymorphisms to variation in VEGF serum levels in a healthy population. Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma. Pooled-analysis of the associations between three polymorphisms in the VEGF gene and age-related macular degeneration. Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy. Vascular endothelial growth factor gene polymorphisms and choroidal neovascularization in highly myopic eyes. Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: differential effect of cigarette smoking.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3652]]
    <blockquote>
        <p class="text-snippet" data-id="3652">The rs1799971(G) allele in exon 1 of the mu opioid receptor OPRM1 gene causes the normal amino acid at residue 40, asparagine (Asn), to be replaced by aspartic acid (Asp). In the literature this SNP is also known as A118G, N40D, or Asn40Asp.Carriers of at least one rs1799971(G) allele appear to have stronger cravings for alcohol than carriers of two rs1799971(A) alleles, and are thus hypothesized to be more at higher risk for alcoholism. However, subsequent research results are mixed, and there are other studies both agreeing or disagreeing with this finding PMID 15525999, PMID 9399694, PMID 12960749Among 200+ alcoholics treated with naltrexone, rs1799971(G) carriers receiving the drug (even without behavioral intervention) had an increased percentage of days abstinent (p = .07) and a decreased percentage of heavy drinking days (p = .04) if treated with naltrexone vs. placebo, whereas rs1799971(A;A) homozygotes showed no medication differences. Upon treatment with naltrexone, 87% of rs1799971(G) carriers had a good clinical outcome, compared with only 55% of individuals with the (A;A) genotype (odds ratio, 5.75, CI: 1.88-17.54)This SNP may also influence the response to opioids such as heroin, codeine or morphine. A 2015 meta-analysis (totaling 5,902 patients) concluded that the carriers of a rs1799971(G) allele consumed more opioids for analgesia (SMD = -0.17, CI:-0.25, -0.10, p < 0.00001), but still reported higher pain scores (p = 0.002) and less nausea and vomiting (odds ratio 1.30, CI:1.08-1.55, p= 0.005) than homozygous (A;A) patients during the first 24 hour, but not 48 hour, postoperative period.A study of 200 Chinese heroin addicts found increased frequency for the rs1799971(G) allele compared to non-addicts (40% vs 29%) ; but another study of Han Chinese addicts found no difference ./ 23andMe blog Alcoholism related rs1799971(A;A) severe alcoholism 2x  rs1799732(I;I) severe alcoholism 1.85x A clinical genetic method to identify mechanisms by which pain causes depression and anxiety. The mu-opioid receptor gene and smoking initiation and nicotine dependence. Association of candidate genes with antisocial drug dependence in adolescents. Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians. Association between mu-opioid receptor-1 102T>C polymorphism and intermediate type 2 diabetes phenotypes: results from the Quebec Family Study (QFS). Genetic susceptibility to heroin addiction: a candidate gene association study. Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers. Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Bidirectional translational research: Progress in understanding addictive diseases. OPRM1 gene is associated with BMI in Uyghur population. OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network. Candidate genes for cannabis use disorders: findings, challenges and directions. Do genetic predictors of pain sensitivity associate with persistent widespread pain? PCA-based bootstrap confidence interval tests for gene-disease association involving multiple SNPs. Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder. OPRM1 gene variants modulate amphetamine-induced euphoria in humans. Effect sizes in experimental pain produced by gender, genetic variants and sensitization procedures. Variation in OPRM1 and risk of suicidal behavior in drug-dependent individuals. Possible Association Between OPRM1 Genetic Variance at the 118 Locus and Alcohol Dependence in a Large Treatment Sample: Relationship to Alcohol Dependence Symptoms. Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment. Pharmacogenetically driven treatments for alcoholism: are we there yet?Naltrexone Treatment Response</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4995]]
    <blockquote>
        <p class="text-snippet" data-id="4995">This 2003 article titled "Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease" performed case control association studies for 14 TG SNPs in 285 Caucasian AITD (autoimmune thyroid disease) patients and 150 Caucasian controls. They found that within the TG gene, "exon 10-12 SNP cluster and an exon 33 SNP were significantly associated with AITD."  Four polymorphisms, considered separately, had ODs over 1.3, but p values were not strong, between 0.003 and 0.12. (Supplementary tables 10,11,12) However, they discovered more significant ODs and p values when combining one or more exon 10-12 SNP alleles with the CC homozygous exon 33 polymorphism:     with or without E10SNP24 T/G = rs180223 = T allele,    with or without E10SNP158 T/C = rs2069550 = T allele,    with or without E12SNP A/G = rs853326 = A allele,     always with E33SNP = rs2076740 = CC polymorphism ODs for risk of AITD were given with the above risk alleles in combination (Table 2):   T,T,A,CC = 2.49 (p=0.0004);   T,--,--,CC = 2.42 (p=0.0005);   --,T,--,CC = 2.52 (p=0.0003);   --,--,A,CC = 2.43 (p=0.0004) The ODs for risk of HT (Hashimoto's thyroiditis) and GD (Graves' disease) were similar, all above 2.38 with p values equally or more significant. (Tables 3,4) Adding significance for the exon 33 SNP in particular, they discovered "an interaction between HLA-DR3 and the exon 33 SNP" resulting in an odds ratio of 6.1 for GD. NOTE: The large odds ratio may be due to the small sample size of this study. In addition, this study focused on a Caucasian sample. Nevertheless, other studies focused on regional samples have shown similar trends. A 2015 research study titled "Correlation between thyroglobulin gene polymorphisms and autoimmune thyroid disease" focused on the Han Chinese population. A total of 270 patients with AITD and 135 healthy controls were enrolled. They found "The Tg SNP frequency distribution was significantly different between Han populations of the Northern regions of Henan province and the Xi'an regions of Shaanxi province" (Abstract).  Separate ODs were found for the following TG gene SNPs:   E10SNP24 T/G rs180223 = TT 1.35, TG 11.50, GG 0.14, (TG OD was 95%CI = 4.89-27.06, p=<0.01)  E10SNP158 T/C rs2069550 = TT 1.07, TC 0.96, CC 1.03  E12SNP A/G rs853326 = AA 0.51, AG 0.23, GG 4.22 (GG OD was 95%CI = 2.65-6.73, p=<0.01)  E33SNP C/T rs2076740 = CC 1.11, CT 0.93, TT 0.98. More significant combined ODs were received when these SNPs were were combined:  GTAC = 0.22 Hypothyroidism (HY), 0.22 Graves(GD), 0.24 Hashimoto's (HT)   GCGC = 0.57 HT  GTGC = 3.57 GD, 3.50 HT  TTGC = 4.00 HY  TCGC = 5.23 HY, 3.00 GD, 4.45 HT A 2016 study titled "Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism" sampled 84 hypothyroidism patients and 62 controls from Gujarat, India. Researchers found that polymorphisms of the TG gene's exon 33 SNP rs2076740 significantly increased the odds of autoimmune hypothyroidism: Odds ratios were   for TT, 1.0 (Genotypes were similar between patients and controls)  for TC, 7.519 (95%CI 2.329 to 24.27, p=0.0003) compared to AA (7.729 after adjustment for age and gender).  for CC, 20.54 (95%CI 5.065 to 83.30, p=0.0001) compared to AA (15.151 after adjustment for age and gender).Researchers theorized that the TG polymorphism may "change its antigenicity making it more immunogenic" (Conclusion). They also found significant differences in patients vs. controls when analyzing the CTLA4 SNP Exon1 (+49A/G) rs231775. NOTE: The large odds ratio may be attributed to the small number of patients and controls and/or the regional sample.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2212]]
    <blockquote>
        <p class="text-snippet" data-id="2212">'''rs4143094''' is a SNP identified by a genome-wide diet-gene interaction analysis (GxE), and was found to be associated with increased risk of colon cancer correlated to the dietary variable of processed meat consumption. It is located on chromosome 10p14, 7.2kb upstream of GATA binding protein 3 (''GATA3''), in the promoter region of the gene  rs4143094 was identified in a screen of 2.7 million SNPs for the risk of colorectal cancer, by combining 10 studies comparing 9287 cases and 9117 controls. Data was obtained from the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) and analyzed by conventional case-control logistic regression for multiplicative interactions between SNPs and dietary factors. rs4143094 was the most significantly implicated SNP in 10p14 for processed meat consumption linked with occurrence of colorectal cancer. The risk allele (T) has an ORinteraction=1.17, p=8.73E-09 with evidenced heterogenetity by p=0.78. When stratifying by genotype, rs4143094-TG has OR=1.2, 95% CI=1.13-1.26; rs4143094-TT has an OR=1.39, 95% CI=1.22-1.59; and the minor/null genotype rs4143094-GG has an OR=1.03, 95% CI=0.98-1.07.  Several other SNPs in the 10p14 region were correlated to the same phenotype, (rs485411, risk allele C, ORinteraction=1.18; Pinteraction=1.72E-08; rs1269486, risk allele A, ORinteraction=1.18, Pinteraction=7.53E-08) though rs4143094 was highlighted due to having the most significant P-value.Colorectal cancer is the third most leading cause of cancer death in men and women , and consumption of processed meat has been linked to increased risk of its development , . rs4143094 is upstream of ''GATA3'', a gene associated with Th2 cell differentiation , which is upregulated in ulcerative colitis , a risk factor for colorectal cancer . Though the mechanism by which ''GATA3'' suppression may lead to increased risk of colorectal cancer is unknown, its suppression has been previously linked to breast, colorectal, and lung cancers . DOJ  Association between risk of colorectal cancer associated with processed meat.rs4143094 on chromosome 10p14 is about 7.2kb upstream of GATA3 gene. GATA3 belongs to the GATA family of transcription factors. Its functional role includes regulation of luminal epithelial cell differentiation, development of T cell, and differentiation of T helper (Th) cell. Genes in the GATA family are involved in several types of cancers including breast cancer, prostate cancer, and of particular interest to this entry, colorectal cancer    . According to dbSNP, rs4143094 has two alleles, G (major allele) and T (minor allele). The minor allele has a frequency of 0.2337 across all populations. A recent genome-wide association study (GWAS), using data from Colon Cancer Family Registry (CCFR) and the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), discovered a strong correlation between rs4143094 and risk of colorectal cancer when ingesting red and processed meat . In the study, approximately 2.7M SNPs were tested across 9,287 case and 9,117 control subjects, all with European ancestry. The result shows that rs4143094 is associated with risk of colorectal cancer (P = 8.73e-9), with T being the risk allele. Specifically, individuals with TG and TT genotypes are increased for occurrence of colorectal cancer with odds ratio (OR) of 1.2 and 1.39, respectively. rs4143094 resides in a 9.5 kb linkage-disequilibrium (LD) block (r2 > 0.8) containing 19 highly correlated SNPs. The third most significant among these SNPs, rs1269486, is located 1420 bases upstream of GATA3 and is in a region of open chromatin (DNA hypersensitivity). Experimental evidence suggests binding activity of Pol2 and transcription factors c-Fos, JunD, and c-Jun in this region . Many other SNPs in the LD block reside in GATA3-antisense RNA1 (GATA3-AS1).  GATA3-AS1 may regulate GATA3 transcript activity, although further experimental evidence is required. Apart from the SNP, this study also observed that red and processed meat consumption increases risk for colorectal cancer with OR of 1.15 and 1.11, respectively. For this secondary result, the author proposed the following pathway: processed meat triggers pro-tumorigenic inflammatory or immunological response, whose recovery depends upon the expression of GATA3 gene. Further experimental evidence is required to confirm this hypothesis.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q349]]
    <blockquote>
        <p class="text-snippet" data-id="349">rs1800497, a SNP also known as the TaqIA (or Taq1A) polymorphism of the dopamine D2 receptor DRD2 gene (even though it is actually located over 10,000bp downstream of the gene), gives rise to the DRD2 A1 allele, whereas rs1800497(C) gives rise to the DRD2 A2 allele. The minor allele (i.e. A1, rs1800497(T)) is associated with a reduced number of dopamine binding sites in the brain , and it has been postulated to play a role in alcoholism, smoking, and certain neuropsychiatric disorders.The reduced number of dopamine binding sites may play a role in nicotine addiction by causing an "understimulated" state that can be relieved by smoking (and/or use of other drugs). It may also be associated with reduced response to errors and increased addictive behavior.A wide variety of reports have been published over more than ten years either linking rs1800497 to aspects of nicotine use and smoking cessation success, or finding no such association. A meta-analysis of 41 such studies published in 2004 concluded that overall the association of rs1800497 with such phenomena was statistically weak.  This same group published (in 2009) a study showing no association between rs1800497 and improved response to nicotine replacement therapy (NRT), contrary to their previous study.More recently, a relatively large study of over 700 patients attempting to kick their smoking habit using the drug bupropion determined that smokers homozygous for the A2/A2 genotype were more successful than A1/A2 or A1/A1 individuals. The A2/A2 smokers were more than three times as likely, relative to placebo, to be abstinent at end of treatment (35.2% vs. 15.1%; odds ratio = 3.25, CI: 2.00-5.28) and at 6 months of follow-up (26.7% vs. 12.2%; odds ratio = 2.81, CI: 1.66-4.77), whereas not so much by 12 months (16.3% vs. 10.7%; OR = 1.70, CI: 0.95-3.05). Basically, A1/A2 and A1/A1 genotype smokers didn't gain anything from using bupropion versus placebo; bupropion only helped A2/A2 genotypes stop smoking. In a study of individuals in the Polyp Prevention Trial with any, multiple (>/=2) or advanced colorectal adenoma recurrence after 4 years, compared to those without adenoma recurrence, rs1800497(T;T) individuals were significantly associated with all advanced adenoma recurrence (odds ratio 2.40, CI: 1.11-5.20).  The authors speculate this increased risk of adenoma recurrence (and an association with colorectal cancer) may be related to SNP-associated differences in alcohol and fat intake.A 2014 preliminary study links an individual's ANKK1 rs1800497 genotype as likely to experience greater positive subjective effects following cocaine exposure, including greater 'high' and 'like', and these individuals may have increased vulnerability to continue using cocaine or they may be at greater risk to relapse during periods of abstinence. The study states that replication of these findings is necessary to confirm these findings.SNPs rs6276, rs6277, and rs1800497) in the human DRD2 gene are associated with decreased D2R expression and function, as well as high blood pressure.  Data supports the hypothesis that D2R function has protective effects in human renal proximal tubule cells hRPTCs and suggest that carriers of these SNPs may be prone to chronic renal disease and high blood pressure.  SNPs, rs1800497 and rs2283265, located near and within the dopamine receptor 2 DRD2 gene, respectively, were significantly associated with improvements during working memory training (p < .003 and p < .0004, respectively).  A small (54 patient) study of patients with traumatic brain injury concluded that carriers of rs1800497(A) alleles recover slower as assessed by memory and attention tests./ 23andMe blog diminished pleasure response from food GENETICALLY DETERMINED DIFFERENCES IN LEARNING FROM ERRORSObsessive Compulsive DisorderAvoidance of ErrorsPostoperative Nausea and Vomiting  A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study.  Living in the moment: Effects of time perspective and emotional valence of episodic thinking on delay discounting.  Single-nucleotide polymorphisms of the dopamine d2 receptor increase inflammation and fibrosis in human renal proximal tubule cells.  Polymorphisms in the dopamine receptor 2 gene region influence improvements during working memory training in children and adolescents.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4962]]
    <blockquote>
        <p class="text-snippet" data-id="4962">implicated in type-2 diabetes according to this  Gene Sherpas postExtensive  blog post theorizing this snp may activate a cryptic exon. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population. TCF7L2 gene polymorphisms confer an increased risk for early impairment of glucose metabolism and increased height in obese children. Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population. Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African-American population enriched for nephropathy. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Heterogeneity in meta-analyses of genome-wide association investigations. A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients. Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans. Variation in TCF7L2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) Study. Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population. TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) study. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Worldwide population differentiation at disease-associated SNPs. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. TCF7L2 variants associate with CKD progression and renal function in population-based cohorts. Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population. Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population. Association studies of 22 candidate SNPs with late-onset Alzheimer's disease. Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes. Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study. An open access database of genome-wide association results. Meta-analysis in genome-wide association studies. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. Genome-wide association studies in type 2 diabetes. Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease. Is the thrifty genotype hypothesis supported by evidence based on confirmed type 2 diabetes- and obesity-susceptibility variants? Underlying genetic models of inheritance in established type 2 diabetes associations. Genome-wide association studies for atherosclerotic vascular disease and its risk factors. ATRIUM: testing untyped SNPs in case-control association studies with related individuals. TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality. Simultaneous genotype calling and haplotype phasing improves genotype accuracy and reduces false-positive associations for genome-wide association studies. Influence of control selection in genome-wide association studies: the example of diabetes in the Framingham Heart Study. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. A genomics study of type 2 diabetes mellitus in U.S. Air Force personnel. Variants and haplotypes of TCF7L2 are associated with beta-cell function in patients with newly diagnosed type 2 diabetes: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 1. Genetic risk profiling for prediction of type 2 diabetes. Gestational diabetes mellitus is associated with TCF7L2 gene polymorphisms independent of HLA-DQB1 0602 genotypes and islet cell autoantibodies. Worldwide distribution of type II diabetes-associated TCF7L2 SNPs: evidence for stratification in Europe. Association between type 2 diabetes genetic susceptibility loci and visceral and subcutaneous fat area as determined by computed tomography.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5324]]
    <blockquote>
        <p class="text-snippet" data-id="5324">rs3025039, also known as the +936C/T SNP in the VEGFA gene, has been associated with age-related macular degeneration (ARMD).A study of 190 Taiwanese patients with late wet age related macular degeneration found that the rs3025039(T) allele was associated with increased risk, with an odds ratio of 2.61 (CI: 1.68 to 4.07, p = 1.45 x 10e-5).Note that this association may be completely due to the tight linkage (D' = 0.99) between this SNP and rs1061170, which has been reported by numerous studies to be associated with ARMD.C->T was associated with increased risk for altitude sickness.  Vascular endothelial growth factor gene polymorphisms in Behcet's disease. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Vascular endothelial growth factor gene haplotypes in Kawasaki disease. VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. Polymorphisms in the vascular endothelial growth factor gene and the risk of familial endometriosis. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Vascular endothelial growth factor gene polymorphisms may predict the risk of acute graft-versus-host disease following allogeneic transplantation: preventive effect of vascular endothelial growth factor gene on acute graft-versus-host disease. Variation in the vascular endothelial growth factor gene, carotid intima-media thickness and the risk of acute myocardial infarction. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis. Polymorphisms in genes involved in DNA repair, cell growth, oxidative stress and inflammatory response, and melanoma risk. Effect of polymorphisms in the 3' untranslated region (3'-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan. Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis. An analysis of growth, differentiation and apoptosis genes with risk of renal cancer. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Association of vascular endothelial growth factor polymorphisms with asthma in Tunisian children. The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer. Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients. Gene polymorphism of vascular endothelial growth factor -1154 G>A is associated with hypertensive nephropathy in a Hispanic population. Vascular endothelial growth factor gene polymorphisms and rheumatoid arthritis. Genetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphisms. Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritis. Contribution of VEGF polymorphisms to variation in VEGF serum levels in a healthy population. Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma. Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy. Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: differential effect of cigarette smoking. Role of Vascular Endothelial Growth Factor Polymorphisms in the Treatment Success in Patients with Wet Age-related Macular Degeneration.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q4816]]
    <blockquote>
        <p class="text-snippet" data-id="4816">rs10937823 is a SNP associated with the gene SORCS2, variants of which may play a role in bipolar disorder. The allele most frequently occurring is C, and the variant is T. In the HapMap-CEU population, CC, CT, and TT genotype frequencies were 0.894, 0.097, and 0.009, respectively. However, in the HapMap-CHB population, CT was the most frequently expressed genotype; CC, CT, and TT genotype frequencies were 0.366, 0.439, and 0.195, respectively. In some sample populations, the TT genotype did not exist (TSI, MKK, LWK, ASW).   dbSNPThe SORCS2 (sortillin-related VPS10 domain containing receptor 2) gene on chromosome 4p16.1 is found to be highly expressed in the mature human brain and kidney. High levels of expression are also seen in the brain during mouse development.   GeneCards This gene family is responsible for trafficking lysosomal enzymes that are modified within the Golgi to their packaging vacuole.   Sortillins have been found to facilitate neurotrophin binding to its receptor, which is necessary for mediating neuronal apoptosis, growth and survival. Given these roles, it has been proposed that alterations to the SORCS2 gene can lead to neuronal dysfunction. In 2008, a genome-wide association study indicated the SORCS2 gene in bipolar disorder. The study conducted by Baum et al. analyzed 461 affected individuals and 563 matched controls (from the National Institutes of Mental Health Genetics Initiative, all of European ancestry), and a replication sample of 772 affected individuals and 876 matched controls (affected individuals recruited from German hospital admissions, and controls recruited from a German census). The C allele of rs10937823 was found at a frequency of 0.949 in cases and 0.912 in controls in NIMH cohort (p=0.001); 0.954 in cases and 0.931 in controls in the German cohort (p=0.004). The resulting combined odds ratio was 1.67 between the German and NIMH cohorts.  Table 3 Furthermore, with multi-locus analysis, the authors found that the highest risk of bipolar disorder was associated with presence of both rs10937823 and rs1170191, a SNP in diacylglycerol kinase eta (DGKH  Rs1170191), suggesting that these SNPs have a combinatorial effect in conferring risk (p=1.2x10-8). A Finnish bipolar family study in 2009 replicated the association between rs10937823 and bipolar disorder. The researchers genotyped the 26 SNPs most strongly associated SNPs as found by the Wellcome Trust Case Control Consortium, and the aforementioned study by Baum et al. in 723 individuals from 180 families. The study classified individuals as falling into diagnostic classes of bipolar type I disorder (cases = 214; controls = 509) or a broad mood spectrum disorder encompassing all types of bipolar disorder (cases = 298; controls = 495). In an opposite finding to that of Baum et al., the minor allele (T) frequency in the unaffected individuals was 0.999; in cases, the frequency was 0.112. The lower frequency of the T allele of rs10937823 in cases versus controls was statistically significant (p=0.004187 using broad mood spectrum disorder; p=0.004703 using broad mood spectrum disorder). In 2011, In a Japanese cohort of 736 individuals, rs10937823 was again found to be significantly associated with bipolar disorder by Takata et al. (363 cases, 370 controls; p=0.0175). However, the results showed that the risk allele (more commonly associated allele in cases) was T, not C. The minor allele frequency in the bipolar disorder sample was 0.275, versus 0.253 in the control sample. An odds ratio for this SNP was not reported. In 2011, Cristoforou et al. identified an association between rs10937823 and bipolar disorder in a Scottish population (506 cases, 607 controls; p=0.031; OR not reported). Like the Japanese study by Takata et al., the minor allele (T) was found to be associated with bipolar disease.   Similar observations of this &#8220;flip-flop&#8221; phenomenon where opposite alleles appear to confer risk have been reported in other genes, such as COMT gene and schizophrenia, and GSTO1 gene and age of onset in Alzheimer&#8217;s Disease. The authors suggest that such different results could be due to allelic heterogeneity, the effects of multiple loci, or varying linkage disequilibrium amongst the subjects, if the findings across the studies and populations are indeed correct.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2794]]
    <blockquote>
        <p class="text-snippet" data-id="2794">A 2012 educational article explained that in autoimmune inflammatory conditions, IL-6 promotes antibody production, drives CRP levels, and has other pathological roles. A 2013 article titled "Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci" stated that the OR for the risk allele was 1.14 (1.18 in Caucasians, but only 0.99 in Asians), but the TT polymorphism was more significant. TT homozygous at rs4129267 had sIL-6R (soluble inhibiting IL-6 receptors) concentrations 73% higher than CC homozygous (28.9 versus 16.7 ng/ml; P = 7.8  1017) and CRP (C-reactive protein) concentrations were 30% higher in TT than in CC (19.2 versus 14.8 mg/l).   A 2008 article. Soluble IL6R (sIL-6R) protein levels A 2008 study titled "Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study" explained that "elevated levels of C-reactive protein (CRP) independently predict increased risk of development of metabolic syndrome, diabetes, myocardial infarction, and stroke" (Abstract). The IL6R SNP rs4129267 had an influence on median hsCRP levels (mg/l). They were 1.65 for Minor allele homozygous, 1.95 for heterozygous, and 1.98 for major allele homozygous. A 2008 article titled "Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein" reported "results of two genetic-association studies of CRP, the Pharmacogenomics and Risk of Cardiovascular Disease (PARC) study and the Cardiovascular Health Study (CHS)." They were unable to find association between this SNP and CRP levels, but said this lack of finding may be due to their smaller sample size. "Interleukin-6 receptor gene, plasma C-reactive protein, and diabetes risk in women." This 2009 article explained that "SNP rs4129267 reported by the GWAS (9) was not typed in the present study. However, this SNP is in near perfect linkage disequilibrium with rs8192284 (D = 1 and r2 = 0.96; HapMap, CEU)." The latter SNP genotype rs8192284 AA (major allele) carried a higher risk of type 2 diabetes (OD =1 in the lowest quartile of the sample, OR=5 in the highest quartile). ORs for AC+CC (C is the minor allele) ranged from 1 to 3.. Published 2011. In the analysis of 15,797 asthmatic patients and 42,003 controls, researchers found rs4129267 SNP's minor allele a risk for Asthma (OR 109, combined p=2410(-8)). Published 2012. Stated "The SNP rs4129267 is in linkage disequilibrium (r(2) = 1) with the IL6R coding SNP rs2228145 (Asp(358)Ala). This IL6R coding change increases IL-6 receptor (IL-6R) shedding and promotes IL-6 transsignaling." (Abstract) Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae. Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. "Multiple Novel loci, including those related to Crohn disease, psoriasis, and inflammation, identified in a genome-wide association study of fibrinogen in 17 686 women: the Women's Genome Health Study." This 2009 study noted a strong association with this SNP but provided no risk alleles or odds ratios. A 2011 study of 302 Breast cancer survivors, and follow-up data from 236 of them, "Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway" examined "The associations between fatigue and SNPs in inflammation-related genes; IL1 (rs16944), IL6 (rs1800795), IL6receptor (rs4129267, rs4845617, rs2228145), CRP (rs2794521, rs3091244)" (Abstract). They found borderline significance associated with rs3091244, but no others. They suggested that they could not replicate the finding of CRP levels in association with (rs2228145 and rs4129267) due to their small sample size. Genome-wide association with C-reactive protein levels in CLHNS: evidence for the CRP and HNF1A loci and their interaction with exposure to a pathogenic environment. A 2007 article "Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project" listed this SNP among supplementary data on a separate website, but did not provide any discussion of the SNP in text.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2516]]
    <blockquote>
        <p class="text-snippet" data-id="2516">rs1799945, also known as H63D or His63Asp, represents a SNP that accounts for a mild form of hereditary hemochromatosis (HH), an iron overload condition in which mutations of certain genes involved in iron metabolism disrupt the body&#8217;s ability to regulate uptake of iron, causing increased intestinal iron absorption. The most common form is caused by mutations in the HFE gene, which are inherited recessively. The gene for HH is closely linked to the HLA-A3 locus on the short arm of chromosome 6 . In 1996, HFE, a gene for HH, was found to have two missense mutations . A mutation at amino acid 282 (C282Y) was found to be homozygous in 83 percent of patients with HH. This is a point mutation from guanine to adenine, resulting in a missense mutation from cysteine to tyrosine. Such mutations are commonly found in people with European ancestry, and is more rare in Asian and African populations. Among individuals of northern European descent, hereditary hemochromatosis is the most common inherited identified genetic disorder. However, penetrance differs between different populations.==HFE Gene==The HFE gene encodes the human hemochromatosis protein, which is located on the short arm of chromosome 6 at 6p21.3. The protein regulates iron absorption by regulating the interaction of the transferrin receptor with transferrin. The HFE protein interacts with TFRC, the transferrin receptor protein 1, so its primary mode of action is through regulation of the iron storage hormone hepcidin.====Mutations in the HFE Gene====The three most common HH-causing mutations in the HFE gene (chromosome 6p21.3) are C282Y (A at rs1800562 instead of G), H63D (G at rs1799945 instead of C), and S65C (T at i3002468 instead of A). At least 17 other mutations in the HFE gene have been linked to HH. 60-90% of people with HH have two copies of the C282Y mutation. The H63D mutation is also quite common&#8212;about 20% of people carry a copy of the mutation, and about 3% have two copies. This mutation is not as severe as the C282Y mutation, and only causes symptoms when someone has both the H63D and the C282Y mutations. Even then, only a small fraction of people with one copy of each mutation actually exhibit evidence of iron overload. Additionally, those who have two copies of H63D do not exhibit any symptoms and are not at risk for iron overload. The S65C mutation is less common, and will also only cause symptoms if in combination with C282Y. For both H63D/C282Y and S65C/C282Y single mutation individuals, symptoms are usually mild if they develop at all.==Influence on Iron Levels==HH has four main pathophysiological mechanisms : the increased absorption of dietary iron in the upper intestine, 2) decreased expression of hepcidin, 3) altered function of the HFE protein, and 4) tissue injury and fibrogenesis induced by iron. Since the HFE gene encodes for proteins that affect pathways centered around liver hepcidin synthesis, this mechanism will be further explained in more detail. The HFE gene regulates the liver protein hepcidin, which is considered to be the principal iron-regulatory hormone. Levels of hepcidin increase when iron levels increase in the blood, preventing intestinal cells and macrophages from releasing iron into the bloodstream. When iron builds up in the cells, signals are produced to reduce the iron absorption from food. Hepcidin levels decrease when the body needs more iron. Mutations in the HFE gene such as C282Y and H63D decrease hepcidin levels, causing intestinal cells to think more iron is needed. Thus, more iron is absorbed. Concentrations of hepcidin in the urine negatively correlate with the severity of HH.==Symptoms of Hereditary Hemochromatosis==The symptoms of HH depend on the person&#8217;s mutation as well as their sex and diet. The older a person, the more likely iron has accumulated in the body over time. Typically, complications may develop later in life between the ages of 40 and 60 in men and in post-menopausal women. If symptoms do develop, these are typically seen in the liver, skin, pancreas, heart, joints, and testes. At first, one may feel symptoms such as joint pain and stiffness, fatigue, abdominal pain, and weight loss. Later symptoms may lead to more serious conditions such as cirrhosis of the liver, cancer, liver failure, diabetes, congestive heart failure, and arthritis.====Symptomatic Findings in Patients with HH==== Liver- hepatomegaly, splenomegaly, liver failure Joints- arthritis, swelling, chondrocalcinosis Heart- dilated cardiomyopathy, CHF Skin- increased pigmentation Endocrine- testicular atrophy, hypogonadism Hypothyroidism</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q186]]
    <blockquote>
        <p class="text-snippet" data-id="186">A SNP in rs1229984 encodes a form of the alcohol dehydrogenase ADH1B gene that significantly reduces the clearance rate of alcohol from the liver. This SNP is also known as Arg48His, with the (G) allele corresponding to the Arg and the (A) to the His.Known in the literature as ADH2 2 or sometimes ADH1B 2, the allele with increased activity (meaning more rapid oxidation of ethanol to acetaldehyde) is His48, encoded by rs1229984(A). Individuals with one or especially two ADH2 2 alleles, ie genotypes rs1229984(A;G) or rs1229984(A;A) are more likely to find drinking unpleasant and have a somewhat reduced risk for alcoholism.  A study of over 3,800 cases of "upper aerodigestive" cancers (mouth/throat, voice box, and esophageal cancers) concluded that the rs1229984(A) allele (in dbSNP orientation) has a protective effect. Carriers of this allele had a 0.56x (decreased; p=10<sup>-10</sup>) risk of having one of these cancer types. A review of the (at times conflicting) findings regarding ADH1B genotypes and maternal and fetal alcohol syndromes is available. study of 4,500+ Australian twins concluded that rs1229984(G) carriers flush less after alcohol consumption, consumed alcohol on more occasions, had a higher maximum number of alcoholic drinks in a single day and had a higher overall alcohol consumption in the previous year than those with the less common (A) allele. The rs1229984(A;G) genotype might be associated with a decreased risk for migraine, and the rs1229984(A) allele may be related with the risk for triggering migraine attacks after alcohol consumption based on a study of 197 Spanish patients.Note: this is not the SNP associated with the "Asian Blush" (rs671), although there are several studies looking at individuals with varying combinations of SNPs rs671 and rs1229984.According to / a 23andMe discussion This is one of the SNPs which were re-analyzed April 2009. Customers with older data may wish to redownload. SNPs effected rs4420638, rs34276300, rs3091244, rs34601266, rs2033003, rs7900194, rs9332239, rs28371685, rs1229984, and rs28399504. A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. A haplotype map of the human genome. Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence. Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. Evidence of positive selection on a class I ADH locus. Association of ADH and ALDH genes with alcohol dependence in the Irish Affected Sib Pair Study of alcohol dependence (IASPSAD) sample. Ethnic related selection for an ADH Class I variant within East Asia. Genetic susceptibility to heroin addiction: a candidate gene association study. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. Gene-environmental interaction regarding alcohol-metabolizing enzymes in the Japanese general population. ADH1A variation predisposes to personality traits and substance dependence. Population differentiation as an indicator of recent positive selection in humans: an empirical evaluation. The ADH1B Arg47His polymorphism in east Asian populations and expansion of rice domestication in history. ADH1B 2 allele is protective against alcoholism but not chronic liver disease in the Hungarian population. The association of alcohol and alcohol metabolizing gene variants with diabetes and coronary heart disease risk factors in a white population. Alcohol-metabolizing enzyme gene polymorphisms in the Basque Country, Morocco, and Ecuador. Shortened telomeres in individuals with abuse in alcohol consumption. Alcohol-dehydrogenase (ADH1B) Arg48His polymorphism in Basque Country patients with oral and laryngeal cancer: preliminary study. Strong association of the alcohol dehydrogenase 1B gene (ADH1B) with alcohol dependence and alcohol-induced medical diseases. ADH1B and ALDH2 polymorphisms and their associations with increased risk of squamous cell carcinoma of the head and neck in the Korean population. Alcohol dehydrogenase-1B Arg47His polymorphism and upper aerodigestive tract cancer risk: a meta-analysis including 24,252 subjects. Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study. Alcohol drinking, mean corpuscular volume of erythrocytes, and alcohol metabolic genotypes in drunk drivers. Population-specific genetic associations with oesophageal squamous cell carcinoma in South Africa. ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry. ADH1B polymorphism, alcohol consumption, and binge drinking in Slavic Caucasians: results from the Czech HAPIEE study. Determination of the effects of alcohol dehydrogenase (ADH) 1B and ADH1C polymorphisms on alcohol dependence in Turkey.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1614]]
    <blockquote>
        <p class="text-snippet" data-id="1614">rs225014, also known as Thr92Ala, represents a variant in the deiodinase, iodothyronine, type II DIO2 gene on chromosome 14. In dbSNP orientation for this SNP, the more common (T) allele encodes the Thr (threonine) and the somewhat less common (C) allele encodes the Ala (alanine) at this position in the DIO2 protein.Polymorphisms in this SNP have associations with various conditions in the literature: osteoarthritis, psychological disorders, reduced thyroid hormone metabolism, Type 2 diabetes, and various other conditions.==Osteoarthritis== A 2012 article titled "Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissues" identified that the minor 'C' allele was associated with a significant, 1.3-fold higher risk of osteoarthritis (OA) relative to the 'T' allele. A 2008 article titled "Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis" explained that "Confirmation and replication by association in the additional osteoarthritis studies indicated a common DIO2 haplotype, exclusively containing the minor allele of rs225014 and common allele of rs12885300, with a combined recessive odds ratio of 1.79, 95% confidence interval (CI) 1.37-2.34 with P = 2.02 x 10(-5) in female cases with advanced/symptomatic hip osteoarthritis." (Abstract)==Psychological disorders==. Published 2015. Abstract stated "The specific variant of the DIO2 gene, namely the CC genotype of the Thr92Ala polymorphism, was more frequently found in healthy subjects than in patients with depression, what suggests that it could potentially serve as a marker of a lower risk for recurrent depressive disorder. The distribution of four haplotypes was also significantly different between the two study groups with the TC (Thr-Gly) haplotype more frequently detected in patients with depression." (Abstract). Published 2009. This study analyzed "(ORFa)-Gly3Asp (rs12885300) and Thr92Ala (rs225014) with potential functions on the activity of DIO2." Findings in abstract: "Both SNPs were significantly higher in the BPAD (Bipolar disorder) patients, with odds ratios of 1.489 ... and 1.616 ... respectively. Individuals with two copies of the variant 3Gly or 92Ala were at greater risk of BPAD.... Haplotypes ORFa-3Asp-92Ala and ORFa-3Gly-92Ala indicated higher susceptibility for BPAD with odds ratios of 3.759 (95% CI=2.013-7.020) and 1.292 (95% CI=1.017-1.642), respectively, while ORFa-3Asp-92Thr probably played a protective role with an odds ratio of 0.395 (95% CI=0.284-0.549)." (Abstract)==Thyroid hormone metabolism and treatment for hypothyroidism==. According to a 2009 study of 500 patients, hypothyroid patients on LT4 (Levothyroxine) therapy who don't show much improvement may have lower brain thyroid levels (not reflected in their serum levels) correlated to the number of rs225014(C) alleles they carry, and these patients may benefit from combined levothyroxine and liothyronine therapy.  "The Thr92AlaD2 Polymorphism May Play a Novel Role in Hypothyroidism" by Elizabeth A McAninch, Antonio C Bianco, US Endocrinology, 2015;11(2):924 DOI: . This article stated "A prevalent polymorphism in D2, Thr92AlaD2, has been associated with improved well-being on combination therapy with T4+T3; the underlying mechanism is unclear as T4-to-T3 conversion appears normal. Novel studies indicate this might be a risk factor for neurodegenerative disease. If the relationship between Thr92AlaD2-expression and treatment preference is confirmed, personalized medicine may play a role in hypothyroidism." (Abstract)However, as of 2016, controversy continued about the value of testing for and treating polymorphisms of this SNP.  See the liothyronine page for further references.==Type 2 Diabetes==. Published 2010. Published 2011.  Abstract stated "Patients carrying D2 Ala/Ala genotype had a higher fasting plasma insulin and HOMA(IR) index as compared to patients carrying Thr/Ala or Thr/Thr genotypes (P = 0.022 and P = 0.001, respectively). A significant synergistic effect was observed between D2 Thr92Ala and PPAR2 Pro12Ala polymorphisms on HOMA(IR) index, with carriers of both D2 Ala/Ala genotype and PPAR2 Ala12 allele showing the highest HOMA(IR) values, after adjusting for age, gender, BMI, and use of medication for DM2 (P = 0.010)." ==Various conditions==. Published 2011. Abstract stated: "The G (Ala) allele of the Thr92Ala coding single-nucleotide polymorphism (rs225014) was protective in severe sepsis and severe sepsis-associated ALI after adjustments for age, sex, and genetic ancestry in a logistic regression model in European Americans." . Published 2009. Abstract stated "studies of type 2 iodothyronine deiodinase (D2) variants have shown that thyroid hormones contribute to osteoarthritis and these variants influence Intelligence quotient alterations associated with iodine deficiency.". Published 2004</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q517]]
    <blockquote>
        <p class="text-snippet" data-id="517">rs2241880, a SNP in the ATG16L1 gene encoding a threonine to alanine substitution ("T300A") in a protein known to be involved in the function of the epithelial cells lining the intestine, has been associated with Crohn's disease in several recent studies. PMID 17200669, PMID 17435756In another recent (2007) report, rs2241880 is confirmed to be associated with both Crohn's disease and ileal disease, but additionally, the authors calculate risk for individuals who are homozygotes for this SNP plus 2 others (in the IBD5 and NOD2 genes). Individuals homozygous for the risk alleles for all 3 of these SNPs are estimated to be at 20 fold higher risk (CI ~9-49) for Crohn's disease.  From the largest most recent survey, the Crohn's disease-associated SNPs for IBD5 and NOD2 are, respectively, rs6596075 and rs17221417.  associated With Inflammatory Bowel Diseases but Not With Celiac Diseasers11209026 had a protective effect for IBD in the case-control analysis (odds ratio OR 0.19, 95% confidence interval CI 0.10-0.37, P= 6.6E-09). Both CD (OR 0.14, CI 0.06-0.37, P= 3.9E-07) and UC (OR 0.33, CI 0.15-0.73, P= 1.4E-03) were associated with IL23R. rs2241880 was associated with CD susceptibility (OR 1.36, CI 1.12-1.66, P= 0.0017). The population-attributable risk of carrying allele G is 0.24 and is 0.19 for homozygosity for allele G in CD.In another study, rs2241880 has been associated with Crohn's disease; the minor allele is somewhat protective in that it lessens the odds of acquiring the disease (odds ratio 0.74, CI: 0.65-0.84, p=3.7x10e-6). Review of role of rs2241880 in Crohn's disease and possibly ulcerative colitis Replicated increased risk for Crohn's disease with rs2241880(C) allele in a study of Italian patients, but saw no association to ulcerative colitis (UC). strongly associated with ileal Crohn's disease (allelic P = 1.24 x 10(-6)). Children with GG genotype had a more than 3-fold elevated risk for disease as compared to the wildtype AA homozygotes (odds ratio OR, 3.1; 95% confidence interval CI, 1.93-4.94; P = 1.8 x 10(-6)) Meta-analysis of 24 studies performed, including 13,022 Crohn's disease cases and 17,532 controls. Confirmed increased risk for disease for carriers of (C) allele (1.9x or 1.4x, for homozygous and heterozgous genotypes), but only in Caucasians and not in Asians. Study of 557 CD and 425 UC patients and 672 ethnically matched Spanish controls and a meta-analysis confirmed an association between rs2241880(C) and CD (p=6.5 x 10(-9), odds ratio =1.62). A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene. Systematic association mapping identifies NELL1 as a novel IBD disease gene. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Fine mapping versus replication in whole-genome association studies. Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northern Europe. CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population. Correlation of the autophagosome gene ATG16L1 polymorphism and inflammatory bowel disease. ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients. Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. Searching for genotype-phenotype structure: using hierarchical log-linear models in Crohn disease. Autophagy 16-like 1 rs2241880 G allele is associated with Crohn's disease in German children. Lack of association of NKX2-3, IRGM, and ATG16L1 inflammatory bowel disease susceptibility variants with celiac disease. Genome-wide association studies--a summary for the clinical gastroenterologist. Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease. The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. T300A polymorphism of ATG16L1 and susceptibility to inflammatory bowel diseases: a meta-analysis. Is there a role for Crohn's disease-associated autophagy genes ATG16L1 and IRGM in formation of granulomas? Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn's disease and early disease onset. ATG16L1 polymorphisms are associated with NOD2-induced hyperinflammation.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q5001]]
    <blockquote>
        <p class="text-snippet" data-id="5001">This snp has been merged into Rs1800470rs1982073, also known as codon 10, +10T/C or T869C, a SNP in the first exon of the transforming growth factor beta1 TGFB1 gene, has been implicated in a wide variety of disorders, presumably connected through the role TGFB1 plays in suppressing the immune system.The L10P allele of rs1982073 is associated with a slightly increased risk of breast cancer.  The rs1982073(T) allele, generally associated with lower levels of TGFB1 protein production, has been associated with increased risk for the following: Allograft rejection   The rs1982073(T) allele is associated with increased risk for subclinical allograft rejection with an odds ratio of 6.7 (p = 0.02).  Chronic obstructive pulmonary disease (COPD)   Although smoking is the main risk factor, smokers with a rs1982073(T) allele (or two other TGFB1 SNPs, rs2241712 and rs1800469) were more likely to develop COPD, based on a study of ~700 Caucasian subjects.  Cytopenia in patients with myelodysplastic syndrome (MDS)  rs1982073(T;T) homozygosity was associated with a severe degree of cytopenia (odds ratio 4.9, p = 0.0071) in patients with myelodysplastic syndrome (MDS), even though the genotype apparently does not predispose individuals to the disease.  Diabetes  A study of 400 Caucasians with type 1 diabetes found an increased risk for diabetic nephropathy for carriers of rs1982073(T) alleles.  Pre-eclampsia and stillbirth  Although not associated with the overall risk, among women who developed eclampsia/pre-eclampsia with severe renal and neurological complications or had neonatal deaths/still births, the rs1982073(T) allele was more likely in a relatively small study (< 100 patients).  Sarcoidosis and chronic beryllium disease  Although not associated with overall risk for developing the diseases, the rs1982073(T) allele was associated with the severity of granulomatous diseases such as chronic beryllium disease (CBD) and sarcoidosis, and a haplotype containing rs1982073(C) was protective against severe disease. On the other hand (strand?), the less common rs1982073(C) allele, generally associated with lower levels of TGFB1 protein production, has been associated with increased risk as follows: The rs1982073(C) allele was significantly more frequent in patients with two Epstein Barr virus (EBV)-related diseases, specifically, primary acute infectious mononucleosis (IM) and hemophagocytic lymphohistiocytosis (EBV-HLH), than in controls (p<0.001).  Alzheimer's disease  Both the rs1982073(C) allele and the (C;C) genotype were overrepresented in a study of ~200 patients compared to controls, independently of ApoE4 status. The (C;C) genotype was also overrepresented in patients progressing from MCI (mild cognitive impairment) to Alzheimer's, suggesting that TGFB1 may be an early marker of inflammatory mechanisms underlying Alzheimer's.  Brucellosis  A study of ~400 Iranian patients with brucellosis found that the rs1982073(C) allele was associated with increased risk.  Diabetes  A study of 400 Caucasians with type-2 diabetes determined that rs1982073(C) was associated with diabetic nephropathy, and even more strongly with diabetic retinopathy; the odds ratio patients with retinopathy but not nephropathy versus uncomplicated diabetes was 3.17 (CI: 2.17-4.63), and the different results between type-2 diabetes and type-1 diabetes were potentially ascribed to population differences.  Myopia  A study of 200 highly nearsighted Chinese Taiwanese found that people with the rs1982073(C;C) genotype were more likely to have high myopia compared to the (C;T) or (T;T) genotypes. The odds ratio was 1.83 (CI: 1.27-2.63, p<0.001).  Prostate cancer and benign prostatic hyperplasia (BPH)  The rs1982073(C) allele was associated with a higher risk of developing prostate cancer as well as benign  prostatic hyperplasia (BPH) in a study of 175 Brazilian patients, with odds ratio compared to the population of 2.6x and 3.6x, respectively.  Ulcer  The rs1982073(C) allele was associated with risk for gastric ulcer with an odds ratio of 1.76 (CI: 1.12-2.77) in a study of 377 Russian patients.  Patients homozygous for rs1982073(C) were at greatest risk (odds ratio 7.7, p=0.03) for graft versus host disease (GVD) after heart transplantation.  Ovarian cancer    showed '''no association''' with ovarian cancer risk 4,624 invasive epithelial ovarian cancer cases and 8,113 controls of white non-Hispanic origin ovarian cancer Genetic polymorphisms in the transforming growth factor-beta signaling pathways and breast cancer risk and survival. an association of (C) with hypertension in rheumatoid arthritis patients rs1982073 chemoradiotherapy (C;C) and (C;T) were associated with a better disease-free and overall survival when compared with the low-producer TT genotype (hazard ratios for interaction 3.42, 95% CI 1.12-10.5 and 3.09, 95% CI 0.96-10.0, respectively)</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2698]]
    <blockquote>
        <p class="text-snippet" data-id="2698">rs1800871(C) carriers are associated with a reduced endometriosis risk by approximately 2x compared with the common rs1800871(T;T) genotype in a study of 196 Chinese patients. rs2222202 (C/T) (p=0.03) and rs1800871 (C/T) (p=0.05) showed significant allelic associations with pediatric onset Crohn's disease. rs1800871(T) carriers were 3x more likely to have their pregnancies terminate early (<10 weeks) than (C) carriers, based on a study of ~500 pregnancies.In a study of 1,757 cases of Alzheimer's disease and 6,295 controls, an interaction was replicated between IL6 genotype rs2069837(A;A) and IL10 genotype rs1800871(C;C). The synergy factor (SF) was 1.63 (CI: 1.10-2.41, p = 0.01), controlling for age, gender and ApoE4 genotype. 23andMe reports that each G allele at rs1800871 is associated with 0.6x lower odds of Beh&#231;et's disease.  Gene-environment interaction effects on the development of immune responses in the 1st year of life. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation. Cytokine gene polymorphisms and atopic disease in two European cohorts. (ECRHS-Basel and SAPALDIA). Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Association of IL10 promoter polymorphism in Italian Alzheimer's disease. Genetic polymorphisms and the risk of infection following esophagectomy. positive association with TNF-alpha gene -308 genotype. Optimization of candidate-gene SNP-genotyping by flexible oligonucleotide microarrays; analyzing variations in immune regulator genes of hay-fever samples. Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia. Genetic variation in interleukin-10 gene and risk of oral cancer. Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection. Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Vaccine immunogenetics: bedside to bench to population. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population. Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity. Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Cytokine SNPs: Comparison of allele frequencies by race and implications for future studies. Association of IL-10 and IL-10Rbeta gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donor. IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB. Toll-like receptor signaling pathway variants and prostate cancer mortality. Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patients. IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. Genetic factors associated with intestinal metaplasia in a high risk Singapore-Chinese population: a cohort study. Asthma and genes encoding components of the vitamin D pathway. Selection for genetic variation inducing pro-inflammatory responses under adverse environmental conditions in a Ghanaian population. Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations. Influence of cytokine gene polymorphisms on prostate-specific antigen recurrence in prostate cancer after radical prostatectomy. Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers. Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study. Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study. Lack of association between the IL-10 gene polymorphisms and features of the metabolic syndrome. The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population. Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. Joint effects of Epstein-Barr virus and polymorphisms in interleukin-10 and interferon-gamma on breast cancer risk. Interleukin-10 promoter microsatellite polymorphisms influence the immune response to heparin and the risk of heparin-induced thrombocytopenia. Association of the interleukin-10 1082G/A, 819C/T and 3575T/A gene polymorphisms with systemic sclerosis: a meta-analysis. The IL-10 promoter haplotype and cancer risk: evidence from a meta-analysis.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q3165]]
    <blockquote>
        <p class="text-snippet" data-id="3165">rs2279744, a variant in the promoter of the MDM2 gene and also known as "-410T-G", "SNP309", and "SNP309T>G", has been studied for several years to determine it's role in cancer origin and treatment. The interest primarily stems from the ability of the MDM2 protein to bind to and thereby enhance the degradation of the tumor suppressor protein known as p53. Studies on rs2279744 include:  rs2279744(G) carriers in individuals with cancer tend to develop such cancers on average 12 years earlier than those lacking this allele, and the frequency of rs2279744(G) was greatly increased in those who developed soft tissue sarcomas at a young age.   Individuals with one or more rs2279744(G) alleles who are also carriers of the TP53 rs1042522(C) (arg at aa72) SNP tend to develop cancers earlier than rs2279744(T;T) homozygotes who carry the same p53 SNP.   rs2279744(T;T) individuals who have a mutant p53 (in their tumors) are at an increased risk of death (risk ratio RR of death = 2.33, 95% CI = 1.08 to 5.03). Tumor p53 status was not associated with breast cancer survival among rs2279744(G;T) or rs2279744(G;G) genotypes.   rs2279744 showed no association with nonsmall cell lung cancer risk in a study of 1,787 Caucasian patients. However, a possible association between nonsmoking (G;G) homozygotes and a higher risk of nonsmall cell lung cancer was reported.  A study in Chinese leukemia patients found that the rs2279744(G) allele was unexpectedly associated with reduced risk.  Another study concludes that this SNP on its own has little or no effect on the risk of common cancers, but it might modify the time of tumor onset and prognosis.   rs2279744(G;G) females are at a 2.76x increased risk (CI: 1.06-7.20, p=0.03) for endometrial cancer compared to (G;T) or (T;T) genotypes based on a study of 73 patients and matched controls.  A study of 148 individuals with advanced nonsmall cell lung cancer (NSCLC) undergoing first-line chemotherapy, such as the irinotecan plus cisplatin regimen, concluded after multivariate analysis that the rs2279744(T;T) genotype was independently predictive for longer survival (HR = 1.742, p = .032).   The rs2279744(G;G) genotype was associated with high grade breast cancer tumors (with an odds ratio of 1.64, CI:1.06-2.53, p=0.025) and greater nodal involvement (OR=2.51, CI:1.26-4.98, p=0.009), but was not associated with an earlier age of cancer diagnosis or even risk of breast cancer, in a study of ~300 Scottish Caucasian patients.  Around 300 cases each of melanoma, basal cell carcinoma, and squamous cell carcinoma were studied relative to this SNP. No significant associations were found between rs2279744 and any of these three types of skin cancer. However, compared with the (T;T) genotype, the adjusted odds ratios of having moles on the arms for (G;T) and (G;G) genotypes was 0.92 (CI: 0.78-1.08) and 0.68 (CI: 0.53-0.87), respectively (p, trend, 0.005).  rs2279744(G;G) women are diagnosed with melanoma 13 years earlier than women who carry one or no G alleles. Note that this SNP does not cause higher risk of melanoma; it affects only the age at diagnosis of melanoma in women and has no effect in men, as reported in the 23andMe blog / 23andMe blog.  Odds ratio for (G;G) 3x, for (G;T) 2x, for breast cancer in a study of 124 Taiwanese patients, along with a correlation towards earlier occurence.  rs117039649, also known as SNP285C, a second MDM2 SNP found on the SNP305G allele (and only in Caucasians), reduces the risk of both ovarian and breast cancer among SNP309G holders (odds ratio 0.74 and 0.79, respectively), compared to SNP309G holders lacking this (second) SNP./ 23andMe blog rs2279744(G) has been associated with earlier onset for some cancers, including soft tissue sarcoma, diffuse large B-cell lymphoma, colorectal cancer, ovarian cancer and non-small cell lung cancer in women, and decreased survival in people with stomach and kidney cancer.  But there is evidence for improved survival in women with ovarian cancer who have the G version of this SNP.  Paradoxically, higher levels of the MDM2 protein (as would be expected with the G version of SNP rs2279744 shown to lead to earlier melanoma onset in the current study) have been associated with improved survival for melanoma.  rs2279744 is not associated with SLE in a study of Caucasians, African-Americans, and Asian children and adults.  rs2279744, rs1042522, rs17878362 and rs1625895 associated with high grade endometrial cancer</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1297]]
    <blockquote>
        <p class="text-snippet" data-id="1297">This is a triallelic SNP - note that the sidebar (currently) only shows 3 of the 6 possible genotypes.====CRP==== claims that this SNP does not affect the serum concentration of CRP, while older resources seem to disagree. However, they do report an association between CRP levels and risk of abdominal aortic aneurysm (AAA). rs3091244 serum CRP level and cardiovascular risk in the NHLBI Family Heart Study.  the AA genotype of the triallelic SNP rs3091244 in the gene CRP|C-reactive protein was associated with prevalent coronary heart disease in the non-Hispanic white population Association study of CRP gene polymorphisms with serum CRP level and cardiovascular risk in the NHLBI Family Heart Study. rs3093059 rs3091244 Weaker linkage disequilibrium in this region in African Americans allows the conclusion that basal CRP levels are influenced in an additive manner by the T allele.====Non CRP==== increased risk for the presence of severe hand osteoarthritis with an OR of 2.3 (95% confidence interval (C.I.) 1.2-4.3, P = 0.009) rs3093061 associated with SLE and functional haplotypes containing rs3091244/rs3093062  According to / a 23andMe discussion This is one of the SNPs which were re-analyzed April 2009. Customers with older data may wish to redownload. SNPs effected rs4420638, rs34276300, rs3091244, rs34601266, rs2033003, rs7900194, rs9332239, rs28371685, rs1229984, and rs28399504. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Allelic spectrum of the natural variation in CRP. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration. Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP Level and arterial pulse wave velocity in healthy elderly Japanese. Genotyping of triallelic SNPs using TaqMan PCR. C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. Genome-wide association with select biomarker traits in the Framingham Heart Study. Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies. Genetic determinants of basal C-reactive protein expression in Filipino systemic lupus erythematosus families. Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study. Bayesian meta-analysis of genetic association studies with different sets of markers. Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration. The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants. Genetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrations. Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants. Genetics of C-reactive protein and complement factor H have an epistatic effect on carotid artery compliance: the Cardiovascular Risk in Young Finns Study. Relation of genetic variation in the gene coding for C-reactive protein with its plasma protein concentrations: findings from the Women's Health Initiative Observational Cohort. C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population. IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study. Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults. C-Reactive protein gene variants are associated with postoperative C-reactive protein levels after coronary artery bypass surgery. C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk. Marked differences in CRP genotype frequencies between the Fulani and sympatric ethnic groups in Africa. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. Association of a single nucleotide polymorphism in the C-reactive protein gene (-286) with susceptibility to Plasmodium falciparum malaria. Novel loci, including those related to Crohn disease, psoriasis, and inflammation, identified in a genome-wide association study of fibrinogen in 17 686 women: the Women's Genome Health Study. Association between functional variants of the ICAM1 and CRP genes and metabolic syndrome in Taiwanese subjects. Usefulness of Mendelian randomization in observational epidemiology. C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. C-reactive protein polymorphisms are associated with the cortisol awakening response in basal conditions in human subjects. Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway. Genome-wide association with C-reactive protein levels in CLHNS: evidence for the CRP and HNF1A loci and their interaction with exposure to a pathogenic environment. Lack of association between the genetic variations in the C-reactive protein gene and the risk of psoriasis among the Taiwanese. C-reactive protein haplotypes and dispositional optimism in obese and nonobese elderly subjects.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q406]]
    <blockquote>
        <p class="text-snippet" data-id="406">The ancestral allele is C. The rs7412(T) allele, also known as Arg176Cys, generally indicates the presence of an Apo&#949;2 allele; see the ApoE page for a full discussion of the ApoE alleles and their association with Alzheimer's disease.Another SNP related to ApoE is rs429358. Current limitations of SNP data from the public domain for studies of complex disorders: a test for ten candidate genes for obesity and osteoporosis. Patterns of linkage disequilibrium and haplotype distribution in disease candidate genes. Variation at APOE and STH loci and Alzheimer's disease. Variation in GYS1 interacts with exercise and gender to predict cardiovascular mortality. Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol. Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association. Association of ApoE genetic variants with obstructive sleep apnea in children. Subarachnoid hemorrhage: tests of association with apolipoprotein E and elastin genes. A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study. Lack of replication of genetic associations with human longevity. Genetic determinants of basal C-reactive protein expression in Filipino systemic lupus erythematosus families. Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat. Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: the Atherosclerosis Risk in Communities (ARIC) Study. APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels. New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. A genome-wide association study for late-onset Alzheimer's disease using DNA pooling. Gender differences in genetic risk profiles for cardiovascular disease. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. Application of two machine learning algorithms to genetic association studies in the presence of covariates. A polymorphism of apolipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers. Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach. Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response. Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample. Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Association between apolipoprotein E genotype, serum lipids, and colorectal cancer in Brazilian individuals. Apolipoprotein-E gene variants associated with cardiovascular risk factors in antipsychotic recipients. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. A simple and efficient algorithm for genome-wide homozygosity analysis in disease. Introduction to the DISRUPT postprandial database: subjects, studies and methodologies. Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease. Genetic variants associated with myocardial infarction risk factors in over 8000 individuals from five ethnic groups: The INTERHEART Genetics Study. Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women. Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project. A susceptible haplotype within APOE gene influences BMD and intensifies the osteoporosis risk in postmenopausal women of Northwest India. A pilot study of gene/gene and gene/environment interactions in Alzheimer disease. Exploring genetic determinants of plasma total cholesterol levels and their predictive value in a longitudinal study. IQ, educational attainment, memory and plasma lipids: associations with apolipoprotein E genotype in 5995 children. Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study. Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. Genome-wide association with C-reactive protein levels in CLHNS: evidence for the CRP and HNF1A loci and their interaction with exposure to a pathogenic environment. Association study between apolipoprotein E gene polymorphism and diabetic nephropathy in a Taiwanese population. APOE haplotypes are associated with human longevity in a Central Italy population: evidence for epistasis with HP 1/2 polymorphism.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1451]]
    <blockquote>
        <p class="text-snippet" data-id="1451">rs1799853 is a SNP in the CYP2C9 gene and is linked to poor warfarin metabolism and risk of GI bleeding with some NSAID drugs. The common nomenclature for this polymorphism is CYP2C9 2 (Cys amino acid, T allele; the SNP is also known as C430T or Cys144Arg). Advanced knowledge of this may influence initial warfarin dosing by physicians. Warfarin is monitored through INR (international normalized ratio) and proper dosing is influenced by a variety of factors including warfarin metabolism and diet.  The rs1799853(T) allele encodes a variant amino acid, cysteine, which has been linked to poor metabolism of warfarin and thus sensitivity. The CYP2C9 2 allele is also associated with higher sensitivity to the anti-epileptic drug phenytoin. Note however that the / CPIC (and  FDA) mention concurrent testing for the HLA-B 15:02 allele, since carriers are at significantly increased risk of Stevens-Johnson syndrome (SJS/PTEN). The effect of CYP2C9 variants on drug metabolism should not be predicted without also considering CYP2C9 3, defined as the common loss of function variant rs1057910(C)  (NM_000771:c.430C>T, NP_000762:p.144R>C) /. In a 2009 article titled "Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?" Authors reviewed prior research that argued: Individuals carrying minor alleles of this both CYP2C9 2 rs1799853 AND CYP2C8 3 (a minor allele of both rs10509681 and rs11572080) have increased risk of developing acute gastrointestinal bleeding during the use of NSAIDs that are CYP2C8 or CYP2C9 substrates, such as aceclofenac, celecoxib, diclofenac, ibuprofen, indomethazine, lornoxicam, meloxicam, naproxen, piroxicam, tenoxicam and valdecoxib.  In addition, carriers of the risk allele for CYP2C9 2 rs1799853 have decreased metabolism of Ibuprofen, Flurbiprofen, Piroxicam, and Tenoxicam.   The presence of CYP2C9 2 rs1799853 allele alone does not confer risk with Diclofenac, but when it is combined with CYP2C8 3 (rs10509681 and rs11572080), Diclofenac induces hepatoxicity and confers risk of GI bleeding.    In a 2008 article (reviewed in ) titled "Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding," the study discovered that carriers of CYP2C8 3 (a minor allele of both rs10509681 and rs11572080) had a GI bleeding event risk OR=1.81 (95% CI=0.953.46; P=0.071) and risk increased if carriers drank more than 20g alcohol/day to an OR=1.99 (95% CI=1.063.74; P=0.034). As CYP2C8 3 and CYP2C9 2 rs1799853 variant alleles are in linkage disequilibrium, patients are likely to carry the risk allele to both 8 3 and 9 2, and when they do, The OR (95% CI) for carriers of such a genotype is increased to 1.94 (1.133.33), P=0.017.   A 2013 NIH review titled "PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8" reiterated that "some data suggest that the combined presence of minor risk alleles CYP2C8 3 (rs10509681 and rs11572080) and CYP2C9 2 rs1799853 is a determinant of NSAID-induced gastrointestinal bleeding." They cited .  Association of warfarin dose with genes involved in its action and metabolism. Genetic-based dosing in orthopedic patients beginning warfarin therapy. Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans. Genotyping panel for assessing response to cancer chemotherapy. The largest prospective warfarin-treated cohort supports genetic forecasting. Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans. Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients. Genetic factors contribute to patient-specific warfarin dose for Han Chinese. Warfarin pharmacogenetics. Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma. Thrombotic genetic risk factors and warfarin pharmacogenetic variants in Sao Miguel's healthy population (Azores). Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies. Warfarin sensitivity genotyping: a review of the literature and summary of patient experience. Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women. Pharmacogenetics of acenocoumarol in patients with extreme dose requirements. Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants. Warfarin genotyping using three different platforms. Are cytochrome P450 CYP2C8 and CYP2C9 polymorphisms associated with ibuprofen response in very preterm infants? VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children. Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients. PharmGKB summary: phenytoin pathway.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q2699]]
    <blockquote>
        <p class="text-snippet" data-id="2699">The IL10 C627A polymorphism in the anti-in&#64258;ammatory Interleukin 10 gene decreases gene transcription.  Effect of Interleukin-10 Gene Polymorphisms on Clinical Outcome of Patients with Aggressive Non-Hodgkin's Lymphoma. An exploratory study with negative results. rs1800872(A) carriers were 3x more likely to have their pregnancies terminate early (<10 weeks) than (C) carriers, based on a study of ~500 pregnancies. Gene-environment interaction effects on the development of immune responses in the 1st year of life. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway. The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. Lemierre's syndrome and genetic polymorphisms: a case report. Novel IL10 gene family associations with systemic juvenile idiopathic arthritis. The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain. Genetic polymorphisms and the risk of infection following esophagectomy. positive association with TNF-alpha gene -308 genotype. Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status. Optimization of candidate-gene SNP-genotyping by flexible oligonucleotide microarrays; analyzing variations in immune regulator genes of hay-fever samples. Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia. Genetic variation in interleukin-10 gene and risk of oral cancer. Common studied polymorphisms do not affect plasma cytokine levels upon endotoxin exposure in humans. Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study. Vaccine immunogenetics: bedside to bench to population. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population. Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma. Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Assessing the reproducibility of asthma candidate gene associations, using genome-wide data. Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health Study. Analysis of inflammation- and atherosclerosis-related gene polymorphisms in branch retinal vein occlusion. Association of IL-10 and IL-10Rbeta gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donor. IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB. Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case--control study. Toll-like receptor signaling pathway variants and prostate cancer mortality. A candidate gene association study of 77 polymorphisms in migraine. Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patients. IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. Asthma and genes encoding components of the vitamin D pathway. Selection for genetic variation inducing pro-inflammatory responses under adverse environmental conditions in a Ghanaian population. Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations. Common genetic variation and the control of HIV-1 in humans. Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis. Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study. Role of polymorphic variants as genetic modulators of infection in neonatal sepsis. Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study. Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project. CCL3 genotype and current depression increase risk of HIV-associated dementia. The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. Lack of association between two SNPs (rs1800896 and rs1800872) in IL-10 gene promoter and breast cancer in Caucasians. The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population. An association of interleukin-10 gene polymorphisms with Graves' disease in two Chinese populations. Interleukin-10 promoter microsatellite polymorphisms influence the immune response to heparin and the risk of heparin-induced thrombocytopenia. Cytokine gene polymorphisms in the susceptibility to acute coronary syndrome. The IL-10 promoter haplotype and cancer risk: evidence from a meta-analysis.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1784]]
    <blockquote>
        <p class="text-snippet" data-id="1784">rs13181, also known as c.2251A>C, p.Lys751Gln and K751Q, is a variant in the ERCC2 gene on chromosome 19.A meta-analysis of 20 studies, comprising 2,308 cases, ultimately concluded that the rs13181(G) allele is associated with increased cutaneous melanoma risk (odds ratio 1.12, CI: 1.03-1.21, p = 0.01; population attributable risk = 9.6%).A preliminary (as yet unreplicated) study of 430 patients with ovarian cancer concluded that rs13181(C;C) is associated with an increased risk of ovarian cancer (OR 5.01 relative to rs13181(A;A), CI: 3.37-7.43; p < 0.0001). Interestingly, heterozygotes were reported to have a lower odds ratio for developing ovarian cancer (of 0.43; CI: 0.270.62, p < 0.0001) compared to rs13181(A;A) individuals. Polymorphisms in XPD and TP53 and mutation in human lung cancer. Decision forest analysis of 61 single nucleotide polymorphisms in a case-control study of esophageal cancer; a novel method. ERCC1 and ERCC2 polymorphisms and adult glioma. Correlation of genetic polymorphisms in nucleotide excision repair system to sensitivity of advanced non-small cell lung cancer patients to platinum-based chemotherapy. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Genotyping panel for assessing response to cancer chemotherapy. Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzoapyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma. Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologists. Inter-individual variation in nucleotide excision repair in young adults: effects of age, adiposity, micronutrient supplementation and genotype. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Analysis of ERCC2/XPD functional polymorphisms in systemic lupus erythematosus. Association and interactions between DNA repair gene polymorphisms and adult glioma. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Gene-environment interactions between DNA repair polymorphisms and exposure to the carcinogen vinyl chloride. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. Lung cancer susceptibility model based on age, family history and genetic variants. Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking females. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma. MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer. Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India. Polymorphisms of COMT and XPD and risk of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China. DNA repair gene polymorphisms at XRCC1, XRCC3, XPD, and OGG1 loci in Maharashtrian population of central India. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis. Gallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes. Analysis of XPD genetic polymorphisms of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population. Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    
    [[Question:Text]]
    [[ID:q1293]]
    <blockquote>
        <p class="text-snippet" data-id="1293">Although somewhat lacking in statistical power, several reports have linked rs1205, a UTR mutation known as CRP4 in the C-reactive protein CRP to the autoimmune disorder SLE, systemic lupus erythematosus. The risk allele in dbSNP orientation is (T). PMID 14645206, PMID 15897982 C-reactive protein (CRP) levels obesity rs1205(G) allele had significantly higher CRP levels than noncarriers in a dose-dependent manner suggesting a possible association with fat localization/ 23andMe blog each rs1205(T) lowered CRP by 20% but no association with heart disease. Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP Level and arterial pulse wave velocity in healthy elderly Japanese. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study). Common variants in the CRP gene in relation to longevity and cause-specific mortality in older adults: the Cardiovascular Health Study. C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. Genome-wide association with select biomarker traits in the Framingham Heart Study. DNA variants, plasma levels and variability of C-reactive protein in myocardial infarction survivors: results from the AIRGENE study. Common haplotypes of the C-reactive protein gene and circulating leptin levels influence the interindividual variability in serum C-reactive protein levels. The Segovia study. Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies. Genetic determinants of basal C-reactive protein expression in Filipino systemic lupus erythematosus families. Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study. Systemic inflammation, genetic susceptibility and lung function. Bayesian meta-analysis of genetic association studies with different sets of markers. Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Fine-mapping the genetic basis of CRP regulation in African Americans: a Bayesian approach. Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream. Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration. Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study. The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants. Genetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrations. Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Genetics of C-reactive protein and complement factor H have an epistatic effect on carotid artery compliance: the Cardiovascular Risk in Young Finns Study. Relation of genetic variation in the gene coding for C-reactive protein with its plasma protein concentrations: findings from the Women's Health Initiative Observational Cohort. C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population. C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older. IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study. Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults. C-Reactive protein gene variants are associated with postoperative C-reactive protein levels after coronary artery bypass surgery. C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein. Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach. Pleiotropy of C-reactive protein gene polymorphisms with C-reactive protein levels and heart rate variability in healthy male twins. Gene polymorphisms in association with emerging cardiovascular risk markers in adult women. Usefulness of Mendelian randomization in observational epidemiology. Maternal C-reactive protein levels in pregnancy are associated with wheezing and lower respiratory tract infections in the offspring. C-reactive protein polymorphisms are associated with the cortisol awakening response in basal conditions in human subjects. Effect of central obesity, low high-density lipoprotein cholesterol and C-reactive protein polymorphisms on C-reactive protein levels during treatment with Rosuvastatin (10 mg Daily). Association between adolescent emotional problems and metabolic syndrome: the modifying effect of C-reactive protein gene (CRP) polymorphisms. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. Genome-wide association with C-reactive protein levels in CLHNS: evidence for the CRP and HNF1A loci and their interaction with exposure to a pathogenic environment. The polymorphisms of C-reactive protein gene modify the association between central obesity and lung function in taiwan asthmatics. C-reactive protein haplotypes and dispositional optimism in obese and nonobese elderly subjects.</p>
    </blockquote>
    <ul></ul>
    <script>
    Qualtrics.SurveyEngine.addOnload(function() {
        let el = document.querySelector("p.text-snippet"); 
        questionId = el.dataset.id;
        hilites = ${e://Field/hilights} || [];
        el.addEventListener("mouseup", initTextHiliting);
    });
    </script>
    [[PageBreak]]
    